var title_f26_23_26992="Chronic tinea pedis PI";
var content_f26_23_26992=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F55602&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F55602&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Athlete's foot (tinea pedis)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 342px; height: 296px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEoAVYDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDwhLFoee/rXRaPOrtg5B962BpYdCACcism90yW0fzIx7jFcbqqejPWjh3BXR1llDuwcZP0rWitlG3pjjqK5rRr9Z1RS7RuCM7cc+o59a6yH5lwDhcdRXPNWO/Du5E+xPqByPf0qmIWuJsKPk71emhYZDcj+dXLOHd9mtVJXzjlz9DWcVqdctEdL4G8NpqDiWVSLYEgAdXx6+1e3aTaW0NpEkMSxxRrkKAAB65riPDX7iCKNeFQbQo/lXZ6fc7NoI6noSMjFelSkoqyPAxrlUlqbYoqOKQP0IPoQetSVte551rBRiimSuFABJGeOB68Um7BYz9UhE+FATI6ZGRWcLOPzMFAR0yB09K23jG7LdznPSlMYJ53Y9OwrmnG5vGpyqyOVvNNDIpMahvReT9K4fWrP7I5lRSFzggf4169cWwcDjv+QrlfEWn+ZDjA5OOlcdanY78JiNbM8w1GEXcDMCAQNvPP44+tefRQiKS6iIAWIlxu9K9kh0pZLuFJI3baxjyvHVSAeOvevJ/iTayWt+6W6+ZLOyxBEH3mzwMfhUUrvQ9Cc42b7HO3N5amTbJIiLn7zd6RF0m5YxvqUa7uCStd/wCHvhZZWlkJteWSfVNizOuQUTcOF2+vfNX5NFso1W2W1t4pNpcIEG8gEDOOuASB+NXKpCLsncyp051tXoeUz+BtMvHR4NYh3yEDGeOTWXqfgL7LLJHDqMEjL3BBB/GvYrnRI5YSUhjA5B4wBis678J2zwput4wMkgg8n8O9EcXLuOeWQevU8RfQr2wukY+UwU9VftXRaewyhPJ9K67UPA+nyxscy28uM5TpnNcRd6XeaNebVJnhY/K4HPr0rf2iqrfU5fYSw+60OljPyk45HPH8quQyqAN2OfeqKuNqSKMYGcCpyuH6kqRWDO+Br2rK8uDyPpnn/JrQjwZVBC5GeT1zjnH4CsGNzlfTv9a07edYupy55OeM1LZukWLmCJ5d5VG3LuPy8DNcxrto72d2lkYUunGI2kX5VORknj0z+ldKx3M56cZPstZ1yh8wuwwT90Hr+NNOwSgmrHF3tqqEjbuKgDcwGW4wSfc1zOoxiKYPsX5Tn7oruNSiDMeMdsd65fVoSQciumlI83EU7LQ0tNEUsK5iiYHnlAa1be0tAhza2hGT1hU/j0rmfDk5MTIx+ZCRXVWuH2k9vyrOomnY3oNSimWIrSzZA4tLQqeARAmP5VcjsLAAE2Vlknr9nT/CmxKOe2fSpUHtx6d6wuzuUIvdEsFhpy8tptgVHOPssZ/pUrWNiG40vTzJkBU+yx9ccZ+Xt1P4U2M8dRnHft704SEcFRgjAGecd/z/AJCrjJkzpx7GJqVhYLGf9CsjkkqVt0yxPVunrwPxNchrNrbRFgLe3UZPCxrj8OOldjqU27dIxyvr69uP5D/61cVrs5SBkIXOSxwPbp9BXRTu2ebiFFJuxxtwqGZyEUDPYAVDtX+6PyqVjnmmGu9HhvcYVX0H5UU760VRJ9GWtt0OB+FWpNMWdcFev581ft4QVBHb26VrQwAsB69scV8852Z9sqaseX6t4dmtJTPa52g9AK0vDt+HAjmOHGBg9q9Pi09ZQFdMDqQSDXI+KfCjiZr6wVI2JLBF4zWkat9Gcs6STvE2bbTzPEOjDj7vXNPOkyRmOW3z5i8jAyapeBtcMbpBO2JV+Vg3/wBevYrS0tr613RoEZgNox1I/wAmnbUxq4h091oeb6fdT2TARucE55Oea7XR/EUnkJ5iBiMe34//AFqw9f08wX8mExGTnIGBnv8ArVWxYxt1P0PSqhUaKlThWjex6fYa0sgHyAZPatSG/jkUZ4bGcf1rzqyuiCuSQM+vWt23v9vBIUHr610xrs82tglfQ7BZAx4+n40P1yfpWRaXudp3ZUjjitGGcOcc/j3rZVeY4J0nAlKlhjJHPY9aeBxj09aavU5GOeD608Gqi0ZMCKy9Zt1eEkA5PFamaqXZyoA7+vFZYhrlNKTakmcnPEYoZmxklgOB069K4qKFf+FjaYoRJPs0bgjOP4duc9jlutenC3Vo5BwpJyG9AK8j8Po+peLp53lRQRyXYAYZiTn8AK8tOzPcwtqinfsdbqmnxpNPLamMR7wAqHIx7cnNNe2223zKgBxlhng9wc1svaC3lPlOv3MgrkjHQCqaqE2wEoWUFj2Ht/Ksne+prCd0kmZEkEeWRkRSFxgcYI5rLuokYg7fl64UfyroGt5FMhkxvJChck4PBz9KzZ4T5hTBDZ5YrgH6ZqXc66bXc528tAxJ2/QGua1PSTKpZVwQOea7yWD+HacHnHBz9ay54flwyk4HIA5PtVRm4m7ipI8xv9PuQpMYAxz9apxvkY5H9DXoU1lFHAEhjVEjGxQBxx6Vw+qWTR3G9QBuOPSuqE+Y5Z0nDUx9X1OS22QWqhrqU5CgZK+9UIdI1mWQzyswYjI+bJya9I8PaDDJ++2I07DLMRkmusOjosX7uMODxwnAFW6yhokYvDSqO82eMRXmr6fkSKXAPUHmtGHxNDPEscgEcx5Zm+8T713+oaRGwbMaj/gPSuO13w5BcFgYsNnqBz+dJVIS3VjT2NWkrxdyjcW6XCb43Dp1yDXPapbAE9cevrVO/s7/AEacmGSTygexP61fs7r+0rMs3+tHDAd/et1Fx1TujllUVS8WrM5e2l+yamVPCP8AzrtdLmyvJHNcVrsJSUMBgj0q/omoFogCfnHXmtasOaPMjlw9Tkm4M72JgenPNWQ3yg9cdK560vAMAdBWlBcgjrkntXG1Y9eE1Y0Qy4O75jnOPWoZ5C2fmyp447j0/H+VV5LhQmO9Ubi7+UgHA+vX/wDXTSFOaGapP8vXLEDp09vw/wAK4TX5sxsoPU4Fb+qXXynBOfXrk1x+qTeZLgHIFdtGOp4+LqaFA03vSmkIrsPKYlFFFBJ9Z2wUbQAf8K0IAThgMnHYZFU7bkheoPOTWtbLzycZHVu35V8yz7zZGtpMBmmRD8zHjbtHP4+ldQlgrWxVlDBRghG3HjsOK57TlMXzKScDsMH3zXeaNIGtlDMu4D7oJP0q4WloeRjpuHvI8e8beFPLnN1ZAwXH384Ayf6/56Vp/DvxSVZbPUSVmT5SGr0TVLNblHxGCCpAzF069z09K8s8V+HlWbz7YiC4jxhkAXJ6+tCqcrsx0nHEw5ZbnsV1YWuqaUqqI5Fddwdcc/jXl2pWrWV48UgI2txxzj1qXwJ4umt/9Cu3KSoTuQ9D7iuw1yyt9Yt/Nt4wLg8ow9fQj3rWpNS1W5hQjPCT5J6xZydpMrqNx2nPJ9a0I5sxr833f4vX/JrIhiaOYoVMcqMVdWGCCK1obZ5B8meOoz3pRnc7p8q1NTTrlScSM2fbg1uWt0DhVySMEE1yggkQs2GyO1aVi0gBBJyOOT0rWM2clalGSujr0nDx85yBzin27M2dw6Vn6bvY4YYK46dx/n+layjA5rpp3m7ni1UoNxHVR1KTZDgdScVZmmWJCznArN1C8isrSa8u3VIUXexP8C/41OJqxtyoVKLbTOa+JGrR6V4eMED4muflDZwQmPmb+n41xXwstH+yf2vcKRDcTMIzt3kqpxgeg9zXEfFLxdJqt7gPt85tscYOfLiH+P8AWvYvh/A9r8PbCLZIB5eDtxncxz0HTr3rkUW48zPeS+rUVT6vf5mxdTxvcNJGX8sKMblAH/16imRMMxK/Nndg9BVWVnkVnwwKkDJzkY44qSN9qhF3FiMBh3J61hchU+VKwsjNIz+b+8JUAE5zn1rNkjEinKpnHYEEfjT5JX3guMNnso/WnSEqrKCwxySueB6VLZ0xjyGXcRnGCp57msuaFUTjBIOOnP8A9etaeTgSBl47EfrWddyAkhOg9DUXO2ncx7qEkcjGTzk4rjfEShXZdoCqueO/vXa3kwBOMHA546CuL8QzDZMcgnbgH39a1pvU0nG6O08HWO7S4pT8xkVRwOnGetdl9jYQHYi7gMElwMnn1FU/BtoqaVYhUXJgUthcEcAAV3J03dCxdcYHXdjFaqLnseXicSqcrM80v9PYLyTnvjB/lXNX9phWDJkdefWvTNW09E3ZUBf4QQCMVx+qW+13HUZxwOKxd4s78PVVRHm2raekqyKVXkVxVlp32C/uEH3ZF+XPQGvWr61DZO3g9sVyGtacGYlRg9ciuilVtoRiMOm+dbo8812DO7IPI5rlY5Ht5cqSCDzXdahAzb0kHzL3PcVxmpxeVcH0NepRldWPncVBxlzI1rDUg68nnpitWG+x0cj8a4gEqcg4PtU63cyj75P1pyop7BTxjirSOyl1A4+8fzqpc6jwTu/WuZa+lIxUElxI55Y0o0LFTxl1oX9Qvi4wpPNZDHJJJOacTnuaZW8YqJwzm5u7ENNpxpKsyY3rRS0UAfWlkAwBUbiRkc9fat22iZVU7hluuDWHYKREBnPfjIA+tdBZpugO3a2R0Hr/AJzXy8z7pvQ1NLdFOXJJB5AGTXZ6Lcl40QSq+R90tyPTgdK4u2jUqm3jGCQRn8K6fTZSuxFZdoweBnA/l3ohKzPLxsFJHRtGrl0LAkjIU5/Ouf1zSRIwDDcOxA4H+Fb9rGcmVwpduvc0XEOUbKFh6VrUjeN0eRSqulPRnjHibQJI7jz4Mh06MAc59/ap/DPiaSMC1u32XCDBBOQfeu91fT/tCsOQ2eT3x+NcJrvhpXlJRSrLja4bpXPGdtJHvUqkK8bS3Ok1C1GowDUbR/34GHUHlwO/Hf3qKw1DysecDsHRh/WuJsda1XQbg+e0jRg8SKOR9a7HR/EGkayspvnjik2lvMX5Tn3HT9K2IqUZQVrXX4nRQTwOiup3cdqu2RgkAdyoIOfTFcm7xRRRyWdwk8LqSVBCsv1H+FFvcxsqyTXDRAnapDYJp87RySo3Wlz0WKaFFPzAHqaR7xWGIvmJJGc8CuE/tjTbCEyT3gkz0j3kkDn0rnvEPxHtoImSwXac/wCskOB7YFa+3layOaOAlN6L7zvtT1m3tEkuLu4URRcbh2Pt6mvC/ip8SZLi3a3iLR2+/McG75pD2Z/8K4rxx4+vrtvKjlZ23E7iAFU+oHc+5rzi4uJbmZpbiRpJD1Zjmt6GFc3zT2NJ1aeF92Gsu/RHQaXcS3+qrNdM0jucn6egr6+8MiKazs3BEdlJEpCEhQw7Y59R1PXFfIHhECTUrdWHGea+nfAX7zQkS6nZRbNuUAZIB6f/AKqrE6OyNaCc6Lk2dPcgIskWYiNuRgnAGc4yOKrNwFAwQPYkcU9meGLbk7DyoPXb24qoLtQ+0sQfVjj+Vee2dNOLtoSEITncFyQNoU9KjlbIbAUDHXmmKWwrPkgnCjk1VvZeGKgEn3qWbxhd2Kd5IFBwTzwMGse4m4JBBz+BqxcSFgCANzdR6CsW6lIV8kexHt7Ukj0IRsiK7uCc568//rrn7uIXl3bROC3mSqMEZzzzVy7kLMcjgZB54/GrPhOAXnimBSMrEC+V6A9BW0VbUU2j23wzbiG1iYIA5UAnHYdhXXYDLg8isvS7YQwqNoBAAPOeKsT3OGZVOMD/AD9K7KMlSi2z47Eydao2jC1mMrM5HKrngjv7VxGsEeY+R065FdXqd4GkZNynkqPf3/nXJaqDJISGx/Fxjn1rzqkrs97ARcUuY5+5j3nPQ1ganCpDZC4xXRXIBLAkH1rF1AgZ4HHHFEGes1dHA69a+XCsgH3Tgn1rgdet+SwFen6s2/cmRjrz2rzyaQ3sjxQQPL8xAKgnIr1MNJnz2Ppq9jlCKQ10mq+HrixwLuyntmZdw3DPHqawZoTGcGvQjJPY8WcHHcrmm08jjpTCMVRA2kpaQ0xCGm040mKYhveiiigR9ewBiqg8j6DmtqwiSMlxkDHUcCsWyyjoSV2n8cVv28qomOFYjvivlZH3Ur2sXSu0II5Ao6HC5P4V0NgkpgzH9AWwSPfHT/8AXWDpxUsG6r16cCtyJyyhAw2Y7jAqE7HBiL7G2kzwqo81ml6bEAIU9qvRTFwRJhs5wawY5TKmE2MF444Gf8KvQZVQr7iB7d/b2rWM3seRUpLruPmO3JVgQTyO1Z8lktwSXjBQjK85z6ZrWDxOxUEgDsvGKgHzqykbiT3z1H4VEo3CE3HY5TUtEgk+UJkd/TPp1rj9V8HwyEtbKySdymeterrArEu6lM8AAdf0pJrVFAYDP94hc5oipLY76eOcdHqeG3ei65ZK3lTSOg7HGf1rFu7nW4QRK0ijoMrXvLWltuJaPftBVRnI5P5//qqlNpts5ZWhQlhwAK0U7bnXHFxluj59ubrUZMCWdyDjgcVUltJJVJclj6mvb7vw1ZFGMsEUmT1x0z2qvb+FdPORJbIeMEnjbjqfetVVRq5QaufOniDTD5W4L+I9a5JgVYg8EcV9Na74Os5WeNoTHk/JtzyD3/8ArV4P460I6Jq8iJkwsxCk+or0cLXUvdZ4+YYa37yOxY+H2xtajWQ4UAmvpDwZAJLfyXk8h/Kd2JPDr1AI/Lmvl/wfcfZ9ZRyMrggj1r3nwzdlp4hJIwDrkFRyc8Vni1aVzfL/AHqLj1PWF+z3Nl5oO2QAbuCAeQOBWJNEm9iMYzgBm/pUujMDHLGHbew2NkjJ54GaJVYA7lKseuD3+tedPudVNezk1cjimTkHaCOOves6/Ybg+Q2PxHSpZRiUsflY5xVK6bccA5AzmoR1Rik7mLdTsd7YIAyAM8f/AK8VkXjgZcDDYx15xWlfA57NxwM4H0rEu2Dlju65G49MVaOtFNpQCDu+Xbzj1Ndn8JrASSyXLjBkfhueADXCX82YQqY3N0HqT0r2fwHYiwsIFAwFQA89DWhyYmXLSkz0eMCKIqSAvbntWLqsjAfIc/N0BqZ543YKHkJ4LEnisO+uV3ODyDnHt2/pTrTurHz2GoNzuzIvi+87j97qo7/jWNej5D69znp71p3bARsQDnHyg8Vh3k4UEDt6Vx7n0dGLsZlySTxwTxWDqkm3cPbGa07ucjkd653VZ/nZRnA7VtBHTLRHM6t5tw3kwk+ZL8gA649a9C8H+B1tNNhVIOQdzkKTz71U+Hegf2hdNqNxHuQMVjBHXFe1R6eqWQVIyuCCeB/U1u5O3Kjza0o0nzPdnl+s6LFG5HEj9srnjtXkvi7werF5bdQshyWA6Ma+iNbtlG7jB+nSuE1i1RjjHbqKmnWlTehbw9PEw95HzPfWctrKUlQqQapmvX/FWhw3KnKAOM4b0ryzUrJ7O4ZJF4zwa9ihXVVeZ87i8HLDy8iieKb0p5FMrpOFiGm04009aBCGikopiPrOxm3EJJj3JP8AOtK3kIOVwOeMVgB96AbuOuc55759hWjbu+AcHDDPPBNfLTR9/HVG5DO8SZRyWbnHb2GPxrdtrsyQI0+MYByB3965yCUkDcNxX27Yq210yR8J0GfpWVjKpT5jrLK4VW3FhwMAHPQdjWh/aCrMkLk7nG4KB15/QfWuGs7l42QE/NnGM9K3I7vMfzOFUY6Dn/PWqWhwVsJrc6d7hmdANp3jk7Txj/PrVXz3WdjKu1G+UNgAfmayo795AHHGec0treLOx3nKKcgZ6/j3qtzlWGcU7o6OzlUxk4A3ZwFbkY7n6/1qZY2RQzHkjketZyOYtvlfu19OQQK0I7pZI1BYA+gGPrWiSOGpFp3RQvkU5yuCW684HoKgkjU8R85xgZzk+3arlwqOxbJBPJ49KpIAuHypYHaCRwKzZ0U3oQsrRk71wAfkBqvIgEW5h8q8kEjoPWrzSohAwNo+7kVm310EgAJUNjkA9D6VFzpp80nsUr7dcTSOc+fn75HYDPA7+grxn4u6Kk+iNcrjz4D5vHUZPIPrnrXsVtunm2lyi45YccZ/+vXJePba3eO4hjDfZ8kHPUkjv6V0UZuElI65UlOLpPsfO/hODz9T2g4wpINer+HtRNpKkNxg+UhjUjrn69zmvP8AwRaBNTuGY7RFuGR14NdrJCHuZGc7cDIOMZNejiWpSscWXwcY3PUPD12senLO8vzShUBAztPuPpW4tx5n3wWTpuYjJFeaeGtStBbrbXZcz+Z8ijoe1dTYaiqoIjKC+dpbHoa86orHp8nPr1Ne8jO8yJ1P8TdqyLybBYE5AOc4FTXF6FLBTlPQ1zeqaoIS44B65A9azSOinBrcfczD5y4FYVyQ6c84OKLm6crkHqMmuZ1rXI7WAxoxaVxhR3z6mtoQbdkOpONNXkzZ0FDqniNUHNvB83Tv2r3DSMw2+1GzkdOw+grxj4cWssMay4LF8knvXsFlMQgIwBj8KU3aVjmrpyprzNrzCqndnHXOcVi6jIRnYME81o3cyhdyn0JHpWFeyc7uSTUy1ObDU9bmfd3DHO44Hr61jzPlSW5GeOepq5dlsZySuflrEvJysjLtIA6N2P0qIxPWikkUr+Qq3ykAgcZ7ViJZy6lqNvZW/wAzzPgk8YHcmrty+NzOecZOe1dr8IdFtpJ5NVvw+XJSBV647mtVoZV5qnBzfQ7vwJoken2UUaoPKToexPrXX3iAQFVA+pzx70y3VY4wsA2qOin09ag1G6wpCZA7fL1/Gt4pQiz5OtVliK3McdrSh5X7AZ+tcdq0CgNuyOO9djrDb5MkgemRXKajjJ56cjnrXHJ6n0uEvyo4rV7ZSCCMj1NedeLNJjmUkIQea9Xv0yMAdRXIa1BkMCM+9dNGo4u6KxdBVItM8QuITDIyOORUBrp/FVl5chkUYIPNcya9unPmjc+PrU/ZycRhpDTqbitDEaetFOORRTEfTttIGLA5LDj2+laisxJZiQVGTWNasu0EZGeF5rUUnb8rc9c18zI+9pl6Mh9vmqpAIZc/zrTjbABy316/jWPCdoXcTgDA3Hk49TWjbzeYX2kM/fP9KyZTJGI343Zbt6Cr9vHjkl3UKAQeg/8Ar1BBGG27uW9q2IbfzUVgOQeMHFK5jOfLuELMiKHAwOo9M1pWkRDBV3DDD7h5P0qJVEUYG3k8cCpIovPUeYmAD91TjGOmcU0ziqSui+7bX8vYWY89M/gasRyNFJnBLMOR6VLFbhIAVwHUE4I6/wD1qZcSFkydqFjj3PrVnnOSlohs1wgVy2M854xms43KnC7sZ+7nr9KbqIPl7YhkdSKzI5iyhmAHJGdvPP8AOs29Tro0E43Ll7cnaA2AD1xWW8hL8nPPTNOuJB5SryB2NUGlWM/KOOxz0FI76VKyL5l8uR2VwrFSucdOeeK5HxIxmhK7i2CcEc5NaUt3zjJIHPT+dch4rvxbwTOJNhQFmbOe2a0grs1UORNs880aUSeI9RCkANIxO1QoBz0Ar0FbTcYd65Dp19ea8s8DT79a3SdZCSfxOa9z0+FJ7YcnMePpjNd2J9yVjhy9qcG/MwL/AEn7ksLYOPlI42kelZRuLiCfLlmK8jNelxxwNYrFNahgWwHXhj7Z/nXPa5om7JiHzDqawUr7nat9NDAOvOyFXAGBWXdao0rdztGcAVLe2c0YZSMAVjzwyZPb1q1CJM601oQ6pq07RnYQg9O1cbPKxuRNIcsWwT7Vv38Z5B6Vz90BvGeg5rtoRS2PHxk5y1bPY/AmoobVIl4KY5z1r0yxu90ec49jXzt4V1WS2YJkADnJ7+1elaH4ieUlZNqIPU9a4K9Nxkz2KE416a7npRnzgEjJHJ7c1RvplRcdccnPesUaz8u5WHIwfaqV1qiSA72BzwcnkisFc0jR5WWNTueCcsB7d65m6lLsZGOPSl1TU12lVIIA4rn7q/ZtqKN0jnaAO5NXGJq5KOhq6daya3qi2se4QggyY649Pxr3rwrpcNjYwrhht4xjjHpXI/DnQYbGzRpVPnMu5yR1Y/yHtXqltFGIwwUBMYAHH404rmeh42aYqy9kvmIV8iHcxOPu5FZOsPhThjk9SD09q1NRuNiFVAJ9a5fUbklzg9OxPSrqSS0R5uEpucuZmTqUpLK2QB1wR/h+Fc5fSI+4kg5OPr9K2NQkwOCAPeudu3JcjIwPX1rme59Ph4WiZF78obBIx1461zepBWBz1rd1B8DnpXPX0nyc9+lbQNKuxxHieENEwIrz2VNrspHQ16X4gOVIrz6/jxcfKPvdK9jCv3bHyeYR965RIpMVtJoc7wBgw8wgELVG+sLizkKTxkEdcciulST2POlFrcpGilxRVEn0rpx+QEZ9ORWtChckqccZ4POK5zT7kKowcnAye30rfs7kbF5wBz9BXzU1qfcUp6GtGgWNSvqKsxgsBz8+Ow6VSjn2gDJzUy3ALdWzjHT9P61gze1zSicFMFQHGME962dOnVQFYjIx9a5lZijBgW9TnoKuw3e18EEHPUipMqlLmVjp/NV+QAV788/hSwzlJSqIAT13Hn6Vkrd7SPmX3xU0LhySMf7o5zTTON0bLU6Jb1DEckfKcbs/54qpd6jhmKgHtzxVYkLEwGGbsKyJlbcd5/XpVXMaOGg2aEl8ZZUwu4E9qiuX3FQpHHcetUpMoobcDxnOKry3ny9xzjpSOyNFK3KLcSLEDkFuMADgZrKMm+UeY21Mc7etNurpmxjpnAU81UeYlSX4VfToPemkdcY2RHPMUaTB+XeQGPUj3rzf4l34j0sIjgy3D7SB2Xqf5V3mubUsvMt3AUHG4ngHGSBXh3izUDe6kUBBSHK5Hr3ruwdLmmn2ODMq/s6LS3eg7wZJ5euRZxgg/wAq+ivDgQ2aMD1j+YHrn0r5q8OTCDW7OR/u+YAfoa+mPD7K0aeXxznn0rfHrVM48plenJHQwwiSwfAbAOOn9aEswxUyrncDgA9fetOxRXtlQNgOcNxz15wKv2VvFJcybPmjB2DI61wWOieI5LnJXvh1by1MbIUc5cbQB2ridX8JXECsQucccDt617tcaeA6Yye/T0rHvrRDOkRzlzlgR09M1pqjOjjlN2Z836vossYJ2knFcFrMLQuuQRg4r6f1vSLfypSzMctsRcfLju1eNeN/DTbJxEp3xgsoA6iujD1rSsy8XQVWm5QOX8P232mRVHGeM11y281qQJA2P72KwPh5GZ7g8fdxya9mt9FS+gEZUbuvXp70YmVp2ZWAinS5jz8XEnVpDtB4AqNrl2YsznAyOua6678HTLI4hD4Dc8dKy5PCl/tJCEH0/wDr1grHa2+5y13O24k5x71f8CRJe67NPO3/AB74VABnk9TSaroV3DGZJk2xqSpYngn2rK8D6mum+ILm3kIxL909DkVry3g7HK6jjWipbM+mNDlRLZVcjfkEDPX611kd2rwRlDt46eg/+tXlul3xiit2jliffHufHJQ/3enX6V1Fnq6KjHcD8uACO/tzXJCXK7HJjMG5y5kal/L5gZldAQOnT8a5e6kZCxLKV9Mcmpry9IcElcd/pWJdzGUsyYxjoKmTudWEwzitRLydWHPQjrWFeSrnhvl5PuasSS5Uo2SevHasTUJgvCHGeCaErnqRjy6FG+kHQH8M1z2oy8HIxjnPtVu7nKuwGTx39a57UbkudpPGa6acbs5MRUsrGZqr+YCB2NUdA0BtTu2kZSQOMVo2trLqV4sCDg9T6D1r1jwr4bSGGNI03HoCeM+/0rolW9mrLc81YX2r557HN6D4Qtyjy30LeQnG4nBzVbW7WwtbuSymiiktWU4x1BPvXpU1soZ0QBkHGM9vpXEeI7OB1chAHzwfQVnTrO+rCrhItaI8q8U+DJbRxc6cA9nI2F+YHHH/ANaity9a6s3xE2Y842NyAaK9GFd21PFnhGpWTN7TboOiA8joMntXRQzFkAVsDrxXA6VdcKAcD1rp7W5IxyOecjpXmVYWPfwtW61OphlKoNgBGB8v61YSbBJBPqQe1YttPk4UYGSfTPNaVuRwQR64FckkepB6GwkvyLuIHHpmn/aWVsAZ4z14qgTmJQrBSO1NWUAgHjNRY0STNRLsgc9ehOetX7O6CjcPzrEgYMv8WOnPQCp0l2kqgy1JoTimrHSpfeYSp2Z60yebLBsZIrFhn2EgkHJ5xTprvaMdyP8AIoMfYpPQuTzFlPQke9Zs833sDIx07YqFrvc3PGTjJ5qKeZt5HGScbielWlc0tyiB87sKdmcbiKhkSY8Kiuem0f5/nTJZHZ/JiPCnJbPXt1p8pZICEkyFGXcdD7f/AK6uxLbOR8XXr2GnytcRlBGCyqT949OteMElmJbkk5Nd58TdWe7NtbE4A+bbnoo4H681wVexg6fLC/c+ZzStz1eTsSQMUkRh1BBr6W8GTl9NiZTkmMHPvXzXCheVEAOWIAGPU19N+A7SWJLeMgiAIrbvU88Y68frms8f8KNso0c30O00d3AbKMdiHcxPTitXTZZEnjhSEO5OTz6+tSRRMtrGCR5bPhVPR3POfetqysY7GAufmkboTwea8+MdSsTiI66bkli0tzKzyJtEfGF6E1Xvo4prx1lyA6kE/wAq1l/coqIoAAJOOlUpp4JZhFwHJJBzznHpW0kkrHmQm+dyitDjr2wEqyQb2MkfKtjgj0Nctf6RFcozN98/pXoFw00bhFUtGzb3yOBz+tZ8yQSz3MkcPl2kYVjGnJZzwOT0GTmuRvse7QxMktf6/wCHPPNB8HWS3En2W3EchJOCwXP512fh+wkt75UnG1lYlmI4xjitSKzt1KQhAk5+82f09DXQ2dhFJHtBVirBnyMk/U1rG9R6mVfGRpxcYqyf9XKj6TFHD5rAsHOcngj2PtUUvh+GWJfMQ7BjCqfv/U+ntXQGECNYpBlR0wOlJIoSJ/LwTnknotdDppHkrF1OjPHPGejxtFc7VwkcpjH5dq+e/FsL6brP2iJdjI/T6V9WeKIsWV8E+YebvJ7vnFfPfxM0xnuLp8ZdG6Dtnmpw87Ts9j2a162H5lujV8EeJlvbcnYwUcMG5CtXocF8qx8ZYH+LOM1856f4nudP0WDTbWFY2SYySTZ5fnO3HavRfCPiyPULdYrpgkyjgA8daWJwzi+ZLQ6sFjYYiKhN+8elG/MoAHpgAnv6mqtxckMzOeevXGc+v+FZi30SgENx65qlPfoxOGJHTNcijc9FQSLk8+AT6+lc9qsysMg9DSajqkceIw2Tjp3NYOo3/wC6wp55Oa2hAyqVUtCLULnA5IzWRHDJeXCrEDubgAUsRe8lEcXzN0Jr03wT4XS3R7iZk8wLuJY42/T3raUlTXmcsaftXzy2K3hTwwLFBJJ88zLzkDj2rurEm1VyGKZUqTjt3xUo/c20x2rgHAYY6+xrJv7tpFCRoEjX7qr+tckm5O7Nrcy5UtCbUJ41R2jJ2kDgntXE6vh3ZgCBnHTkmty8eRl2seD97P8AKsG/YBGH6+tXDQcqdkcpq0eXGASM9qKn1AZPBKnPUUV1RloeZUp+8zjdKucgDn611FlfHA3c9zzXm+m3hUhWzx05rqLK5BAwefrXXXpHnYWud7a3Q4K8HvWrb3Y4OBk+9cZZ3JwAfwNbVtcZQAtya86dOx7lKtdHRGfnI5z+OKUzFgcnp+FZCXCDcOST15qZbgjhgD+FZcp1xmbUNwEI3H5fTpV2O4D4QNhuoHasCGbzAFBJfr61ZLtt4A6VLiVzXNT7QiqdzqB1yDSfaA6dVwfX+lZJIlXgdP4icY96RJVjO4Nj9aFEOY05MiPJcevuKpyT7iFQ5HqBUQk8xtke4KeCzdhU627LEHz1OAAevvTtYd77jrTEcud+Rg55/PmqGt3X2aEoCQpyzeu3+lSXswgRtmWGMZPr7Vxfiq6lNsYsEyTkqQD0A61pThzSsY4ifJByOF1q4a+v5bg9GPyj0A6Vd0zw5rE1uuoxafK1lGPNMpXKkD/9VJBa7nVGBwx5wOfpXuehS6ppvgLTYdKgm8qeTy7i5kT91bpu6Ad24r1Z1fZxSifLwoOtNuRy03hay1PUbfU50ubW+cRym0bACjHAYdvX16V7D4cs2Fk1xK5LBo4Y1OBvbsAewA5NQaX4KZrOPVUe4LTjfI1zgyOCeGHoMdq3bC08i/VWQskIUomOWZjwPzxmvMqzcmkz1abp06clB69fkbWhQtPcRrIxMNqvYYBJOTx9f0rV85LzdclSsMTYU9z2NQ2MTR291JNMWgWPZlB95urt/QfSqJ3Sag/2dGjtyR8mNuBjjinKThFJ9Ty5fvZyfb+n82bEb75lL8ByMD0Hao4oYJ9UeQAs8eOT0FLGGMkWcFY+Bx7dqt2yRpcSOiqplx9Tjrx+VaU1ztJnLKXLe3b+vwM7XEDxZ3BWHbGfpXOP+6VwgJLcYJzyP511+rlFgIZQxPbP+f8AINc4ArROe4B2gjH1NYV4cs2jtwc/cLum2q6lbNKsnlzHCsp5B29/bNas6GxsHZMbzyx3Yx9KwdGAhnzkoDwMGtuUbs7/AN6vXB6Yq4TXJtr3MsQmqlr+6UGv5hb+WwDBh1OetM0+8IjeA5bOWGeDn0NWLuEKoIXjqccY/wAKyIiFvUjU5Bbk9OKzbkmjWEITi7IbqcK3NvcynCwsAhc/wnvx614r4ptTcG4eQADOw+/vXsMs4gurlXw1s7enQ+orhte06PznR23QTZAwOnGRQpa3PYwcbRcXs9j5z8R6UbG5MiElZDnGOBVOymeEqyEgj0r1PVdM+1QvauqukZPbnnvXCzeH5redhH86duOa9KnXU42kefXwcqNTmhsadhrVwUAZ8r6Gr0usTFcAY+nArEt7GUEJtYE+1aKafOcqwIK8YIzWE4wud9KrVcbXK01824ueWrLnuHuruKFjsRjzite60+62ZMRwM4rnpGa31e3EuAQ4z2xmtKaT2OetOSa5trnrnhLw7Ha2yXEp3O/IHGB+td5aJthJkykS9Ao+9WForo6RA/dZd6nsRWpcXhYLEuQo447DtXlybk9T23GyUUS3Vw1y6qowv90c4FZ05WLLNjLc4z/KrAmCJtU5Pv2rKvZs85P/ANemkOMbaEF5JvXHQd6w7wkoRn5R1Ge9WJ5zz/TpWZczZznp1rRIU7WMi9OXGMn6UVFeuXbp0orojsedPc8jUkcg8it3TbveAOjCsAVYtJPLmB7HivYnHmR8lTm4O53djOdo5/xrdtpyQpyRjn0rkrJwyjHQ8EGt+wZjgdvevPqQPbo1GdFD84yScnjp0q0qkrkHt1PP4ZqjZcY/iOOB6VtWqLKRuRSPQnj8hXJKJ6tOV0VolKqMbzIT94dqkhjupGRQpBI6YwCPatgRl3XEfy46gcA+v5cYqxEiH/W/Ie5XqB+NQ2jdRKFvps0gUbxEz84px04iYR5L55HP5VqWlrIxGAzIo6+3ucVpW1kkkhUkoQMFgN2PpUXNLW3M630pVWMK+9zkLGvGMdyfXPb2qVtPnLbYgARwzP0X/PNaEdubQggEluQ3I4+lRXPEDIjEZGWzxn6D+nek5Ak3screISxjbduB4G3rWDqWmXF6k4TCBRgjHLDvXW3VnI0jhDmUZLE/w+prY0HTwibpYQ8GAgDHO9sZOR+PSqjPl1HXgnGzOc8EeA1nS3uLlk2hizq3GcHkA17XEdPuNJi07ULbFpGxlRIvkXaOmcHvn8awdPtclAvloGXytu3IUE88eprp/sUaQOkDD7JGF8xu5I9P0q/aSk2zxcQoRajt6FLU7l3kjdA8EaRLDHEOMfh+VSaJLdwxBCqJIyjcQd5HBJAOOmc88ZxT3tgzLltx5xgdT1zmrVlA6HjawxjaeP06msW23cxnOCp8qLS3MsVoEh2EMMqCeV56n17VBACrh5JBJI3TPVqtyQmExKFRmZsuyjqeePXFROQck5jHcHj9adn1OSLWtluXbdydhwcdiD1//X6VdUbnDgcLkAjqay7WVs4Dbti4x3/z/wDWFa0YOFBxgjp1rsoanHWXKzP1UO8R+Tj03dz2/H+Vc4ZGPKjHPGe//wCs812ssJkxyAQawNW01ImUxHBI5PfA/wDrmliKEo+90OnCV4r3GZtq6ibcOhIxn/PtWpbX/wAuCFxk9elYoj8uZhjO3jPrjIqzbthV3KQWIzg9iK5Vozsq04y1NO6leQhhjywCWB6sfr2FYYnQTozsDub7o6/jV57gCRUyDggtnuK5i8dknkkyeDlTjHBNObLwtC94m3rcCXTGSOMRhhkoO/vXKskUt3HDcMRGpPIXJBPFdQlz9o0oqD8645NcfeBhdOWxk8/L0OP6VE+534NOzg+hzF7YfYtVleNwyltoUcg+tR3mhR3TLPbjk9V9K0bxQ8inuMkVetYiqrtPUA8Ucz3PQktNTj0so4H2Swh+/XFbmn6dbXKj7MQrqv3SuTkf/rq9f2obnZgj15rI81rO5DxErg9M0+dsnkTV4kmp6crJFHs2gA54Pzc9a8h+Its0d1E6rtAyvA6/WvaBfG7jHnMd6gDPoDXnXxKsg8BZR9w9T1row8rTRx42nzUWupb8Ba4b3SohI37+3AjK57dq7KWY7g4I/edB3+teEeF9XOj6kA23ybjCyMRnb7ivVre+3qHDbgVzkdMUsRR5J6bM2wGJVakubdaM2pbjg/Nj8aoXE2VYfqT1qvJOMdSahaUOuc5GOeKySO1yRXuZO4z6YrMuHJzjtVu4lyM1l3Uo78Dpz3q1E5qkzPuiMgbQfqM0VUvJRu4yfrRXVGOh58panmoNPU1GKevWvWPlDq9GlzGvc4rstPjUqmwjBH51wPh6YrgDqDXoemhdivyGIHToPoO2favPxCsz2cG+ZI2rS3DEFuOK37G02ovXPWsuxdSQD/8Arrct5c8ADBHHrXBNs9ynFGrbEKMCNNxH3ioNWVt4mjJx8w6cfrVONh5X+13HTNWI5Rjpke/audnRy22J1URW5GARnucj3p8ZGBtORnA/wA/wqJXy+1ic+46VZtWTouAG755x/X+VJBsWwhnhG0lmzwP/ANf8zWfJZPJGjxnAL4Xn7x9v8a0YCZiNkUmDwB2JHc/0A9a6LTtCe5UuxREYAbj0A9BWig5HPUxEaCvJ2OKttOaV2WJQUTG9vX/OO3pWtDZGJgoUkKO4/lXXSWtrYwJDbr5gHLHGM+gz/nrVZYd/yPFyp7c/hSlFLQ5/r/PqloVtKHl7FYBF3YJxz71u3EkfkrGqiNH+6u3Jx2NVY7MJDG6sJJd3KqOnX/OBUs6u9yJJ2LseuDwPp6U1dI8+rJVJ3DByBGThj827n8cfhWiuIxlV6KM9OOv86rAkuNnBAznt/wDrpyOZCTISgVlPHJbrxTSOafvE8CkSy5JO1ATxyRnP8u30qjdo7EAgx9DuP+egrVgjZLeXhfOfPB5GayLdp5WK3QUu3ygHn9fSqcbImk7tyXQmtZYllMYc5B9M4HoT+v1Na9u75YE5GfvetZNtbLHI2CCBzx3qZ5nt3Pzgv2B/SnCTjuTVipu0TY8zYuS2egqvOwmzwNq4yT+eB+lVLctJCGkcnaDz6nGB/M1I5EUCkY3E5zngf5Fbus2rPY51T5X5mWIN13FO4zCGwy7c7vlY8D8arCPZNJgZUKAMnPUZA/SrnzM0jFi2VKrg5BPT+p/yKo3Tld3lsS543DnjBFczselTbbsUFlZb+NomUpnEgbOenb3yBkn0rOlLNLKXy4b/AD+VXzbNEmdpz7+lRR2Us6uVwGX5jzwv+fSs7X0PRhKMdblzSNInnshcyyLFa4zzwcVzmo2sgDSYGXJyRnHt7/8A663tU1e8S0WJc/Z0jEa443AYyfqay7y4m1GxgMm19qbVOPmVRnjP4fpWslC1kOg6qlzztZs5kIrvu6rnt1P+eauWqHKgDBJ4HpU1xY/ZUjEpw0jZUKAc+tQPMyyqwBGORnrjtWNj0OfnWhZ1KNcdRtAxXNanCSzjIAAweK6LVJhsUKpBK8r6Vzt07P8AeHvTsVSvbUzEmMLhuqtwVx29axPFSme1nRzux91yPvZrYvsg4zyeOP1rK1AG5gmR8KijgZ6DNbU3Z3IrxvFnj+oWxXcB26VueEPEZhZbS6b0CMen41FqUG2eTjAzxXNX9u0EpdeAe4r1FGNWPLI+ac54Wp7SHzPXf7RRyQpGfVaHuwVwf/115npGuSRMqTsSgGAe4rok1RWGA+fxrklh3BnqUsfGoro6KW4U/T1rJvLj73OSf1qAXPmdOvPFVLpwx4z7miMNRzr3RBcSbmznA96KglbPriit0jjlPU4kU8GmCnCvQPANXRJNtxj8a9J0aQNGuS2AK8s05tlyhr0vQmDRIRzxXFil1PUy962Ost3OAuSMjOBxkVo23mYyc4Pb0rLtXwF3ceuf8K2bf95GpBHH5V5kmfTUloXIJZC2Sw2+p/pVuB5SMrhQThcnOfWqiYPy9QOADxitC2UKoO3oOB6Vm7G9rEmyUkZYZ6cjmtGzgRUWUsXfOMP0qGJiGG1Rk8AAZq3A2TsYZz+nvWbZLvY2bK7YzKXjBK/dA4wO1bkd7NJGfMLc9R0B+vtWBbFI2RkYlT37GtoMGUMH69AOaSmzy8RCLa0JJDPMoO75cjO3gYqWJixwHxjJJ7VXMwEasHBAPRuB/wDXqS2lRXUs3B7kdfeqRyyi7bGio8mLbyOOD3H/AOumyyAxfLwiqTntVa5nUkeW+QB+dVmnLqVyNxJG3NU30Mo0m9WalrOVKFWAyDhB+pPYdKuJDCAzt1IHBPQVzFnclHGMFQDkngVJe6szSbInKIMEkjA71SmktRzws3K0TehuWL71cFOoPrWfdXiR3CIGXeTkdOv4fWmx3G+NGPykr0qjcwR/aftG8HuMHnPalKTClRipPmNWKfktHwzH5QTj8P0p5kEiAKP3g+b61lySeUo3AFT3B5/zxVsYWJXQ/IT97OMH0qeZilTS1L0UksrhAAPXkDPHH161LcbgoQtx0/LnP6YrPSfG5lViTncwGeD29ulMXUFJIlZjySSPSq5uhl7GTd0ieWVSq7SzD/Y6Hn1/z0qZLi2aN0mjZ+AV2jvjk5rOe68wP95FbA2rx+FZ81y0S5Hz9sdABxxSU7G8cO5qxcu5zPcuwBKhBGq5+8c9SRxj296z7u68vZtk+U8yAcckEkD8MVCLlTciQl8AZCLwB6f59qoSYJLPgEf3j1OQM/oaOY7adFLRkmq4nMDCXiLcCSvJUDAHtzzxVaxna0nJ6jafl9v/AK2P1odmErSHIxxkjOP8mmh0lnOACW7gdeRn8KV7nUo2jy9C3Pdl7aG3dUaUAYkwMjrkZ7DrVYizJfezrJtyc9z6VXlnYs5H3wCoJHA46/lVORxv3y5D4zx2/wAmq5rhGn20EvrkHc3PA59SaxHly27sSRx2rQudssaJkBmHGfT3NZsyKYAI1B59f1osdMGkijegOcleMemKxr5iG689K1bwuoRXIBII61jXe3awGS+evYjP+FWkKb0Ob1aBGB+Ul89hXMX9uSoyhKseBXZXsf8AFjp0rGu4EZBtBUr3HauylOx4+JpKVziLi1aM748Fc496fa3DI21ywx0NbsljkfIpFVrnSZ2Cl1C++a7FUTVmeW6EoO8Sayus9WyDVtn8zhBkVWsNNuFG+MbtvDLnk1uxW8W1DFlX6FT2rCbSeh2U05LUxZI2xk8D3orWu7UsB0+tFCkhSi0zzIU4U0U4V6B4RNbNtmQ+9ej+HpT5aLknI6ZrzRTgg13Xh+fMacjpXNiVeJ6GBlaZ3NtJnaBgYHPc1rW0jAgA8dfm71z9lLwvOTj6Cte3IG0jAyOteTJH1FGVzoIZBjORk9yP5VoQNkjGcfyrDhkO3ByM/ma0bR8KAeABmsWjsRswu2dwY8e3Iq9GNxw4KgnnisyzlXIJOOfTp71f8xdwAOQf4j2/yahkyNJJT0yF7cdR7fWr8Vx/eOR046CsZGBYYznPHPTinrMM4zhh0AqTnlSUjUkmO9QBgnp6GnLcgs8SqQUx95Tg5yeD3P8ALvVCKQMqh8jJ6j1qXenOHIIOTu68+1MxlTS0L32ggAE8HuO/NRG5B3BN2SefXFVZGAyxbcD0wetVGdYoyzAnJxik2VGkmXxLwDkKBVtR5rBsfIoGcjJPWsAyF2GxcHB/CtKCTFptmf8AeDGF9+apBVp2V0bRkXyt7o27/ZHRaWe5jVYWWMEHpH2/E9zmssX72hQocr1C/wCNVbvUDclSqqoUYAXoO/8AOqbsc0aDk/Iu3l7vmJ5UemOg9aWO9PlHcSe+0dhj0rCW6c5GOcmp4piq5fOMnB9azvqdDoJRsasV88SyBG27hwAKjacM2GJyRkBf89KzWm2kDGMU1rjLkjHI78ZoGqS3Rq/bFJ+Zup+uM/zqN7pmVgnTHAJ5HvWOkuDgj5vQdqdJJ83ze3vxnPX8vyoH7JI0IpSAd+Aw4IPUjNV5rosS5wO34f5JNV2uSAQrDJ+YnqcDrj88VVeQ5y7YByTk/dqwUdbk/mhiQjEKSTluc/h9KN6xhjGeny4z/n0/WqJdlUbRhByMnoKaJiGKEHng/X/OKZpyj5pWbOe/J5/z7VDM4bBY8jn1zxRKwP3ScZyv+fyqu0nzLzk+nXjr/IUIq4SsuWBJ2j5cA8mqckoiCYXK8En8P8akuOMANkEZOD3qrOzDDkgqGwB61ohXKd4yzMCpPyZyDwayLlA+QenNbLRxRAEgsxXc2OmT0/pWVcg56+vOetWkRKWhj3ce4NzlV6flWSw5APAPJNaty+1iM5zWVIf3nHIHGK2icNR6kcMQMx459cVaa2EhBIG1e/TNJCpUg5HzfpWq0qPBAixqHXJdh3/GqbZnFIoW0Gxs456cVcaxJd3AwCe9TJGgJxyPWryzZ+QgKmemKjmZt7NbnPXQSMgu20E9ziip9XRRLgc5OaK0SMXe54wKeKYKcK9c+YQ4V1Xh+XCR5PGK5UGtvQ5doAPY1lVV4nRh5csz0WxfGCDz1zW1aMdqkdK5fTp8ouewrdtpRtH0ryakT6bDzNyCbbxnk9vWr8EwGOM+3bFYUE2Tg9D2HerkT85Y1ztHpQlc6G3mB24YiryykqVJxz196wIJwO+D61oRzqRg4x0x2rNo13NiCdth2Ha2fWiObJUDp1JJ61QhkHIxwPenl9pznjqR61NibG3Fc5QBcZ9Ksu8bwhXCuBzgj86wIZs8n07VPHPu+8VwCDg9KRnKmaM8vyKIuGH4AcVTE5AJPB7Z70olRw2Ty2ScccVQvnIwq5RB1NKw4roaMcqqx3MqKWA9avLe+WjyRhMZ25Y8468j3rm7eQGbAYkBe3WkNwydxle+apEzpp7mtdXZyQxALnJGMY+lVJrgkApyo69if8mqEt2SoZj0OB70pulwU2kZ7HqBRYcUkjRjkIiOcZ9c0sEgO9uQWO48k9Bx9KzjORGwLZPvSwTblILDI59KVhtGw0wkj+UqOev9KqNKAOp9iKoG4VACzgEjoOKatwGIJILHj6U7EpWNO3m3OqEgHgHPFJNdKZQrkk8/j6Vky3GJNynPPUdzUfn5k3HJI5+tNRE11NcXqrvUMpHAxj3qu0qJDly2/jnr9Rn8qzZdyguGALDPXp2/xphnBA5DIOf6/wCFUkLQ05H/AHYfpHnA9Caj88E4yCe3Hp3H+e1ZZmdvlONg5GD/AJ9KPtGBgEk9/pVcoXL882Du6kZ4Pr/+v+VQNKFzhtpwQXPpVFrgnLMGBxxg9+39TVWa54wG6d+lNIluxoySq+Cc59c+9VVuAxABOACcf1qr5hKkMwUH3yfxqPeAWLNkDoatIhzLk0qGIrkhSQD6ZrNuHATkgL/Cf6Usjbk6gADkZqhcTDyQBkAHOPSrSMZTsVrs4JeI8gZHr0//AF1j8iQqeTWpLMvmo6P8mCDn1rMvkcy+YEKoxPT2raKOOctSYgxFe7YztHb61asX+YnOFzyfSs+3uUWxuRIhdz90+ntU9iGaEsv15pyQoSNaOZCcKPkz1JqzHtZ1CvgZxz2rK83cpAG3HpQ1yxPTgdPWs+XU3U9BdWP+ksF+ZQeoGBRVKc75CS2e+M4orQzueTCnU0daUV6x8uh/er+lybJsVnipYH2Sq1S1dGkHZpneabLwME57V0FpL8vXJ9643TZsAGt6zuBxnH4151WB7uHqaHRxSDOCefrV+GUBRluCa52KYEkkkj61oW82RxXJKJ6lOob0D9CeavwScgE9PzrAt5x06ge9W7edsAll3HhscD/9VZNHVGZ0VrL6sPxq3LJlRkAE8devvXPw3HOA31OOtWxcbsMef8KhxNEzUd9y4Bzx0HFKsoz8vI789Pas9bg4Jz16k0wzDn5wcjHHFKw7mq1wGOQcEfrUV3OHj+YgqcYGeKzHlUjJIyR6VXmud2BuOB6UKJLsXkba+dx5HT/69F1cKQFVQAe+az5rngYI+uelUri4eRuX4Pb2q1EiUjTW5QqMuOBgelNNyu4fvAQR9KzIpFJIPPfHrSF9u0quNp+Y570WJ5zba4BG3cNwGM08y7EDE+gGKx97fJuyed31qUTlwqoeB14o5Q5zRE/DKQDn9KBKY4yMZHQVnS3HGAQeOSOKVLgNGBkjJ3Z6GjlByL8rjCAEHjPHaoWkUudh4HJPTiqk8rodpZQxI4zTHlDKVyqgnHXrVKJDmWbi5O0Hdnj6dqg+05PP0qjJL97cTtFQvcEIRxnGcVSiZupY1ZbtVkBjx06EcD3qBrgqFwenB9z3rKkukEZXdl8dfamJd+WRk8dgPWq5TP2prTXBI5OGPOM/5/yaqNNz1GCcVn3FxuBIdQQR78ZGR19P51FFOGdQWGwn1p8pLqmkZYwxG/oM4+vSmNc54I4+vaqFzcDzDyMg9j7/AOFQs5LDdgL1OT/n3qlEzdU0UuSjZJyMdSKqT3G4Hg7Oh9jUEso8l84xnB+naqs0rSBQgyep9KtRMZVLjnbcrc4Y9T7U68u3nmZpMYKhVXHQCqjErgOMMOTmmmRi/LcmtEjGTuTIAGGD7Y/rVm0mFvMHdQy54HrVEsVGBzn0onmXzODuGBz2p2uLnsaMl99pL8JG0YJA6d+lVWuFkQDq+ecfzqm0yDkdBwBULT/PuXr0HajluNSsW5WUD5nAbPSis+WQsR82ffNFVyi5zgM+9L3po60teieAPBpwP0pgpRQNG3p037teeRW7az8DmuSspNj4z1ragk4B/rXNUid+HqaWOkt5xjqff3rQhuR0DcAVzMUvvVyKc54OPxrllTPTp1jp4roY5POAMelXY7jO3tjvXM29wM/NV6G6AwTwO1c8oHZCqdLDODyDz6DvVlZ8LgjOT1Hb8a5+C5B59PerIm3HOfwz0rJwOiNY3RNlDz1PUcmmPKwXknGccVnibgds+9E03y8HNTymntSy1zjGDxgY9qhluWAOMlun0qm8wIGDznk5qvLdbcqvP9KpQM3VLzXGYRgFW7+lReeA2cg1ntcAgknJqJZ8Ed89faq5DJ1TajlCwMxHI6e9RR3GfvtyO3vWb9qDRMgPuOarJOd5BPJGMk1SgZuqdJf6jgQxRbRFGoG7HJPc5+tMivCGUcbRzisGaZm56oOB7UJcFXVj9MCjkEqtjaa4Jb0GanNzGIwoJyB19axDeZQjAIJp5mLAFmHAGeentS5B+2NCS4AKnOc9z1qOS477j/Wsu5u8gfNwO3tUDXu1GxhmPc1SgZyqmhNd4JYH6H1NVp7olFGePU+tZrT78Bm6fpURmzj26VooGTqGj54LfNwD+NQPc4zhuc8E1nNMSOTz1ppkyM1agS5mg8wJ4PtxTRLgjn/69URMAjcnNRmYjnJ45xT5COc0XuGDZBpGuSzjLAnpzWX5rMCwPQYpnmnIPeq5CXM0XuyA6H1yc96iW7kDEKxUH071SMmSTnj0piSYcE9qpRM3I2JJQzbywJ4A46+tQtIcnaRn19aqfaFLAs52kYOPSiS53v8AIvB4X1p8pDkXhMohyzfP06e1VzKcAk/KO1VZZiyBSMEVEspAIPPFPlDmLbSDH/16haXBPNVmbAxmo2bjrT5Q5iV5SOAeKKpyyYXPHXHWiqsZuZzvrSikpa6zyxRThTKUHrSGSKcEVq2k2QKyKngkKNUyV0awlys6BHq1C2cc/WseCbKirkcnFc0onfCoa8cuWGeMdBVpZMHgniseKXB61ailB6n6VlKJ1wqGvBNz/Kr0VyR16evrWHHIO5xzUyTcnsM1k4GyqG79qxjGQKRrncDjOTxwe1ZH2gAZJyaXz8g9v8/yqOQv2hoPLkcE49DUUkjBSAflPb1NU1nzgZ5xzmmNOzKMkYXNNQE6hO8pJIFM847CAc9zVRpOOtQNMctyRyAPyq1EzlUL/n89OR0ppmUhiev1rPaYkHJJJ6YqIykd+KtQMnUNMXZxtHrTop/nOTnisgyEcn9actz5ZyhxT5Be0saj3BB2qMf0oa4zkehz1rMNwCGJOT1NRecTk560cgOoaJuCFOO9RmbOR0qh5vINMMpHU01Al1C682QwXrTPOHO0np+dU/Nzn3phfpg1SiQ5lxpPm49aakpz1PrVXfk80B6dhc5YEhJ68mnK2TyarhhjJ7mk3YosHMTs+SeeKZuzzzUJY5NIHUKefm7U7EuRKz5OajZqhdwM89BTTICDzTsQ5FjzMZI7U8XIyrHoBjFUZJBjjGKbu59xVWJci+8wOOaYXGapCQDvSF6LC5y2ZBk1G8gzVcyD1qNmHNPlJ5yWV8gZoquzcUU7C5jNpc80UVucQuaM0UUDFzTgeaKKQ0TwykVfhmz3oorOSN6bZbjlBFTxy46GiisWjrjJk6T+ufwqVZvU80UVDRspMkEnHPUdqBKeOelFFTYu7DziBzjr2NNknwBjnJxjNFFOyBtkbTHPBqASZGcEZ55680UU0iG2IJSpyvpiml8jJPSiiqMmyPzRTRKMkAiiiqsQ5MQycdaPOXkEkfTmiimkS5Mb51M83Oc0UUWFzMaZffilEnSiinYLsPNpTJ7c0UUrDuJvHFOD+uPaiiiwXYjSDnnrTDLjoBnHeiinYltkO/jkkn1NN3YA5NFFVYlsaX/OjzOeetFFOxNxhfpSF85NFFArhuxTS3NFFMVxrNRRRTsB/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Ringworm infections of the foot, also called athlete's foot, can cause the skin on the bottom of the foot to turn red and form scales.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of John T Crissey, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_23_26992=[""].join("\n");
var outline_f26_23_26992=null;
var title_f26_23_26993="Central line fem needle";
var content_f26_23_26993=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F66432&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F66432&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Aspiration of the common femoral vein in preparation for placement of a central venous catheter",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 273px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The common femoral vein lies superficial and medial to the femoral artery. When accessing the vein, orient the needle with the bevel up and introduce it angled 20 to 30 degrees to the skin. Insert the needle 1 to 2 cm inferior to the inguinal ligament and just medial to the femoral artery. The vessel is normally reached within 2 to 4 cm but may be deeper in obese or edematous patients.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     UpToDate acknowledges the invaluable assistance of the University of Massacusetts Medical School, Department of Anatomy and Department of Emergency Medicine, including Thomas Ellis, MD and Jean Marcelin, MD, for the photographs of central venous catheter placement.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_23_26993=[""].join("\n");
var outline_f26_23_26993=null;
var title_f26_23_26994="Patient information: Dysarthria (The Basics)";
var content_f26_23_26994=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?29/61/30674\">",
"         Patient information: Aphasia (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?7/13/7378\">",
"         Patient information: Dysphagia (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?14/14/14562\">",
"         Patient information: Myasthenia gravis (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?13/40/13954\">",
"         Patient information: Parkinson disease (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?3/45/3795\">",
"         Patient information: Recovery after stroke (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?23/55/24435\">",
"         Patient information: Stroke (The Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Dysarthria (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/dysarthria-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H6590949\">",
"      <span class=\"h1\">",
"       What is dysarthria?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Dysarthria is the term doctors use when a person loses the ability to control his or her mouth and throat to form speech. It can happen along with another disorder called aphasia, which impairs a person&rsquo;s ability to understand language. People who have only dysarthria can understand language; they just can&rsquo;t form words clearly.",
"     </p>",
"     <p>",
"      People with dysarthria might:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Slur their speech and sound as though they are drunk",
"       </li>",
"       <li>",
"        Speak very softly or in a whisper",
"       </li>",
"       <li>",
"        Speak too quickly or too slowly, or mumble",
"       </li>",
"       <li>",
"        Sound hoarse, nasal, or breathy when they talk",
"       </li>",
"       <li>",
"        Drool or have trouble controlling their saliva",
"       </li>",
"       <li>",
"        Have trouble chewing or swallowing",
"       </li>",
"       <li>",
"        Find that their face droops to 1 side",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H6590964\">",
"      <span class=\"h1\">",
"       What causes dysarthria?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Dysarthria is usually caused by a disease or an injury that damages the brain or the body&rsquo;s nerves or muscles. For example, dysarthria can happen because of these conditions:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Stroke",
"       </li>",
"       <li>",
"        Parkinson disease",
"       </li>",
"       <li>",
"        Amyotrophic lateral sclerosis, also known as &ldquo;ALS&rdquo; or Lou Gehrig's disease",
"       </li>",
"       <li>",
"        Multiple sclerosis (sometimes called &ldquo;MS&rdquo;)",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Some medicines, including medicines that make people sleepy, can also cause dysarthria.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H6590979\">",
"      <span class=\"h1\">",
"       Will I need tests?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Maybe. If you develop a new problem with speaking, your doctor or nurse will want to do an exam and learn about your problem. He or she will want to know what medicines you take and what else was happening when your problem started.",
"     </p>",
"     <p>",
"      It&rsquo;s also possible you will need 1 or more of these tests:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        MRI or CT scan &ndash; These are imaging tests that create pictures of the inside of the body. Doctors can use them to check for problems in the brain or in the nerves and muscles that control speech.",
"       </li>",
"       <li>",
"        Electromyography (also called &ldquo;EMG&rdquo;) or nerve conduction studies (also called &ldquo;NCS&rdquo;) &ndash; These tests check how well nerves and muscles are working.",
"       </li>",
"       <li>",
"        Blood and urine tests",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H6590994\">",
"      <span class=\"h1\">",
"       Will I regain my ability to speak?",
"      </span>",
"      &nbsp;&mdash;&nbsp;That depends on the cause of your dysarthria. If your dysarthria was caused by a stroke, you might be able to speak normally again one day. But if your dysarthria was caused by a nerve or muscle disorder that gets worse over time, it is less likely you will be able to speak normally again. Still, people with dysarthria can often learn new ways to communicate. For instance, they can learn to use alphabet boards to spell out the words they want to say. Plus, new technologies are being developed that use computers to help people speak.",
"     </p>",
"     <p>",
"      If you develop dysarthria, you will probably need to work with a speech and language therapist. He or she can give you exercises to do to improve the way you speak. If you have problems swallowing, the therapist can also help you learn about things that can improve your swallowing. For instance, he or she might recommend that you eat and drink only things that are thick and have few chunks. That way you are less likely to choke or have foods go down the wrong way.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H6591009\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?29/61/30674?source=see_link\">",
"       Patient information: Aphasia (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?7/13/7378?source=see_link\">",
"       Patient information: Dysphagia (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?3/45/3795?source=see_link\">",
"       Patient information: Recovery after stroke (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?23/55/24435?source=see_link\">",
"       Patient information: Stroke (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?13/40/13954?source=see_link\">",
"       Patient information: Parkinson disease (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?14/14/14562?source=see_link\">",
"       Patient information: Myasthenia gravis (The Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?26/23/26994?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 83334 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.55.141.10-F6FDDAB425-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_23_26994=[""].join("\n");
var outline_f26_23_26994=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6590949\">",
"      What is dysarthria?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6590964\">",
"      What causes dysarthria?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6590979\">",
"      Will I need tests?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6590994\">",
"      Will I regain my ability to speak?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6591009\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?29/61/30674?source=related_link\">",
"      Patient information: Aphasia (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?7/13/7378?source=related_link\">",
"      Patient information: Dysphagia (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?14/14/14562?source=related_link\">",
"      Patient information: Myasthenia gravis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?13/40/13954?source=related_link\">",
"      Patient information: Parkinson disease (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?3/45/3795?source=related_link\">",
"      Patient information: Recovery after stroke (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?23/55/24435?source=related_link\">",
"      Patient information: Stroke (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_23_26995="Anatomy female genitalia";
var content_f26_23_26995=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F62557&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F62557&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 487px\">",
"   <div class=\"ttl\">",
"    Anatomy of the female genitalia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 467px; height: 391px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Important landmarks of the female genitalia are depicted above.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_23_26995=[""].join("\n");
var outline_f26_23_26995=null;
var title_f26_23_26996="Disseminated gonorrhea";
var content_f26_23_26996=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F69978&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F69978&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Skin lesions in disseminated gonococcal infection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 367px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A hemorrhagic vesicopustule is present in the web space of this adolescent patient's hand. There is also a pustule on the sole of the foot.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Fleisher GR, Ludwig W, Baskin MN. Atlas of Pediatric Emergency Medicine, Lippincott Williams &amp; Wilkins, Philadelphia 2004. Copyright &copy; 2004 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_23_26996=[""].join("\n");
var outline_f26_23_26996=null;
var title_f26_23_26997="Dyshidrosiform bullous pemphigoid";
var content_f26_23_26997=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F50357&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F50357&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Dyshidrosiform bullous pemphigoid",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple eroded blisters with hemorrhagic bases on the palmar surface of the hands.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.&nbsp;&nbsp;",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_23_26997=[""].join("\n");
var outline_f26_23_26997=null;
var title_f26_23_26998="Cinacalcet: Drug information";
var content_f26_23_26998=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Cinacalcet: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?2/43/2741?source=see_link\">",
"    see \"Cinacalcet: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block spa drugH1Div\" id=\"F16254839\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Special Alerts",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      FDA Stops Pediatric Trials",
"     </span>",
"     <span class=\"collapsible-date\">",
"      February 2013",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:0em;margin-top:2em;\">",
"       The FDA has stopped all pediatric clinical trials of Sensipar&reg; (cinacalcet hydrochloride) after a recent death of a 14-year old patient in a trial. The FDA is currently evaluating the association of the patient's death and the use of cinacalcet. Cinacalcet is not currently approved for use in patients less than 18 years of age.",
"      </p>",
"      <p style=\"text-indent:0em;margin-top:2em;\">",
"       The FDA reminds healthcare professionals that patients receiving cinacalcet should be monitored for low serum calcium levels. Serum calcium levels should be monitored 1 week after initiation and after dosage adjustments and monthly thereafter.",
"      </p>",
"      <p style=\"text-indent:0em;margin-top:2em;\">",
"       Further information may be found at",
"       <a href=\"file://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm341255.htm\" target=\"_blank\">",
"        file://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm341255.htm",
"       </a>",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F151617\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Sensipar&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F5062253\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Sensipar&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F151636\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Calcimimetic",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F151619\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Do not titrate dose more frequently than every 2-4 weeks. Dosage adjustment may be required in patients on concurrent CYP3A4 inhibitors.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Secondary hyperparathyroidism:",
"     </b>",
"     Oral: Initial: 30 mg once daily (maximum daily dose: 180 mg); increase dose incrementally (60 mg, 90 mg, 120 mg, 180 mg once daily) as necessary to maintain intact parathyroid hormone (iPTH) level between 150-300 pg/mL.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Parathyroid carcinoma, primary hyperparathyroidism:",
"     </b>",
"     Oral: Initial: 30 mg twice daily (maximum daily dose: 360 mg daily as 90 mg 4 times/day); increase dose incrementally (60 mg twice daily, 90 mg twice daily, 90 mg 3-4 times/day) as necessary to normalize serum calcium levels.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F151620\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing. No adjustment required.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F151621\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No adjustment required.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F151622\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Patients with moderate-to-severe dysfunction (Child-Pugh class B or C) have an increased exposure to cinacalcet and increased half-life. Dosage adjustments may be necessary based on serum calcium, serum phosphorus and/or iPTH.",
"    </p>",
"   </div>",
"   <div class=\"block dot drugH1Div\" id=\"F151637\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adjustment for Toxicity",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Dosage adjustment for hypocalcemia:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     If serum calcium &gt;7.5 mg/dL but &lt;8.4 mg/dL",
"     <b>",
"      or",
"     </b>",
"     if hypocalcemia symptoms occur: Use calcium-containing phosphate binders and/or vitamin D to raise calcium levels.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     If serum calcium &lt;7.5 mg/dL",
"     <b>",
"      or",
"     </b>",
"     if hypocalcemia symptoms persist and the dose of vitamin D cannot be increased: Withhold cinacalcet until serum calcium &ge;8 mg/dL and/or symptoms of hypocalcemia resolve. Reinitiate cinacalcet at the next lowest dose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     If iPTH &lt;150-300 pg/mL: Reduce dose or discontinue cinacalcet and/or vitamin D.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F151594\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Sensipar&reg;: 30 mg, 60 mg, 90 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F151582\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F151597\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Administer with food or shortly after a meal. Do not break or divide tablet; should be taken whole.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F151596\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;margin-top:0em;display:inline\">",
"     Treatment of secondary hyperparathyroidism in patients with chronic kidney disease (CKD) on dialysis; treatment of hypercalcemia in patients with parathyroid carcinoma; treatment of severe hypercalcemia in patients with primary hyperparathyroidism who are unable to undergo parathyroidectomy",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F151634\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Fatigue (12% to 21%), headache (&le;21%), depression (10% to 18%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Hypocalcemia (&le;66%), dehydration (&le;24%), hypercalcemia (12% to 21%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Nausea (31% to 66%), vomiting (27% to 52%), diarrhea (&le;21%), anorexia (6% to 21%), constipation (10% to 18%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hematologic: Anemia (6% to 17%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Parasthesia (14% to 29%), fracture (12% to 21%), weakness (7% to 17%), arthralgia (6% to 17%), myalgia (&le;15%), limb pain (10% to 12%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Upper respiratory infection (10% to 12%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Hypertension (&le;7%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Dizziness (&le;10%), seizure (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Testosterone decreased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Chest pain (noncardiac; &le;6%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Postmarketing and/or case reports: Adynamic bone disease, angioedema, arrhythmia, heart failure, hypersensitivity reactions, hypotension (idiosyncratic), rash, urticaria",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F151600\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypocalcemia (serum calcium lower than the lower limit of normal range)",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:2em;\">",
"     Canadian labeling: Additional contraindications (not in U.S. labeling): Hypersensitivity to any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F151584\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Adynamic bone disease: May develop if intact parathyroid hormone (iPTH) levels are suppressed (&lt;100 pg/mL); reduce dose or discontinue use of cinacalcet and/or vitamin D if iPTH levels decrease below 150-300 pg/mL (NKF-K/DOQI guidelines).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular effects: Cases of idiosyncratic hypotension, worsening of heart failure, and/or arrhythmia have been reported in patients with impaired cardiovascular function; may correlate with decreased serum calcium.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypocalcemia: Use is contraindicated in hypocalcemia. Monitor serum calcium and for symptoms of hypocalcemia (eg, cramps, myalgia, paresthesia, seizure, tetany). May require treatment interruption, dose reduction, or initiation (or dose increases) of calcium-based phosphate binder or vitamin D to raise serum calcium depending on calcium levels or symptoms of hypocalcemia.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Testosterone level reductions: Cinacalcet may cause a decrease in testosterone levels (free and total).  Although below normal testosterone levels may occur in patients with end-stage renal disease, the clinical significance has not been determined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with moderate-to-severe hepatic impairment (Child-Pugh classes B and C); cinacalcet exposure and half-life are increased; monitor serum calcium, serum phosphorus and iPTH closely.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: In the U.S., the long-term safety and efficacy of cinacalcet has not been evaluated in chronic kidney disease (CKD) patients with hyperparathyroidism not requiring dialysis. Not indicated for CKD patients not receiving dialysis. Although possibly related to lower baseline calcium levels, clinical studies have shown an increased incidence of hypocalcemia (&lt;8.4 mg/dL) in patients not requiring dialysis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Seizure disorder: Use with caution in patients with a history of seizure disorder; seizure threshold is lowered by significant serum calcium reductions. Monitor calcium levels closely.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CYP2D6: Cinacalcet is a strong inhibitor of CYP2D6. If on concurrent therapy with a CYP2D6 substrate, dosage adjustment of the CYP2D6 substrate may be necessary.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CYP3A4: Monitor serum calcium and iPTH concentrations closely in patients on concurrent CYP3A4 inhibitors; dosage adjustment may be required.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F151630\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP1A2 (minor), CYP2D6 (minor), CYP3A4 (major);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential;",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP2D6 (strong)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F151588\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antifungal Agents (Azole Derivatives, Systemic): May decrease the metabolism of Cinacalcet.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Itraconazole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP2D6 Inhibitors (Strong) may increase the serum concentration of ARIPiprazole.  Management: See full interaction monograph for details.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP2D6 Inhibitors (Weak) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     AtoMOXetine: CYP2D6 Inhibitors (Strong) may increase the serum concentration of AtoMOXetine.  Management: Initiate atomoxetine at a reduced dose (adult doses -- patients up to 70kg: 0.5mg/kg/day; patients 70kg or more: 40mg/day) in patients receiving a strong CYP2D6 inhibitor.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Codeine: CYP2D6 Inhibitors (Strong) may diminish the therapeutic effect of Codeine. These CYP2D6 inhibitors may prevent the metabolic conversion of codeine to its active metabolite morphine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Conivaptan: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2D6 Substrates: CYP2D6 Inhibitors (Strong) may decrease the metabolism of CYP2D6 Substrates.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Tamoxifen.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Moderate): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Strong): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fesoterodine: CYP2D6 Inhibitors may increase serum concentrations of the active metabolite(s) of Fesoterodine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Iloperidone: CYP2D6 Inhibitors (Strong) may increase serum concentrations of the active metabolite(s) of Iloperidone. Specifically, concentrations of the metabolite P88 may be increased. CYP2D6 Inhibitors (Strong) may decrease serum concentrations of the active metabolite(s) of Iloperidone. Specifically, concentrations of the metabolite P95 may be decreased. CYP2D6 Inhibitors (Strong) may increase the serum concentration of Iloperidone.  Management: Reduce iloperidone dose by half when administered with a strong CYP2D6 inhibitor.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivacaftor: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metoprolol: CYP2D6 Inhibitors may increase the serum concentration of Metoprolol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May increase the serum concentration of CYP3A4 Substrates. Management: Minimize doses of CYP3A4 substrates, and monitor for increased concentrations/toxicity, during and 2 weeks following treatment with mifepristone. Avoid cyclosporine, dihydroergotamine, ergotamine, fentanyl, pimozide, quinidine, sirolimus, and tacrolimus.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nebivolol: CYP2D6 Inhibitors (Strong) may increase the serum concentration of Nebivolol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Peginterferon Alfa-2b: May decrease the serum concentration of CYP2D6 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimozide: CYP2D6 Inhibitors (Strong) may increase the serum concentration of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Propafenone: CYP2D6 Inhibitors (Strong) may increase the serum concentration of Propafenone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tacrolimus (Systemic): Cinacalcet may decrease the serum concentration of Tacrolimus (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tamoxifen: CYP2D6 Inhibitors (Strong) may decrease serum concentrations of the active metabolite(s) of Tamoxifen. Specifically, strong CYP2D6 inhibitors may decrease the metabolic formation of highly potent active metabolites.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tetrabenazine: CYP2D6 Inhibitors (Strong) may increase the serum concentration of Tetrabenazine. Specifically, concentrations of the active alpha- and beta-dihydrotetrabenazine metabolites may be increased.  Management: Tetrabenazine adult dose should be reduced by 50% when starting a strong CYP2D6 inhibitor.  Maximum tetrabenazine adult dose is 50 mg/day when used with a strong CYP2D6 inhibitor.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thioridazine: CYP2D6 Inhibitors may decrease the metabolism of Thioridazine.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     TraMADol: CYP2D6 Inhibitors (Strong) may diminish the therapeutic effect of TraMADol. These CYP2D6 inhibitors may prevent the metabolic conversion of tramadol to its active metabolite that accounts for much of its opioid-like effects.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tricyclic Antidepressants: Cinacalcet may increase the serum concentration of Tricyclic Antidepressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F151614\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Food: Food increases bioavailability. Management: Administer with food or shortly after a meal.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F151590\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F151603\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     In animal studies, there were no teratogenic effects observed, although decreased pup weights were noted. There are no adequate or well-controlled studies in pregnant women. Use in pregnancy only if potential benefit to mother justifies risk to the fetus. Women who become pregnant during cinacalcet treatment are encouraged to enroll in Amgen&rsquo;s Pregnancy Surveillance Program (1-800-772-6436).",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F151626\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F151604\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Due to the potential for serious adverse effects in the nursing infant, the manufacturer recommends discontinuing nursing or discontinuing cinacalcet.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F151605\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Take with food or shortly after a meal. May be taken with vitamin D and/or phosphate binders.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F151602\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Sensipar Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     30 mg (30): $532.44",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     60 mg (30): $1064.88",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     90 mg (30): $1597.32",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F151592\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Secondary hyperparathyroidism: Serum calcium and phosphorus levels prior to initiation and within a week of initiation or dosage adjustment; iPTH should be measured 1-4 weeks after initiation or dosage adjustment. After the maintenance dose is established, monthly calcium and phosphorus levels and iPTH every 1-3 months are required. Wait at least 12 hours after dose before drawing iPTH levels.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Parathyroid carcinoma and primary hyperparathyroidism: Serum calcium levels prior to initiation and within a week of initiation or dosage adjustment; once maintenance dose is established, obtain serum calcium every 2 months.",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F151595\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CKD K/DOQI guidelines definition of stages; chronic disease is kidney damage or GFR &lt;60 mL/minute/1.73 m",
"     <sup>",
"      2",
"     </sup>",
"     for &ge;3 months:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Stage 2: GFR 60-89 mL/minute/1.73 m",
"     <sup>",
"      2",
"     </sup>",
"     (kidney damage with mild decrease GFR)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Stage 3: GFR 30-59 mL/minute/1.73 m",
"     <sup>",
"      2",
"     </sup>",
"     (moderate decrease GFR)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Stage 4: GFR 15-29 mL/minute/1.73 m",
"     <sup>",
"      2",
"     </sup>",
"     (severe decrease GFR)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Stage 5: GFR &lt;15 mL/minute/1.73 m",
"     <sup>",
"      2",
"     </sup>",
"     or dialysis (kidney failure)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Target range for iPTH: Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Stage 3 CKD: 35-70 pg/mL",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Stage 4 CKD: 70-110 pg/mL",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Stage 5 CKD: 150-300 pg/mL",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Serum phosphorus: Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Stage 3 and 4 CKD: &ge;2.7 to &lt;4.6 mg/dL",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Stage 5 CKD: 3.5-5.5 mg/dL",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Serum calcium-phosphorus product: Adults: Stage 3-5 CKD: &lt;55 mg",
"     <sup>",
"      2",
"     </sup>",
"     /dL",
"     <sup>",
"      2",
"     </sup>",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F5539832\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Mimpara (AT, BE, BG, CH, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HN, IE, IL, IT, MT, NL, NO, PL, PT, RU, SE, SK, TR);",
"     </li>",
"     <li>",
"      Parareg (ES);",
"     </li>",
"     <li>",
"      Regpara (HK, SG, TW);",
"     </li>",
"     <li>",
"      Sensipar (AU, NZ)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F151583\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Increases the sensitivity of the calcium-sensing receptor on the parathyroid gland thereby, concomitantly lowering parathyroid hormone (PTH), serum calcium, and serum phosphorus levels, preventing progressive bone disease and adverse events associated with mineral metabolism disorders.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F151599\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : ~1000 L",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: ~93% to 97%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic (extensive) via CYP3A4, 2D6, 1A2; forms inactive metabolites",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Terminal: 30-40 hours; moderate hepatic impairment: 65 hours; severe hepatic impairment: 84 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, plasma: ~2-6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine ~80% (as metabolites); feces ~15%",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Block GA, Martin KJ, de Francisco AL, et al, &ldquo;Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2004, 350(15):1516-25.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/23/26998/abstract-text/15071126/pubmed\" id=\"15071126\" target=\"_blank\">",
"        15071126",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Eknoyan G, Levin A, and Levin NW, &ldquo;Bone Metabolism and Disease in Chronic Kidney Disease,&rdquo;",
"      <i>",
"       Am J Kidney Dis",
"      </i>",
"      , 2003, 42(4 Suppl 3):1-201.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Marcocci C, Chanson P, Shoback D, et al, &ldquo;Cinacalcet Reduces Serum Calcium Concentrations in Patients With Intractable Primary Hyperparathyroidism,&rdquo;",
"      <i>",
"       J Clin Endocrinol Metab",
"      </i>",
"      , 2009, 94(8):2766-72.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/23/26998/abstract-text/19470620/pubmed\" id=\"19470620\" target=\"_blank\">",
"        19470620",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Moe SM, Cunningham J, Bommer J, et al, &ldquo;Long-Term Treatment of Secondary Hyperparathyroidism With the Calcimimetic Cinacalcet HCl,&rdquo;",
"      <i>",
"       Nephrol Dial Transplant",
"      </i>",
"      , 2005, 20(10):2186-93.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/23/26998/abstract-text/16030053/pubmed\" id=\"16030053\" target=\"_blank\">",
"        16030053",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Guideline 13: Treatment of Bone Disease in Chronic Kidney Disease. Available at file://www.kidney.org/professionals/kdoqi/guidelines_bone/index.htm",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Silverberg SJ, Rubin MR, Faiman C, et al, &ldquo;Cinacalcet Hydrochloride Reduces the Serum Calcium Concentration in Inoperable Parathyroid Carcinoma,&rdquo;",
"      <i>",
"       J Clin Endocrinol Metab",
"      </i>",
"      , 2007, 92(10):3803-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/23/26998/abstract-text/17666472/pubmed\" id=\"17666472\" target=\"_blank\">",
"        17666472",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8850 Version 42.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-8E53C3882F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_23_26998=[""].join("\n");
var outline_f26_23_26998=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16254839\">",
"      Special Alerts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151617\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5062253\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151636\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151619\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151620\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151621\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151622\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151637\">",
"      Dosing: Adjustment for Toxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151594\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151582\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151597\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151596\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151634\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151600\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151584\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151630\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151588\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151614\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151590\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151603\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151626\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151604\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151605\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151602\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151592\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151595\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5539832\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151583\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151599\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8850\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8850|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?2/43/2741?source=related_link\">",
"      Cinacalcet: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_23_26999="Neonatal hypocalcemia";
var content_f26_23_26999=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Neonatal hypocalcemia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/23/26999/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/23/26999/contributors\">",
"     Steven A Abrams, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/23/26999/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/23/26999/contributors\">",
"     Joseph A Garcia-Prats, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/23/26999/contributors\">",
"     Joseph I Wolfsdorf, MB, BCh",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/23/26999/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/23/26999/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?26/23/26999/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 12, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypocalcemia is a common metabolic problem in newborns. The diagnosis, clinical manifestations, and treatment of neonatal hypocalcemia are reviewed here. Calcium (Ca) requirements and the etiology of hypocalcemia after the neonatal period are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/39/40567?source=see_link\">",
"     \"Calcium and phosphorus requirements of newborn infants\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/24/35209?source=see_link\">",
"     \"Etiology of hypocalcemia in infants and children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PERINATAL METABOLISM",
"    </span>",
"    &nbsp;&mdash;&nbsp;During pregnancy, calcium is transferred actively from the maternal circulation to the fetus by a transplacental Ca pump regulated by parathyroid hormone-related peptide (PTHrP) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/26999/abstract/1\">",
"     1",
"    </a>",
"    ]. The majority of fetal Ca accretion occurs in the third trimester. This process results in higher plasma Ca concentrations in the fetus than in the mother and leads to fetal hypercalcemia, with total and ionized Ca concentrations of 10 to 11",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (2.5 to 2.75",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    and 6",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (1.5",
"    <span class=\"nowrap\">",
"     mmol/L),",
"    </span>",
"    respectively, in umbilical cord blood at term [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/26999/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    After the abrupt cessation of placental transfer of Ca at birth, total serum Ca concentration falls to 8 to 9",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (2 to 2.25",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    and ionized Ca to as low as 4.4 to 5.4",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (1.1 to 1.35",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    at 24 hours [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/26999/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. Serum Ca concentration subsequently rises, reaching levels seen in older children and adults by two weeks of age [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/26999/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     MEASUREMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Within the plasma, Ca circulates in different forms. Approximately 40 percent is bound to serum proteins, principally albumin; 10 percent is complexed with citrate, bicarbonate, sulfate, or phosphate; and 50 percent exists as the physiologically important ionized (or free) calcium [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/26999/abstract/6\">",
"     6",
"    </a>",
"    ]. The ionized Ca concentration is tightly regulated by parathyroid hormone and vitamin D.",
"   </p>",
"   <p>",
"    Measurement of the total plasma Ca concentration alone can be misleading because the relationship between total and ionized Ca is not always linear. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/8/23685?source=see_link\">",
"     \"Relation between total and ionized serum calcium concentration\"",
"    </a>",
"    .) Correlation is poor when the serum albumin concentration is low or, to a lesser degree, with disturbances in acid-base status, both of which occur frequently in premature or ill infants. With hypoalbuminemia, the total Ca concentration will be low while the ionized fraction will be normal unless some other factor is affecting Ca metabolism. In general, the plasma calcium concentration falls by 0.8",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (0.2",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    for every 1.0",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    (10",
"    <span class=\"nowrap\">",
"     g/L)",
"    </span>",
"    fall in the plasma albumin concentration.",
"   </p>",
"   <p>",
"    Disturbances in acid-base status can change the ionized Ca concentration without affecting the total Ca level. An elevation in extracellular pH, for example, increases the binding of calcium to albumin, thereby lowering the plasma-ionized Ca concentration [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/26999/abstract/7\">",
"     7",
"    </a>",
"    ]. The fall in ionized calcium with acute respiratory alkalosis is approximately 0.16",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (0.04",
"    <span class=\"nowrap\">",
"     mmol/L",
"    </span>",
"    or 0.08",
"    <span class=\"nowrap\">",
"     mEq/L)",
"    </span>",
"    for each 0.1 unit increase in pH [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/26999/abstract/7\">",
"     7",
"    </a>",
"    ]. Thus, acute respiratory alkalosis can induce signs of hypocalcemia, although the alkalosis is primarily responsible. Conversely, with metabolic acidosis, binding of Ca to albumin is reduced, and the ionized Ca concentration will be increased.",
"   </p>",
"   <p>",
"    For these reasons, we recommend the measurement of whole blood ionized Ca concentration in newborns who are premature or ill and are, therefore, at risk for hypocalcemia [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/26999/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     DEFINITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The definition of hypocalcemia depends upon gestational age and birth weight:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In term infants or premature infants greater than 1500 g birth weight, we define hypocalcemia as a total serum Ca concentration less than 8",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (2",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      or an ionized fraction of less than 4.4",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (1.1",
"      <span class=\"nowrap\">",
"       mmol/L).",
"      </span>",
"     </li>",
"     <li>",
"      Premature infants with birth weight less than 1500 g are considered to have hypocalcemia if they have a total serum Ca concentration less than 7",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (1.75",
"      <span class=\"nowrap\">",
"       mmol/L).",
"      </span>",
"      In general, symptoms are uncommon in infants &lt;1500 g whose ionized calcium is &gt;0.8-0.9",
"      <span class=\"nowrap\">",
"       mmol/L.",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     EARLY HYPOCALCEMIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;The causes of neonatal hypocalcemia are classified by the timing of onset. Hypocalcemia is considered to be early when it occurs in the first two to three days after birth. Early hypocalcemia is an exaggeration of the normal decline in Ca concentration after birth. It occurs commonly in premature infants and in infants of diabetic mothers (IDMs) and is seen also after perinatal asphyxia or intrauterine growth restriction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Prematurity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately one-third of premature infants and the majority of very-low-birth-weight infants have low total serum Ca concentrations during the first two days after birth [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/26999/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. Multiple factors contribute to the fall in total serum Ca and include hypoalbuminemia, which does not lower the ionized Ca, and factors that lower both total and ionized Ca such as reduced intake of Ca because of low intake of milk, possible impaired response to parathyroid hormone (PTH), increased calcitonin levels, and increased urinary losses accompanying high renal sodium excretion [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/26999/abstract/5\">",
"     5",
"    </a>",
"    ]. Most premature infants are asymptomatic because the fall in total serum Ca typically is greater than the fall in ionized Ca; this fall results from hypoalbuminemia and, in some cases, mild metabolic acidosis, which tends to raise the ionized Ca. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Measurement'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Infants of diabetic mothers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypocalcemia occurs in at least 10 to 20 percent of IDMs and in as many as 50 percent in some series [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/26999/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/48/44809?source=see_link\">",
"     \"Infant of a diabetic mother\"",
"    </a>",
"    .) The lowest serum Ca concentration typically occurs between 24 to 72 hours after birth and often is associated with hyperphosphatemia. The extent of hypocalcemia is related to the severity and duration of maternal diabetes. Hypocalcemia is thought to be caused by lower PTH concentrations after birth in IDMs compared to normal infants [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/26999/abstract/13\">",
"     13",
"    </a>",
"    ]. Why this lower concentration occurs is not well understood. Higher serum ionized Ca concentrations in utero in IDMs may suppress the fetal parathyroid glands [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/26999/abstract/13\">",
"     13",
"    </a>",
"    ]. The development of hypomagnesemia, prematurity, and birth asphyxia may be contributing factors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Birth asphyxia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infants with birth asphyxia frequently have hypocalcemia and hyperphosphatemia. Possible mechanisms include increased phosphate load caused by tissue catabolism, decreased intake due to delayed initiation of feedings, renal insufficiency, acidosis, and increased serum calcitonin concentration [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/26999/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Intrauterine growth restriction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypocalcemia occurs with increased frequency in infants with intrauterine growth restriction. The risk increases with the severity of growth failure [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/26999/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. The mechanism is thought to involve decreased transfer of calcium across the placenta.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Other causes",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Gentamicin therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;In one case report,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/48/37632?source=see_link\">",
"     gentamicin",
"    </a>",
"    therapy was associated with a decrease in serum Ca [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/26999/abstract/18\">",
"     18",
"    </a>",
"    ]. Further studies are needed to confirm whether or not there is a causal relationship between this medication and calcium to evaluate the effects of different gentamicin regimens on ionized Ca.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Maternal vitamin D deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neonatal hypocalcemia due to severe maternal vitamin D deficiency has been noted in a single case report from Australia and a case series from the Middle East [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/26999/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. In these patients, neonatal hypocalcemia mostly occurred during the second week of life which is later than is typical for other causes of hypocalcemia [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/26999/abstract/20\">",
"     20",
"    </a>",
"    ]. Levels of 25-hydroxyvitamin D were extremely low in mothers and most infants; however, it remains uncertain whether vitamin D deficiency was the primary etiology. Further confirmation is required to establish causality. Nevertheless, these findings emphasize the importance of adequate maternal vitamin D intake, such as the 600",
"    <span class=\"nowrap\">",
"     IU/day",
"    </span>",
"    recommended in the Recommended Dietary Allowance by the Institute of Medicine [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/26999/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     LATE HYPOCALCEMIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Late hypocalcemia develops after the second or third day after birth and typically occurs at the end of the first week [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/26999/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Hypoparathyroidism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypoparathyroidism associated with excess phosphorus intake is a common cause of late neonatal hypocalcemia [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/26999/abstract/22\">",
"     22",
"    </a>",
"    ]. Hypoparathyroidism also can occur as part of a syndrome.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     DiGeorge syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most prevalent syndrome that includes hypoparathyroidism is the DiGeorge syndrome (DGS, also called DiGeorge anomaly). This disorder arises from a failure of migration of neural crest cells into the third and fourth pharyngeal pouches. Affected patients typically present in the first week after birth with signs of hypocalcemia, such as tetany or seizures, secondary to hypoplastic or absent parathyroid glands. They have characteristic facial features that include a small mouth, a submucous cleft palate, abnormal and low set ears, upturned nose, and a widened distance between the inner canthi (telecanthus) with short palpebral fissures [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/26999/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. Cardiac defects, especially abnormalities of the outflow tract or aortic arch, (eg, truncus arteriosus, tetralogy of Fallot, or interrupted aortic arch), frequently are present. Thymic hypoplasia results in an immune defect that is highly variable. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/37/32343?source=see_link\">",
"     \"DiGeorge syndrome: Epidemiology and pathogenesis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/15/15608?source=see_link\">",
"     \"DiGeorge syndrome: Management and prognosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Approximately 80 to 90 percent of patients with DGS have microdeletions involving chromosome 22q11-pter [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/26999/abstract/25\">",
"     25",
"    </a>",
"    ]; fluorescence in situ hybridization with DNA probes specific for this region establishes the diagnosis. DGS appears to be the most severe phenotype of a group of related disorders known as CATCH 22 syndrome, an acronym for cardiac defects, abnormal facies, thymic hypoplasia, cleft palate, and hypocalcemia caused by chromosome 22q11 deletion [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/26999/abstract/25\">",
"     25",
"    </a>",
"    ]. Other rarer syndromes that include hypoparathyroidism are Kearns-Sayre and Kenny-Caffey syndromes, which are mitochondrial cytopathies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Maternal hyperparathyroidism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infants born to mothers with hyperparathyroidism frequently have hypocalcemia. The mechanism is related to increased transplacental transport of Ca caused by high maternal Ca concentrations, which results in fetal hypercalcemia that exceeds physiologic levels and leads to suppression of fetal and neonatal PTH secretion. Affected infants typically develop increased neuromuscular irritability in the first three weeks after birth, but they can present later [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/26999/abstract/5\">",
"     5",
"    </a>",
"    ]. Some infants also have hypomagnesemia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Hypomagnesemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypomagnesemia causes resistance to PTH and impairs PTH secretion, both of which can result in hypocalcemia. The most common etiology in newborns is transient hypomagnesemia, although rare disorders of intestinal",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    renal tubular magnesium transport can occur. In transient cases, the serum magnesium concentration typically is 0.8 to 1.4",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (0.33 to 0.58",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    (normal values are 1.6 to 2.8",
"    <span class=\"nowrap\">",
"     mg/dL,",
"    </span>",
"    0.66 to 1.16",
"    <span class=\"nowrap\">",
"     mmol/L);",
"    </span>",
"    more severe reductions occur in the transport defects [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/26999/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H198229277\">",
"    <span class=\"h2\">",
"     Vitamin D insufficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Any disorder of vitamin D metabolism can lower serum Ca. In a case series of 78 neonates who presented with severe neonatal hypocalcemia, levels of 25-hydroxyvitamin D were deemed by the authors to be insufficient (ie, &lt;25",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    [62.4",
"    <span class=\"nowrap\">",
"     nmol/L])",
"    </span>",
"    in all of the 42 infants in whom they were determined [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/26999/abstract/22\">",
"     22",
"    </a>",
"    ]. However, this value of 25",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    has not been established in infants or in any age group to be biologically the value for any clinical disorders. Therefore, the true role of low vitamin D status has yet to be determined. Maternal levels of low 25-hydroxyvitamin D levels were not measured but the authors speculate based on other reports that maternal vitamin D insufficiency was a contributing factor to neonatal vitamin D insufficiency. In addition, these infants had severe hypomagnesemia and parathyroid hormone levels that were inappropriately low. The combination of multiple biochemical abnormalities may have led to severe late-onset hypocalcemia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/24/35209?source=see_link\">",
"     \"Etiology of hypocalcemia in infants and children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     High phosphate intake",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intake of excess phosphate is an historically important cause of late hypocalcemia that was seen in term infants fed bovine milk or a bovine milk-based formula with a high phosphorus concentration. The mechanism is uncertain, but the high phosphorus level may antagonize PTH secretion or actions, or it may produce increased Ca and phosphorus deposition in bones, leading to hypocalcemia [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/26999/abstract/26\">",
"     26",
"    </a>",
"    ]. Symptomatic infants typically present with tetany or seizures at 5 to 10 days of age [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/26999/abstract/26\">",
"     26",
"    </a>",
"    ]. This condition rarely is seen in the United States because the phosphorus concentration in infant formulas has been lowered. Severe hyperphosphatemia and hypocalcemia also can be caused by phosphate enemas [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/26999/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Other causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Critically ill or premature infants are exposed to many therapeutic interventions that may cause transient hypocalcemia.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bicarbonate infusion, resulting in metabolic alkalosis, or transfusion with citrated blood, leading to formation of Ca complexes, decreases ionized Ca concentration. Lipid infusions also may reduce ionized Ca levels by formation of Ca complexes with free fatty acids.",
"     </li>",
"     <li>",
"      Mild hypocalcemia has been associated with phototherapy for hyperbilirubinemia. The mechanism may be related to decreased melatonin secretion, leading to increased Ca uptake by bone [",
"      <a class=\"abstract\" href=\"UTD.htm?26/23/26999/abstract/28\">",
"       28",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other causes include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute renal failure of any cause, usually associated with hyperphosphatemia. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/30/27114?source=see_link\">",
"       \"Acute kidney injury (acute renal failure) in the newborn\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hypocalcemia has been described with rotavirus infection [",
"      <a class=\"abstract\" href=\"UTD.htm?26/23/26999/abstract/29\">",
"       29",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/48/26376?source=see_link\">",
"       \"Clinical presentation and diagnosis of rotavirus infection\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most infants with hypocalcemia are asymptomatic. Among those who become symptomatic, the characteristic sign is increased neuromuscular irritability. Such infants are jittery and often have muscle jerking that is induced by environmental noise or other stimuli. Generalized or focal clonic seizures may occur. Rare presentations include inspiratory stridor caused by laryngospasm, wheezing caused by bronchospasm, or vomiting possibly resulting from pylorospasm [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/26999/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the previously mentioned case series of 78 full-term neonates admitted with late severe hypocalcemia (median levels of total and ionized calcium of 1.5 and 0.81",
"    <span class=\"nowrap\">",
"     mmol/L",
"    </span>",
"    [6 and 3.24",
"    <span class=\"nowrap\">",
"     mg/dL]),",
"    </span>",
"    most presented with seizure-like activity that was deemed consistent with tetany in the context of low calcium levels [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/26999/abstract/22\">",
"     22",
"    </a>",
"    ]. These patients also had hyperphosphatemia (median level of 3.2",
"    <span class=\"nowrap\">",
"     mmol/L",
"    </span>",
"    [9.9",
"    <span class=\"nowrap\">",
"     mg/dL]),",
"    </span>",
"    hypomagnesemia (median level of 0.58",
"    <span class=\"nowrap\">",
"     mmol/L",
"    </span>",
"    [1.4",
"    <span class=\"nowrap\">",
"     mg/dL]),",
"    </span>",
"    and inappropriately low parathyroid hormone levels.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because most infants with hypocalcemia are asymptomatic, we monitor serum Ca in infants with risk factors. Ionized Ca is optimal because only this measurement can be used to assess the risk of symptoms in all age groups. Total serum Ca is measured if ionized Ca is unavailable. However, one should recognize that relatively low total Ca values (5.5 to 7.0",
"    <span class=\"nowrap\">",
"     mg/dL,",
"    </span>",
"    1.4 to 1.75",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    may not be pathologic in premature infants. Similarly, ionized Ca values of 0.8 to 1.0",
"    <span class=\"nowrap\">",
"     mmol/L",
"    </span>",
"    are uncommonly associated with symptoms in very low birth weight infants.",
"   </p>",
"   <p>",
"    In infants who are extremely low-birth-weight (less than 1000 g) or who are ill, we measure the Ca concentration at 12, 24, and 48 hours of age. In premature infants with birth weight 1000 to 1500 g, Ca is measured at 24 and 48 hours. We continue monitoring until Ca values are normal and Ca intake from milk or parenteral nutrition is adequate, which usually occurs by 96 hours. The use of early parenteral nutrition is usually the optimal route for providing calcium to this group.",
"   </p>",
"   <p>",
"    Serum Ca also is measured in any infant with signs consistent with hypocalcemia and in infants with congenital heart disease. We do",
"    <strong>",
"     not",
"    </strong>",
"    routinely monitor asymptomatic healthy premature infants with birth weight greater than 1500 g or healthy infants of diabetic mothers who are taking milk feedings on the first day. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/48/44809?source=see_link\">",
"     \"Infant of a diabetic mother\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The effect of hypocalcemia on cardiac repolarization may be reflected in prolongation of the QTc interval (QT interval corrected for heart rate) on the electrocardiogram (ECG) to greater than 0.4 seconds. However, the QTc interval does not correlate reliably with blood ionized Ca levels [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/26999/abstract/30\">",
"     30",
"    </a>",
"    ]. We do not recommend use of the ECG to screen for hypocalcemia.",
"   </p>",
"   <p>",
"    Infants require further evaluation if they have persistent early hypocalcemia that does not respond to treatment, develop late hypocalcemia, or have associated seizures. Genetic and cardiac studies are performed to detect possible DiGeorge syndrome. Serum levels of magnesium and phosphorus should be measured; additional studies may include serum PTH and 25-hydroxy-vitamin D levels, urinary Ca concentration, and assessment of renal function.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most early hypocalcemia is asymptomatic and resolves without treatment. Thus, management is directed at providing adequate Ca intake by initiating early feedings, if possible. For infants who require parenteral nutrition, Ca is added to the solution as 10 percent Ca gluconate (500",
"    <span class=\"nowrap\">",
"     mg/kg,",
"    </span>",
"    50",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    of elemental calcium) per day and given as a continuous infusion. If parenteral Ca infusion is continued for more than 48 hours, additional phosphorus also must be provided based on serum phosphorus measurements.",
"   </p>",
"   <p>",
"    Treatment also should be directed against any underlying disease, if possible. Examples include hypomagnesemia, hyperphosphatemia, and vitamin D deficiency. (See below). For the last disorder, we give the vitamin D analogue calcitriol and monitor serum Ca levels at least weekly.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Symptomatic infants",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infants with signs of hypocalcemia, including severe neuromuscular irritability or seizures, are treated with 10 percent",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?40/13/41175?source=see_link\">",
"     calcium gluconate",
"    </a>",
"    (100",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    or 1",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    IV) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/26999/abstract/22\">",
"     22",
"    </a>",
"    ]. The solution is infused over 5 to 10 minutes while the heart rate and infusion site are monitored. The dose can be repeated in 10 minutes if no response occurs. Alternatively,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?18/63/19446?source=see_link\">",
"     calcium chloride",
"    </a>",
"    (20",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    or 0.2",
"    <span class=\"nowrap\">",
"     mL/kg)",
"    </span>",
"    can be given; this preparation is metabolized more rapidly and may be preferable if it is readily available.",
"   </p>",
"   <p>",
"    After acute treatment, maintenance Ca gluconate should be added to the intravenous solution. If enteral feedings are tolerated, we use Ca glubionate (30 to 50",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day PO in four divided doses), although its high osmolality and sugar content can cause gastrointestinal irritability or diarrhea. Alternatively, 10 percent Ca gluconate (500",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day) can be divided and given in four to six feedings.",
"   </p>",
"   <p>",
"    For late hypocalcemia, some recommend the use of calcitriol as an adjuvant therapy to gastrointestinal absorption of calcium. This usually is discontinued after 1 to 2 weeks.",
"   </p>",
"   <p>",
"    In a single case report, recombinant parathyroid hormone (PTH) therapy in a 17-day-old infant successfully corrected hypocalcemia with hypoparathyroidism that was refractory to calcium and calcitriol therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/26999/abstract/31\">",
"     31",
"    </a>",
"    ]. However, the long-term effects of PTH therapy are unknown and further studies are needed to determine whether recombinant PTH is efficacious and safe in neonates before this intervention can be recommended.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Risks of calcium infusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intravenous infusion of Ca gluconate is associated with risks that must be weighed against the benefits of treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/26999/abstract/32\">",
"     32",
"    </a>",
"    ]. Risks include bradyarrhythmias that can result from rapid elevations in serum Ca concentration and extravasation into subcutaneous tissues, resulting in necrosis and subcutaneous calcifications. Hepatic necrosis can be caused by infusion through an umbilical venous catheter if the tip is in a branch of the portal vein.",
"   </p>",
"   <p>",
"    Ca should",
"    <strong>",
"     not",
"    </strong>",
"    be infused into an umbilical artery catheter because arterial spasm may result, potentially compromising intestinal blood flow.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Correction of hypomagnesemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;When hypocalcemia is associated with hypomagnesemia, correction of the hypocalcemia requires correction of the hypomagnesemia. We treat with 50 percent",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/29/34262?source=see_link\">",
"     magnesium sulfate",
"    </a>",
"    solution (500 mg or 4",
"    <span class=\"nowrap\">",
"     mEq/mL).",
"    </span>",
"    Magnesium sulfate (25 to 50",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    or 0.2 to 0.4",
"    <span class=\"nowrap\">",
"     mEq/kg",
"    </span>",
"    per dose Q12h, IV over at least two hours or IM) is given until the serum magnesium concentration is greater than 1.5",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (0.62",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"    The magnesium concentration is measured before each dose. One or two doses usually is adequate to achieve normal levels. We avoid rapid intravenous infusions that may cause arrhythmias.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Hyperphosphatemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infants with hyperphosphatemia are fed a diet high in calcium and low in phosphorus. Human milk is preferable; if it is not available, we use a formula with low phosphorus content such as Similac PM",
"    <span class=\"nowrap\">",
"     60/40",
"    </span>",
"    or Good Start. We also provide oral calcium supplements such as",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?24/29/25045?source=see_link\">",
"     calcium glubionate",
"    </a>",
"    (30 to 50",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day PO in four divided doses) to increase the relative absorbed calcium to phosphorus ratio.",
"   </p>",
"   <p>",
"    Serum concentrations of Ca and P improve within three to five days after starting therapy. We discontinue Ca supplements gradually after one week, and switch the infant to routine formula after two to four weeks.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypocalcemia is a common metabolic problem in newborns.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the neonate, hypocalcemia is defined by birth weight (BW). In infants with BW greater than 1500 g, hypocalcemia is defined as a total serum Ca concentration less than 8",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (2",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      or an ionized fraction of less than 4.4",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (1.1",
"      <span class=\"nowrap\">",
"       mmol/L).",
"      </span>",
"      In very low birth weight premature infants (BW &lt;1500), hypocalcemia is defined as a total serum Ca concentration less than 7",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (1.75",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      or an ionized fraction of less than 4",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (1",
"      <span class=\"nowrap\">",
"       mmol/L).",
"      </span>",
"      (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Definition'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Causes of hypocalcemia are classified based upon their time of onset. Etiologies of early hypocalcemia (occurs in the first two to three days after birth) include prematurity, maternal diabetes, birth asphyxia, and intrauterine growth restriction. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Early hypocalcemia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Late hypocalcemia usually occurs at the end of the first week of life but may occur earlier after the second or third day after birth. Causes of late hypocalcemia include hypoparathyroidism and high phosphate intake. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Late hypocalcemia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most infants with hypocalcemia are asymptomatic. If symptomatic, neuromuscular irritability is the most common sign with jitteriness and muscle jerking. Less common findings include seizures, and rarely laryngospasm, wheezing, or vomiting. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis is most commonly made because of the detection of an abnormally low serum Ca value during routine monitoring. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Early hypocalcemia generally resolves without treatment. In asymptomatic infants, management is directed at providing adequate Ca intake by initiating early feedings, if possible, or parenteral nutrition and correcting any underlying disorder resulting in a low calcium value. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In symptomatic patients, parenteral calcium therapy is provided as a 10 percent",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?40/13/41175?source=see_link\">",
"       calcium gluconate",
"      </a>",
"      solution at a dose of 100",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      or 1",
"      <span class=\"nowrap\">",
"       mL/kg.",
"      </span>",
"      Further supplementation is provided either parenterally or orally, if enteral feeds are tolerated (see",
"      <a class=\"local\" href=\"#H22\">",
"       'Management'",
"      </a>",
"      above).",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/26999/abstract/1\">",
"      Kovacs CS, Lanske B, Hunzelman JL, et al. Parathyroid hormone-related peptide (PTHrP) regulates fetal-placental calcium transport through a receptor distinct from the PTH/PTHrP receptor. Proc Natl Acad Sci U S A 1996; 93:15233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/26999/abstract/2\">",
"      Rubin LP, Posillico JT, Anast CS, Brown EM. Circulating levels of biologically active and immunoreactive intact parathyroid hormone in human newborns. Pediatr Res 1991; 29:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/26999/abstract/3\">",
"      Loughead JL, Mimouni F, Tsang RC. Serum ionized calcium concentrations in normal neonates. Am J Dis Child 1988; 142:516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/26999/abstract/4\">",
"      Wandrup J, Kroner J, Pryds O, Kastrup KW. Age-related reference values for ionized calcium in the first week of life in premature and full-term neonates. Scand J Clin Lab Invest 1988; 48:255.",
"     </a>",
"    </li>",
"    <li>",
"     Rubin LP. Disorders of calcium and phosporus metabolism. In: Avery's Diseases of the Newborn, 7th ed, Taeusch HW, Ballard RA (Eds), WB Saunders, Philadelphia 1998. p.1189.",
"    </li>",
"    <li>",
"     Marx SJ, Bourdeau JE. Calcium metabolism. In: Clinical Disorders of Fluid and Electrolyte Metabolism, 4th ed, Maxwell MH, Kleeman CR, Narins RG (Eds), McGraw-Hill, New York 1987.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/26999/abstract/7\">",
"      Oberleithner H, Greger R, Lang F. The effect of respiratory and metabolic acid-base changes on ionized calcium concentration: in vivo and in vitro experiments in man and rat. Eur J Clin Invest 1982; 12:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/26999/abstract/8\">",
"      Husain SM, Veligati N, Sims DG, et al. Measurement of ionised calcium concentration in neonates. Arch Dis Child 1993; 69:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/26999/abstract/9\">",
"      Tsang RC, Light IJ, Sutherland JM, Kleinman LI. Possible pathogenetic factors in neonatal hypocalcemia of prematurity. The role of gestation, hyperphosphatemia, hypomagnesemia, urinary calcium loss, and parathormone responsiveness. J Pediatr 1973; 82:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/26999/abstract/10\">",
"      Venkataraman PS, Tsang RC, Steichen JJ, et al. Early neonatal hypocalcemia in extremely preterm infants. High incidence, early onset, and refractoriness to supraphysiologic doses of calcitriol. Am J Dis Child 1986; 140:1004.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/26999/abstract/11\">",
"      Rosenn B, Miodovnik M, Tsang R. Common clinical manifestations of maternal diabetes in newborn infants: implications for the practicing pediatrician. Pediatr Ann 1996; 25:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/26999/abstract/12\">",
"      Mimouni F, Tsang RC, Hertzberg VS, Miodovnik M. Polycythemia, hypomagnesemia, and hypocalcemia in infants of diabetic mothers. Am J Dis Child 1986; 140:798.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/26999/abstract/13\">",
"      Tsang RC, Chen I, Friedman MA, et al. Parathyroid function in infants of diabetic mothers. J Pediatr 1975; 86:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/26999/abstract/14\">",
"      Tsang RC, Chen I, Hayes W, et al. Neonatal hypocalcemia in infants with birth asphyxia. J Pediatr 1974; 84:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/26999/abstract/15\">",
"      Venkataraman PS, Tsang RC, Chen IW, Sperling MA. Pathogenesis of early neonatal hypocalcemia: studies of serum calcitonin, gastrin, and plasma glucagon. J Pediatr 1987; 110:599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/26999/abstract/16\">",
"      Spinillo A, Capuzzo E, Egbe TO, et al. Pregnancies complicated by idiopathic intrauterine growth retardation. Severity of growth failure, neonatal morbidity and two-year infant neurodevelopmental outcome. J Reprod Med 1995; 40:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/26999/abstract/17\">",
"      Kramer MS, Olivier M, McLean FH, et al. Impact of intrauterine growth retardation and body proportionality on fetal and neonatal outcome. Pediatrics 1990; 86:707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/26999/abstract/18\">",
"      Chiruvolu A, Engle WD, Sendelbach D, et al. Serum calcium values in term and late-preterm neonates receiving gentamicin. Pediatr Nephrol 2008; 23:569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/26999/abstract/19\">",
"      Camadoo L, Tibbott R, Isaza F. Maternal vitamin D deficiency associated with neonatal hypocalcaemic convulsions. Nutr J 2007; 6:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/26999/abstract/20\">",
"      Teaema FH, Al Ansari K. Nineteen cases of symptomatic neonatal hypocalcemia secondary to vitamin D deficiency: a 2-year study. J Trop Pediatr 2010; 56:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/26999/abstract/21\">",
"      Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011; 96:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/26999/abstract/22\">",
"      Thomas TC, Smith JM, White PC, Adhikari S. Transient neonatal hypocalcemia: presentation and outcomes. Pediatrics 2012; 129:e1461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/26999/abstract/23\">",
"      M&uuml;ller W, Peter HH, Wilken M, et al. The DiGeorge syndrome. I. Clinical evaluation and course of partial and complete forms of the syndrome. Eur J Pediatr 1988; 147:496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/26999/abstract/24\">",
"      M&uuml;ller W, Peter HH, Kallfelz HC, et al. The DiGeorge sequence. II. Immunologic findings in partial and complete forms of the disorder. Eur J Pediatr 1989; 149:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/26999/abstract/25\">",
"      Wilson DI, Burn J, Scambler P, Goodship J. DiGeorge syndrome: part of CATCH 22. J Med Genet 1993; 30:852.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/26999/abstract/26\">",
"      Venkataraman PS, Tsang RC, Greer FR, et al. Late infantile tetany and secondary hyperparathyroidism in infants fed humanized cow milk formula. Longitudinal follow-up. Am J Dis Child 1985; 139:664.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/26999/abstract/27\">",
"      Walton DM, Thomas DC, Aly HZ, Short BL. Morbid hypocalcemia associated with phosphate enema in a six-week-old infant. Pediatrics 2000; 106:E37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/26999/abstract/28\">",
"      Hakanson DO, Bergstrom WH. Phototherapy-induced hypocalcemia in newborn rats: prevention by melatonin. Science 1981; 214:807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/26999/abstract/29\">",
"      Foldenauer A, Vossbeck S, Pohlandt F. Neonatal hypocalcaemia associated with rotavirus diarrhoea. Eur J Pediatr 1998; 157:838.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/26999/abstract/30\">",
"      Venkataraman PS, Wilson DA, Sheldon RE, et al. Effect of hypocalcemia on cardiac function in very-low-birth-weight preterm neonates: studies of blood ionized calcium, echocardiography, and cardiac effect of intravenous calcium therapy. Pediatrics 1985; 76:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/26999/abstract/31\">",
"      Newfield RS. Recombinant PTH for initial management of neonatal hypocalcemia. N Engl J Med 2007; 356:1687.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/26999/abstract/32\">",
"      Mimouni F, Tsang RC. Neonatal hypocalcemia: to treat or not to treat? (A review). J Am Coll Nutr 1994; 13:408.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5060 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-E57427EB1A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_23_26999=[""].join("\n");
var outline_f26_23_26999=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H27\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PERINATAL METABOLISM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      MEASUREMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      DEFINITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      EARLY HYPOCALCEMIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Prematurity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Infants of diabetic mothers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Birth asphyxia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Intrauterine growth restriction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Other causes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Gentamicin therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Maternal vitamin D deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      LATE HYPOCALCEMIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Hypoparathyroidism",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - DiGeorge syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Maternal hyperparathyroidism",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Hypomagnesemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H198229277\">",
"      Vitamin D insufficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      High phosphate intake",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Other causes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Symptomatic infants",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Risks of calcium infusion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Correction of hypomagnesemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Hyperphosphatemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/30/27114?source=related_link\">",
"      Acute kidney injury (acute renal failure) in the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/39/40567?source=related_link\">",
"      Calcium and phosphorus requirements of newborn infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/48/26376?source=related_link\">",
"      Clinical presentation and diagnosis of rotavirus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/37/32343?source=related_link\">",
"      DiGeorge syndrome: Epidemiology and pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/15/15608?source=related_link\">",
"      DiGeorge syndrome: Management and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/24/35209?source=related_link\">",
"      Etiology of hypocalcemia in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/48/44809?source=related_link\">",
"      Infant of a diabetic mother",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/8/23685?source=related_link\">",
"      Relation between total and ionized serum calcium concentration",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_23_27000="Stinging insects PI";
var content_f26_23_27000=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F82765&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F82765&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 537px\">",
"   <div class=\"ttl\">",
"    Stinging insects that can cause allergic reactions",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 517px; height: 401px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAGRAgUDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6b1vVrPRNOe+1F5Et1eOP93C8rlndURVRAWYlmUAAHrWP/wAJtpX/AD6eIf8Awn7/AP8AjNHxE/5AFp/2F9L/APS+3pfFnjDT/C2paJBq81raWeoySxteXVysMcJSMuMluDkjHUde/SgBP+E20r/n08Q/+E/f/wDxmj/hNtK/59PEP/hP3/8A8ZrO0z4laHeWd1dtOr266lJp1o1gHvmvCiK5eNIVZiME5wCBjk1YvPiR4WtLe2nfUZZYri0N8jW9nPPiAEhpG2IdoBBzuxtxzigCz/wm2lf8+niH/wAJ+/8A/jNH/CbaV/z6eIf/AAn7/wD+M06+8b6BZXcdvPeuS3lZlitpZYYvMx5fmSqpSPdlcb2Gcj1FWLPxXo16dPFreGRr+ea3gUQuGMkO7zVYFcptKMCWwM4HcZAKv/CbaV/z6eIf/Cfv/wD4zR/wm2lf8+niH/wn7/8A+M1l+IPH9r4d8cXGl6yWi0yPSo7/AM6GzmndCZZFdnMYYJGAi/MwABPJrYu/GugWmpJZTXzGVnjiMsdvLJBG8mPLV5lUxoW3LgMwJ3L6igCP/hNtK/59PEP/AIT9/wD/ABmj/hNtK/59PEP/AIT9/wD/ABmptO8YaJqOrLptpdSvcOXWJmtpUhnKffEUrKI5CuDnYxxg+hroKAOZ/wCE20r/AJ9PEP8A4T9//wDGaP8AhNtK/wCfTxD/AOE/f/8AxmumooA5n/hNtK/59PEP/hP3/wD8Zo/4TbSv+fTxD/4T9/8A/Ga6aigDmf8AhNtK/wCfTxD/AOE/f/8Axmj/AITbSv8An08Q/wDhP3//AMZrpqKAOZ/4TbSv+fTxD/4T9/8A/GaP+E20r/n08Q/+E/f/APxmumooA5n/AITbSv8An08Q/wDhP3//AMZo/wCE20r/AJ9PEP8A4T9//wDGa6aigDmf+E20r/n08Q/+E/f/APxmj/hNtK/59PEP/hP3/wD8ZrpqKAOZ/wCE20r/AJ9PEP8A4T9//wDGaP8AhNtK/wCfTxD/AOE/f/8AxmumooA5n/hNtK/59PEP/hP3/wD8Zo/4TbSv+fTxD/4T9/8A/Ga6aigDmf8AhNtK/wCfTxD/AOE/f/8Axmj/AITbSv8An08Q/wDhP3//AMZrpqKAOZ/4TbSv+fTxD/4T9/8A/GaP+E20r/n08Q/+E/f/APxmumooA5n/AITbSv8An08Q/wDhP3//AMZqK68faJaW01zdRa7BbwoZJJZNBvlRFAyWYmHAAHOTXV1zPxQ/5Jp4t/7BF3/6JegDT17XLHQobaTUGuP9Jm8iFLe1luJJH2M+Akas33UY5xjArM/4TbSv+fTxD/4T9/8A/GaPFv8AyH/BX/YXk/8ASC7rP8SePE0Hx7pHh+509ms76ESSah5wC27M/lxhkxyGcqu7PBYcUAaH/CbaV/z6eIf/AAn7/wD+M0f8JtpX/Pp4h/8ACfv/AP4zWbZ/ErRRolnf6sZbOW4FxJ9nghlu2SKGVkaVvLQlU4BLMABnGeKPF/xK0Tw/pWr3Fu0upXthafavs1tBK4ZTHvQtIiMqIwx+8PyjPJoA0v8AhNtK/wCfTxD/AOE/f/8Axmj/AITbSv8An08Q/wDhP3//AMZrBuvidYWevxR30d5b6RJpbXxd9LuvPRlkKsWTZuWMKCdxUDvnFdrqOrWdhoVzrE0ymwgtmu2lU8GNV3ZB+goAyP8AhNtK/wCfTxD/AOE/f/8Axmj/AITbSv8An08Q/wDhP3//AMZrK0L4j2M3hN9Y8S20mhzw3Ysbm0+a5aKZtpjX5EydyujD5f4qvaZ8RfDOpX8Fla3tyLiac2gE1hcQqs4BPlOzxgJJhSdjEMccCgCf/hNtK/59PEP/AIT9/wD/ABmj/hNtK/59PEP/AIT9/wD/ABmoX+IfhhFunk1CVIbeCW6Mz2c6xSxRf6xonKbZgvfyy1J/wm2kf2jK76rFBYQ2UtzItxYzRFlR0BmSVsK0fzgDap3FgVbgigCf/hNtK/59PEP/AIT9/wD/ABmj/hNtK/59PEP/AIT9/wD/ABmmp470R7J7mNdYkSOTypETRrxpY22hhujEW9QVIIYgA54NVr34l+E7MxedqbsklpFf+bDaTyxpbyEhJXdEKohKnJYjHfFAFv8A4TbSv+fTxD/4T9//APGaP+E20r/n08Q/+E/f/wDxmtjVtWstIggm1GfyYZp47ZH2sy+ZIwVASAcAsQMnAyRzzWReeONAtJp4XuriaeGd7d4baynuJC6BS+1I0ZmVd6bmAKgnBIPFACf8JtpX/Pp4h/8ACfv/AP4zR/wm2lf8+niH/wAJ+/8A/jNczrXxEuI9UmXRvsF1ppj0eW3nKsS63l28LnIYdEUFeODnOeldA/xD8MJPdxNqEg+yrOzyfZJjE/kAmURybNsrIFbKoWIweODQBN/wm2lf8+niH/wn7/8A+M0f8JtpX/Pp4h/8J+//APjNP/4Tfw59tuLRdUje5gltYZI0R2Ie5/1A4HO7OcjgDk4FWNf1yDTNS0Wyluvs02oXPlR77KWZJcKSYxIuFjc4yC55CtgHqACp/wAJtpX/AD6eIf8Awn7/AP8AjNH/AAm2lf8APp4h/wDCfv8A/wCM0kfjvw+ZL2O4urmye0t2upRf2M9p+6VgpdfNRd4BIHy55I9RWVcfEXT21rSo7aYQ6dJ9p+3yX9rNayW4jhWRTtlCFQQwOSCCOlAGt/wm2lf8+niH/wAJ+/8A/jNH/CbaV/z6eIf/AAn7/wD+M1HefEDw5ZxQy3N3dJHJCtyzfYLgiCJiQrzYT9ypwcGTb0JrP034l6RcNqwvoNQtDY372Cf6BcyC4YEBdhEXzOcn92u5sDPTmgDU/wCE20r/AJ9PEP8A4T9//wDGaP8AhNtK/wCfTxD/AOE/f/8AxmtnRtUtNZ02G/093e2l3BTJE8TAqxUgo4DKQQRggHirtAHM/wDCbaV/z6eIf/Cfv/8A4zR/wm2lf8+niH/wn7//AOM101FAHM/8JtpX/Pp4h/8ACfv/AP4zR/wm2lf8+niH/wAJ+/8A/jNdNRQBzP8Awm2lf8+niH/wn7//AOM0f8JtpX/Pp4h/8J+//wDjNdNRQBzP/CbaV/z6eIf/AAn7/wD+M0L430fzoI5Y9Zg86aOBHuNFvIY98jhEBd4gq5ZlGSQMmumrmfiJ/wAgC0/7C+l/+l9vQB01FFFAHM/ET/kAWn/YX0v/ANL7erur6H/aHiDQtT+0eX/ZbzP5WzPm+ZGUxnPGM56Gsb4tGT/hDQIJnglOp6YqyoFLRk38A3AMCMjqMgj1BrH8jXQ2D4x1zk4H+j2P/wAj1x4rH0cK1Gp1NadKVT4S9N4Du4dTfVdI1mK21QajcXsbz2ZmiCTRojxMgkUt/q1IYMv0qPSfhwunW0sS6o0jS6TPp0jtAAWkmleV5sBuBvdsJ2Heo1s9cYZXxnrZ7Z8ix/8AkamNa68M/wDFZa3nOP8Aj3sf/keuX+2sL3f3F/VqhSb4RW66x9uim0Wd5YrVJ31DRI7uZWgjSMNBIz/u9youQQ4B5HNbHhXwjJZ/ETxN4guYZIbaWQJp8LyKyrvSM3EygZ2+Y6JwTnKEkfNVX7JrmQP+Ey1wn2t7H/5Gpk1r4gVWMfjHW2I7fZ7H/wCR6P7awvd/cCw02aPizwZqWsa9e6hput2+nxX2lrpVzHJYmd/L3yMWjfzFCtiQgZVgMZwayG+EtlB4hk1CwOjeRLLbysL/AEaO7uYjEiJiGdmGwERr1VsEkjBNQ58RlSR4u1rI7GCx/wDkekZvEPUeMNZA97ex/wDkej+2sL3f3Gv9n1i/4M+GEHhbXoLy0fRWtrd5middFjS+YSZwsl1uJbbuIyFUkcEnnPo9eXquvEgf8JlrTZ7i3sR/7b1Otvru3LeMtbz7QWP/AMj0f21he7+4iWEqR3PSaK83+y69/wBDlrf/AID2P/yPSfZ9dx/yOWt7uuPs9j/8j0f21he7+4lYaoz0mivNHg18IWHjHWs+n2exP/tvVPf4hxn/AITHWf8AwHsf/kej+2sL3f3GscBWlser0V5I8/iJTj/hMNY/8B7L/wCR6ja68Rjr4w1cf9u9l/8AI9R/buE7v7i/7Mr+X3nr9FeP/avEhHy+L9YJ/wCvay/+R6bJeeI0jZj4w1fgcf6PZcn/AMB6P7dwj6v7g/syv5feexUV89XXinxZHcMi+LNRCjgbrWzzn/vxUQ8WeMGYqnirUCQO9tZ8/wDkCtf7Yw3d/carJ8S+33n0VRXkthL4jmiia48YawjMuSFt7Lg/+A9W5U19Y9w8Zazx1Bt7H/5HqP7bwtr3f3HPLAVouzPT6K8IGueKpb6WODxdqZhjbaSbazz/AOiKbq/iLxLZKBF4u1Rm6ndbWXA/78U1nWFbtd/ca/2ViL2svvPeaK+ftI8QeM76YofFOpEDnctpZgbf+/HWukNx4jWLLeL9YDen2ey/+R6Us7wsXZt/cKWVYiO6X3nrtFeMtqHiMMqjxfq+WOAPs1l/8j1o248SSKN3jDWN3U4t7LA/8l6SzzCPq/uJll1aKu7feeq0V5W58QAE/wDCYa1jt/o9j/8AI9Z9xqPiCHO7xhrP/gNZf/I9H9uYTu/uCOXV5bI9krmfih/yTTxb/wBgi7/9EvXkGo+LPE9u5WLxbqZwM821mcf+QK5Lxd428XXHhPWY5/El3PbyWk0csT2tqA6FGBGViBwR6EH3raGa4ebSV/uL/srEJc1l959GeLf+Q/4K/wCwvJ/6QXdQeI/BNr4g1u8vNQnY2t1pL6U9uqYYbpA/mK+eCCBjjg4OaqfE1Z5L3wZFa3s9jK+ssBcQKjOn+g3ZOA6svOMcqeCeh5qjqiahpdlNe3/jvWbayhTfJPJDYhUGcc/6NXqKLaueZfWxW0z4Z6ppGkWUGleJ40v0sJtOu7q40/zROjytKHVPMGxwXbklgc8rWnF8OLSHQfEWjw3sq2Wq6bDpifJl4EjtzCGzn5jjB6DpWfpU9xrNqZ9H+Imo36Lw7Ww0+QKcdDi34q19j1kt8njTXSu3tb2Oc/8AgNVKm2roG7aMujwdf3M1zc6tq9tPdz6PJpLNbWTQphmJEm0yucgHBGeevHSret+EF1bwRZ+GZr10tEW2huXRSrTxRFSyAhgU3hcZBJAJx61jrY6382/xnroA4/497Hr/AOA1Y3inUdU8OaFc6ne+MdddIAAI47exLSyHhI1H2b7zHih03FXY17zsjYk+GNvFq73WnapdxW0t3Y300N3JLeO81tIW3ebLIW+ZNqY5A2Aj0rQbwRmV3/tD72vrrmPI9FC+V972+9+lcr4Pg8c3eiwzeJvFeo2moyks9vBb2WIFz8qsTAdzcZyMDnGK3jpmvlU2eM9aORnd5FiAf/JahUpNXE2k7HP2XwWt7HRL/SbS60WC2msbixhuo9DjW9CyqVBln35k2g9ghbHJNdV4r8Bp4ivTcSag9v8A8SttPQJECVfzopUlyTg4aIfLjnPUVWTTdcz83jPXNo+8fIsRj/yWp40nXDgDxnrufTyLHn/yWo9lIXMil4h+H+s+JJLGbXde0q/e1eXFtPou+zKuiLnyTMcyKVLBnZgC5+XpiHT/AIVfY/C2p6P/AGzv+2+HoNB877LjZ5YmHm7d/OfO+7kY29TnjU/snXBnPjPXWP8AswWP/wAjUo0nWsZPjTXRxn/UWP8A8jUezkHMjW8daW+peBNX02C1kvbiSzeOCKORY2aUL8hVmICkMFIJ6YzzXH3HwlguNM8PGWXTLnVdPhmW5fVdNW/gupZ2WSaRoyyEP5gLBgwIBIOQa1xpeuE8eM9cHsYLHP8A6TU86Xq6kZ8a69z0HkWOf/Saj2Ug5kUW+GQJXGpwx4i0uPZDYrEg+x3LT/KisFUPu24A+XGfm6VNp/w7lhu7CC/1aO88P6ddXN3aWBs9km+YSKRJLvIdVE0gACKeRknFLcaV4gMEwh8b6zFMUbypJLWydFbsWAtwSOmQCPrWD4Rvdf1Wzng1TxXrdrrFhN9lvoI4bEosmMh0JtsmN1wy9+3alyO9ilqrou+GvhDa6Lf+Gbx9Wnu7jSGla4Z4sfbiQRCX+bjygcDrnHNbvjnT9S1nXvDNnZWFyLSzv1v7jURLEscaiKZNgBbzC+XUj5NvPXqKrDTtZLYXxl4g9/8AR7Hj/wAlqz9Zmu9Etzc6p4/1e3twcZeCx3MewVRbZY+gAJNDptasSd3ZGVpXwUW080z6tZ+Y2mNp4ntNM8maR/OilS4nkaRzK4aEZzgEHjb33PEHw4u/FrWLeLtdS7azklkiFjZm1EbNGqoyfvHO5WXfliwJ4wAK5dNX8b6m4Ggf8Ja8DjKXepnTbNGHrsNszj8RXXWml+ImtojeeLtbiuCv7xUjsXVW7gH7MMj3pRi5bFSi4bmbrnwrm1jVDqd9f6FeajcWkVrdTahoEd1zGWxLCrSYiYhsEHepIB29qu6p8Pb+6h1azt9W0waZe6h/aK213pJnKOQNylhMvy8ZBUIynHzY4M503XN2P+Ex17OOnkWP/wAjUg03XSCf+Ey1wdh+4sefw+zVXspE8yOl8G6LN4e8OWmmXOoS6hLBvzPJuGdzFgqhmYhVBCqCxICgZNbVcB/Z+tbQx8aa6B6GCxyf/JahtP1rDbPGmunbwf8AR7H/AORqPZSDmR39FcAdN1zA2+NNcOf+nex/+R6iFjr7AbfGGuZ9Db2PX/wGp+ykHMj0SivO/sWvDGfGOuHPXbBYnb9R9npY7HXGOG8Z62D1GILH/wCR6PZSC6PQ6K89NhrqA7/GeuHjPEFj19P+PasbxBql9oFtDLqHjTxCTO5jghgsrOWWdwM7UQW2Scc0nTaV2Ne87I9brmfiJ/yALT/sL6X/AOl9vXn+l6l4y1K9iVJ/FlpYs2Gub46ZEwHqIhblvwyKt+KLbV4LTTJLrxNql/D/AGxpgaCaK0WNs30A5McKt7jDDkc5HFJQbVxyXK7M9boooqBHHfFgZ8IRj/qLaX/6cLemuh24VuP72OlP+LH/ACKEeOv9raX/AOnC3pD244NfMZ9/Eh6HdhNmVUlML7DynXOOtTJtlTKjpT2RJE+nGRVNhJBOBk7B0I9PevBep3qKmvMsgsDk4x6elSkk5z0PpTEdZDngDv65pdvAUHJ9zSIehBcWnmYMZAI6jsapPHtJBG0jqv8AWthBhT2PpTJolmUhhz2PcVVjanVcdGYowpFX7VvkJyCR1ye1V5oJIvvAYB+9SQuUjK5AYkdfSny2R0VEpx0NAbtpPbvTDwwI9ODTInVgN340S7lhLKfcVnbucnJaVmSKR5gRcZI5BrOu4fKmG0ZRu/pTxcEvlwB9Km1BcwLjqO9LdG8E6ckn1MO4cD5s4x1HrUDSKcEEgk9az7+Zo7gKjEKPvfWniUuYiRjHc9qjlPT5OxtW0JncENgAfnVK+k8uKXcu5R2q7a6hZWaRiWZEL927mmaxLDNatNGEKnkFTwaOVJXMlJ89mtDzq+cteldg+duCf4a27XwfebVk+0CSUkEkcEiua1ado9QVwAMk8EZJ+laFr8SV0eWC31I5DHAYAkgV18smlynfN1Ix/dfielwxmMIrZ+QDr7UzV52isnfB4UkE1wfiD4kxQabJe6XAZyvR5lKqx9BWH/bOv+KLS0lleWGCUFnQDYAO2KhUJct3ojghQnKSlJWOs0yHyopJw6/vGy4znNYWqyy3OosuFY5wAOc1teG2hstMn3qJIh8oOf4ql0DTUuHW5dAcE7fc1F1FuR0p8vM5I0dCsBZ2iZOHPJHoafq94lravLKQFHr61pSqFUnPAFcPqU51nWotOzugL/MR6Csoxcpe8RSjztyexs+FVudSujc3CkRL9z/a966+XEa4XPHBpllbxQW2IwB5a4UDjiqt7c+WpLOAmOap6anHObrVNNkRX12sSFjhR6Vw2va2q4HmAc4xVnxPrEQtpAsgLgED2rzq4vZZwSGBbOCMdRXRRo83vM7qFDS5oT3plYCFjubI3sP5VjeJXZ/DmsCUMG+yS85z/Aa2LGAXEiqiM8jnAVe3v7Vva/4egsfAHiGaaMfaBptyQSen7pq6YTjCcV5oWInGEJK2tj2r4ggHV/BAPIOsyZ/8F95VvURCmm3MlzAbmOOPe0Qj3s+OcBe5qr8QP+Qx4H/7DMn/AKb7yr2197EtID149fb2r9ApK8T4KW5w1z4J8LaqsWpaXbvpd64wt5pEptZB3w4X5TjPII61m65quseDxGbvW9N1TTgrkrqbrbXjEf3GRdr9f4lH1roLC1i0fxbf2kMu20vrZbpYn/hm3sHIxx0K+/1rxr9orSo7rXtOvtVN5HpttbbVFvAZC5Lc8/dXnA5PfvXNOo40XPaSdtO/od8aalWUL3i1dX7GjeftD6PFKBbaVqEg28l9gYN6dT+dbngLxTa+P9at9V1K+sM2m6TTtEiYs8MmMNPJkDc4GQMDaucjmvl7xDJF9uSGC1mt44IhCEncO/c5OAADzXofwQtJbnxzol1BYX4uLQZea3AaGSIqw/eH+E9u+SMYzWMMROUo82t/66HTPDU4Qk46aH1NqV9eSz2lnpwRZ7ou/msCUjRQMsR1JyQAK09OtZooT9ruRO7HIKpsCjjgD61n6HCTrep3TF8qscCqf4QBk4+pPNdEVPDNxiuyk+dufm0vk7bHm1moxUI9k3311/4AzGAAf0p248HA4pcbmJZ+PU1JtDDhR+FbM5iJWRgflYEHBz/nkUMH5CrwMfWpkjCjkDH8qGUOOpwSD9KVwIxwQWHJHXHP0pi465xx+lQ6hFcNDIto8aztwrTAlR6nA5z6VmLrEllIsOuwrbAjbFco++KX68ZVu+D+dZzrRg7S0XfobU6MqivHV9uv3dTSudyhmBAQdQeciuC8YrdaHqkXirTZbZfLhEeqWchUPe26tkGPPSRMsR6jiu9uvngO09BuBHRhXyZ8VPD9qPF+r6n4r8RCCNpW+zWMCPJOyAYUDPyr268dajF1lSgvN/1sb4Kj7STv0PatU+LmiPPDpXhi7s9S1S6BWKSaby7WEg/emfrjqcLkn2zXQ6D4S0+z1FNX1L/iZ+IXG5tQuuXUkfdhX7saDsB2718a6guinU7G++xTJpM6Ze1huY2myvB6D5M8HketfUn7PEv2jwGksbXr2gu5Ps4u+XjTj5c5+YA5wePpWOGrutL31/wDoxOHVGneD9fM9SHUfNlhxjPNPCDcFzkkHnPT2qjqV+tsTb2qrc6oUzHah8Eg92P8K9yaba2mprIs13d27pkny442GAR0BJ5+v6Vu66cuWCv38v67HEqL5eaTt2v1/rvsaARQxIPQU3buQI2GBOT6ipkhKMcDcCOpNNhV1eQnG3HVTzW9zEqzxsy43HIPP/6qU8PhASOOfQVOyHO4Y5OTzTWHzc9c96dwImG4qMjk8euKy9c0KDXbVIL+e+jtw2547W5aDzfQOV5K+wIrVmyQEIJOMbh0Hv8A59aSVmCZXaUxk4NDV1ZjUnF3R5zrXgjw9pLwS2VtPosrOFXU7G7kWSFycL5m4kMpPrkZxmnapr2peCrYXPiO+ttV0wDa06ItvdpzjcYwdsoHUlcH2NdV4lSG40fUknJaI2sm4DnopOB6HivlL4rrq15qWl3+srPCZdNjjlRMs2ACScdMZxnmuStP2Lsuux6FCHt4rme2/wDXT/hj3F/jL4YnuVs9MlkvbyR1jhUYjV2PAy7kBQPU/rXQ+G9OvbzV313xBNYy3yIba0gspWeC2Q4LFWYA+Y3Qn0AFfE95FbCZVsZZp0IAy8ewlu+Bk8Z6V9M/svC/i8O6vDqEMyKt2pi85WU8od3XtkDpSoVpVJpS1KxGHjSpuUD2O9voLG3jlmWT99IIo0iGXdz0UD/OBWL4tZn0bT3e3eE/21pa7WYH/mIW/oTWhNL5uv6bZqqL9nSS5ck5yCCgx+Ldfaq/jjjSNOJAXOsaUAMY/wCYhb10c3Nza6LQ4pRUYx7vX8T0aiiiucRx3xa/5E9P+wrpf/pfb02Nz5a9WI74p/xX/wCRSi/7C2l/+nC3pGBbPJx7V8zn38SHoehg2uVpj8ckjFMmi84EdGPem2zl1wxGM4BqRiy9PmOfyrwTrs4szn3QSj65arkbJKCoI3dRipJoRMuCOccYrLYPbS47+vY0WNklUXmawUrgMc+1DFdpySD2qC3nEyhTwfWpJztBK4JHp1oMnFp2Y4gGMBhuz1BFY91G0LgNkjsfatcNwCSScdKguoxNGQc/KOKG9DSlPll5FGGb5sOB9cVoDY0fOST2rGPyMFU8juav2825cHHHb1qE77m1el1RXuYTFeBTjaw4NTzIGtgFY5xjJ71JfwefauwO2TBIxXz5onxH1az8d3WgXMiz2xlKpI/VK1p0JVFJwWyua0l7VJ3s07HdaoRJrS2cZYzu2Bnp+NdI2iT29orxyozqPuHv61lNoR1m6+0/aHhZRlSnXPrXP6J46vpPFy+GdRaGN920OThiPapUHOPu62Wp21JNr3WtNyDx/BNc+G7trVW+0xA7Av8ASuC+F2vahBJcWOtNOn2eIk+aTtA6816Z8Qrmx0qxaUXCJDtbaC2TM/ZVHUkmvMvBWk6p4yuLgeIYbuPTkIMdtANpfnlS3oO+a78NHmoSUlp36/LuTOtytPX0/wA+xv6lFf3hhurJoobWViVupOd2f7g71h6npC6apuLrfPNL8oyd0jf7q+ldhq2mReGdInj02Qw2kaElnXf5JPRVJ6VyXgmdjrbTKLqedCHMzDd+VON0m1svvOiFWTXNI7jwT4fa6gtNQ1wh4oRthgcYRB6Y7muk1txMy2WjIJblvlYgYWNaZbFpNFTyYnea5kMhZ85FdB4S8Ez3Es95e3LQuFxGFGCPf3rlp0amJm1BXOeviI0v3lVmVa6QxgitI8JHHjfjua6ZIY4IgiAKAOAO1L5RtVMb8uvBb196wvEVxeQac88MZIH3j3Ark1Ts9yLus0k9Ct4m1uGzidBKA+Kz/ANrvnuL5yCGPy5FcTCG1C/eWdi7NxtzwfQV6XatDpeloikA7ep7GrmlTXKt2dlWkqcFCO7Ni7vo7eJt5x347ivO/E/iVGZ40chR6HvVXxTrrLbtGshLEkZDfrXCSytLMCW3cc5ralRv70iqGFUVd7l+6vJryTAbd9Owq7pWmy3jNDbRANgEv1wKzdKtZLu7jhiJy7csOwr0+DytBs/JhRZJTz7mtqk+TRbmleappRjuWdD0u30WDzJQn2hh8xNYfxA1A3Pg/wAQoCFA0+f5T1I8tqW51nzcSTffHAQVx/jHUGfw3rCs2SLSZFAGGIKHk+1Rh6blUTlvc4pYeUoSlLsfSnj8/wDE58D5/wCg1J/6b7ytBsKcjjPVj0rI+JdyLTUfBMzRzSBdaYbIk3sc2F2OB361BdzeIZWU2lnZW8GSS0sm59nPO3oDnHev0CNZQVrN+iPiI0XU1ukvN2LGr2UV7ahwXWaJt0cqYLIcdR7V8y/F3VfECahPHqTpLFZw71EDEAl8KkzLkrlSSoIwQeetfQ+pHxFDAz27WJn27lVhgZPXJzXyn8TrzUdR8US3PiWxn067LRQXNrHlQYgARjqCSDnv1FcmMabTs1ffs/x3/rsergKMrPVO22uq/wCB+B57FBLMkkiAEIMsSwz/APX6Guw+GTXFxqMtlDevpyZSaS+WQoLeMMFfJHOG3AY9cHtV/XtH8B2DaaYb/U2Wa5UzqpDslvg7jjaMNnGM9s8U6+0HwxNrWm23hS51C8tJgftcjEnAz8q42jng8GuB4mNRKyav5djtjSk5cp9j+H7JbGwSAq/yZAZm3FvcnvWr2yTgHv6iuJ+G2mXMXhDTRqF1dLdJGRKVm/i3HqOR0xXWrbzRqTHeSsTjiVVYD8sV7VOU4pLksrdH/wAMfPVoR53eWt+v9MuhRtYZ+Xrk9qI4yDx6dRWRLqVxZMf7VttlsSQs8IZ1xkAFwPu5zWna3KXMKPbOkieqnjGOlVTrRqaLfs9GZzoygrvbv0J3cBsc568dadtJAIz9TUT5DZYn2x2qY5Iz+laMyIJAzOCTwR3pkiJIMOqsp52sAQfwqyFycg4qvIuWyrYG3oOMmmrPRj9Dhdem1zQlkm0ew/tTT03SfZy5WSMDJIRsHI9ARXgHxf8AF8t9ama7sDaahdqkcUEwy8EQQOXOON5ZsYPIAr6umSYjKMu7Oc5x9Pxr5R+I2nrqnxGuItUnu/7Hk1KfzzHyVZdwyvBJIXYOM8dq8vHU/YxXve5fbtbXT/I9rL5e3bfL7yW/f1OQvLYW/iPXYUtIo91mblGVRiORYVkOzt1PQV9G/CPxpe6z4Y0uKK0M8xHllwyosYAx8w64yGAwOcdq8Duf+EbuvFNvaz+I9cudHU+T5gtiGVDGFwGxkjjb93oK7/4UXV34fvLEaUJ50vLuWzSC6lIQR8eWzkcAqN2Bgcsa4qdV05JRbV0un+fXT5HZOh7aDTV7d3ZH0pZ2a2yuwCvcucPL3P8A9b2qySNjEnv0HUVHBIt1bxyxMTGy5GRgn/69SbfmI2D6/wBK9ylGMYJQ2PnJybk+fcXLFCeAR6c01vnAI4PqOtOIPRQMEetLlBkcc/rVkFdiM+nAGR0pAORuJAzjmlkBCDP3R7/0obIADLj9asYhGQ20ZPYDqcVhfbtTR2F1o7GNcYa3uEfOevynaa3WYbwRk+9VZ5HDIYl3gsB04AIOT+lDi3s7FU5JXTjf7zLuLq1u7V0U4IUBoXUrIMjup78818qfFeN9A1a5gW/u7nTrtZHitmkPlLKGwOM42qDkDjnFfVuuW1tNZtLe5iEIZ2mzhowASxHtivkbxrdw+INWyt//AMS15Et1nRC0aqpY55GRjcpOPXpXnY1tWU18z1cvjzKTht1X+RxupaPLptpaXL3FtIZsFUjfcV4BGR+OPwr1v4N3/iDxHqz2ej67caRo1uFkms1kaTGeDsLAkAkdzjLYFeR2NnYTapHa3momG180o1yIyyqgz8wHU5wO3evUPgaIYNdiFrqF2kU9ybVpEkEZ8tl3KSvPBdQD9RXMnFzX/BW53Ti+VtdPn+B9Q6LYRWluwEs08rHLSzncz/8A1vpWd45G3SrEf9RnSscf9RC371rLBciILb3oDbiC0sQcn24K4rmvGcOqRafpYlubaW2/tnSvMCw7G/4/oOnzHvivW+CPLGNl/XmeBJc7cnJX+f8Akep0UUVgI4/4r/8AIoxf9hbS/wD04W9PVgVyuDngVF8WxnwcgJwDqul8/wDb/b1RL7P9Wx9QtfM57/Eh6HpYGHPFmkyYOeB6io45AQSSSBwRVdLncvIIK/nVfUjdT2TnTpUtrsfceRdyn6ivB3OzlezNQtkEKSMdxVWeMFCpP0NcXpHjqW114eHfFVstlqWP3V0h/wBFuvZGP8XtXc+azSKmwJu9aqcHF2YrOLuZfzRv8w5FX4blJeGBBA596s3FvaiLzbmRjnjanJHvVO9u9PhYLbSeZLwBtYHA98VtLDyjDmkzR1FU0tqTqWXDJjb3z1p6scZZc89aiTepHmRODtyu7uKezEEAAgkdPSudq25m0UdQg3wl4wN4yWA61X0kPcLySqdzWi3yMcjJJ6VyviHxH/wjpUtbSXEb9FjGWH4VKjd3R10eacHBbnUxsUyGbqcAd68r8Y/Cyz1vxvZ65aXJsivzXIjH+sI6EV22h6umuQtcm3ls1VtmJvlrjfit45tdKnGleHxLqWrEZcWpDrAP9o11UIVbt0tHsKMeSVpaM29b8S6Z4RsI4rmUvdFNsNsnMkpH8h71886jcy6x4jutTtrBrvUpW/16sVhtj/dz3xXfaF4NtJdRe88TXFxrmqXKeZ5dq5McQPIR36/gK3PEdpBomhfbdSW0sWAEdrYoQoAJwCR1P1relCOG+D3m9H29P6/4B0wqxu76ef8AW3qYXhDT1sr+M6zeR3WtMgKPdcrbr32g8KPQ9c16VoHjDw/4agGn6LaXEwyQwYbi7HksTXl+ravofhuV7bUGm1u8lRXmntyBGG7KW68e1c+PE+qa6txBYqLO1AOBHEASPQNXTTdaF5p28/8AIidKNbRrT7vn3Z3/AI/8bWmtTra2FsjQ/wAcTrlGf6dzWj4Da9t9Ldp7DZE0oUNLtVgPYeleQac11q729xa+fbbCFZmXaxI6kH0rrrNrvSiZYLrzPMfaxZi1c2Ii5JqTuzrjSgoqMP8Ahz6I0qztPsSLBdW6tnPzDkD2Naskciwys17E6onyhDzXi2jfE3RrgjTtjwzRnY7OQAD+ddtaQ24i+12rbjPzuVsjFXSx/wBXh7KVPp3seVWwcnLmlLr2RLc/aLl1dW4A6HvWHp/jKzvNSu9GuAkN9DwYW53j2rbhmdWzKAo7V836Z4lgHx3vdSkjaSIs0K/7PbNefhqDrqbXRXOzRWi16Ho3kpY6lcSyW5iO8kKegrM8V69Odq+W0cbAldykAn61JqPjqyk8RxTXdszWURwRkZPPWvUbxNM8R+H5FWKKS2lj3KRg447e9PWDUpo9CdZ0eVzje/4HzfPNLckDfkEHmrdlCXkjiiOWbAY4qKaJYp5IYnUYYpz7H+ddRoUCWlo1zIuX/wDQq7JSstDtqVLK6NXRLRdMt1d1Uzk5DdxWbq+qsJM+YXY9wc4qrqesu/yqBnBCk9hWIZgwK8ISOtZRp680iKcHfnmXJr6R5cSEnqeKyded5NC1JiST9klzn02GtzQ9GuNXlCwAAZ5Y9q7DxJ4asdO+H/iB2AkuU025O738pq0jVjCpFdbozxVeEKckt7M9o+IJK6x4IIGT/bL8f9w+8rVYcdAAR19RWV8Qf+Qx4I/7DMn/AKb7ytTeJMruyQMGvvqOx+az3MnWXFhp9xeTbPIgVppF6ZVQWx7ZxivA729tF8PFPFtu2qX926OscO0upkEroCSR91AAeew9a9H+MeoM2kWOgWsrp/a9ykUjodv7oHdIufcKRXz18UtflTxLbXel7AkSqZA8I4kPTI75REPHr9a8nMKvtayox+z+fQ9/LMPyU/bTvZ9uxx3iGOe21K3trqO9S1UhokuOH2k8kDJA/A1674d8S6PoFraaVpfhLUGmu5FS51C8kRXJ67hyQMDPcACvNrrxv9s+zyalotlNd20hkhlBZApx0K85GcHr2p0PivXNZv4be2itYVdldkSMAOFOeSc8cdq5P3yjZxS0dzvtSnJ6t6q1j6R+DfiDULhFt9XtbeyTUV+3WkcW/PJKvu3epjPHbHvXrkIwmDzgYOBXh+mR3NjpmiXF7PLPd2M5hedmyz+Y3J+gcR/gD617DoWpw6xpFvf2swmjmQNuAxkfTtXoZfi1Nuj22/yPFzLDctqsVvv/AJ/M1VbHHLKR6VHbQwwCcwRpGJZDI2wYyx6sfelAcqD0zjFPQHGARuHXFek0jyrsUnPAAPv60qbhk7eOo9aYT6KDxnr1qRVJBLHNDEOBO3OCOeneopThgASAepAp28biACWHGP60yZWLDGOeAv8AWhDsY3iHXIdEs/tFzbz3JXO2GCPc7lVLYH4CvnPxkl9caVp9rb20Et6n+m3BjDNc7pYkK7ccZ5I3dMqe4r1X4t6q1tfWGlRSldSuxts2xwsrNtXPthW/KvCPFen33ifxDd3tvbrd28aqu2K7NuSGzJtUYPA34H0rxcdWUptPRR/4HofSZbh+SCnFXctf8ih4c0nW38SQxeK/+EphsT80zwRs7mLkc4yecYyPevdraPw3peg22n+HbNbktL5lvvBDLKh3ZcnlQWCAj6V823+k/ZNVTT2t9etb+RcpbidJAV65DZGR17V23wx0PU5rG+uY77UbG8spY7i0WVllSTquXXsRuFcbk3H3Wr/d+rOqVNy+K6S9bfPQ+ndFvhE8LGMx2N6BNbzO3AZwDsb0YknjPtXSbnyykAn9a88+GWpWt9o66TMVeOVPtdvC4JzC5y6/8AlLrk8k8iutNjdxHyrbU2WHokc0fmbQO27OT+Nezh5NU04q6/FeXofP4inF1GpOzXrr59dTV+bOSoz096QD5QAuBSIScEEk9OacDuzjkc8+9dhwkTjHJAIPSot3JOAD6GrDLvOD1Hao1bMmQOhzzVJjI2+bAC4PU471HvwvIII6kD9anfJK7Wwe4A/rULn5SxJ45OKpAYfjK4jt9GmklwYuVfJ/h6lfxAI/GvnL4j6Sl3pmmW+i2ST69eW6XsiRHYwQksSF43MxwCBz8tewfGSM3miQwlmVZ544Vx0VpHCh/cry1eA/FPRdWn1nT7m1SWYz7TE0bYMXmZMcQHYKFbB968fGVH7Rq9v6/wA7nvYGmlRUu9/6/I4GLRtZm1N7KLTr5r8Z3ReS2/vnIx7GvX/hdb2ml6NdjVtJOnXVvcxm6MjN5kkMgKKwB5ADEdPavMh4l8W30jWI1nVZXKlGi+0NnCg8HnoADXpv7POhTahbeJbq/Zzb3VqkSFiTISrg7hn0OMe4rCKnKSTaXpc6ZSUYt2Z758P9a/tjSf8ASJvNv7V9k7eX5fm5zhzH/CeoI7EGrfj450awPA/4nWlcf9xC3rzzwzcDw3qMHmxLELc+TcpCp2+VvCswycnY5RgDkkMfU16F4/BXSbFcYI1rSgf/AAYW9enhsR7am77rRniYygqVTTZ6o9AooooMDjPi9/yJY7f8TTTP/S+3rNyjnlsHvxWl8XufBY/7Cmmf+l9vVCOykdVYEYbofSvmc9v7SHoetlzioyuyFVbfhTzUhSYhec9hzVkafjOHPHQ064WO3iVjncMAAdzXiRi3JLqzvlVV9DC8QaFa69p0llq9mJ7VvXhoz/eU/wAJ9xXmZ8ar8Ldak0y71J9a0LG1FuTuurRj05/iU12PxC1W+lubTR9Kdkubk7WOcbB6mn+H/BlqukT2WtSf2vcXL7pJpEG4L/dB9K66VT2ErT1Xb/Ic6fNBOWl/wPCvHfxn8TalqZj0lBp9qvMYiXeXHrnuKn8B6H8S/Ek8s0V9NpNlcj97czoFLD/ZGM/lXoGoXng/4e6ve3Nonm6ZLIIbm1Chmtph/FGD/Cc8ilvvjjpFprLWVpbyXtqcbJoVzwR1xXoe2nKKlh6a16vV+f8AWphOL+Gd/TYz5LXxp4e8YDQPCGoT31u8SyyXepuZAj/xBT2HtXvNsVSyiWb5p9oDkH+Lvj2r511L4zWGna9PP/ZbvujxFOrZ3exFereB/FEHivw9a6nbAr5h2sh6qw9a4a3tIRU6sd+vf/gmkqalpHS3TqdJcXPkTGKQqSxynriuR8b+J9I8ORJf3ssRIUqASC27sAPWuldcSFmUF88mvDPi54T0ESpJNqLWuozvnz7gl1yegC9vrXNRhGpWSnon2Rso8sbx3scL8R/ilrfiG4ayVZdM035S0Cja7+5NbPh/4ueH9C0eGz0/wTatMRtnkkmbMx9S3UmvNvF+iXui3vk6lew3NwMD5H3HbjIOawM4r62jh6MYJQWn5+vc8ypVlN+8fU+iX/jXxLZRjTW8PeH9Ol/eLHDOiTIPRt3NcH428H60WeTWL7SJnYkG4bURM6gdwo6fQV4uZpc/62TPruNKrSFsh2yfeh4bqnZ/h9xrSxDjpb8Ff79Ts5tBlUyu2v2RUJnJyATjpisW28TarZMohuFwnAGBiuv8OfDv7VZwXuu3gtreYbo405eQd8+gqL4j/D+Dw9p6atYXkP2CZsRwMxMh/HFclOtQnP2U2pP00Omu6kFzQuvm2dx8CtWstetrnStZ1MC+eTMEBQD5e+0967/xX4J/siynvUy9nGvmPsOW+gr5M0+5n0+8tr21do5YnDI6nBBFfbfwe1lPF2kF7qf7YpULIoGADjoRSq4Gm6vKl8X4M51iqsE6l9tz458UwXcGqyXzWs1rBdMWiD9SPrWr4W+I/iHw68MdreNJaqwJgk+YEele2fGn4f3N5q0r2lysNjAhVYXX5R9K+fb9bOy0qexaHdfpNxMOmBWyjGpBUq0Ltaf8HU1VRyTqU5WW/wA+x9N3vj21n8KR3U0Yhup4j+6DfcJHXNfMWm3f2XWZLmaTc24nd6k1lSXlzJGqSTyMicAFuAKhzzUYTLVh1JXvzDnjI3i4LY39e1E3OVSQ7G54NbfgPxrr+k7rGxuna1dSpUjIX6elcJn8a7XwB4og0mG6029to3t7rpNt+ZG+taYihFUHFR5v63KpYp1cQpSdv62Oz0yIlmuLr75O4j1PrUt9rGcRB8IDkKO1cJqniMyyGKAuqqdufWtfQbWa7lQO2VHPPevJnhnCPPU0PoaWIhUbUdbGobx7iVcAZbg/Wuq8M+GDdBprv5IcZGTjNM0WwtbRN7xq8zEfL/d963IdXdgfs4DlOCDXFUk9oGk6n2YnY6PZ2lharHAVjVuuD1qt8QJkHgLxGAFBOm3Iz/2yasW2vDOSjNtIYDOOp9Kh8ZbE8FeIFEhJFhcD2P7tq5KdN+1i2+qPPrU/ck32Z7Z8QP8AkMeB/wDsNP8A+m+8q/dzJDA8szKsSKWYnso5J+gFUvHmDrfgbP8A0Gn/APTfeUa48dzJFpbqGa5VmlCnGIV+8fxOF98mv0eM+SDfU+FjDnml0/TqeSazcXXiXxDBNZxSSeXHsUyR7VijkbZu+uwttPfd7VwXxR0/f4qu2fSLdop/J8i0klWIMkQVAVYHB+Xbn617Z4etJYLU3OqSwx3dzfJIkQ5H2dCpijPfcqAqe2TXI/HbwvLqXhJtSuo/tclkS0n2dBvWJz1TPGVAX6jNeGsL7kpptu92z6WljIqoqbSS1S/rY4LxT4ZOq3ukztpSXzmTYJ7eYIoABOJAQdyjGc+xHek1jTGg13T1NtZpmH7OtwZ1BXc2BEEBGck9QMc1ycV74MnsrbzY9S0toH3Twqz5u1wflUZIBBx6dT+HU/CjR9D8SfEOGfQbC6FnYwiWWS5jyqMDwQSSd5OAB6A1x0cPUnKMNe23/Bt9x3SxMKalUdu/9aHrFposkdnfaasUciSSb4FZsMQ+NwOOmCuR6kEcZrpfAr/Z7CFrni8u5pYrwrD5S/aUYgkJ/COMD6Cp9dT7LLbSBjBlof3qxFsFZOcgdBg0+1svtV5q0ayr5d6EuIsZDJInyMfYArH068+tevRwyo1Go7r+vxWnz7o8GvX9tTvLZ/1+evyOp+bb8rEj6d6fkBQSxA6/Ss/RJ5JYZILwD7dany5QvR/R1zzg/wA81qx8KAcZxXqxmpxUkeRUg4ScWMBIyvQY6mpDJsGByT2FLjJ9famr99+efSjcgb0fsM9jWfqWqwWJijcPNcy5EMEa5ZyPf+EZwMnpV+UEqDj8MVStbWKCa4kDMZJsFyT1xwMDsPp1pTjJr3XY0puCd56+X9f1+Z5H8TY71rqztGtjfalKPtMsyjCWm99kZz/0zVXA5+bcxrxb4kWEEfjvWHTVLrS4PthhgaO3kaF41VQuwp3x29xX0frEzR+J7s+SbuKeaJUjPPlmOMLtxkA5LFsVyXxG8J30mktr2hXJjSNGuLv7NcNC7AH5WUhSpwOuRkAV4dTmlKaprb8l5tfofR0ZpRgpu1/uu/y7I8Ou9C1Ox1G3kt/Ek+5IsrLLDMksSHJxtIOBye+K9e/Z70e7l0nxDq1zeNqE8switp2JKvhCScNz12GuE0q+1bxDqCaVY32sT3EziOBF1yPAY/xA7SzLxk5xivp3whoEPhzQLTTIJGl8pP3srtuMkh5ZievJ/pWmX0pVJOU1ovT/ACIzGsqNPkW79Tyfwpe3ttr0OvxXons7e8ezurfYFMcLsQZEwckZIcqf4skele8sfvLuIHI+teOzWa6T4l1CwkOzTr1vsTKgCMjMNqyjsBhsdc55xXrGhMp0mz8374hVeevAx/StMtm05Un0OXNUpctVLf8A4dfqXAuDxjGMcdqXk8D7uMZ7ilbA24bJxwKY3oDk9d2a9Xc8UQqh3OeQfWmugUhhuznI/wDr0SMoYBxnPP0qQIhGOoBz9KewyuVZioJx+PWmTZ25dyqAc44wO5qy+fMUk5OPu1na/bz3tqlrbgBJ2CTzbgCkXU4HfOMfjQ5NK6RUIqUkm7I818ZbtTi02JWd7i/nae28kbNkIwhDZ9Vcn/DrXI/F/Truw1+LVNM1W80JUijtzPCGlhaNGI3MqgkfeGCeOucda9E14yDxJ53kLPGoW3BP3UQEnHuck9OcV02o6PZ6tpRs7vc0W0DcrFXU+qt1BFeOsN9Y9pFbrv1/Pd3PaeJVBQ5lo7/K/wDlp6nzLbXmqnV4raPx3NLcz8D7JprG5lHYbNgOPcnFel/A6wvBNqt3fXGpXvmKsJub2Iw52tnaseflA55PWn2ngDXL7xM9tq1zero8cOGuF1OVvtCtn5VGNwYcE5bbzxmvUPDmhad4e01dP0e3MNshJwzlySeSWZiST9anAYKqqiq1Fa3ktfuSFjcXTVN04O7ZxPjrSJIdRiv7SZ4H2gh05HA2uuD13KVH1XPGM1WbW438PaZpN/cFdSi1fSmjjmctJJF/aEG05P3iACCepxnvXe+JLMX2kXESfK6/MpGMocdefbNebPbRx2GmSmUXUyazpcQnaPazJ9vgIP6H8/euirGdHE80HpLoYwnCthbT3j/SPfKKKK6Tzzj/AIr4/wCERiyQB/a2l/8Apwt6lKEJuBUp2APNRfFf/kUov+wtpf8A6cLeqzQzpIxtbhU7iNlyK+czuSjUhddD0MErp62L6qSyg/LnuT0rjrrxVFda4dG0sxz3zBlBJwsRHc+v4VuyWt3eWBtdSulaFuXWFdpb2z6Vj3Xh230+CG48O6ZbfbEmEj7yQzr3APrXjqrGGsdz0KahtJ6/h95Ppfh6PTnlv9QmF1qMgzLNJ91PZR2FefeOPiSlpqU/h3wjaz33iCUbIjEMohPUk9gPWtrxNF408V3cNpp9pHoukK5W4lnfMkg74A7VHqemaB8L/DOoajbRBr6SMg3D8yStjjnsKVPl5uaSu+i8/P8AyN0rKzleT6bpfofOvxMstK0dbXTYpLm88QMfM1K/klJjMh6onY49a42y1J7SXC5SPaVPlnk/jSapqtzqY/0ohmWV5Af948iqdvM9vKJI8bhnqMivrqFFxpqNTV/1/Vjz61T3r02Nlcu2ct75Oa9P+B3jN9D1g6Xd3GzT7o8buiv/AEry0nJJ9aVHaN1dDh1III7GniMPHEU3Tl1IpVXTlzH3LHd4AZnklTcBlRxivEvi/wCHL7W5ZtRtLvzIw2REDwoFdv4S8T2MNnYRX1yxee3Q7mOQTjn6V538SPFTar4Xnj0JJrWEXPlSLjmbGeV9q+VwcKkK65d77nrcnKnzLS33njNy8zPid3dl4+Y5IqGnSJIjYlRlb/aGDTa+xWx4zeoVNbgtPGqnBJAGRmoafE7RyKy8MORQ9hxdmfTnwmsVv7GNNXkhluoQvkuTuUr2yK0/jN4L1LXfDO3TYY5pkkDFUYBQPX2rzP4Q+JblZV0+X5ix/dug5P8Ask16/rug3OuAiW/uo4QATBCxXJ9z3r5pzeHqOMo63umejVp88lNy0Z8kapYTaZqEtldbPOiba4RgwB+or6Z/ZR1cG0nsNii6WUHCtkyLjqfQCuAi+Es+q/Eez0OS6kW0uA0z3ezJx3Udia+n/hr4N8NeAbG6i0aFVlJHnTGTzZGHbLdvpXvU71lGSeqPNxEo07x3uedftYWmrxaHaX+lC4WINtuDFkgD1OK+Q2d5Dh3Ld+T3r9I9Vsl8RRG1u4gdJYfvVf8A5bD0+leOfFf4Q+F9W0S6t/BulxWms2y+YHt87Gx/C3ua15Um5LqRTrWioT6Hx0aSug16exj0y206PTBbajbMVuJt2Sx9KwKVOfOr2sbTjyO17gKegLOAoJYngAcmmcVo+HtQ/srWrK/8tZPs0gk2MMhsdqc21FtK7CCu0mdBp/gzxB9n/tC70m7isEAZpXjIGPWupsNVtLSCOKAKSByx6169onxf8O6zpF210xiCRHzIJP4uOgr54uP+Jlr97Jo9nL9mlkLRoOwPavn41KuLclXjy8v3H0GFl7GFkr3e+9/uOyGrF2K7iF6ZB5NX7W/VPlzjjO7OCfrWf4U8D6tqdxEHh8iItzJIeFHtXs+h/DXQLVCb2eW5k6fNwPyrirzpU3ZO52TxMKa9/c8+sbyebYiE468dTWv4msNQPgjXpHtpBCun3DEkdB5Tc16pp9hoWkRiOztYVZP4iM5/Gsz4j6xayfDzxPFG67n0u6XAP/TJhXPTrJ1I27o8/E4qdSL5IaWZ23j8hdZ8EMxAVdZkJJ7AafeVU0QXeoW93ql68AW4QiyjVMNFDyVDHPLZOc1Y+IkYm1TwXGxcK+sSqSjFTg6fedCOR9a2ooBHEiKMIqBV5zjHT619/GDk03svzPkPaKEWktXb7v8AgnLalCVWFIFX7TIqqpB6BiehPQ4zxW1qmmW+pWV1Z3K7rW4iMEkeD8yEHj2q+LSDyolMYIibcmWzg4xnNSKjKpBPJ4qqVPkTT6iqVuZpx6Hh3ij4VyRT6DDpUEt/aW85Mc003zWjEElpDjLJwMDrnArv/BPg6HwxBcN9qmubi6IMjsNqgLwqovZR6HJ967KMABlcD3poBKFccdRzmopYOlRm6kFr+XodFbMa9amqUnp+fa5ga9bFms7hS3mxTHB7fNjJwO/y4/GptLIN4HZZhIsbj94MEZcNj8/xrXlhQ7RIoYd+1RrFGhYwpsLdSvPAHFaey/eOd9zn9r7nIVzYltXTUI7l4sw+VLCEBEoBJU5PQgk9Oua0UbJwTlu2abGMKpOWz1OMUBWxkgcjg96tRSvYzlNztfoOdsOMEZ6dOtNIzymACOp7in4+fGP/AK9RYYqBjJxge1NE3GhiSxU4B6HNDReYvytswMkjinRx5wM457VDd2sF9GUuA+wHBVHZR+OO1Em0vd3Kja/vHEW0Empa3e30AZYRMJE3ZAki2gb1PruQ889a7WwjL6dEsuWYxrknvkd6smCJlAWNAnQ7QAMen0p+FULtXkdCBXNQw/spOV7tnVicV7ZJJWS2PPfA3wq0Dwd4h1HVbCF5J7mTfb7z/wAekZBBReeep5PbArvUCopO1cHI71Koy+SdxHfGMUKuFGcZB6kV0RSirI56lWVR80ndnHeOvDsmqsstm+2RlVsBd2HT5k/DcFGPetbRtQC2llZ6jZ3FvqJjw6CMshb+Iq44K5rcXO7nnI60rE7TxjjvXNHDKFR1IOzZu8U5U1SmrpbDGKKepzjnHp7UxT93sw6+1OwTI2Cu7pjFKoYDnafTtzXWcgyUk4OAD6g5qQknlunsahfGMjJzntTz1bOCCOT/AJ60MY52yVIG04xnNRNgghvoeeo/wp6n5lDNuHYY61geItbv9IuI0s/DGratDs3PNZtEAh542swJP0pNqJUYuWiMe5sPtmsSoEO0Xo3nkY4BHPcAfzrr54keQFxu/HpWH4b8Y6T4gvms7Zru21CKIyNZ31q9vMFzgthuoBIBIJxXQbWRl3YPf1xWWHhGF3F7m2InObSkrWGjPOMk9z0/Gmpk87sj3rC+JOoXOkeAPEd/YuUu4LCV4mXqjYwGHuM5/CtrR2VtKsisvnK0Mf7wtuLHaMkn86259bGXJ7vMSGNTuEh3ZG3jpg1wfinR1sY4JYlIiOtaSU54AN/BwB7GvQCBuwCCucAjk1zvj5CNFscgEf2zpWD/ANxC3qKkYzV5dAhOUbpbM72iiisCjj/iuQPCMRPT+1tL/wDThb04hXXqCPY1F8Xv+RKH/YU0z/0vt6yd7p91iB9a+Zz6Vpw9D1MBS54uzNMxzx58pw4PY9hSQSPu2SRlD2NVIr8xt8657VYN0txGyAhD6k14F01odsoSS95fMtO2wFmOQBXjPx+1FbjwnIkaiR93JxkxfhXqj3flnZwVxjNeHfG2/h02xmiBdGuDtlcEcqeoHvW2FTlWikupvhafK3KXZnzWSec9c9aQ1v8AjZNKTWIhoUplsvs8eGPXdjnPvWBX3EXdJnkMSjqKWimI7mx8TWV3Z2Vvdxtay2y7TNEfvip/FuuyWDW1rYSEuv70SMvBB7j3rgVJ6DkGtLV7tr4ws5AEabR9PSuB4OCqJ201PTjjJzotX1VipfXk97OZrqQySHvVaiiu9JRVkea227sK7Lwh8Pta8TWn262jit9OV9r3dxIERR3PPJxXJ2sLXE6RRlAxPVzgD6161YeH/Bdlp8CeIPH15erCoeTTtLhJQ552q5OM+pxUSfRMcfRv0R2fhbV/AHw/WKx0Jv7c1uRwHu7lSAJCcAInQDnrXt2n6HLdgXuvXyW0cwDNbW5xn/ZJH9K+f9L+JXw+8LSQr4T8GR3Ds6+Zc6hJvlHoRnP6V6lo/j3xdr8//EktfDbW7jMMZm2yn6g8A1yVIQcr1G35bL7tL/O5t7Oo17it5tr/AIZHVeL9a03w1p9p/YWkTXlyWaGAQLtSNm6lmPQnFYXhbxvpSXw0660DV7a+k+fyAgdHbvgr1xTPGFl4s8RaGLO+vYNOnVhI8EWFwR0wfaqPhqWbw3dQyeJ/F8d7qDtttrSC3/esx4xkdqn20m7r3UtNUl+pn7GCXK/elrs23+R7DLdPe24hSKW2jdfnkcY2D0+tZF3qug+F9KnT7bGrupJIO5mJ4zxWf4t1XXE0BrlbSKOAEeYzvtKj1x3ryax1VL3WJvs5sFaVCpuLjLFW7bR6VVXGKDStr3en3Izp4VzTfRdjyqX4PeJNc1i/u7N4GsJp2aG8lfas2Tnj86848R6LeeHtZudL1OPy7u3bawHQ+hHqK+sXhhtBa2+o6xLKq4bZBHgAk84Fbvi34baV4+0F7a7svsmoKm6z1HbiQ46BvUVrhqsqujW39dBTmovyPh7FOGScd69P1b4L+JdP1eHT0NtOZHCNIGwE56kVnfEj4Yav4ESG6uJI7zTpCFFxHxtf+6R2pRxtCU1BSV2dHsZRV2tDl9Dt4hfKL7cikcD1r13w3d6bZgfZ4kVQOucnNeKwyu0wJLFq9C8PRXLqgjgbc3ciuDMqfMrtnu5Zyyi4RR6vZ+LBAiqoG1STjjrTZvGeoXD7bZGZ+wRc5qh4L8NS3t2kmoqRCDyuOor1rT9PsrOIJbWscSL0IFfN1HShK1rs7akqVJ7XZ55DP4g1NgEt5kjY4ZtuCai8ZaPq0fg3XGmhUQJp1wztn5uI2r1ZH25C4A+lYHxEf/i33ijjk6Xdc/8AbJqdGqnUjp1Rx1sVLkkoxSVmd348/wCQ34G/7DUn/pvvK3DkdQcHjBrD8d5/tzwNjGf7ak6/9g+8rdZS4xu/Cv0ensfDT3Gl+nbk44zTskL93HNICMAk9Dj0puNwyWYDHpWhAoyecE/pzTdrcY4PTI708nIJJH4d6QsN2Ac/QdKBjWG4/MNp70wZ5xxxzT1xIWboMZJPYetIpVijKwdW6Ec5HY07hYU7ip5Y8fnmnryIzQqkPkk+1AUlCNxGDwRSAeRg9fyqNmAUhmHXPXFOHzbSTtBB/OmsFDDO3PuKSARjtIOQoI69qjLBj8ozkHAAokTpgEgHA4pYyqnJHA4wBxVdBmF4N1mTXvDGn6ncwpBPOG3oucIyuyEf+O1uJ3ye1efeGtYsfAkd9oHimZrFft809jdSRt9nuIZnLrhwCFKklSrYx16Gu9tZoZIEnhkjlikG6ORGDqw9VI4P4GohK6t1NqsLNu2nQtAjcMd+eKyrDWre81jU9MjZ0uNPMe/cOGEi7lI/Ig/StHG9mGGO0cH/ABrzPzpLf9oqC1Vx5V1ohlkT0ZCwBP50Tly2IpQ5+a/a56erg4LN26DrShtytjLEevejKOgKkFB3HNKAADjp1J6mnpuZjAeVIPbOM01H2t0P+IqQqHIYAn0HrTV2YzliO4PNPQZEQdwY/Kp9PSnu/wB4DAwwzjg0oA5CrhuPmp2AM7gCo4BA5pgMKbSBg8ntx+VOVcDBVVY9Bmk3KCg7Yxkn+dMZwxzg7hxn8KLML3OP1e1XxbYCaylOmeItGumMM+3d9nmxyrj+ONlIDDv+FWPCniyLW2msL+E6fr1mB9psJTg4HBkiJ+/ETnDD8anWM6dr17PJIxgvvn2gcBl7flnP4V8/fF74m2uvTTWeho1jd6HcmSG8kLefIwJRlj2j5UIPIJGeK4o1XCHNP4k7ev8ASsej7H20uWPwvVPtff8AHQ+m71Yrm3uIriONoJI2SRH+6UIIbPsQTXn3wa+zW9trmm6NqK33h2wvvK02TzRI20xq0ik91Dtx9TXyzN4s8QvdRWmtXWpyWcsqNNaGVwZ1zwpB6g+nevpb4L+INO8T6zrF3ommw6bYW1rFatDCgjjVwzNkLjg4z+VOOI55xXLYqphPZUpXlf8A4dHqoVydxJ2g8jH8zWB4/JbRbEg8DWdK/L+0LeumGAgAPGMcnP8A+uuX8eA/2LZ5P/Ma0nj0P9oW9dcndM81bnfUUUVzGhxfxg58E/8AcT0z/wBL7esQZxjnPvW38Xv+RK/7immf+l9vWRxzkdq+W4gV6kPRntZW/cl6kJVieh4rM1XXNJ0qPffahbo3QRq29yfQKOa5y/0DxF4o1GQ6zqT6PoiMVisrF/3sw/vO/bPoK3dE8JaFob+Zp2nxCf8A57SkyPn1yc14fs6cV70r+n+f+Vz1W3sjlbnxd4j1wNB4P0GWOEkodQ1IeWq+4Xqa868deAL9IRd65qsmo30oOxUBWNW/2RX0VIxcjcCQaqXVslwhSSFGXsGGcfStaeLdGSdNW/P73+li6cYN/vFdHw9qWmXWmzeXdJtY9OaZFp99KcRWVy/0iJr2z42eCRbyQ3tmmxXBJ2jO01xF78SdSGhW+mW1vFbzxpsluR956+poY2piKcZUopvr0scWIwVGlLmlJqL26+q9TgpEMblXGGHBHpTacxZ3JJLMxyT6mrNzp11bWqXE8EiRucBmGAa9BySsmzzVByu4rREdqm5s+lS3jKWyowDUMLmPk9DTJid5yc0rXlc251GlZDKKBQKo5hykA88e9dR4a1Lw7p6eZqdld3dz32OFTH0rlaX+VRUpqouVlwm47HsMHij4eXGnizuvDOoQibBLxuC5weqmtKLWvBn9mJZ2GtalbRpJvVbi0+ZR7OOc14xYqZZo83axbWABdiNo9vSvQNJ0WLUpIlfXrSKJ+DJLMqqn9a4K9OnFJSV1+v3Hp4O93Pm5fx/4Y7HUfiI1jp1vp+n60ksMYJL3aEyMp9GPU0/wZP4Uh8RWeuN4oWaawYzIt18uDjPI71y3jTwx4a0UaVOfEb6vIWAuESEmMD/ZatyDR9G8SIYPC9n4faVgFcTbklXj+EE81wzpwhFS5nfv/wAGxvJtpqNkn5Wv5/1uafjTWvFXim5Oqxazp1tpzvvtozcAfL6lagTxR4lSyjg1nStF1a242zWkyRS4HvnJNZPxB+Es+naXZ3mmJKtyqhbu2Bzx/wA9B6D2rmfFXw21DR/D2l6zYztf21wv79owf3DHoK1hUoyspTV5aarX56/8Oc8ou3ux0W1v0PSLPxlpmly4ezvo3YjbHcMsrKPYjrXr2m+JbjXVin+1COJY/lDx+W35GvnX4L2Fhaa48vijTtQkkcD7HK0LNGD612f7QdxrOlJZapZ3arbt+5AXhl4rBVnRxH1en187J/cTLDwq++9H16kHxf8AH2m6N8Q7GTSJZLye3RPtLbv3Wc8j3NZPxT+JWl+LvBg0iwDm9kuUkwB8oAHrXh8jS3E5Z2Z5HOSTyTX0F4T+GPhrxZ4Mtjp0s1hraKDJI3OW9x6V0Y2nh6E4V6q97y2v5lUZSqQcfsrS/VL5HmPh3Qo4pUlnk3Nj7pr1/wAJeG9QvI1ktrKXZgYdhtA+ma7LwZ8LNJ8OSpdXrvqN0gBHmD5AfUCvRFbAwuAAOFA4FeLi8a60tHc7njoUI8uHicnoHhy8tDm5kXfn7o6AVvDT2IwX6GrhJ3sRwMYzUb3UEQ/eyKu3rk4rz2k9Wcc8TWqO/XyRHHYE9ZFAzjpzWN8R7NE+HXiofMxXSbtgc8f6lqsXniWyiDCEmeTHAWuP8ceIL678A+JAtvHFC2nXKEl+cGJga2w9lUjp1Q50MRODk9D1Tx2xXXPAx6/8Tp//AE33lX9ZnvotNnfSIree/VN0MVw5RJDnkFh0yM4PrjPFUPHuRrfgbHX+2n/9N95WnLcJHJDFM6rLMSsSn+IgZIHviv0mFuXV2PlHfm0VznPDHjay1i9OmXlpdaJrqjcdM1JRHJIv96M9JFznlTnjoK6oApgAMG5J3DFUNZ0vT9Ys/s+sWVveqpO1Z4w20+oPUfUVx2oeFI9A0S5bwtrmoaNcIhaP7TeNPaKxPV0k3cduMGm+eKu9SkoTdlod+wJUMec9uhrJ8S+ItP8AC+kvfavKIYc7Y0A3STuekca9WYnsK8QHx8TSrKax1wQXesxEjz9MAktJARkFTnPfBHqK6r4Ka1pfiCD+19SvLS88VagzzujHJt0B+WOIN9wKOuO+TmpVZT92LNHhnBc09jftNK1Txif7Q8YRy6VoUZ3waEHKvJj+O7YfeHUiMfLjGc11ejX9jORb6Rbsun26bY5Iodlv1xtjPfHsMUsim+1IWrjdZwIHkHQM5OVHuPb1rUUBECou1VGAAO3tWdNuUm1stPUKjio2a16dl/myQ4Dcjt07U3cADn600vlgMdaAWzjGa6LHMGQUznp+NOXGenJ9aRTgkDoP88UpOMFQT9KAEGd2McDpWXq2pSaXLC8lsGsnO2SVOTCT0Yj+71ye2K0XEh4Q7femSxGSPEillbIKHHIxg/hUyTa0dmaQcU7yV0VNYvIbHTb25uFVrWGB5WyNysoUk/gQP1r5Ku/jBqOiXckvgrSpNG0u9jEv2K5BkhjkLHMkA42A9CBx14FfS+oSWmlJeWWszrFp1wNsJdTtVWGGQt2wfyr5A+K9tpml+JUTQbi4eBh5kfmzGQhP4WJPQsQzY7Db61wVa7k4rZ9V1T/y7M9TCUIrm5tU9n0f/BOw0f4v6hrszL4x1HXILBSiFNEK28e0nlpXxuGOOQe2K+lNA0LRND86702zjjlnTfNel2ldxt+8ZHJbp718h/Duz0jVLOea/uBb3djcC6uAjsrXNqACwUA4JXaxPHQ19YaJqcXiBYo9Ihc6WuEeeQbAy4BGznJBAx0pUMTGLlF6y2S63/y8x4mg7Jw0j17HReGNq6DYLHG6xiMgbxhjhjyR79fxrQdiyksPxxTSChCgDaOmOwqRQcNwMn/PNehCPJFR7Hk1J883Luxsb7sN2Ax9KUHK5IwAe2aYgIkUEEY/P86lxnDAexq2QQFmLknGTwOKeN28K4O0dPSnS58sDBHQjmg7/MXOAoyTRcZHMuCNucHrntTBgMOgPr7VK6O3ucdu9U7jUIFfy2cTSnosQ3EY9cdPxpSqRgryY4wctIq5i+PpZLbw1fXluiu9qhlVecOADlTgE8jPTmvlHxHdWOs6fqGs6Pbw2lmqAXU9zEBMsrHKwxlWG9uMliO2a+pPFA1ZtIvJIZFgdImaMJglsDJz+FfG3i+40/zLGXT5w5lLTXdsN3lrLnrg8HIzyOOO1eViX7Sasmr912/rr9x7WChy03dptdiHwitlfa9a299bS3ombZ5Es+zzOOArj7r5zgnjseua+qPgzpemadLfS+GhfDTzGEmW6cZ8zORgAfeGCCT2r45mcblMbAbRwQNpzX1z8Ev3ujagNL1WO9u4ZY2upIx+6d3TIOCOu1QCR3FSnKNWKWvX7jXEpeyl/XU9jQbmIGQAehrm/iAMaLYkE861pWQf+whb1qW995KJFqSmJ248xR+756DPb8azfH+DoFgUYOh1nScMDkf8hC3r041o1I6fc9zw503B6/8AAO6ooorMZxfxf/5En/uKaZ/6X29ZHb1rX+L/APyJQ/7Cmmf+l9vWPu4PHFfLcQfxIeh7WV/BL1EIwMnims4C8kcUxicHPIprngDAwa+bcux66iK0m4DHFReaQvJNQPMPmAByD0qlNdFg4LhQFPJ4pK7ZvGlck1WODULZoJsSLnlSucV5be/CHSxNNLGwdpZCwUr0B7D6V3730Y28jbxyD1+tPklkmDESCNR90V1UqtWj8Dtc3UEtGk/VXPNJvh7p+mqPJ8ncuBhk6j61neMtPt73STpyMFHDEleUIr0y6t55R5YVWY8nPRq5jWvDaiJnleQYH3BySf8ACuqniJOSlOWqOqChKPI9trHzrqVhcWrhZUO0HAbtUEFs9zdCGDlj0zXpviHRWe3MaxgHJwDxzXG2cFxafbHNlkuuwSNwEHc19LQxntIX6njYnKowqpq7i/6sc/JG0Tskg2svBFdr4J8CTeJtF1O7inMd1bKDFAUz5o7kH2rjrNVa8hD8xhxuLHqM819MfDjWLHTfBd7eaZbr9otgQCehHpnv3qcwxM6EUo7vqebhqCqXmls9jxG/8CalBB59rsukUkSKPlZPqPSuXms7iGQrLDIjD1Fdl4v8ZXWq300mleZbwOSjxdWB78+lc5FqV5Jcx/bpZHiA2nK9q0oSxHLepb9TepTwsmlG6v8Ad95WsrSWR1JhZkPpXT6X4cMt4j3sUkVqFJ+4SoI9xVW4+y2Ucn7yV0cAefGvyg9lx/WvTfC+qXMPhG3vP3ktmi4mktzvkC/7S9q5MXiaiipR66HoUcNCleGja11t/X6FLRdM0vUbOKzmuWu4GHzHysNEw6YHcV3vhDwHoTW7PtNxIWIWQoYynFc94c+J2kR3ghtNMe5nnOIiIQGf2GOc16ba+K4l8P3t5qGntpsaKVEc52sSRxivDxMq8XZpxTNpTdRXpr8V/wAOZl34Zv8ASysmnX8t3Fja8Mh6j3PerHgXwzc6HY3aTXQvYr2YytBIPlh9h60eHPGGnXWi2093eW++Rir4cEIewNY/xq8VjTPAzNok4ee6IjWSBslF7niuaCq1Zexa3f8AWplUjOOj27+h2D+JtItrlLeG4iZ1fytsQBCt6V538cZdKGo2sN7KAPLzLETwuf4sV474XtZbGEapf3kqMWMixhzkn1P1rA8VeINR8TazLe6hI8ksmFA9FHQV6uGyq1b3Z6Ld+fkKdSOFhGs4u8k9P8z6n+GPhzwjbeHbU2FlZX/m5c3UkeWYnt7U/wAe28PhT7Nr+nmO2t45Qk0KnaDn+YrwLwF491nwpZx6bHHG8IfzFSTg89R9K9T8ceKdL8b/AA7itAyR38siloSeYiOpzXLXwlWlX/eu8W999B4eE+ZTprR7rovLyOotPi74fkVjNI6n86Sb4r6QQfslvPI38J6A14ppvw9tpyhTUip45PTNdbbfDnUlh3WdxDKo9Tg1NWhhIbTfzO2lgqC1rR5fmdbe/Ei5ukC2dv5Gf49+T9MVlR61LqEp+0eYWxktuyKxZ/CetWSZntyyjnKNnNJb2eoW0g/czIORnbnFZqnTt7p6dPD4eEb0rHTWlyjgtCxPT2qPxdNnwbr7MoOdPuFxnp+7bmqFvLNGoMsUikgBflPJFL4slLeENc+Uqv2CfH/ftutKnG1SPqjlxlNezk12f5H0D48ydb8DYOD/AG1J/wCm+8rQ1SzNxZFI2RZ42EsLPztdTkH27j6E1n+PM/214HwcH+2ZP/TfeVtnaFLfKTjrX6HGKlFxZ+Y8zhJSRnQXjofK1GH7O7DKvuzGT9ex+tcH8e9CvvEHw8vLbT5oo/KdbqYPKIhJEgJILHjA6/hXokqLJA0cgV0bqpXOa8B+O8E+j6bO2m6lc/2PPtt7mxMmYt7fMGGc4HHOMZ6Vz15zox5ZvmT+T/y+eh14WEa1ROHutdOh82X1hcaTPFHexBLhl3tBIpygPTcOxPXFep/B86NZ6xpOv7Y4dQtnaGKCO4I+1ykEBShB28Hk7sY5xXk95cSXN7NNeymad8ln3ZyccHP5V3fwIvoLb4gacl6VktzKGWJhwZMFQ31AY/WuRqVk72f9fkepK1ndXPtfQ4pI7LfcIqTysXkA9emP0q+QTt+Yjvjpmq9nIjRAq+RnqTk1O5GwsWUADluwr1YQ9nFR7f1c+enJyk5MUrz7/XrQxYfd59iaj3IOhyMZ9qXzQQw2swUDPHXPpVkgqsxyxH0FSrlcY249MVWGdrbQRnv7U8ybCRg+2TQ1cCbHuRn17UxyR97KsO3Y04FChkZwiLzlu3uaxZmm1WQrFcy29gmRvj4ac9chumzB7daynPl0irvsa06fNq9F3KPiu40uWwvrW/ntZJGgfFtKw+c7ThR6E5A65r4m1q0uZ/FdzJc2V48UMgVopImYrsA/cllB6Abcj2NfW/xN1aw0TTrKylWSOznEjzrBB5rNAgG8ZHKZLL8x9DXhOqXljb2mpQ6D4wv9MvPs6yXlrOvlJPIV+YxnPBIwOOSK8vFyqKrfS9v8vv8AuPcwVNexclezel9v+B/WpxEEd7Pqtr4jtNCuE01NomFujRRc5XG/GMN3xx2r6o+F/iQ3Gg2lpJCH1GFBHKlpH8jZHysOmARnqOxr5f8AAmsaSklpY+KNW1IaXBN5qQRRmWPPXG0sAOQDwK900vVdFXUbHV/DV4xTY0sQiAST5fv27x55LjoOo2g+ucXVqUp+0bt0v1t8zapShVpum029/I9vjN0yg+SIyw53S5x+AHP51Yg81Y2aVombOcAED+dV9PnjvLaC6tnDQzIGQjkEEZFTgRsC545xmvaVPq5N/wBeR85KXS1inI+o78La27Y5A+0nB/8AHPWtFC4j+cgHHIB6HvTUzyAxPPccU5V+bPfvj0q0mt3cUpJ7K33gw4PRvQZpG+6ctjnGBzTgCWOSMdenSo5ATjkYz1/xpogqXtgl5IhuJZxEP+WSylUJz1IGCfpnFPight4CkUaRxjIKqAAD9KslSCRkYJ/EVG6DBJbOO1EYxTui3OTjyt6HIfEvXH8P+Eb+/ht0uXSGQ7C+3jYQSDgjj0PWvlzU9Tt7G6YjRUu75LUWdzbX1sZEd+vmIU+6+eo44r6A+NZef/hHtJtHRJr2+VSC+0FMjcCP4gQDXi114hv9Plv9Qh0K5uLC7mk814JnDA5OXZdpxkHg5FeJmFRyqONr287dj6HLqcVQTel9/vaRwvhGN7v7TYt4fivftMiRG58lt1t83ODnCnkdelfR3waWSy12ayiMZsLi2Zk2bSFaJ9uNw68s3BrwDRdesLXUGg8N6bey3l9KoU311lYyTzwv3j/tHkYHWvYPhx4mdfFWjh0cQTSzxSYQcyOFWPkcYOyQ5HUg1EJSVTntazX3aX/A1qw5qLitU0/v6H0SqZQk4KsORt7fSuT8d2FpbaPYvbwxxOdZ0kHy/lB/4mFv2HH411UTbog3Qn+92Fc38QP+QNaY6f2zpPOP+ohb17sop7nzMZNaJnd0UUVgWcX8X/8AkSv+4ppn/pfb1ikc4Uncegra+L//ACJP/cU0z/0vt6xuSflDMcdF5r5XiH+JD0Payv4JEbkFQTx6iqs2EUFjjjrWilheXDAQ27c8/NxVa60eZPmugRg4Kk8GvnXTlu0exCpBOzkYd7cksI7ZCzn+LsPeqS2UjNKbobm6qQfvGuhNmm0qV4PpThbqucj3pKVtkdSrpKyMGCyGS0iYBGQuO9advp29s7N7EAYqx9hQPuZi3TC9hVmO8ktlwoQLng0+a+5E6smvc3Hw6RgL5gCqew7VX1q1tktfLARW4AYjpVDUfEhtwd0y5zj5fX0rz7xN4suGu0KrxH1z2rWEHPSKKw+Fr1JpyZa1bTLJQ0kieayt8xJ5Y+wrz74j2Ua6BOLaNYWUAsAetP1LVr+dpXWVVMh3HPGKr6N4V1zxBcC7klkSyhO5p5hkNjsB3r08PH2TVScrWPUqw5aTUnurHlWk2M2qXcVrZxNLO5wAO1fRFhpdnYeDLjTp1UkoDtzgZHX8a8r8dteaF4kj+xiOFDiSKW3TZv8AXP416PoEx8T6AJYAq3cKAzjPD++PWuzMasqsIVNonl4HDwouVNv3la+lvQ5YWdpC7eXBEuTnhetYuqxxRh3EaEgZ4HSuyNkdzjKl1J3DOMVy+t2VxdB0thgsCBjuaxozvPVnuyglB8qOG1jVmvbeO3A2xockDvXcfs9+IbbQ/HqR6i5FlewtAwPK7scZFcFquk3WmzBJ42Ge+K9A+Hvg43F1ZSTkI0xHzMfuj1r1cXKhDCuPRnyVPC4jF4l+20tv6eQnjjVv+Eb8RSXPh/yraRppGikRR8gz2qh448aap4v0CwW9uDI8BxIF4z7mt749eF9P0UaVcaY80hfckzucgnjGK0P2bfCtnq763qepQx3NrAotxC4zyRkt+VcdOVGGFji7Xcfv3sbYnEXxEqb+GSsu60/U8u8NCUzMih9jjkZODXr3hXQrPUdHuRd6jb2iQpuCzP1PqAa84+JMlrp/jG8tdCcxWsLFQEPA/GuYihuNQuAhmZ3Pdmroq4d4uKq83KnqbU8Z9Vh9VpJyknvp9x3motbW6tcSyJLaZ2o6cg1hW3iHTo2ZWs8pn5XA5FOHgzxSdEklgsp59LRtxMfIyOpxVLwzDbh289A6MMMrdqIUqKpyfNzW7P8ArU2WMxNatGlGKh3ur6/5Gh4kmtbuwF5ZspOQOOtUtG1AK+GJye9egaF8PdF17YtpftbTONwhf7tO1D4b32iZae1EkCk4lTnj1rnWMw8Y+yu7+ZvGFZ4hTbUXbbuUNLvhvUiQkDBxmvRPDfiLyZoxJIeuA2ciuEXRfKCsq7ePyFX4LaWFQoDMDz09fevOrxhU2PWcFNWke4adqtpfLsSQMW6KeuKxNX0nU7K5N1pJM1ux5hzlhXDaVdtaSB38yJk4z6CvRNF10S7UM2ZQM59a82VN0ndao8yph5Yd81PVdmYtnrZR2jvIvnUnKuvOag8ZX2nzeB/EA2Ksx064C4HU+U1dtc2Vhq6brmFfMxt3rw1cR498JNZ+D/EE9rdh4o7C4crIOcCNiR+VaUOWVSPTVHNWrUZU5c3uuzPZ/H2P7a8D56f21J/6b7ytc4zwRg+grJ8eDOt+BhyP+J1J0/7B95WrfQedblWmliXuYjtZh6Z6j6jB96/SqbtHQ/PZJN6mfrF4kQjs7aUDULgHyweqL/E5B7DPfqeK8r+JOktq3w61eC3ljFhEF2SqMm5mMoVR7BSxHufYc+lw6faWsLW1vaiOKVjJcO7F2f2LEk+vsOa+fvjm8Q8PTzxG8tX+0pEF89ghIGVAQHb90Zz2x715+Im1JOS3uvy/p/jtr62CinpB7a7f1by1ffrp5t400fVPB4Twtew2wvYpklLrYqXlB5UrL1ZcnG3A5GOa9A8M+EvFE1n/AG7c2FtFPY2hmtd9mtrI7q6uCUQZYkKV+bHXgV5vHpeveI7G01EifVBaOYzM2ob2jQc4weUGSTmu48E+LNb0/VtNtLjxY9u09ysH2C4kN6oBPygk52g9Mj1FckJUeazV9Xta9/69PM9CVOpy3i1dd72Pobwd4gPivQYb/TITaGdTukkG4RfNjpxuPXrWzNotvcMkmoXNxfAAnypn2w89/LGAfoc9a4bwHJJ4b1K+0WdBHZwNG1uqvuCQyE7Gyecbg6kHJB9uK9MjYSL+8xnpjrXp4e9WP73WS7/5bHi4lujP91ontb/PcSJEjhWKMKkarhFUYCgDgADtUyBfvM2Mc9aQxlgNuOM4p6rxtJGDx0/rXY7dDh9R64CkhhtNQsmDjjHTGcCnEY6Zwem0UB2zjjA9vzpAZcGlxm4M19czXkgyVV/9WoOQAEHGcHGTnPWtEyBT8qDavAHQCnIsbSMQOP5+9ZninU4dG0a51CeQIIUYoCR87bSVUe5IwKhRhTu9jXmnVajueIfFjX2k8UapHHJIIRYvZrHGpzIodTIox13HOG9iO1eOSeJPDuq3OtLrVrdwreXDSRTQRozIM4UYPIAAHANernQLm7udM1opJ9oimeaNWP3Y0zh8DuXLMf8AeHtXmlnp2nXEMza74S1e4vTAkj3WnyZQg/8ALQLj7x7jnv0r5f20aspVJ31fR7a+Z9eqfsIKFPorMxrCPwfpcck1zqF1qd0Q4ijjtcRhSMDduI+bntwMV9F/DvSNF8WfCvTJ4tPEM6oVSYKv2hZYiQDvAGScdT/e9q+frbSPD8uhXE0GleJL+dG+a4jiCxw88LgZ5x1yfyr6y+ENt9l8CaaklkljIN48lefLXccDPc4xn3r0MIoVakoSu7p3vby2Xz7HBjpzo0lOLtZq1v1+45LwNrN94T1aPRtREsnh+eYpFeS5/wBFmcZEbHoqscn6t9a9iRdhK5yRwBiuH8eeELTVraZvLJRwAUEjKrLnJDAHBBPfqDVPwD4sa1uIPDWvzF9SjX/Rrhhgzw/w57bhwp+g9a1w2IlhpfVq/wAmceJoLFweJoLXqv1/zPRwAp5IyelSgYGMdOOB0pCCDgfcA69OaAy5wAQR7Y/GvUuePYQ7X+RSM9GzQ6jLfNjntximOwV8qvPH40okJZiyc5655p2AaQu0ozfhSFTgkEMTx9BUjbSQGB9eelJMYwAzZAAJJ9McmncTPLPE6Q6t490gRqrjTXkVjweSpCsD3wzCvL7u6021vdLtdYXV7UL5sZitlMi3qAcq2w7gR97pmvXvCOmxDxVLdoimS4t3uGyT1eQYOO3C1jfE3w1qFk0GseHrhbeQXIM5FuJtoOQWVSPlPI5BHvXzmKw1SrB1/N+X+f5eZ9NhsRCnJYfbRW9Twjw/F4J0jxel5Y3Opa2E+a0sVs28wS5/izgEKOnvyeldD4KSK40611K0R4ltRLMiSzZcCK4Vic99qySn8aytM1fxEPEV6mnWuj295dgRyXFrbbncnOFVMn5ic54we9et+HPAtzo3hO1tNfWE6os00jfZUUIgkUDZkAAjHJx3PtUKlOak9dlre/5JI3lUjRceb7j2DSrq3v7KK6t23wzLvRj6c1i+PlVdEsAOv9s6V/6cLes7wJeSW9u2j38xknhldYpWUqZlGCTjoOvAB6VoePjnRLDj/mM6V+H/ABMLevfoVHVoqT3tr6nzeJpeyquC26enQ72iiipIOR+KQU+FrcSY2f2vpW7Pp/aFvmrk15b24Bs4ot54ORjArP8Ai1/yJyf9hXS//S+3qq2ARwN3rXz2dYmVGcOXsd2DpqadzT+2SKNxn+8eijpWZeTNOCsjE8nGahkkVSdzYI9KqT3XykjkCvm6leU3eTPWo4ezukPKjHX8qjIC5OeKzL3U2jwqjZu4BxmuY1S6vJmeN5JIU4HXFZr3j06WGlPd2OoutRtYAQ0y7weFzzXPanqwlDBJ0Rf4R3rk9U1BbYqIS0lzu6dTis28vHnYB1CRknJH8s1rDD9WerRwKjZs3Zr2JoAcBlLckjkH1rm9SEbzBndSW5z3J96juLmSM4STCEfdznH1961/h/pDeIPEkEM6breL53PfArpjHkVzsly4eDqS2RrfDXwSNW1Rr3WbSUadAN0aONolb39q9K8QWLW0JWGHEYT92qjgfSupIGI1ThR8qr6e1OuIGVNs6ZDcYzxUVIOpufIVcynVqqpLbsfI3xZ02a4t7aWeEx3MLEt/ueorK+G988E01qJfKeRRwxwCtfT/AIq8JWmp253oHwpAbHK186+IPAureHNQuryOD7btOYxHx8tdlDExnReHqaPoexhatKtUVaG/VeRu3zlTiNRl+/Xd6mu3+HenW3Eht1lXIIdxkqa81stbkR4TqWkXWEwWcITke30r0vQfHGhafp48yRoGX5irxkf/AFq5K8JqNkjvxbm6TjTV2bXxG8IWOsaYr/Y4/tUTZVlAGR3FYmj+GQlxDttWRFXls11+lawPE1rBc2KsLRz8rsMbq6KG0Znx90EYwBXKpz+A8RYyphqfs5vU8V+PltbReHtE04RlmmmL5I5Kjg8/jUX7O+n/ANlajrkSlxaXEAIRuQW9frTvjZqcep+NLHTYBmDTYihI7yMef5Cuq+GOnJapLIG3Ocbvpiu2pUdLDKkuv+Z1yoReC9rVXvPbvufO/i/wjJHqepS2qSFhOxKn0JrN8F6ZJPrq2zxHzm+VQ3HNfYet6Ha3in/RUbPVsYzXn2o/DuRdXi1XThGDC4Z4z1A9q6IZtJ03Sn23M6H1SpUjXj7rXTozvtEsE0nw9b2QTKLFtcE9c9a8E+IfgEaFdPqmlQObGRsuBzsJ9vSvoMNI1vGP9kfWo2t4pYWilQPE67HQ9xXlUMVOjPmj138zOjW9lNzlrdnzLpV08DxujFcc8V7L4N8TR3yfZL6VCWHy7+/tXBeO/Btx4c1KS5sUZtJcgoQeUJ/hNY1jOySBwMAMMYPSu+tCGIjzRPofZU8XSume5aj4btJIzLaQL5nVlB4asaXRVUgJCyx9AjDoaxvDvjJ7PC3JaRMgbSegr0y2mt9RgEkLrIpHbqK86SnTdmeTVdfCu09V3PN9R8OynzXVcyk7iuelZrpcWWSqlHyCT7eleqS2RXlfmHbPWs2709n5jRJSOiuOv1pqu9pGlLHX0Zk6DqeItksiqVzhj3qz45mRvh34jO/cW0u55Hf901VrnTjHIoWHCnrsP8X0rI8YTQ2/gLXYS7ln0+5Az0B8thgU6STqxa7o58XTjUhKUT2jx8dut+Bz6a0//pvvK0J5JGyiIN5+7u6AZ61n+PhnWvA/Gf8AidScf9w+8rVKjJwME8mv06lax+dz3KN3uW02K5Yuu0se/FfN3xztL250uQvkQrcJKFYYLOEZQB9VBOf9mvp6U7wNxAHcnsK8u8X6LJr+ganpsUEZnvWKQsTlARxksOg69PWuHHUm5Rcel9PuPSy6soOXNs7Hyva+F/EVvKIhpF86zFQRBGZNx5wMrnB6n8K6Lwp4E1e28XabdeIIDYQ+eksaysolmk3ZVFTOckjnjgU2DQXtNRm0wNq9ncwfLcwwajGGI64w5QgY7449DXofw18PWE3jOyXS1tzeQwtJNO98b64VMjG4r+6TJ44Oe2O9eX7arOapxer8v+Dp+J7M4xprmey1/rQ9Y17dp3ijR7kOGgvLSWzZHwAzowlQ57HDSflXW6NcM9vErs5Ty9ysy4LL2JHUfSquu6Ut9YKsyo8ts/nwZP8AGAce+OSMVBot+twlvOiukMq4EUmAwPXaQec4r3Yr2ddpvfVf16/mfPTftKKaW2/42/D8jqVl+Vdqg8dM1KCB15Ppiqy42AAfeHXPSpoW2hQB07Gt2jkHtgYAXnqDUeSGYnA49ak+mM01xuAzgjuMZpAiJDzlCCc8+9cH8V4/7Tg0nSgqujT/AGybOcqsXKsMdTuPTvXoCqR36en9a53xXZee8LM8YeRTCrSZUDkHqO/HA71x5i5fV5cm524BxWIi5dDD0XTo5rW6ghDiOOLysNzkMoHXvwo59a8R+JUGveEfF0dpDr76do11M8lv5sG9IweQFwCW54xnI/Gvf/C1vcW0Fy054eUDcgzu2jH4A8/Sp/Ffhm08S6eLe/QqykmK5iwssTcHKHseBXNTwEauEhZK+/T/ACZ2/X3SxMuZ+6fMGj+M9YlsrpG8U/Zngl2R/ZtMafzGY9S+BtJJwAe9fWHhPT30/wAO2Fq4kLrGGk8wgsCeTkjvk15T4F+EVxo/ia91HXdQnv7RLhJrWKIiNLggffmQfeIOOPbNe0Mx35ABGcggVeAwfsW6lrN+n+S/EzzHFRqpU4O63FmgjuI3inTKSoVPPVa8k8Qaaul60ItQuDG7yg2MpXloxkFMjjJDYyeQfwr11dzNvY7gOBVbWdOt9Y0yewv4lnt5xtIPBHoR6EGtsZhFiI9pLZnPgsY8LP8Auvcr6fqCmSCzuBMLjygUlZDsnGPvZAwGI529q0XbaN2MkHnjpUcKeRHFbo2Y4owoJ68ccmpivTnJ9utdNOLjFKTuctSUXK8VYrsxO3zOQfT1qRG4G4AsD8rZ606RCF4wBnpSMCCFBBB7Adq03I0E+YyDKjjnJFUfEVz9m0K9nCjKwlFHueB+pFXRI5bBBBJ4pLm1W5jWOTBjDKxXHBwcjP44P4VMk7WQ4tKSvsc54V0C60q+v7i8Nq4uQoh8oMHRQOjZ4/Kt+4Ectu0TDfG6lGXOOD1/SrBDb+cEnj0NBCqVXaM/TqamFOMIci2LqVpVJ873/wAjkPC3g3T9B1W41BC0t7Iu1X27dq/1PvU/iO2d1h2Nt2tu+c/eI7fzrpnQgEqAR1wec1marbPcXFr8v7qOQtIoPUbeKzdCEKXs6a0NXiZ1aqqVHdlHT9DgSZ5pwzSRXHnKQcZYJsyR6YqDx6QdGscjn+2dJ/8AThb10MSEclGBY52t2471z3xAJGkWHBXOs6VkEf8AUQt60hBQhyxRlObqSvJnfUUUVkM5X4m2F9qPhF4dKtJL27jvbG5EEbojOsV3DK4BdlXO1GPJFcg0viY5/wCKK1z/AMCbD/5Jrt/H+rXui+Gmu9KNst493aWsbXMbSRp51zFCWKqyk4EhONw5Arn5LzxuvXWvDZ/7gk//AMl1yYjLaeNac1t5m1LFyw+kepgsviZjk+CdbP1urD/5JqGS38TsP+RL1sf9vNh/8k10hvPG466z4b6Z40Sf/wCS6I7vxzIDt1rw1x2/sWf/AOS65P8AV3Ddn950LOKy2a+45SSy8U4yngnV2btuurEY/wDJiuf1Pw7441D5ZfCOpiMjlRd2Qwf+/wDXp4n8bn/mN+G+D0/sOfP/AKWUNP44XOdb8Nf+CSf/AOS6qOQYeL0T+81hn+Ig7pr7jyCLwJ4tikEi+EtWEmeT9qsTj/yYpmo+C/G88Qjg8F3iAHqbyz6fTz69iWfxuc41zw0cdMaJP/8AJdI1x44HXW/DXX/oCT//ACXWn9iUb7P7zZcTYtO/MvuPDT8OPGzk7/Ceoc9SLuz/APj9d58PtF8Q+GY7lrjwTrL3EuAGjubFgB+NyK7gzeNwATrnhoZOMf2JP/8AJlKJfG5H/Ic8N59P7Dn/APkum8movdP7zOvxBicRD2c5Kz8iO31fXIpg7eBNfI/6+NP4/wDJqlutY16aUsPA/iEDsDcaf/8AJVOM3jcD/kN+G8+h0Of/AOS6aLjxsU3f254a2/8AYEn/APkun/Y1G1rP7zzfrbvzXIv7T13BH/CD+IMH/p40/wD+SqqSSapIPn8Aa6zZzk3Gn/8AyVWoknjdumueG8f9gOf/AOS6aZfHGcDXPDWc9P7En/8Akus3kWHejT+8tY+cdmYssequrBfAOtgEcZn0/j/yZrOuNL1SW3kgb4e6rJE4IKyS6ef/AG5rrPN8b4JOu+Gv/BHP/wDJdAl8bkn/AInvhr/wRz//ACXUf2Bh+z+82hm1aO0jn9Eg1nR9Mgs7TwNrqxwjao+0afgfT/Sa2U1PXEhbb4H8QifbhW+0afjP/gVUwm8bkA/254bGf+oHP/8AJlO3+OCM/wBueG8Yzzok/wD8mVayOgnez+8ynj51HzSZ5Jd+DPFlxrhv28Gamd7lnzdWWT+H2iur0aw8R6dux4J1rBOflubD/wCSa6/zfHG3I1zw0f8AuCT/APyXTt/jfvrnhv8A8Ec//wAmUpZFh5bp/edtTPsTVjySat6GYl5r4Xa/gfX2Hp9psP8A5JpqXfiGMuU8D66N3BH2iw6f+BNabSeNx11zw1+Ghz//ACZQ0njcf8xzw2f+4HP/APJlL+wsP2f3nF9fn3MMt4hB+XwRroX0+02H/wAk00nxHnjwTrmP+vmw/wDkmt3zvG//AEG/DZHr/Yc//wAl0hn8bhtp1zw3nOP+QHP/APJlL+wMN2f3mv8AalXv+Bzt7ba3fWcltd+BdckikGGU3Nh/8k15VefDHxml5KdO8J6j9m3ZjWW7sgQPQ4nNe8iXxvkj+3PDY/7gc/8A8l0jS+OB01vw2T2/4kc/P/k5VwyWhT+FP7zpw+f4rD39nJa+R4VD8PPHiqQ/hG9Of+n2z4/8j1veH/DvxD0ifenhbUWUgAr9rsiD/wCR69X87xxj/kN+G/8AwRz8f+TlKZfG4xnXPDYJ9dDn/wDkyqlk1CSs1+JtU4lxdRWk19xzlrJ4s8vF34I1cN28u6sT/O4FPkXxCxyPBGug+v2mw/8Akmtw3PjcEA634bB7/wDEjn/+S6VbjxuwyNa8OH/uBz//ACXWP+r+G7P7zh/tWre6a+45p7bxGwx/whWtn3+02H/yTWJ4p8P+JtW8OarY2/gjVVubq0lt43kubEKrMhUE4uDgZPpXf/aPHPIGs+G89v8AiST/APyXWX4n1/xvofhzVdWGqeG7j7DaS3Xlf2NOvmeWhbbn7WcZxjODinDIMPBqST08yv7XrtWvv5HS/EK11GSXwze6VplxqR0/U2uJoLaSJJPLNpcRZHmuinDSpxnOKonWtcJ58DeISD1/0jT/AP5KrQ+IWtarpKaFDob2UdzqOoG0aW7t3nREFvPMSEV0JOYgPvdzWINS8cEkHV/DY9P+JLPz/wCTdd9THU8O+Wbs/RnJDDTqrmii3JrGtlSF8DeITnjm408f+3VZ2l3WvWhAk8E6+VUsQFuNP7n3uvSpjqfjYYP9seG8H/qCz/8AyXSrqPjgkj+2PDWP+wLP/wDJdYPNMO5KTnqvJ/5GiwdZJq2/ocd8UfDep+LraGe2+HV8+pwkKGvHsNsiejOtzu46jtyQeK2vAtlqfhfR1tU8B6z57HdI8DadGpOeAB9q6DPf1rXbUPHCjJ1jw36f8gWf/wCS6cL7xwems+G//BJP/wDJdZrHYRVPaqWvo/8AI1dPEul7J/D8iebV9bZwV8DeIgA2f+PjT/8A5KrKik1uK+uZ08C67slk37Dc2B5OCW/4+uCDnp61fN944BIOs+GuP+oLP/8AJdOW88bHrrXhv/wST/8AyXWks0w0rNy28n/kZRw1WKaS3JU1jW1hC/8ACD+Itw6/v9P/APkqpv7e1ojH/CC+IhxjifT/AP5KqsbzxoOmueHD/wBwOf8A+TKDc+NwCRrfhs4/6gk//wAl1bzWh/N+D/yM/qk+xb/t/Wf+hG8R9P8An40//wCSqP7f1kn5vA3iMj/rvp3/AMlVVSfxw3La34aUe+iT/wDyXT0l8bvn/ieeGx9dDn/+TKX9qYf+b8H/AJB9WmuhOfEGs448CeIs+v2jT/8A5KpG13WGXa/gTxEU9DPp/wD8lVAZvG+0ka54b/8ABHP/APJdK03jdSQdc8N5H/UDn/8Akyj+1MP/ADfg/wDIPq0+xIut6wu4DwL4iCnsJ9Px/wClVKNe1sDH/CC+IW54zPp/H/k1UAn8bHga54b3ZwR/Yc/H/k3S+d43wM654b5/6gk//wAl0f2ph19r8H/kDw0+qJP7d1vP/Ij+IwPa40/j/wAmqT+3NcO3PgfxEABjifT/AP5KqMz+Ng3OueG9vr/Yc/8AL7ZQs/jdiQuueGiB3/sSf/5Lo/tWh/N+D/yD6tPsWE1/WgP+RG8Rdf8Anvp//wAlUN4g1vPHgXxF6j9/p/X/AMCqhWbxuVB/tzw2M/8AUDn4/wDJymifxwRn+2/DWM9f7En/APkuj+1MP/N+D/yD6tPsTrr+tgnPgbxHj08/T/8A5Kpx8QazkkeBPEWT38/T/wD5KqBJfG7ddc8NA9cHQ5//AJLpRJ43xn+3fDWPbQ5//kyl/amH/m/B/wCQnh59h513W+f+KH8R8/8ATfT+P/JqlOva0Tx4G8RD38/T8/8ApVTFfxuxwNd8Nf8Agjn/APkymmXxsP8AmOeG89T/AMSOfj/ycp/2rh/5vwf+QfV5diV9e1pyP+KH8RjB/wCe+n//ACVR/b2tBTt8CeITn1uNP/8AkqoTP43ABOueGuT/ANASf/5LpTL43HP9ueHP/BHP/wDJlH9qYf8Am/B/5D+rT7E58Qa2y4PgbxH7f6Rp/wD8lUg17WQR/wAUN4jx3Hn6fz/5NVCZPHAA/wCJ54a56Z0Sf/5LphuPG+R/xOvDmDzn+w58f+llH9qYf+b8H/kCw0+xYbX9bPTwL4i/8CNP/wDkqmrrmtr/AMyP4jI/6+NP/wDkqoRceNyB/wATvw1k9B/Yk/P/AJN0ef44yc614bC+v9iT/wDyXR/auH/m/B/5B9Vn2LJ8Qa3k48C+ItvQZuNP/wDkqsrXZNd1yKwso/B+s2ijVLC4ee5uLLy444rqKVydlwzfdRuApJOKtrdeNSedd8Njnn/iRz8f+TlVb/XPF+lCyubvU/D91bSahZ2ksUWkzROUmuY4SVc3LAECQkZU9KccyozajGWr8n/kDw046tHpVFFFdRmcf8V/+RRi6/8AIW0vp/2ELenhVUkYODjBxTfioM+FIQcj/ib6V0/7CFvV3q2BgAdADn8QK6KOzOes9UV8IqgMD1yQT2p+2JGVGIUs2ArMAScdB61I6guMPjIxtI61T1PS7K/dftVrDcyopVd652gkZx6HjqOa0d+hkmupKzqvEzqMttAPHPYVMSfoa851rxfovh7UbFrrXo49JR2xHPlpGZdyHyjgs6KTgg9NvB7Vq6N460XxZqBsfDOr2crqhll3Kxl29yqEY4yOW49jWUa0ZaI6Z4acUpdDpL3UbLTYDc3s0dtADjzJWA3Hrgep9hTtJuXvrRLuWPYrkmJDw6p23e/tWbFoVk2tWd0jST3MIeWWSdzI2eApGfujOemOntXTKCCVP8+SPWnGTk22RNRhFJbv+v8AgkBQjvnBz0pvPlnIPTmp967vlGT3GaVVVhuAAyOfY1pcx9CAKSoABJHTPGKDGqLgkrjJxVgqqk/3emOgpShOeoyenalcCJCwAK8A+tNOTggkYP51OEIJyckc49qccFgM8nkUXHcrgmJdx+UA43dBzQyjgsME9c1lan4U0zVpR9u+3SqScxC8kWNue6g4rG023TTPCs1/b6xqMdvEkkoeWX7UoiQtjCv7DkCsnOSdmjdU4uN0/wAO/wDwx1u3HGDSrx0P1B714Xa/HgBlit/Dd9eLM/l20gKwl29CuW5yR3/Cuy+H3jGTx3bahJDfz6bPZMEng+wxq0THd/E5cMMKfSojiYTfLF3ZrPBVaceaasj0HGW2+vSpGAZcruJ65FcVp+hrr8kV/Jr2rahohw0SNdbY7og8MVUDC5HTviu2VFUgBVVcYGDVwk5620MakFT92+v5f8EZgkEkYHakC7jxwetThAFBJHPX3o+VmUjGT0rQgrOPlweQT9KPmDHcRjHIxzUyqOAvODz7U8qmBgcHgD/CgCu2QQcc9s0jFsBhkqOuKmWMF/Uc59hRtBKjIPfHSgDJvrmaBlS2s/tdwcuY1mWM7R1I3dfpx9RUem6zb6kXii+0QXKcvb3MJikA9dp6j3GR71fv7JLy3dAAJgMwsOGRxyCD25rz3x/4oEfgCPWoLby8T+X5jcSQOGIZo9pHzZXjnGPvZ6VlOfJeUtkdFOl7VJR3vb79jub68NrCzmN5pvuRwx4DSt2Vc8D6ngDJrLi8OrLdR6hrMv2rU0fzIzGxWOD0RBxkDplsk8njpXjvgP4n6prvjbTrC7lt7pHmMAysb7VIJZlKKpXgdfmHavc9ZuhaW6QwB2url1iiWJfmBbgvg8YXlj9KzhVhWXO1ou/9bms6FXDyUE9X1Xb/AC7k0bLLvMEgba5VyvQEcEVzvxNJb4b+LCp/5hF32/6YtXUxW0cdusMS7YkAAA/mT6+9c38Twv8AwrbxaM8jSLvA/wC2L103dtTkdr6bF/4okreeCyoyRrTcf9uF3UODK5JHQ5Azj8an+J4JvfBgHX+2X/8ASC8psXKnev4Cvkc4f75en6s97L3ak/X/ACGMD5QGAB9KUndHwOSKk/d9OdxPrT0UgEEHI9a8k7XIjAO3Bxn096k3sIxngd8dqRU2scdB39adjJxhtpp2JbuCHcePvHjFSx5DdAMdD3pyIfLY4GMcccijADAH8Qe1UloZt3GhW+8BwelOVBtB6k8UpyzcA7sdB9KnMahW24yBwB2oIcrEJDKWYAAg8E+1O2tkscYHGTxmpSu0bwAST2PP/wCunkKy7WU7hgdaLEcxnWl7b3Es6QsSYjtcEHg1b/eFtwb5m7EVkQXsNlLqDylFKOW4OCwx1Fcz4kXxFrWnb7eK4toFIJhiBWSXPQkinynfTwftalrqMdNWd5s2lsfwjnn2pT9wjpkZx7145D4L1TT9LudcS6u7C/iUOkcLuWAB6sGOCMZOK9A+Hus3GuaJPJqLRS3cMhjd4BhHHUEDt6fgafKaYrL/AGNN1qc1OKdnbo/ya+Z0ZJDDHTGCWHJzT8ktHtAHHenbE3BmzjoFbuafxnJBJ4zk0rHlOQyNcD3po4OG/h42jtUrgRgnLHHIAowp2nCkn8cUmhXGru3c4B9PbsKYgZG4GQTT34XJXPTj9KGwUOVzjqo5NL1C40SMvYZJxnFRoSz7zjPKkGli/e7d6bSDggk9KnwNmO47Dr+FFhtpaERVtwHXsB/ntThjj2wDT2ODjblPVf60h2qcleD+vvTFe43zNw2rkHt9aiMzL8uOozmnbg7hBgg+/SlKZ5Yc4xyaLlaLcYzBnViMHGeD2pAOSNpwOc0/dhB0LHp/n86aDmNjnaNwpDIypVvk5OR171heNlxpthgAD+2tK/8AS+3rpAiMWG4Mi8gf4mud8bf8gqxKgbf7Z0rkf9hC3rowq/fQ9V+ZNSV4P0PSKKKK+wPJOQ+Ki7vCkK+ur6UP/Khb1oFGCYHIyOnas/4qME8KQsxAVdX0okscAD+0LfrWqrP8gZSGJOe1bUnoc9fdEJTDgqNynjJPQ1R1uzlvbGa1t5fJnlXCybiMc88jmtXawQKp4PGcdKzfEGoWukadc3+pTpDawrudmIA2/wD6zVzs4tSehFO6mnHc+VfjTLZpr0dtdafe6dPp8CwCCJVZRydrxueqNncSec5HXNSfCFbhfEVi/h8SahcRRtMlvcRBHif7rKzj+EZBOTg5Xiszx/e33iHxreXVnpN/cXLwxiaOMb9g8xXQgDOPlG3Hrk10Xw+11rH4mz6hc6Vd2s19f75EkGGt45PlCODjqWB+grxVO9RPz8j63kaouNtbbdP8/wBT6P8ADGlyafBLLez/AGjULgh7iUcLu9FHZR0x7VtKQp6ZB4zTYd2Oec9KlCgdete1GKguVHydScqsnOXUjlVcg5K89fWn7NqkD9aUDBPp6UpGOcZJFO5Nug0rkbcDGaXbgd+aUYYcqRx0owfp6UBYQKASR6YpeMcjn1owefWlAPXHSkPUjfj5u+RivNZdW0Pw4b3wdrMsllHcxXFzaTSuds8UjOXRW/vrkjHftXprcfXP5V4V+1LqNqugaZpk6Wsk0zy3AkmUF41RQMRnsWZgPTg/Wsa75Y8/b9TpwkfaT9k+v4W6nynvcMSjMQM4Ne6fATxtp/hbwprQmguLrVLq6hgtbWIFmuZGD4HsBnk14skVrE8yTXEhKj5GhUMrH8SOK7T4Oau3hnxbp2pB7RRLII3+0YOIi4R8HGVYZ3A5HANcEZqLT2Poa9P2lNp6/rbU+y/C+lDR9AstPUALbx7QoOQuSTgH2zitV9qjJ4OcZFRqr7SyqBg4yRzipXX5CCfavVSUVZHzEpObcn1BeRu6duaTA6BfzNOCt8xPUDoaRMlF3ALnqOtAkRQoRnOOe47ipNnzbs/hmnbMg5zgc4HelRTwxP0B6D3ouAwqCc/pTGUscDoOv1qFrHZIz2s8sIdsuqAMhJOc4YHBPeobu31KS3ZbW7tYpcjDTW5dcfQOP51PM+qNOWPSRaZlB4GOcnivDfj/AAPovhuSGz1a6FrqKtGNLaFZEZwQ5kV8blx3Gfcd69ggtdW+ysJtQtjckcSRWe1R6fKXP86+c/iHdeI/EXjNdH1rTodTXTLSSUtoSuwTzBgSMHOfl6YrnxMrx5ba/wBXO7AU37S/Mmlq/wBN13PM/DS6l4P8QWOs3EZtzay7dx2ybZCpwHQMDj1GRxX2R4U01rTTobjUL99U1S5USyXciBQcgEKi/wACjsPrmvmy38LWE3iW0sbSKyS6VYpf3ysUc7XEgkHXaWC8deRjrXpXw4m8X3xOl3Hi22tl0qZ7CSGLTo5HxGcLmRznJA64PGO5rkwdVN3av29Tvx1Nzh7rt39Pku57WRt2qRgkc9q5H4rSeT8NvFSKDI76TdgKOoXyWyx9APWty60zUZkVbfW7i2K8Fvs0Mhb/AL6WsP4jW0lv8LPFn2if7Vdf2PdrJOY1Qv8AuX7DgD2FeleUla1jw+WMdb3+80fibn7d4Lwcf8Tl+f8AtwvKQcOWz2OcUvxOA+3eC92cf2y+cdf+PC8pVf5T6H25r5bOP4y9P1Z7OB/hv1/yFIXO/jceOlLknjnFR8quE5X3p5YbAArY3V5NzssBAB4YjdnPPWj5pFIBwfXvSgAn5h3J6ZqRSRHgA8449KYmyQDAVTj5Qdw9aJgzROkbFZc43YzikjAbJyeR1z1NTQnbx1649KZk3YxdDvJPtF1ZX0rvcwMCHC43qehH0raSQBGOSPbPWsTxBpU97c297YTCG4hJADDgj0rn77xDruiRuNS0iKWQnEUkDkIwwep5x2qrX2O5YX63aVFrme6ulr5bevkd4jkrjGCGHA5qXhiQpww5J9eK8dn+J2sQRq02l2ON2NqzMMfif8K2vD/xKeaykutc0S50+0jwUuIWMyOOmMYBB6U1FmlbI8ZTipON79mmd1NpdpNdC6nhRpgflb+VXUPII4UnGc8g9vpXKp8QfDnnIl3dz2DOu5BeW7QhgfQkYrpba7gu4zLYzw3CHHzwuHUZ9wfSk7r4jz69GvTsq0Wu17/gSOqhim0PkYIPGR6GvEdAv5vCHxEvrOV5VtPOCSAn5DC5+VgPVSw59Ca9yJG3BGcYOO9eNfHa0ktdZ07Wli3WssTWcv15wPyOfwprU9XIXGrVnhKm1RW+a1X6nsreWCOpYdh2p7KdwA4Fcr8L9YOteDLO7mB89GaGbHOGU/4EV1gBLDHTqaW54uJoyw9WVKW8W19w0KN+fcYqPcFbGPQfrVkYB54B9qZJgFR2NJowUiLG4Ybp6UqkbuvOfSlIyOPlzx9KAqglhz0zipKuM74IJUkcntS4HDNjaP4acSGAwevSkUYUDI4phcWPaoIGevrTTkt8wDe+OlZ2p63pWj/8hbUrSyyM4nmVSfwzmudg+KPgp5zCPEljuHdicH8cYqkpS2NFSm9UmzsGZY+SpA6nuRRHkoCfu+hFVtP1Gy1KFJdPu4LuFh/rInDj9KmkDMpEYBYjjJwKkTVtGKvynLLn0PpSYbBbIPPHb6U7jIOeQMD35pzKCMgYJ9+lSFxq7eQy5AGQR61z3jnJ0uwLD/mM6UcjoP8AiYW/FdGg2kDkjgAnvXP+OyP7JsByM6zpWM9/+Jhb104b+ND1X5mdR+6z0OiiivsDzTj/AIrRJN4SiilRXjfVtLVlYZDA6hbgg1ZGlIrKbe5vbZVbdiObKnjphg2B7DFQ/FD/AJFe2/7DGlf+nC3rVkbA4GD3yO1aQimtTKpUlHRMybnSrieVydX1EW21QkMOxDnuS+MnP6V5Z43ltNe1+x0XRZbeK6hmcRXM0xYyTKPmIJJ+SPnOfvMcDoa6z4jeJJLKCTStNlMd3LH/AKRdK20WkR9D3kYbgoAJyQTiuW8IeBdO1eHUItasgYJLdI44SAHijLZG04ypwvUHnJ7muOrKNWoqMPn/AJXPSwsZUaX1mq7Lov1a0v8Aqcv4x+Hkuiab/aGsSRX9rFEyJ5TSW7RNguC5B+ZWOQT24rkrG0j1mHTrvSYXjQWOY189isU/JlGWyWKoq498Vv8AjvQ/Fug6fceF5Nesrrw9fBpLGTUbkefDt6rlsHkHHcc8VyvgKz1Hw7fWQ0q+0/U9WlkUTaRBMHleIMrlU6KW+XJAbkD2rlrU4+05Y6eR6mGqTdJ1JST318j2r4f+IPGfjKa6hkvtJ0iPTZUgu4IoGkuGbByctwucZHB616c8moWsZLJHeqvXZ+7kYdzg8E/lmvn3w7rWt+GfH9re6roNzo+nXj/ZJfMQgvGT8gfkgspwAR/CAO/P0dDKk0ayIQ6now5Bz6V34aTqxbk2pLfU8XHxVGUeWK5HqtPv13/EiivoGjR5C0BcZCzrsYfgasI6Pyjoy+oYGjIZWU4ZDwVPIPqDWfNoumSkNJp1uOOMLtx26D2rq99HAnTe91+P+Ror3zk470p59fzqGyghtbaO3t0VIUGFUE8d6r3ltdmSWexu2SQgbYJcNCcevGRn2obaV7BCMZO3NZef9MvZ4yRg5FKDwM/pVSC4uHG2WymRwAThlK/gc1ynifUPFr6mItFh0zStIhGbrUdSkBO3qWjUEgYHdxjNS6itdJ/16lRovms2l8/8jY8ZeI9O8LaHNqmrXBgtYmCEqMlmPRQPU18ealq2o/FP4kvelUiiyPJgkYFYoVPyxnoCSevqSaPjZ4yXxR4mMGn6jdX2kWQ8uGac8zv/ABSYHABPTAHFeqfBv4P6JfeGLDUvE2ky3V7ODOFeZgiofuKVGO3Jz64rlcpYh8vQ9alSp4KHtJ6tnhHizRH8M65cafN5VwMKyS4wCpGQQAeD2rV1Pwpb2Hgi21M6jZx6jKvmvatON7Rk4CheucEEipfjDaRaL8Q9W0yytYLe1s5wIoYlIVAUU8Z7ZJP4mvoL4beB/Duu/DDRptQ0OwvL6WNn+0yw4c/Ocbm6njArGnSlNtLodlbExpQjN9bfkY/wQ+M1jeadpvh3xELldWiTyIbpVMi3Cj7oIHIbHHTnb1zXvdrcQ3UCy2skc0Z5LxtnH+FfCnxK8O3fgXx5OlkJrWFJBc2EysQVXORhvVSCPwr6K+HOuaP8TfD0F4b+50/xlaRlLt9Pn+zSucff2j5ZEPB5BwfSuilVnflZ5+Lw1Ll9rG6v8/6/rQ9m5Bz1xUVzPDbRCWZwiFguT6noKp20F6unwRHUDcXSqA00sSDee5IUD+VWlso1uhcSSPPKmfLMgAEeRzgDjPv1xxW7lN6JHnxhBaylp5b/AJFgDC9eKVQSfbscUrMDz0OKaCvAH3q0MhMcHB/D1pm0465BOcGpeOvOMVG+QASQOeTTQGD4012HQdDeaWWOKWU+VC7nCqx/iPsoyT/9evDPhb4uhhuPEniFtFv77Ur9xGwtIdkENvCmDI8x+VAx+Y4zjb71u/GN7vWtTu9NjTdcSkWNnG64zuxkp7tnGfpXa/EvShD8JtY0rTIh8lmIo44/lyQy5x0HJB+ufeuDmdScqmyjsexGEKNGFN6yqb+mlv69TwLw74XWT4i2uoQ65pUkVzeq1ksl35hnJb/VuEOQCOMjOOK6LxhrOp+EfiR/aF7osul212RIJWkWdd4XaxV0HCNhcqRnIzXlUXg7xDZWkF+dLuraWO45eQeXs2hSGJOAOc8+1fX/AI30dNf8IXltPD9ole3E8ewAs8qruGPqcj/gVYUKXtISjfVanfia6w9WnN6xd0/6/rY2PDmrwa5pMN9AUZJEBPlvuXp2PpWb8U1B+Gfi7K/8we7P/kF683+Gdxr/AIb02a6XTZ73QpZC729kokmXjBkRcjODjco7ZwMiu/8AiDf2uo/CPxPd2U6TW82i3bI6g/N+4fqDyD7HBB4r0KNRzhrueJi6Co1Wo/D/AFoaPxMO2/8ABZH/AEGX/wDSC8psbhsg/eGeKd8S/wDkIeC+cf8AE5f/ANILyjHzHBUcHNfM5x/GXp+rPSwP8N+pHjDDnuTtPfipA4yQrD5TzikbChNwBYDrilBXAC8dTx6V5B2vUdjdghyOoH+NOLkKo5YAAH3xTAOhY/TisfW/FWk6JCW1G5IwceWilnP4DtQtSqdGdaSjTi2/I3QPnOTu47dqnYkFsjBGM/41laFrWn67Y/adJukuIQADjgoSOjA8g1qxSKQA4P8Ad5PGPerMasJQk4zVmugBiWycD604JlHDDcCM9OBQCVCZxg8gnnFVNX1K20nSbm+v5lS3hQlsnG444UfWixnGMpNRitWStbxMsh+zxOAcsWjHpXFeJ/iR4T0pn03UJRdoBtkig2uh9vvdRXhXxC+JuteIVkgt72eK1MjBbeI7cJ0AJGCeD+teWXCTpIVlDKx5xmu6jg3U1k7HtPL/AKvrWfM/LZP17n1DL4d8JfEXTg/hnUpbS+jTctvJNu6A8MmSQPcV5jd6d4j8C6tlJbrTbjcVSePcsb49CRhh9a88sbi802+gu7Qy2b5/dPCxBUj0P+etfWXgPxpaeIvh7LqXij7OsdofJunuQCrsFHzAHuc9u9FWk6WzumejDG18NF+0j7SG1nur9nbW/mij8OPimusXUel+IIEt76Q4S6QhYpDjowP3Sfbr7V3PjLR49f8ACt7YzoyswMkOOodBkY+vI/Gvi3xR4gk1HV7q40+IWNi7nyYI+AEz8uc9TV3w/wDEjxboUqvZa5eMinJjmfzEPths1f1GbXMrHn4unh44hVsHeFrPXa/lrt8j6V+A3mW+k6nZMWXZOr4PByRjp+Fep42sMHnt6V8leG/jVdW3iAahqWmwu0ihJ/s7eXvUdCF6bule423xj8EyaUt6+r+SxHMEkbeap9No61zTw9SD1RzZvCWJxMsRTV1K17dHbX/hz0ZuVwQSO4B5/CkKqfqCPxrxmb9oTwsNVjhjgvpLHHzXHlgYOOy5yRXpvhjxVo3iiyNxol/BdxrjcqnDR/7w6iolSlHWaZ5M8PVpx5mtDXHzD39u1AXC8nj0FJPPHBBJNO6RQxqWkeQ7QoHVie3FeaaP8Z/CeqeJ30iO5khUDEV5MAkEpA5Geo9ietTGDlflV7ChSnUTcVsekFsFSOdx6d6+ffjd8YLnTb+48O+FH8m4hbZdX6sGIP8Acj64xnBPXPFct8QfjZ4jn17VLPQ7qG00kbreMRoruR0L7+oY84x0rxyVi+XJJ3Hkk5JP1r0MNgtVOoehRwvI7z3XQfe3VxfXDz3k0k87nc0kjFmJ9yaY77i2FVFPYDpTKK9OyR1XNTQNf1Tw9epd6Pez2sykE7G+VsdiOhr6m+EXxWh8aRLp2oxrba0F5CMNsoAyWUHn8K+RataZqFzpeoW97YytFc27h43U4IIrnxGGjWV+pE4RqK0j7+QKw6Z6HGe2acFVpQ7HAxjbu4/z0rA8BeIE8TeEtN1VQitPGDIoOdr5ww/OujZs7iAvTqe/NeDZp6nm1IuEnFgWHljJGfy6Vz/j3B0nTs5J/tnSsZ/7CFvXQffRSpAPauf8cBho9jkYX+2tKwP+4hb81vhv40PVfmc9T4X8z0SiiivsDzTkfil/yK1vxn/ib6V/6cLeqHjLXZtNsgtioa6uGMcTMMqpA5P0HQ1d+KzBPCULM4RRq2lEueij+0LfmvObW1vfE3iWa4haXyZWxCrHKxQAjLHnjdgHj1FZV6klHkhuzpwlGE6ntKvwx1ZP4C8Em7mfU9Ynlune4M2+UZLtjkgfwjp+A612nhhhPrGu3HlPEguFtYiwx5kcQI3D23FwPpW0/l2VikMBVWYeXEDx8x4zx9c1Yt4Ft4o4UOVjXaD6+9aUKMadorpv6mWKxcsReUtnol2R81ftKWc+reKBaJY3F3dxWcTWpiUkRguS+e3J/GuZ+H/hu80i1tbm98PXiXUl1FNBchQShU/L0O5BkHJIwR1r3X4v6Fd6hZ2t7Y391Ym3J817UDey9RyQe/t6VwnhHRbnW9YtPN1DVLpod8LpMflZC5AkcYAJAHXp045rz8RzRquN+t0e1gJxeGUraJNM9S+JWgya94Uu0iMQuY4y6A5AIwMgkcjoDx3APasb4U+JL240uKz1GNmaOT7PJK3WJ8cAjoVPBz716WFKxqBglRwT3+teR6hbXHhD4jQXC86Tfkg87VGTwCBx8p4H+8K7K8HTqqtHZ6M8rCzjWoSw0t1qv6/E9bYhevX09acFAIJ60yFlliSSNyUYbhnvUgHHXmu69zy2tdRRjnjqfSmHbnk9Oacc8nk0bQVB9Dmgb1IpJNpCjqeh7V8cfHf4l3vinxBdaVplw8WgWjtCqxsQLpgfmd8dRkcDoAPWvrXxXI8Ph7UJIc7xCwUDrk8fnXw74y0tpvHD6VplisErMqJEvcsM5PpwefQDmuPEz95U/merllBSUq0umiLnwl01LnxD9tufDWpeIre1XKWlmMBpT90ueygZP1x2r6JfSfiT4qVn13ULXwboeCXs9NYPdMvUhpP4enUEcHpWx8ANAttI+H1jcQpiS8UtuIwXQO21+g+91+hFeiajALqxuYD0kjZfpkEVdKm+S7+4jGYpOraK26nwhqniHQtS1Myz+H3ht0wESC7beQOisWBGPoBXpvwl+McegqLG80ZLbwzG4Vnt3klayLscOc5yhJ5HX09K8f0O3tTrU8Fzex21s0E6+e44z5bYH4nA/GvXv2TbC3vtd8RwX0MU9vJYqskEqhlcF8EEHjFcdGCUk4ux6eLa9lKM1dI9w+IHhaw8feC7m2ie2kNzCsljdhgUEmMo4Ydj0PsTXxOj6l4d1xwr3Gn6nZSlGKEo8bqeR+Yr7Y8G+Hf+EJuzotlPcT6HdvJPB53ItnJz5K9gMAkCvIv2ofh/M15H4t0e1Z0cCLUI4kyUIHyynA5BAwSemBXVVXtE5Jarc4cJP2M/ZN3jLVHrnwW8at458FQ310VGp2r/AGe9VVxmQchwPRhg/XNd/wDePJ4J/Kvn/wDZemt49GTyrdImuQ0UskZGZHjORu59CcV78R3XOK0w9T2kL9tDlx1D2FZxWz1XzJs4UADB+lNwpXaMAe3amBsN83fnmnA8kAflWtjkDO1flG7AprKpGCCSOfpT1xvBIP4VS1JFu8We91Eg3O0ZGQoP8ieKUpWWm5cI8zs9jkxocepeM7LV5FlMcG+WMH7jAcISPUsSwP8AsD1rptW0631fSrvTbkb7e7heFxnHDAitDaAAMAYoAA54P1pQgopruXUqym0+2x8Y22iWcnjqz8MyaU51D7Ytq8VzfvLApDfMwUAN06Z49a+yBEFCpGcKvyrjjA7fpWJdeHLa48X6d4gIVbm0tpoTiMZk34wSeuQAw/4FW+m3II5I6Vlh6HsUzpxuLWJ5LLZa+plWujQ2eq3F9bSGFJ/mkgCjZ5n99fQnv6nmue+KytafDvxfJEjPDcaVdeYq87WMLDePrxn8/Wu1JycEAdMZrlvil/yTLxfk9NIu+vf9y9buKscqqO+uvQm+J3/H94L/AOwy/wD6QXlORXZTtHuSKb8Tv+P/AMF5x/yGX6/9eF5ToyQ3y4yB1618rm/8Zen6s9jBfw36/wCQxPlCg8nk07cNueBtzuJNUNbvf7NsDcqpkkX7oA6n3rltO0HU9ZuRd69eyJbH7trA2FP1ry1G65mexRw0akHVqS5Yr5t+iNm48QvcXLWWiWzXswBVrjdiKFvc/wAWOvFWNC8Px2ltP/aDpf3dxzPLInDnuAD2rRs7KCytVgtIkghDcLGP1NXUxuLLg4wvJo5uxFTEKMXCgrL8X69vRficBL4TuvD+tjV/DxBi35mtl+XfFj/V45yPQ9RXcaNqtvqVpHLE21nX/UsRvTHXI/TNWidxBzg9vpWNqnhuyvJpLi33WWpDJW7hODn1I6GqTT3Cpili0liX7y05v8/89/U3xIB5YIU7RkHnivEPj/rAnvrXRrcki2UyTAHgs3QH6Cu11LxTf+FbYJ4mtftqOdsN1Z/KZD02sp+6eR9fSvE9cvG1R7nV7gYmuJ97KT97uBgdsDGaqK1ue9w5lco4n6xU1itmno2/8td1uQaV8OtSfRZtYk+zwwRgZ3Nlu56Dp07159riyPfEhSUXgHHb1r2bwXpmq+Mv7Wt47w2GjonnTRqMgkfdUfka808U6XJZTMgbkEhSO49xXpRdnGdtz2sRS56dTD8yvFp2S2Vuvdkvie/0658OeGxbXXm31sHSSIRYKjORz3rl0ivNREirI5VAXKOcKcdfxrX07w7eah4e1DVLQAx2JUy5PQE4yBU3h/Rb3V9Jubqxt5JxaON5jG4/N2IHP4+1auSpxueX7P20+Wo7J67+n46/kdHqfhzTNJ8D+H9cvZob9JtyT2aAxupYHB3Z5I6/hXP+BvDEmsG5u47Rrq1g3b1U/Migffx3xVzTGm8QaWvh+4mjhNnI0sDTNtXn7ynjnOMg/wCNW5Lq38K6RqelaZcS3N1eqIriZPkhTn7o7tj14pcys43saOg+dVXZ27+v6LQs+OfCmm2HhVLq1uALhpgY4Wi2kjodrZ5FeaJbyODFjBBzk10Ahubi1R7iZpAhwC75xn0okto4GdScjaGyOKUK3IuVF1sv9tJTlpdeX6fcbXhv4ZS+IPDKanY63p4uiWDWkpKGMg4AYnpn1q38EPGFp4B8XagdaExtJoGgf7OokIdWBBAyMjg81jX+vX+veTp8Yhs4l2/LbIIxIVGAz46tgdfXnvW/8M/hhJ4n8RGK/u1S0twJbhUf94yk/d9iaqrVg4uNQ8bE4SMaTqW93Zv+v8ja+L/xlbxNpbaT4et7yz0+T/XzSsA1wuMbCozhfxryq3sln8L3N2bViYZ1iWcNxuPO1h9AcV9R638EPClzpjWmnC9sHJykizGUA+6t/iK57Sf2fdNttUVr7VZ7zTs/8e4j8ss2OpIJ/SsKWKoU42joefTrYdRtF2XZ/wBM+brW0lu/MS1RpDGvmFQATjufoOtPu4ooLi5h+0faEh+WGRPutz2z0HWvpzxz8D9N1a8iutAni0VSgimiWNmRwP4gAeDxz69a8o+IHwwPhGWIR3Rv0Sze6uBtMYQBggI6nqwPP0rop4qFTRGtKcKnwPV9P60PLamtLdrq4SFOCxAziomAHRs1Y0yQx38DBS2HHA6nmuqW2gQS50pHpnjD4QahoHhX+1vtMU/lRLNII14ZG5yD6jv9K8qFfR3i/wAYCx+HFtp08IWR7Boyuc4Vj8oxXziBxmhOL2KqRaep9Lfsva15+g6hpMhfNtKJl6EbW7D8RXuXmAPgcjGBx0/Cvmr9lxXOs6sU4BiVSe33q+lU43lmDMvA968DFJKtJI4cbFKafdL/ACJExgbUxjkH1rB8dYGkaeAeutaWf/Khb1teYAAsfBP6VheOP+QTp+DjGtaUCP8AuIW/6UsL/Hh6r8zzqq91no9FFFfYnlnG/FqMzeDkiBAL6rpagnpzf29WtN0+10bTxGnlRxxRjzZSMbgo6n2Hp2qL4o/8ivb/APYY0r/04W9XdWsjqNkbbzjErsvmYUNvQHLIfY9M9auC3ktyJS1UG7Re5FBBFfSRX9xAA6824cYaNSOuOzHuPTFaBwSR2o+i4H8qMZbnNaxVlYxnLmGvGksTLIqurDaVIyCDWfo2i2ejtdG0Rg1xKZW3Y+TOPlX0UY6VqAALxjHpQRk5P5GlZN3sUpyScU9GJtz1HSs7xBpseraXPaSYVmG6KQjmKQcow9wwB/CtJhxwBkelNbkYJB9KbV1ZkqTi01uY2mR3NlCJBG8vmqGntlb/AFT9GMeeoJB4/Eda17aWC6hSaCQPE4yGUdaUDaBuyM9M1Vt7M297NLBORBPl3gKjAlJ5dT1Ge49eanlcX7uxo5Kablv+ZcwO3bpTCwDE4OemelLK6RRvJI6pGilnZuiqBkk/hWboF/Pqlk9/NbfZLVmP2dZD+8MY/jbnADdRjtjPXArmSM1FtEPi1I/+EeumlB8lNryc4woIJ/QV4H4F8CazrvhvVNbs0tbe/wDEksnmXVwpL21kxP8AqB3kcZznGFIGRk19C3uNU0+ayiQtb3CtC8p+UBGBDFc8n0/WrNhYQabp1tZWcYjtLaNYokBztUDA5rmdNVKnP0tY7add0KPs7a3uLYWkFjYWtpZxiO2tokhij/uoqgAfgAKlcbkK5ODkYxT9vPOfwpSflH866jh31Z8MfHTwuvhT4iX1nbw+VYTKs9r6GMgD8wwavUP2PbMGXxPfEHKpBADn1LN0/wCA10n7VHg59Z8LW3iGzA+0aQCJl7vA5HI/3Tz9CfSuq+BPgqPwj4GtGlV11HUYkuLtWPCtyVXHYgNg1yU6fLU8kevVxSnhNXq9DrPGYuh4X1ObS0V9QgiNzbhjgGSP5gP0I/GrGjX9jr2hWep2YEthf2yyqpGco4yVb8yCK0WRWRgwDAjDKf4h3Fc94W0i28G6PBpCTu2mo7fZpZcfu9zZ8okdsk4J7cdq3k1CV3szz4Lnhyrdbfqea+APCUngz4m6noMSFNIuZE1TTnLbsxg4dPqpwPXGD3r25UAY8nrVe50+1lvrS9miVrm1V0hlzygcDePx2r+VWBgEEdeoxzmppUlT5rdWVXrutyuXRWBsEAjtSoi7slm3DjFIFyMjjHY05QSxKnBz/KtTAa4HzksDk9qqWkDQzTyTusssr53AEYQcKPw/mTVxsYwcYqnZ3lrdS3UEEnmNbP5cpCnYG7rnoSO4HToaTtdXKTaTSLEmOcnj9aPlVlAzx+dNK8MAwOBk0pAG1uueme1UTfqKF/hxx9elKABjAGPajOVPpjn3pMLnIx8vHWgEJIPlIIBBrlviiAPhj4vwMD+yLzr/ANcXrrG5yR19K5X4qc/DLxec/wDMIu+v/XF6Og+pN8TOL/wXxn/icvx/24XlTRMjHLqQSp4zntUPxKONQ8FED/mMv/6QXlSo5DE9Mrgj6ivk84/jr0/VntYPWm/UjO3cT8pGec84pxKAksMswAH5UhbgEdc09gpjwykOPU9K8i52sVsAg+g9KWPBTcQcH8KaVZo2OCAPQ09JNoG4EHsaCXsOGMfKCSOOmRTljDE5yDge+KRR/D90fnn8KcA3lsxJJ6AHn8cUyGyC/tor20mtpxvjlQqVce3X8DXzckdmurXdruEjrIw3bcDGc4/DmvppcF1LDJIzjPQ4rwW78BXGoXWsalob/wDEujd1gcy5dyM7iP8AZByOTWkGfT8N4mnR9qqsuVWVu1/8/wCuhF4Q15vBGpSRXH+l6Xcf6xE+8o7HH41e8c+EtM8WSW2o+GtUtnllBBiZtuMdsHoa8zMN7cLcSwGR2iyJQRhl6Z3VntPONzQySwP2MbYAIrvp1ny8kl7vTyPqq2XqdT6zSladte0vVd/uPQNI8PXfgWLUbzVLy3SDySn2dZP9arcdO/0rkvh5f32nfEDTLvSHdRNcCF4gSivGzYII74HNZtrDrXiC9it555tRkkOxUBJJIr3v4V/DV9Cul1LW1ga5QKbaFMnyiRyzds9vaorVYxTSPJxtSlQw0nit2tFs32srvTzOi8Z+AdH8WR77iNba8VdiXEQ2n8R3rxPxH4Av/Dt+8UsM91au2Init2dm9OnHbvX1BGAUUY4A4I71HNOlrDJNKxCoCxycDgZ/+tXJGbWh8vgc4r4b3PiXRP8AQ8B+Ffhi0m8Xz2WuaY9sklkfLtbhc7snlmyODgZGK5jxD4Wt7XxBc6fBEwxMYkTO4Mc/L15JzivY/h1P/b/inxBrUgcv+7giDDGwbemfp/Ot1be1b4kqJ7SJttnmKRlGfMByWz644pqbezPdnmksPiqinG9oK6vona+n3ni/iP4UwaTfWsP+l+VdohSQEMFkwN6HjnnOK734I2Vjpl3q9nZwzqRFE7yzEFm+Zh/PHHtXqOradb6lZeRcKcZDqykgo3qCOlefaFB/wiPj66srl2e01KFBFO3aQHOOe34051HKNmzzYZgsfg6lFr94lfTrZpv8OnkekMwAH1xn1pqbc7cEgYGMcUyQjAwAxHBHSlc4XIU5OKxv1Pm0hzqrtyfmHv0rlfHfhRfE1rD9kunsNUtwwtrpcEcj7r8crx0rp1UDA24649qlAJC8Nk8c0Rk07ounVlSkpQeqPjvxBe3nhfWp7Txn4R0m8mkfc7eU0AnUfxRsmBzzyBTtJ+IHhnR55ZdJ8Jm3lIKQyyTCVoge4yOW96+rda0rTdYtmttWsra9hK4CTRBtpIwSO4P0rxLxp8AoLq4e58K3cVrGwAFtcM5APs/P8q9WjjoNWnoepSxim9dPyPBvFOsSa5rVxfPG0fmnhScn8feslVJ7V6qfgV40EzL9nsyAfv8A2lQD7+td58P/AIGjT7yO78Uta3Ow7ltYixUntk8Z57Yroli6UI6O5q6lNtynJG9+zz4Yn0Xwm97eReVJfsJFBGG8vsT/ADr1pI14ZjlgMcfzpLaMRqUAVV/hA6Y+napdp8w888HFeJOTnJyfU8vEV3Vm5bEESOQVLZGeAB05rE8dDGl6eCOms6Wc9P8AmIW9dC65UZBwOMZxXO+OSv8AZlhnO46zpWM9v+Jhb1thf40PVfmc1R3iz0eiiivsDyzkvih/yLFt/wBhjSv/AE4W9aysrAhWBP16Vk/FD/kWLb/sMaV/6cLetjADZUDJ9BWtPYxq7oEVh97nmgtjPzYpCx3YB6daX0OM1oZeg4ngcj6U1j3ajIOD7Udsdcd6AuOP3ST+HFIwAxzRnJxUF5JPFFvtYllkVgShONy9wD0z6Z4pN21KSvoZuo6GLi5N7p9zJYakR800QBSTHQSoeHUfg3XBFWNMv3uC1reIkGpQrulgVyykdN6EjlD+nQ81NDdx3MRlQygBijLjDIw6qR2NeZ/HrxVL4R0HTtQsbIPqDzNDBe+a0f2ZgpPO3lwcY2ng96mclGPOXThKpNU+p3+vsLtLbSsPm9fEm0EjyUw0gJHTPCj3b2NPW0W1SW61G6kuhDvkUOAqRqBnAQcHGDg+lfOfhT41eKbrX9OW8tLG+urtorcRJbSoREW+Z1wcZJ5yAQfoBX0b4nLjRL6OERmaWNoIvMJCln+UDj69vSslKNSLn2OmVKpQlGD6luzNzKoe5WFNyhlVCSQPQnv+FWQTjBIGetNjO1FXIJUAHFOyMA46njNbpWRxtpu6FQcDJzj8KcV24IwTmkPKDjp1xTiSwzg/hQMjCK8ZjkVXQjBVgCCPSnlRk8kg9c9qQEn7vHr7UDJJx9aADGeM9O1LtDhgxBU8EMKEyASetGTgEnJz6UAUWkbT9yuGayAyJACTD7MOpHoR070+31Gxu5hHbXsEsxz8iPkjHt2q0RuO1gCG/vdPeoPsFql4twlvEky5HmIm0nPXOOvQVlyyi7RehtzQmm5p38v1M/xBpbX9sZ4Lq7trmAbo2huHjBxyQQDtOemWBxVOPUb2xsfO1JTPaFVIulUqyA/89owPlx/E68d8DmtrVI5ZtOvIbYhZ5YZEjJOMMVIH05xXlXjnxZfW/wAKZrjw7q8UmqacsUWpMVQSqF/dygo4+Ulsckd+OtE5cjcvIulB1Uo+f5+Z6Dq17JPcJpFj563NxDulu4QNlrGc/MST944YLjPPJwOas2yR288Om2Si2tLOFWIXqS2Qq+/3WJPUmvlT4cfEHxafFthYWGtNMl9PG0i6hNHKoiA5UsVBUhQeAR24r6W8Kzw6rq+vaxYTzT6bctDDBI4+R2iDh2j/ANglgM9yDWVOr7Vq+5vWwroJ31Vvx2/zsdMqhRkflQB83VcewzTzwBtG3tSAYbpx2yK6jgElX7uCdxpMD8vbrStksSwJx09qXGSOvWmAjAMBnpXLfFRc/DPxeT20e8I/78vXUOSw6gdua5f4pg/8Kx8Xgjpo93z/ANsXpPYFuS/ErP8AaHgvHbWXP/kheU9Coc7skYwcfSm/EttuoeCzgH/icv1/68LyhiWfAOMDJJr5POP469P1Z7eBV6b9RVVQgUAjHI70NIAFDknJwO/akBwORk0YZjkbeOfwxXknb6kikHHlqWUnbycdqUbtynGe1RqwUDP3vSpQxK8H5uMjqaCGSM7Bj0BzjB7H1p7k7MqFABwfr6YqNASvGd3VSD0pyLkKwBXjnApozdgutws7gxgA+W2PQHaf61hfD5IZfBOlKqAg25Eg7Fsndn15zXRKNoO78QT2xXFfDS6liv8AXNBuG+exuHkhAGP3bnP6HP51R10oOeFq8v2XF/LVfm0ct42+Gt/PeSz+Hysq3DN5qbgreoznr+HpXOeGfg94ibVHl1rULeGwZeIc+YxPuOg/OvofZjHAAqIIBhgQEHPPHGKpVJK6OuPEGLVONNP4evX/AC/A5nwd4M03w0pNknmTtw07gBvcAdq6YqUA2qozjv0p6h8NtVSc4FOIPBPyjIGKhnlV8RUxE3Uqyu2MYsinC8dQR615T8X/ABRIx/sHTUYv8n2qQdBvPyJ+Ndb8Q/FaeG9NSO3Mb6rdYS1iY9CeN7eij1rkvhr4Yjv746vd3MmoW6StKskqFRcXHeT3QDhc+5q1HS7PYyqjDDR+v4haR+Fd3/W3nr0Z1fwz0ObQfD6RX0aJeXEhkmCnhecKPyFHxBMtpDa6la4We3bCt9en/wCqusiZs4Iy2epqLUbCDUrCWzuVDxyDaQRyPQj6VKPPWNcsX9Zq63evo/8AgGV4K8U2/ijRzcQqUmgfybiPHRx6expPG2jPrmhS2sG37WuJIWbjke9ea/CyzvfDfxN1jSJ5GeC5VmXH3SVOQ2PoTXtanCcrj60bM1zCksvxinh9tJR9H/X3HzlZ+L/Ffg/Xki1Ay3emo2JoJmDMV77W9a9y8Pa1ba7pcGo2LMbWUfLuXDAjggj2PFXNR02z1CCSG9gjlSRdr7l5I9M9RXKeCJk0fU9T8O48t4XM1spP3ozycfTND1R04mvQzCi6lOny1I6u2zWzfyf4Ha87AOc+/wBaNxX02jg+tRnO/BPQc9qkBOTtBIB9Kk8OwjEl++V9O/tRjKjgHHPvTiT/AAn5R+tNP3gwwc96BDNo3KB0wf50YQEtjDDgmnKNoXjr39aSN12nkEjk5NCKuKEYtk4PHAFPJ3A5IBIPIHX600OSmGAB9KFYghSQcdfWmvIWorNmJSowB0Ptmua8c5bTLAkf8xnS8HP/AFELeuiYzMoHTPTpk+1c543wNMsQGyf7Z0rPt/xMLeujDfxoeq/MmatB/M9Iooor7A8w5L4of8ivbf8AYY0r/wBOFvWuevHPtWR8UP8AkV7b/sMaV/6cLetjBz2x0xWtPYwq7iRnKZKkHPQ09uvoDSH27Uh6e9aGa00F7YpM0o9OmKMc9KADtjOMUmT370vX60nU+5oA57WtK1Q6xb6noN8lvKCI7u0nUmC6QHrxyknYPzxwR0rxT9o7x8s3hqbww2l39pfNcoZmnT92Y1JIMb/xAnHYV9GjJHGa+X/2oL681XxXZ6Dbh7hLa2EvkoeY3JZmYgHn5EHXoDmubELljo9z0MvaqVUpK9uvp/XU8Q8N6xeaLr+n6pZSt9stJVkhycjcDwCP7p6EehNfZ3gXTL3WZbPxN4i1k6ncR7ha20cHk29q3KswTJJccjcexr4kgUJJh4FmCP8AMCxCsOmOD619I/su+J51utR8L6tJN9s2rdW0U3ynA4dQP93Y30BrCg1zpPY9HHwkqbnHdfl1PorgHgCndVI5/KghgOQ3vkUA8EnPHPtXoHz6F5AB4JFAbsc0rEgcE4oBIxngj86RQZHT5ufbFJuIP+FOZuMZGKExg5I/EUgGk8n17Cmgk5HGRT2yT1+lQzXEdtE0szqiDqSM4ptpK7BJ3siRieh5xxQWYMCMYJ9KpjVLFgGFyrj1UE9/YVFqWoTW8EP9n6bdX7yttUIVjRBjO5mcgAfmc9qj2kOjuUqc+qNE8DBxivm39qC80WGEWdrpqR67I6S3V4ibSYsEBWYH5iSO/oK9w1Rdfm0eWRdR0/RZo8yNKkRu1VAMnO7b+g7V8nX0msePbPXNf1V4ry2tX/dXBiEJuJPkjVAFOFG0hsep965cXVajy2PTy2gnPncvz+XkcP4TkgTxPpUlzEstul1GZUddysgPII7jGa/QO1MH2aIWqotuFXyhHjaExwBjjGPSvib4ffDq+8Ywas1qIo3tImZEnkYSO3zYChQehXByOTX0V8FPEnifxH4X0+5uxoos7eP7Oyr5q3GU+QFhyoyV/TpU4afK9VudOZUueOj1jv8APY9VMmRwCO54pV5JDA56k4rHtNeX7ctlqNheWE7bvLeVRJDKB3Eq5UHAzhsGtsHONvKnuOldyknojwnFx3Fbtg9Bge1MBBXI4wcYp4JyQeD7/pRtXbgnB60XAj7Dpx6Vy3xTJ/4Vj4vXd/zCLw/+QHrq26nGc1y3xTH/ABbDxgOp/se7/wDRD03sC3HfE04v/BZ/6jL/APpBeUqIu8s3XGM564pvxQOL3wWSCR/bL9P+vC7psYyxbLDd8wx0xivk84/jL0/Vnu4Ffun6/wCQ5WJyDgc9DziiTOC0eASOM84pFJLDsQM/hUigsvU46gnr0ryDtehIi5VSVPI4qUMmOMjnqTUCM7sFQk9QB+FO3EOQ55HamZNEjOFIUYGTkrVgsDwm7lh9P/11UdR5m8r8wx83c+1PVt4Cr1I5x3qvQhxuTgZYgYGBg+v51wd1G1j8TLOa3RkS4UK7qOG3L0Pryv4V2rMqozOVCqOT0AAFYOj7/EGtR6sGB0y3BS14wZG6Mx9uOKqPU7cHJ0lUnL4eVp/PZep1hcbTnIyO3Ue9IfujGMHoCKNrBzls96U8NtH455xU67Hl6dABAA3Ngjoc4xUF9cR2thPcyyLFFFEWLv0GAcGnzPsQMxCqBksegry7WfET+LNQsNIsYWt7S4nxFJJz55XJ3Y9AOcGqirndgcDLFSvtFat9l/SKvhDwvN4q1eTV/EKzXVswG5pgU8zjhVHHy+uPpXsFvGsUKRxII0jQKqKOAB2xTFIRNqsqqFChcfdxThjjA+f0obDMMfUxs05aRWiXRIcpJOT09aCcEMzY2jr6UK25RyCOxrkPiZq/9leHpIkfbNdkxqx6KoGWP1x0qUc2Fw8sTWjRju2QeC7xda8UeINUSNXVHW1hbAyEXsPyzXcgAjHc/nXHfCnTWsfCFtIECyXbG4cDtn7oz9BXYjOeuTTOjNJQ+tShT2j7q+St+hG2TjBwQRzjNeX/ABSjudN1zT9W0oeVctEyeYBncy9vyJr1LaQ2e/SsXxVpb6tpRhhfy7hXV4X/ALrf/qyKFa+o8sxMcPiIyl8L0fo+/kS6HfxanpdnfwnfHPErDjoejD6g5FaBJDY4z2zXAfDLVWSbUNGulCSxyNcqAOBlsOD/AMC5+hFegMxZgACCOaUtHYnH4d4avKn06enQTghifxzScHocHOaUgBm3YwelIcg7h0PTikcgbgHG4kL7d6QdBtQnilOCCWxxznPb3pJB8wKk4C59/wA6fmNCuMuvOVBII70FRwVBYnt+NKS2DhTk9jSkklhz06+lCEMO4xAYy3O7mue8eZ/svTeBj+2dK6dR/wATC3roSxIK5GfSsDx0Cmk2Gc5OtaUP/J+3rbC/x4eq/Mmp8L+Z6JRRRX2R5hyXxQ/5Fe2/7DGlf+nC3rZGKxvij/yK9v8A9hjSv/Thb1s9QO31rWnsYVXZoT0NHXOTQTml9+K0MriZ79Md6Aecc/lS9RUN1HLKqrDO1uRyWVFfPt8wNDdkNJN2uTDkdM96yNc1k6fpd1PZ28t/doMQ2sClzJI3CA4+6M9WPAGTVpNPUgfaZ7i5PB/ePhc5znauBVpQIo8RoFQdkUAflUe9LyKvCL3v+Ryb6N9v0Jn8cTrcSNCZbtI5DHBbDHzLHtIOAM/OSScdulfOvwg8IaR418Z69qU9tP8A2Rbz7bWJLh1wCWwNxO44VR3710n7TXxFmgkPhDR7llO3dqLx8HDDiH6EHc34VmfDnxi/hD4bx2fhnSf7U1jbJqOpTsx+zWkRxgu3TeUVcLnr6niuaTp+01Wi/E9Wj7aNBtPWW3Zf5HD/ABM0iw0P4o39nbRtZ28E6MibiXwFUhgSMHce/rmrXi3w/wCX4D0Txvb2UtvPNeywXke98HDttJJO4Z2kHGM57VyXizWLrxfrep65f3DvKxQ4aI4VOFCjaNqge+M/U1654E8fr4q8NP4P8ZsZrDUIzYw6pKn+ouOsIfHAX7u09cqc8HjGEYyb89jsqSqU4Ra1tue3+BdJ8M6j4XstU8ORyW0V7AGWeG4kMkZxhhlifmU5HOenOa1/Dt/qsVzd6dr8MjywSf6Nfxw4juoT90tjhZByGGAOAR1xXyh8NPG2u/C7xfc6NqUc8tgkzW95ZZJ2ENzJEOm7v/tA/SvsbTNQttSsbe9sJ0uLO4RZYpUPyyKRkEf4V1UmpL3dGjysXCdOV6j5ovZlmGaJ8bXRs9gwoMi+YYyy+ZjdtJ5x649Kjlt4Jn3zQxvIOAxUEgemetMt7O2teLe3jQ56gfN+Z5rVc19TmfJbd3LJbeScYPXA9KeuMHG7HHamls5+709KTPTv3xVWIuOJ4Jx+FBJHQdeuaaW5759KNxyeM4osMF+X2Oe1BJbnPOenagFh0ye1ZPi7V5dB8N6hqcNsbie2iLRwgfffoo+mSM+2aUpKKcn0HGLm1Fbs8u/ad8ZP4e8Hx6Np1x5eo6udrheHW3H3iPTccL7jdXmf9r61Y/CK10aw0K303R7m28o6hfkK93OfmdIw5AAJyQ2Oi8YrM+HGk6j8TPjCJ/E1zJepYs11dsScYRvkiX0XcQMema9P/az02W48HabqCcrDebJMt93chxx7kGuCcXUi6p7VJQw84YZ6vdnmXwn8W6v4Ae686Gx8q8kjZ7ST5rmUAnJTblgcHIDcE/nXRfDDxXpOi/HDVorPU0Xw5q5eSA7tsQaQCRQ2fuEHKnvnivJtDkGoeMPD4sbaGKbzbWIRW6MN7hgCx/2jjJNez/tDeA9Ph8SaZeaVbw2DasZo5mjOxJJ1w6EjoMruzjGTioTlGDk3dROqoqcqqhJWc01/l/wD6SVsIQw5PVfWopbK1nbzJreN5Nu3cRzj0z+NcX8G9Y1DVPCVtDrSk3tpGsYnXpPGBhW/3hgqwPORnvXe85BUH+Wa74SjWipLZnz9SnOhUcHo0V7e2htF2W0McS9CFGKsF8HjtyDikO4Y479+9Ju+b7pBz0rRIybbd2ITzwf6VzHxTI/4Vj4wyT/yB7vH/fl66did3A4HWuV+KjH/AIVj4uAHB0i75/7YPTewr6knxP8A+P3wX/2GX/8ASC8poYLkDbtHGD2pfiiM3ngzOP8AkMv16f8AHheVXi8wtlsAEZz39xivks4/jr0/Vn0OXq9J+v8AkToQGVsfN2OaMsvGck9DjtioWDM+0ZAap+PLPy//AF68nc7WrDk3LgggnqKUZ25yOnUHk01MZBAIzzj8KEUAntnFBDJwwPPIP/1qfFnABIz6YqFM546+/WpLiSKCGSV2KrGpZmY8bQOaaRm1rZHPeK57m8uLTQdNkMc12pe4mUZ8mEdc+7dK6KwtY7C1htLRPLgiXaijpgDua5b4fSvqCarrNzvD3VxshduP3ajpjtzXWod21gTtYBj25xVPQ6sanR/2ZbR385dfu2+Xmywkm3aCpGPbNOJ9sk4/Cooy3ByxHGeM8028mMFlPJhQyIcZ4H4+1C3PO5buyOc+IV8ItMezFx5UTxNNdOOqwjqB7scD86yfhzo0ksp1y7tBD+7CWMRP3Im5LY9SMflVDwTpf/CS3D6xrAFza+azIXIIlkU4GV7qgHAPGTnmvSodyllYnGfwq5NJWie3iqqwNF4Km7y+0/zX6Py07jk3A5bGSPTrU0WTjO09QaiRTufeR1wPTFTHOPl65zWfU8GQi5GPT0FeU/E5H1rxFDp0TMWjVYVQf3nOWP5YH516t8w2/NwBz/n0rl9M0gS+KbzUJFDLD8sLbjy54Yn6dBTilrc9LK8RHC1JV3vFaep0en2ws7G2togPLgiWJSe4AA/pVggjnNCsclQuCR1PamsRkMecHH0osrHltuTux+7IxjJ4/OmDlgS2Mevemcg8cdsse9BABPIx1OfSkOx5j4mtJPDvxDtdUtVYWj7pXVehU8SD6/xV6SsnmOHT7rAFfp1BqC/sba+g8q8i86HqByCM8cHrXLXMWq+G7uOS1Fzf6ETmWEEyzQe69yPbmnJqR7Eqix8IQbtOKtr9pdPn+fc7Q7mJJY5+lNYkkH5stxVLS9UsdUsvtNhdJcW5OCynkN3BHUfjVrrkNlSD0qTzJQlCTjJWaJMfKQQCP6UwnaTnAbHb0p5yNrc+4A4FR5+QkgnPA3fWixKBMqFBLD+lSO5zkJnJxnPao3XIJPXuak2uFOeeOM/WhDdtxm0gDDnklvp7VgeOPm0bTjk8a3pf/pfb1veUdhyoz/n9KwvHBzo+n4Bx/bOldT/1ELet8L/Gh6r8yKvwM9Fooor7I8s5L4of8ixbf9hjSv8A04W9bHf61j/FH/kV7f8A7DGlf+nC3rYU5AOOta09jnrbhSZGcd6XtwcUvatDLUM89KQnFJzu/wBnFHQADp0HFMBx61l6/qP9laNfXgGWgt3lUEEksBkDgdzitIEHockVleJy39jSeW5jZmVdyjnGazqy5ISl5F0o89SMX1Z8IX8Gr654iTS5Gku9Ru7rIRurTSkZ5PqSPavr/wAY+EbTTvgvrOgaTbxW6iwaRjEOHkQB2YnuWKn868y/Zz0ObV/GniHxbeWjNAQVsnlQBZC0nLLnuoQDI7k96+kHOYzlA6jqp71hh6X7u73Z6WY4m1VQjtHU/OmDULq2sbyyikeOC7KecnTdsJIB+hOa+gf2afDsOueBvF8OpQK+nXzpaqCu7a4QkuM/xAshHvXn3xf8D6hYfFu50zTbWWYaxP8AaLEAff8AMbJXp/CxYH0Ar6v+G3g6DwP4TtdGhmM7Rs0sswG3e7HJ+oHAHsBSoQfNr0N8biY+xThvLU8A+KHgyQ6X9tif7Z4q8OBDqv3lkubQACOf34UZIycE5PFe5fBySxk8A6e2lSO1q5eZd4AZPMYvtxkjjJX8Kd8S/wDiU2tl4mhhV/7LmAvlC5MtlJ8kwb1CjD89Npqn8M9Hg8M32qaJp+1tOSQXdi4P37Wb51I/vbX3rn02+tEY+zqr7v6+45alb29Bp9Nf81+Oh6F06cUL+nrQegHenAgqOM11nABKt1AFN5B5z9cU9VwPm/nincdVHsR6UrjtfciJ7cn2pwchOuMH0pzEKCGHfpTd3HAA59aNw2AvwR0HPHWuZ+It2tp4SvbmXJESmVseiqxP6CukyByfp+NUNa06HWbQ6feR+ZaSnM6k4JUc4+hPB9qyrw56bj3NcPPkqxk+h5d+zl4H1DwvoV7qmsHZfayY5BCQMxxgFlLH1O8nHb613XxJ8ON4t8D6tosZjWe5i/cM65CyKdy/TkYz2zXTqMnIPOcCngjkY6dMiqUFGPIOdaU6ntep8bfAzwDr8/xQtpb2yntINBuw980igeXIAWVME87iByM8EHpivfvjH4ebX9O0mFZBCv2iVPtLLlbQtHxKT2A27c/7dejxRIs0kiQokj4MjAAM+BgEnuQOKSaKK4haGVFljbhlcAg1CopQce50TxbnVjVeljhPhDYX+m6NLaam3+kRAK49Tk8/XGK9ADjIxnbjp61h+HLP+z0vomY/68hVxgBMfL1655JPc5rbXODgfn2pYan7OmokY2r7WvKfe35A2c8jFDEY5HToRSAk8nsPzoySOeTnp61uclxrsOu32zXL/FT/AJJj4v4/5g95/wCiHrqSeeT9frXK/FQ/8Wx8Xkcf8Se8/wDRL0dBLcX4pgG78GA4x/bL9en/AB4XdQSSIG3kqFJwQ3G49uas/FAf6b4M/wCwy/X/AK8LuqzRfKCRu4wB/n0r5POP469P1Z9Hl1vZu/f/ACHx7T843Z7gduOlP+5369OajQEY2gA5yTS8Yx1wTwB7c15J2takhba4GO2dwqQLlsspCY9cGmoqrhlG0t2PYD2p8a5ySR6HnOeOtMzbJmKtyoIOfzFc18Qbh4fC0qglfMdUYqOQuef/ANVdJGSpwAfbjNc94/ikl8Ps0IY+TIHZV545B/nWlO3Mrm2Bt9Zp37om8E2htfCmn26sBK0XmbsZ5bnofaugj2nOSMY4H4VleGkK6BpoKHctugHbHHpWmQQPlHzZyWqDLFyc6023u3+ZPBGyEEyls8qD2FYXjuRv+EeuoomAM+2EE9geT+gra3ZPzKDgY57e1c94r3Xl3o9mJNivdJI/HULzj9DVR1YsGr14yfTX7tTX0LToNL0m0sowB5cQBK8ZYjk/jV1mDFdhPJGeeDSsF3nBPQDPtTwqxsFQY3ckVJzTm5yc5at6iHnJBwcDp3pyOjNnPPYikK4BC/L/AEpR9wZXBGCCOmaDNkd1cJaWc1zccCFC7VX0KFrbTolkDNNJmWTPcsc1V1ydjb29qDxdyrCTjjbn5ifwrV3hemcgAYx+VNaI2cXGlbu/y/4NyQknGepprfMRycjjHtSqeFAXgY/Ckx0yGJznd3zQYCvyoPbvTWIdSpGTSqSRhgevfvTBuJUt99O/eluNDiNmMkkA03cpkxkY7fnSvtPYk9ORjNNOGCkg59+DSGjB1Twxa3Vy93aXFxYXjc+baHbuPbcvRvxqs2tX2lTxW2vWm5DkR39qpaJsf3k+8p/MV1JIKuSwLY9PyqLG9W3ADgjJ4yO4p6dTrhim1y1lzJfevR/o7ryK9pe29wha2uFmBPWM5Gf8anDrJjOQAOlc7F4atLaeabSpriwaRQrLEcxn04P1qxFba9HEqi9sp2HDSPCV3D3APXoPwo3KnRpN3pz+/R/qvxNxNpx97r3PSnl1V8HuehNc79n8QmaOWW/tDEG+aOOELkZ5wSM1vgRu5crgkcn0OafS5hVpKFveT9P+DYGBwCx245OOcAdq5/xvg6Vp7dC2s6Xx/wBxC3roNgZAxYHnPP8AOsDxsN2kWLH739taV/6cLfpW+G/jQ9V+Zz1PgZ6PRRRX2B5ZyPxR/wCRWt+//E30r/04W9bDHOMHvzWP8Uv+RWt8f9BfSv8A04W9aiMRtBAznt+lbU9jmr7ol+tA6/ypEBAwecc9c0vPYVZkAAH0pTjHvTACSOAPalA+bNAaiBt27HasfxLuutHvtOtHH9oXdtKlsjHGG2kBvoCRVltUD3U9raW9xNPCdrfKFQHGQSx4xVqGIo7SzMjzM2AwXG0dlH+eazk1UXKjaMfZ2nL5f12KHhzRrbw5oGn6daLlLO3W3Vm6tjk5+pyfxrTyu4pk5PJFK+wEZxk8DPf2oUbR7961SsZyu3dmbeaNbXevaVqksYNxp6TpAf7vmBQf0B6+tauQ3OOaQH86OOKVkVduyY2SGOVWDKGVl2MD0IPUGqVpY22m+WI4sQwxmGFskmJMglT7ZAwa0G4zgZPakZSyYwCrDBB7iplFvVPUqE+XR7DhnO4Hj1pBwKreXNagi3jEkKgBYQQrJ9CTgjpwelLZ3aXSvsDpJE2yRJF2sjYBwfwIpRlfR7jcHa62LQGEyx4pQAcjB/OmnpwcAUpGGP5GqEGMsxPT1pD8zEnPPpTihxk8N6GjYR1UH3ouKwwgE5HaquJP7aUBD5H2ZsnHG7eMDPrjNWhn6A9DTl4x6e3elJXHGVmIsyNJNGCC8WNw9MjIqQZJJ/EfWmKEDM2xQzfeIGC2OmaeAeo6+9JX6jdugHABJX5hzTQMMMcDHejBL8kgjgLnr7mhjjpgD3piZWuraRj51q0QuVG3L5KkZzg46cnqOlOsZJpofMntZLVwSPLd1Y4B65HHNWFzu4IIAz+FIT3PT+dLls7oq+lmNPzHAwPXmkGPTj2obbxjIPelIw4xjd7VZmxjgkYDEHrnrXLfFQg/DTxeOdw0e7PH/XF66l1bJx+XFct8UuPhj4u5BzpF5zj/AKYvR0F1JPikcXfgzv8A8Tl//SC8qEqGALcH25xU/wATxm98GZGR/bL/APpBeVVkUKwIBH07ivks4/jr0/Vn0mXfw36/5E8SFcFs4PoachHXgZ6YOeajj+UkDJBAwT1P4VIEBTDLg5xj0ryTrl5isSXIPT+lOZI3Hl8kHG4qSCMc8Y7cVFGwlJCq67WweODUqYyTxyOnrQS1YmZ8nqBjv07U6QRtA6yITxgjGVI9PeouPl4ySe1PJxHjHQ8+/vmqRnYfGBtTHyqMKNvYe1ACHh8beMYPShCGdc8DBOM05SxUEjrg/N3oJY9VUyEBgFA4561x1tM998Rpo5EDW2n24MbY+7I2O9da4AcBifQc4P4UyGzit5ZHijXe5BY+p7n9aDahWjSU7q7asvK+7+4sxDIJkOU7E9qJMLgAk9ASewpzABlI5z0+vvSL82QxAXHBP8qEtTkv1FG0IrL16fWh2IZSoDfwn/Gm5J3HBwuACOD+FOaIMmAAwJHJNOz6Bp1EQDy92BnGMY4xT1AYqR0z+uaIgoXGMKBwT3ojGHX5WGeeOO9Kwmx0fB6Agnt60shxxwSOmenX1pwXpkHI7U3IKknbkDuenNMnrcSQfIO/OeaANqgMMntTg+/p27jr1pmeDncR6g80B5A2HUk/eJ6Z546UmPmJOMjHPvmnAfNlgvsfSjIVzkj6d6TQxjSAZD+mFPrSMCM5Gex55NLMQXZdoDfTrSyfcwwANDGugxsJs4Pyn061Bw5BUHvxn3qc8ge/BINN6RgP8vB3A8jrRYtOwhC7cYJwxwfahHwMgDJ/U0bucdWyenaggscfw+3B/wD1UB6kikqgAAJGSD0+lc/43Zjo+ngheNZ0rOPX+0LfpWxtbduDg56AH0rH8cnGlaeACD/bOlE/+DC3rowr/fQ9V+ZnVVoM9Gooor7A8o474syCLwekrLIyx6ppjkRxtIxAv7cnCqCzHjgAEnoAarL4rsAMmy8Q5zkgaBfY/wDRNanxE/5AFp/2F9L/APS+3qh8RPHa+C7vQ0m057u1v5ZBczLLs+yQooZ5SuDuCgkkZHAJqoycSJU1Lcavi7TwMfY/EP8A4IL7/wCM00+LbIk/6Hr49P8AiQX/AB/5BqzD4+0xBfnUFlhMOpSabbx28cl3LdMsavuSONCx4Y5wCABknmpZ/iB4cSC2kgvZbtrq1+2W8VpaTTvLFkrkKiM3BBBGMrg5AqvaMn2MSmPFunAYFl4h/wDBBff/ABmg+L7AKdtl4hz/ANgC+/8AjNY1h8V4L218IX/2G8trTWI5GuITp9zLKjiFXVYcRgyrlsb0VlIHGK9D0bVLLWtKttT0y4W4sbmMSxSgEBlPscEfQ8ij2jD2SOUTxbp4Zj9h8QAn08P33/xmlHi+w6fYfEIHvoF9/wDGareGPibp+qaTrmp6rbNpVlpoW5WRnM3nWb58q4AVcgNtf5QDjb1NXI/id4Uedovt13G6PGknm6bdRiLzCojaQtGAisWXDNhTng0e0YexQw+LrDtY+If/AAQX3/xmj/hLdOA4svEP/ggvv/jNar+M9CTWP7Ma7l+0GY24k+yzeQZgCTEJtvl7wAfk3buCMZqjZ+O9G1W50h9L1VFsrzc6vPp86pcp5LSfu5m2opUKS2d2MFSFY0e0YeyiQ/8ACXafn/jy8Q/+CC+/+M0v/CX6eORZeIQf+wBff/Gat2nj7Qb22mns31K4SJUkxFpV27OjkhZI1EWZEJU/OoK+9RXHxH8MQW9lK17cv9rWd4o4dPuJZcQsFlDRrGXQoTghgCOfQ0e0Y/Zog/4S/T8j/QvEP/ggv/8A4zS/8Jfp5xmy8Q/+CC//APjNdDca/pcHhp/EEl2h0ZLX7ablFLr5O3fvAAJI288DNZln460K9t7yW0k1CY2gjaWFNMujOFkzsdYvL3shwcMqleDzxR7Rh7JFE+L9P6Cy8Qkf9gC//wDjNIPF9gc5svEAz1xoF9/8ZqzL8RPDUcFnJ9ru3a7eeOGCLT7mSctCQJVMSxl1ZcjIZQcc9AafdfEDwzbWdtdtqLy209st4JLe1mnWOBs4lkKIfKThvmfaPlb0OF7Rj9mip/wl2n7ubTxCR6f8I/fc/wDkGnHxhp2f+PLxCR/2AL//AOM1sad4p0jUtVn07T7iW4uoJGim8u3lZImCq2Gk27FyGGMn5ucZwcRXHjHQLa+WyuNRSK6bUF0oROjgm5aMSKnTujAhvu8gZzxRzsPZoy/+Ev04Diz8RE/9gC//APjNA8X6fzm08Qj/ALgF/wD/ABmrV14/8PW1hBfy3F7/AGfMCwvE025eBVDlCXkEZVBkHliOOehBqWXxvoEWpXNi93P51v5olcWcxhDRoXkQShNhdVBJUMTx0o9ow9mjP/4S7Tyf+PLxD/4IL/8A+M09fGGnqeLTxBxwP+JBf/8AxmpLf4i+F57O5ul1CZIYIY7hvOsp4meORtiPGrIDIGYhQUDZJA61uaDrVlrtm91pzTmNJGhdZ7eSCRHXqrJIqsDyOoo52Hs0c+fGGnEc2niD8PD9/wD/ABmnf8JjpxKn7H4gBzz/AMSC/wD/AIzXYUUuZj5Ecd/wmGm8/wCheIMn/qAX/wD8ZoHi7Td3/Hr4gx/2L9+f/aNdjRRzsORHGnxdpuOLXxAP+4Bf/wDxmg+LtO/59dfJ/wCwBf8A/wAZrsqKfOxciOM/4S7T8Y+y+IOR/wBAC/8A/jFNPi3TyP8Aj11/P/YAv/8A4zXa0Uc7E6aZxJ8Waf1+ya+SOn/Ehv8A/wCMVzXxH8R2l18PfFMKW2tCSXSrqNfM0S+jQExOASzQhVGSMkkAdSa9brmfih/yTTxb/wBgi7/9EvT9owVOJj/Fif7LL4PnMdxKI9ZYlbeB55DmxuxwiAsevYcDJ6A1jHXYT8p03xDjOSf7Cvef/IVdj4t/5D/gr/sLyf8ApBd1R8Y+L9Q0XWWsdN0qyvFh02XU55brUDahY42ClVxE4J57lR7152JwFPEyU5t9tP8Ahjto4qdFcsUjnv7eg2kf2d4h5GP+QFe//Gaemv2yqf8AiX+Ie3/MCvv/AIzXSSfELQLewsrm/mubb7RaRXrp9kll+yxyDKmdkVliHXlyBwfSqmueP7OHXtL0rR2a6nl1VNPu3NpM0MeUZmUTACPzBhfl3Ejnj05v7God3+H+Rq8fU7Iy08RWwGDp/iLk5/5AV76dP9TSDxBabgf7P8QgY/6AN7/8arsPEPiC00PULUX+oQW1sbW6upYmtZJHkjhVWZ1dThQoOSCrFsjGMHOJ/wALW8H/AD7tQvECRrO5fTLpQkLcLMxMXER/56H5fem8noPq/wAP8ifrtTsjLTxFbK+f7P8AEGOnGg33Hv8A6mnHxHB942OvnPUDQb4H/wBE4rpP+E88O/222lfbZhdpdCyYm0m8lZyAVjM2zywxBGBu5zxmkt/H3hu4u7i3i1B90KTyeY1rMsUgh/1vlSFNku3uELGj+yKPd/h/kL65PsjnP+EktQyE6d4iIxg40K94/wDINPfxLalWxYeIOccHQb7/AOM1cT4naRP4p0rSbG31K6t9QtpJ0vItPuWTKtEFC4iwynzDlwdqbcNjIrTTx/4ZZ5w2otFHFDLcefPbSxQSRx/faOVlCSgZGdhan/ZFDu/w/wAg+uT7IwF8R2ROZdP8QnkHjQb7jH/bGnf8JNasxL2PiHnjH9g33T/vzWr4Q8ZDxL4r16xtYpU06xtbOaFrizmtpmaYz7srKFJXEaYIUdTye2Np/jy6v/GWp2LXdvYadZ6oulxxz6NdO9xJtQnFxuWNSSzADaeAG5BGV/ZFHu/w/wAhfW59kTp4msQcmw8RZzn/AJAN92/7Y0n/AAkliGBFjr/Gcf8AEgv+P/INbMXxB8NzWouILy5mhZxHG0VhcP5snzfu4wEJdxtYlFywAyQBzW1o2s2OtaWNQ02ZprYl1OYnR1ZSVZWRgGVgQQVIBz2o/sih3f4f5C+tTONXxPZjANh4gxweNAvv/jNSDxVYqV22HiIDOf8AkA33/wAZrSf4h+G4bW+uLu6vLNbJIpJ0vNOubeRUkfy0YRyRhmUv8uVBAPXFZ+q/FDRrSPT5LOG/vBPqa6bcRCxuUntmMTS5MJi8wnAXC7RuDZBODT/sij3f4f5CeJkxB4qsi4/0LxCB3/4kF9x/5Bpf+ErsduBY+IB0/wCYBff/ABmtvTPGmh6nrH9mWVxcvd7pIxusp0jLx/fQSMgQuvdd2Rggjg10VH9kUe7/AA/yF9YkcEfFNiSP9C8Q4xyP7Avv/jND+KbBmP8AoXiEgjB/4kF9/wDGa72ij+yKHd/h/kH1iRwS+KbBQcWXiAZOf+QBff8Axmj/AISqwwf9B8Q+3/Egvv8A4zXe0Uf2TR7v8P8AIPrEjgpPFdkQAth4g/8ABBff/GaT/hKNPBJFj4h5/wCoBff/ABmu+oo/sij3f4f5B9YkefjxRY8n7F4gyef+QBfdf+/NB8T2JYsbHxDu9tAvv/jNegUUf2RR7v8AD/If1mZ59/wk9gMkad4hOQB/yAb4f+0aY/iezctmw8QhT1H9g33P/kGvRKKX9kUO7/D/ACD6zM89PiawGcWPiHOTgjQL7v8A9sabJ4msycrYeIOuf+QDff8AxmvRKKP7Io93+H+Q1ipnnJ8SWJBIsPEQc8knQb7n/wAg1leKddt76y0q1gtNZjY6xpmGudJuoIwBfwHl5Iwo4Hc89ByRXrdcz8RP+QBaf9hfS/8A0vt6unldGnJSTenp/kKWJlJWZ01FFFekc5zPxE/5AFp/2F9L/wDS+3qbxB4ai1rXtE1C4lXydOFwr27RbhOs0XlkE54AB9DmrviTR49d0prGW5uLX99DOk9vs8yN4pVlQjerL95F4IIxWZ/wjeq/9Dr4h/782H/yNQByvh/4W3Phu0tf7E8Q4vrO+uLi2mvbMzqIJY0j8l1Eiliqxphwyn5enJFbfhLwJH4evLef+0HuSmnyWku6IKZZJJ2nkl4Pygs7YXHA71f/AOEb1X/odfEP/fmw/wDkaj/hG9V/6HXxD/35sP8A5GoAyvC3gW80dfC8d5rEF3D4ejkt7UR2RiZ4miEahyZGBYYyWAAPoKv2vhGa0+HU3he21QxyyW80Avlh5TzGYlgm7qAxxz1Gfapv+Eb1X/odfEP/AH5sP/kaj/hG9V/6HXxD/wB+bD/5GoA5jVvhFp8ltcQaJqV5YRXGlvpUy3M018DHuRotvmy/IEKthVwDvPStrX/BH9rP4lb+0PJ/tlLRP9Tu8nyGJz94bt2fbHvV3/hG9V/6HXxD/wB+bD/5Go/4RvVf+h18Q/8Afmw/+RqAObs/hbb2Xim61S2fRTHcX8uoF5tGjkvUeQlmRbktwm4kj5NwHAarqfDmFvD/AIT0i61BpLfQ7SSzkZYdpuVe1a3JHzHYcNu/i9Petf8A4RvVf+h18Q/9+bD/AORqP+Eb1X/odfEP/fmw/wDkagDm9S+H2u6rollpmqeJbG7trGSBoYJNI/cTLGrrtuUE2ZdwZSQGRcoDt6ipvBnw1Hhq5sJhqUMotYtQi8qCyEEf+lTxy/KoYhFTy9oUcEHtjFb3/CN6r/0OviH/AL82H/yNR/wjeq/9Dr4h/wC/Nh/8jUAZOs+Eru1+CN54S01vt97FobadA2BF57iHYpwWwuT6nA9azdV+G2oa6k11rWt2c2pSLbRBBp7C0MEJdvJlh84mQM0jFv3gBwvGAQeo/wCEb1X/AKHXxD/35sP/AJGo/wCEb1X/AKHXxD/35sP/AJGoA4ey+HWu+H9X0AeHL3TIkgfUpprn+zQtvB9oMJWNLdZlOPkbBDEDHIqW7+DVnutZLOfSp5UsEsZX1jR47/JVnbzYwWURuTI2fvKeMqcV2f8Awjeq/wDQ6+If+/Nh/wDI1H/CN6r/ANDr4h/782H/AMjUAT+EvDo8O/2uFuROL++N4AIhGI8xRx7MA4P+rzkY64xxXN+LPhjb+IPEGraqNSltZbyxWGFViyLe6RgVugcjLAJGAOOFPPPG7/wjeq/9Dr4h/wC/Nh/8jUf8I3qv/Q6+If8AvzYf/I1AHC+J/gtFq+nRWFvqdlHax6TFpaC8037U1v5e797ATIojdt3zHDHjgitHWfh1qEmsazq9rqkBa5iuitra2ht5LkyRMiRzSCXy5FUkEExhsquW456n/hG9V/6HXxD/AN+bD/5Go/4RvVf+h18Q/wDfmw/+RqAOTs/h3q1/ocf9u6rYNqI0qDTYY/7MDQwRqyO6yI0reaxKKNysmNuVwea7DwJ4dm8MaK9jPfm9LTvMNqukcIOP3cau7sqDGcFjyT9Kj/4RvVf+h18Q/wDfmw/+RqP+Eb1X/odfEP8A35sP/kagDpqK5n/hG9V/6HXxD/35sP8A5Go/4RvVf+h18Q/9+bD/AORqAOmormf+Eb1X/odfEP8A35sP/kaj/hG9V/6HXxD/AN+bD/5GoA6aiuZ/4RvVf+h18Q/9+bD/AORqP+Eb1X/odfEP/fmw/wDkagDpqK5n/hG9V/6HXxD/AN+bD/5Go/4RvVf+h18Q/wDfmw/+RqAOmrmfih/yTTxb/wBgi7/9EvR/wjeq/wDQ6+If+/Nh/wDI1VdU8GXmq6Zd6ff+MfEMtndwvBNH5Viu9HUqwyLYEZBPIOaALXi3/kP+Cv8AsLyf+kF3VDxl8OtI8Ya0L3XEjnhWwezjTyh5kLtIriaOQ/dYbccDvzxkHd8SaGNbXT2XULzT7ixuftUE9oIi4YxSREESI6kFZW7elUf+Eb1X/odfEP8A35sP/kagDkNW+FNxquoHUdQ1LQ7/AFGe0jtbm41Hw/HdEmMttliDSYjcq2GzuUkA7R0rUj8AXsOrW5h1uBdFg1mTWkszY5l82QuzJ5vmY2bpGI+TIzjJrb/4RvVf+h18Q/8Afmw/+RqP+Eb1X/odfEP/AH5sP/kagCDxx4O/4SmeKT7d9l2adfWGPJ35+0oi7/vD7uzOO+eoqjrPw+/tK31qL+0/K/tLw/FoWfs+7y9hm/e/e5z533ePu9eeNX/hG9V/6HXxD/35sP8A5Go/4RvVf+h18Q/9+bD/AORqAOV0nwNrNxqusR6peQW+hPr8eqR2y2+6a58pISjeaJMKm+IZUpu+U84NTwfDS5EVtZXGupLpOnxXcemwLZbZYTOjx5lk3kSbEkcABUznJyRXR/8ACN6r/wBDr4h/782H/wAjUf8ACN6r/wBDr4h/782H/wAjUAVX8I3cGoeF73TdUghuNGsm0+Tz7QyrcQv5W7AEilGzCMHLAZOQa5HTfgrZ2Olz6ZFcaRFaG3lt4bmDRYo77DfdMtxuPmbeOiruxyTXcf8ACN6r/wBDr4h/782H/wAjUf8ACN6r/wBDr4h/782H/wAjUAReE/Dep6Z4h1nWdb1e21G71GC1t9ttZG2SNYfNwQDI5OfNOee3ocCsfA2bieX+0f8AW+IE1zHkdNsap5X3v9nO736Ve/4RvVf+h18Q/wDfmw/+RqP+Eb1X/odfEP8A35sP/kagDA1H4Y2994Q0LR5rq0uJtIumuonvbBbi3lLeYCskBb5lxIejAggEEVv6D4X/ALL8H3GiJPa2zzLMvm6XZJZJEZM8xxqSFK54JJPGSTR/wjeq/wDQ6+If+/Nh/wDI1H/CN6r/ANDr4h/782H/AMjUAcTpvwc+yw3iHU9Nie4gtIGay0ryN5guFm8yTMrGSRtuCxPfPtXQaz4CuLvWL7VbHVore9l1O21ODzrQyxxtFb+RtZRIpcEFjwVwSOuOdb/hG9V/6HXxD/35sP8A5Go/4RvVf+h18Q/9+bD/AORqAMfQPAd5pvjN9en1e2be80kkVnYtbG4MnaYiUo4XqDsDEgEsTnPfVzP/AAjeq/8AQ6+If+/Nh/8AI1H/AAjeq/8AQ6+If+/Nh/8AI1AHTUVzP/CN6r/0OviH/vzYf/I1H/CN6r/0OviH/vzYf/I1AHTUVzP/AAjeq/8AQ6+If+/Nh/8AI1H/AAjeq/8AQ6+If+/Nh/8AI1AHTUVzP/CN6r/0OviH/vzYf/I1H/CN6r/0OviH/vzYf/I1AHTUVzP/AAjeq/8AQ6+If+/Nh/8AI1H/AAjeq/8AQ6+If+/Nh/8AI1AHTUVzP/CN6r/0OviH/vzYf/I1H/CN6r/0OviH/vzYf/I1AHTUVzP/AAjeq/8AQ6+If+/Nh/8AI1H/AAjeq/8AQ6+If+/Nh/8AI1AHTVzPxE/5AFp/2F9L/wDS+3o/4RvVf+h18Q/9+bD/AORqin8IXN21uuo+KtdvLeG5huvIkjs1R2ilWVAxS3VsbkXOCKAOrooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Stings from these insects usually cause the area around the sting to swell, turn red, hurt, and feel hot. But people with insect allergies can get serious, sometimes deadly reactions to the stings.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: American Academy of Allergy and Immunology, Monograph on Insect Allergy, 3rd edition, Levine, MI, Lockey, RF (Eds), 1995.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_23_27000=[""].join("\n");
var outline_f26_23_27000=null;
var title_f26_23_27001="Risk of embolization in atrial fibrillation";
var content_f26_23_27001=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Risk of embolization in atrial fibrillation",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/23/27001/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/23/27001/contributors\">",
"     Warren J Manning, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/23/27001/contributors\">",
"     Daniel E Singer, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/23/27001/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/23/27001/contributors\">",
"     Peter J Zimetbaum, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/23/27001/contributors\">",
"     Scott E Kasner, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/23/27001/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/23/27001/contributors\">",
"     Gordon M Saperia, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?26/23/27001/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 31, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Atrial fibrillation (AF) is a common problem, with an incidence that increases progressively with age. It affects more than 10 percent of people older than age 80 years [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/1\">",
"     1",
"    </a>",
"    ] and is usually found in association with hypertension or overt cardiovascular disease [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/2\">",
"     2",
"    </a>",
"    ]. The lifetime risk of developing AF is approximately 25 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/54/28522?source=see_link&amp;anchor=H4#H4\">",
"     \"Epidemiology of and risk factors for atrial fibrillation\", section on 'Incidence'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The most serious common complication of AF is arterial thromboembolism, and the most clinically evident embolic event is ischemic stroke. Peripheral embolization accounted for only 7 percent of events in one review [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/3-5\">",
"     3-5",
"    </a>",
"    ]. Autopsy studies have shown that most noncentral nervous system emboli are subclinical.",
"   </p>",
"   <p>",
"    Antithrombotic therapy with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    has been shown to lower the risk of clinical thromboembolism in virtually all patients with AF, including all levels of risk and irrespective of type (paroxysmal, persistent or permanent). However, in the lowest-risk patients, the risk of anticoagulant-related major bleeding begins to exceed the risk of thromboembolism off therapy. Decision-making regarding the initiation of warfarin requires tools to predict both embolic and bleeding risk [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/6,7\">",
"     6,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The individual predictors and the models used to predict embolic risk in patients with nonvalvular AF are discussed in this topic. Issues related to the risk of anticoagulant-related bleeding and anticoagulation for the prevention of embolic events are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/32/42506?source=see_link&amp;anchor=H6#H6\">",
"     \"Antithrombotic therapy to prevent embolization in atrial fibrillation\", section on 'Warfarin'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATIENTS WITH VALVULAR HEART DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of systemic embolization in patients with AF and rheumatic mitral stenosis or prosthetic heart valves is significantly higher than in patients without these valvular conditions. Issues related to anticoagulation for AF in patients with these valvular lesions are discussed elsewhere.(See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/37/4697?source=see_link&amp;anchor=H14#H14\">",
"     \"Medical management and indications for intervention in mitral stenosis\", section on 'Anticoagulation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/11/18618?source=see_link\">",
"     \"Antithrombotic therapy in patients with prosthetic heart valves\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     INCIDENCE OF EMBOLISM",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of embolization varies according to the presence or absence of clinical risk factors. In addition, the risk rates have been assessed for patients at different levels of risk assessed by risk-stratification systems. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Risk stratification'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Patient age",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of stroke or thromboembolism associated with AF increases with age, with or without anticoagulant therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. The following two studies demonstrate the magnitude of the impact of age on stroke in patients with nonvalvular AF:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a study of over 27,000 men and women, ages 50 to 89, with a hospital (1977 to 1993) diagnosis of AF and without a prior diagnosis of stroke, the rate of subsequent stroke (percent per patient per year) was 1.3, 2.2, 4.2, and 5.1 in those aged 50 to 59, 60 to 69, 70 to 79, and 80 to 89, respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a study of over 6000 hospitalized (2000 to 2010) patients with AF who had no CHADS2 (",
"    <a class=\"graphic graphic_table graphicRef61615 \" href=\"UTD.htm?39/45/40668\">",
"     table 1",
"    </a>",
"    ) risk factors (aside from age), the risk of stroke or thromboembolism per 100 person-years was 0.23, 2.05, and 3.99 for those aged &lt;65, 65 to 74, and &ge;75 years, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Type of AF",
"    </span>",
"    &nbsp;&mdash;&nbsp;The 2006",
"    <span class=\"nowrap\">",
"     ACC/AHA/European",
"    </span>",
"    Society of Cardiology (ESC) guidelines on the management of atrial fibrillation classify AF into four types [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/11\">",
"     11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/41/31384?source=see_link&amp;anchor=H356405846#H356405846\">",
"     \"Paroxysmal atrial fibrillation\", section on 'Introduction'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Paroxysmal AF (ie, self-terminating) &mdash; AF is classified as paroxysmal if episodes terminate spontaneously in less than seven days, usually less than 24 hours. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/41/31384?source=see_link\">",
"       \"Paroxysmal atrial fibrillation\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Persistent AF &mdash; AF is classified as persistent if it fails to self-terminate within seven days. Episodes may eventually terminate spontaneously, or they can be terminated by electrical or pharmacologic cardioversion. A patient who has had an episode of persistent AF can have later episodes of AF that classify as paroxysmal (ie, self-terminating in less than seven days).",
"     </li>",
"     <li>",
"      Permanent AF &mdash; Permanent AF is considered to be present if the arrhythmia lasts for more than one year and cardioversion either has not been attempted or has failed.",
"     </li>",
"     <li>",
"      \"Lone\" AF &mdash; \"Lone\" AF describes paroxysmal, persistent, or permanent AF in individuals without structural heart disease or other known predisposing factor. Lone AF has primarily been applied to patients &le;60 years of age, but older patients also may be at low risk. Some experts feel it is not useful to include lone AF in this classification. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/22/361?source=see_link&amp;anchor=H439358969#H439358969\">",
"       \"Overview of atrial fibrillation\", section on 'Lone AF'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Most clinical trials have been conducted in patients with persistent or permanent AF. However, the risk of embolization appears to be similar in patients with paroxysmal, persistent, and permanent AF [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/12-14\">",
"     12-14",
"    </a>",
"    ], particularly in the presence of clinical stroke risk factors [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/15\">",
"     15",
"    </a>",
"    ]. Furthermore, embolic events can occur in patients with acute AF for as little as 72 hours [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/12\">",
"     12",
"    </a>",
"    ]. In one study of AF of less than 72 hours, 15 percent had transesophageal echocardiographic (TEE) evidence of left atrial thrombus [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Among patients with paroxysmal AF, approximately 90 percent have recurrent episodes of AF [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/17\">",
"     17",
"    </a>",
"    ], and up to 90 percent of episodes are not detected by the patient [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/18\">",
"     18",
"    </a>",
"    ]. In addition, asymptomatic episodes lasting more than 48 hours are not uncommon, occurring in 17 percent of patients in a report using continuous monitoring [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/17\">",
"     17",
"    </a>",
"    ]. Thrombi can form during these prolonged episodes, possibly leading to clinical thromboembolism, although the precise relation to AF burden (that is, the duration of AF per day) to thromboembolism remains uncertain. Two studies evaluated the duration of time in AF after which a thromboembolic risk increases: one found after 5.5 hours [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/19\">",
"     19",
"    </a>",
"    ] and the other after 24 hours [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/20\">",
"     20",
"    </a>",
"    ]. Thus, patients with paroxysmal AF should be assessed for stroke risk and managed in a similar manner to sustained",
"    <span class=\"nowrap\">",
"     (persistent/permanent)",
"    </span>",
"    AF [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with AF and rheumatic mitral valve disease or prosthetic (mechanical or bioprosthetic) heart valves are considered to be at very high risk for clinical embolization and all should receive oral anticoagulation. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Patients with valvular heart disease'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/11/18618?source=see_link\">",
"     \"Antithrombotic therapy in patients with prosthetic heart valves\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Rhythm versus rate control",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both ventricular rate and rhythm control are acceptable approaches to the management of AF, depending upon the specific clinical circumstances. The AFFIRM and RACE trials demonstrated that embolic events occurred with equal frequency regardless of whether a pharmacologically-based rate control or rhythm control strategy was pursued, and occurred most often after oral anticoagulant therapy with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    had been stopped or when the International Normalized Ratio (INR) was subtherapeutic [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/43/5817?source=see_link\">",
"     \"Rhythm control versus rate control in atrial fibrillation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/32/42506?source=see_link&amp;anchor=H14#H14\">",
"     \"Antithrombotic therapy to prevent embolization in atrial fibrillation\", section on 'Underutilization and discontinuation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients treated with rhythm control probably remain at risk for embolization even when no episodes of AF are evident because of undetected periods of AF, because of associated left ventricular thrombi, or aortic plaque. Recurrent episodes of AF are common and asymptomatic in up to 90 percent possibly because of the discontinuity of",
"    <span class=\"nowrap\">",
"     rhythm/function",
"    </span>",
"    within the atria with atrial fibrillation in the body of the atrium and sinus rhythm on the surface electrocardiogram [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/17,18,24\">",
"     17,18,24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/56/7048?source=see_link\">",
"     \"Indications for antithrombotic therapy in heart failure\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/35/10809?source=see_link\">",
"     \"Embolism from aortic plaque: Thromboembolism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     CHADS2 score",
"    </span>",
"    &nbsp;&mdash;&nbsp;The rate of ischemic stroke or peripheral embolization without",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    ranges from 0.5 events per 100 person-years (essentially equivalent to 0.5 percent per year) in patients with a CHADS2 score of 0 compared to 6.9 events per 100 person-years with a CHADS2 score of 5 or 6 (",
"    <a class=\"graphic graphic_table graphicRef61615 \" href=\"UTD.htm?39/45/40668\">",
"     table 1",
"    </a>",
"    ). The rates in the ATRIA study were 0.3 and 6.3 per 100 person-years with CHADS2 scores of 0 and 4 to 6, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/25\">",
"     25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/32/42506?source=see_link&amp;anchor=H9#H9\">",
"     \"Antithrombotic therapy to prevent embolization in atrial fibrillation\", section on 'Net clinical benefit'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     RISK STRATIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Risk stratification for embolization in patients with nonvalvular AF can be performed using both clinical and echocardiographic parameters [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/6\">",
"     6",
"    </a>",
"    ]. These parameters have been derived from both randomized trials and community cohorts.",
"   </p>",
"   <p>",
"    The rates of thromboembolism can be predicted using either single risk factors, such as age, or a combination of risk factors included in validated risk models. The embolic risk appears to be equivalent in patients with permanent, persistent, and paroxysmal AF (",
"    <a class=\"graphic graphic_figure graphicRef82291 \" href=\"UTD.htm?2/1/2078\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/12,26,27\">",
"     12,26,27",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/41/31384?source=see_link&amp;anchor=H11#H11\">",
"     \"Paroxysmal atrial fibrillation\", section on 'Risk of embolization'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    These rates are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/32/42506?source=see_link\">",
"     \"Antithrombotic therapy to prevent embolization in atrial fibrillation\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H7\">",
"     'CHADS2 score'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Clinical parameters from randomized trials",
"    </span>",
"    &nbsp;&mdash;&nbsp;Five randomized stroke prevention trials in patients with nonvalvular or nonrheumatic AF (BAATAF [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/26\">",
"     26",
"    </a>",
"    ], Veteran Affairs SPINAF [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/28\">",
"     28",
"    </a>",
"    ], AFASAK [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/29\">",
"     29",
"    </a>",
"    ], CAFA [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/30\">",
"     30",
"    </a>",
"    ], and SPAF [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/27\">",
"     27",
"    </a>",
"    ]) used their own risk-stratification schemes. However, the endpoint event rates in the control groups of each trial did not permit risk stratification with a high degree of confidence.",
"   </p>",
"   <p>",
"    The Atrial Fibrillation Investigators (AFI) pooled the data from these five prevention trials in an attempt to develop a stronger risk-stratification scheme [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/31\">",
"     31",
"    </a>",
"    ]. Four independent risk factors for embolism in AF were identified:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Age greater than 65 years",
"     </li>",
"     <li>",
"      History of stroke or transient ischemic attack (TIA)",
"     </li>",
"     <li>",
"      Diabetes mellitus",
"     </li>",
"     <li>",
"      History of systemic hypertension",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients with none of these risk factors (15 percent of the group) comprised a low-risk group with an annual stroke risk of about 1 percent without",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    . Patients with at least one risk factor had stroke rates of at least 4 percent per year [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The risk stratification scheme derived from the SPAF III trial of nonvalvular AF identified the following clinical high-risk factors for clinical embolism in AF [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/32,33\">",
"     32,33",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Women greater than 75 years",
"     </li>",
"     <li>",
"      History of stroke or transient neurologic event (TIA)",
"     </li>",
"     <li>",
"      Impaired LV systolic function (clinical heart failure [HF] in the last three months or fractional shortening less than 25 percent on transthoracic echocardiography)",
"     </li>",
"     <li>",
"      Systolic blood pressure &ge;160 mmHg",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The CHADS2 score, which was derived from the AFI and SPAF models (",
"    <a class=\"graphic graphic_table graphicRef61615 \" href=\"UTD.htm?39/45/40668\">",
"     table 1",
"    </a>",
"    ), is the most widely used clinical model for assessment of stroke risk for patients with nonvalvular AF:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Congestive heart failure (HF, any history) &mdash; 1 point",
"     </li>",
"     <li>",
"      Hypertension (prior history) &mdash; 1 point",
"     </li>",
"     <li>",
"      Age &ge;75 years &mdash; 1 point",
"     </li>",
"     <li>",
"      Diabetes mellitus &mdash; 1 point",
"     </li>",
"     <li>",
"      Secondary prevention in patients with ischemic stroke, TIA, or, as most would add, a systemic embolic event &mdash; 2 points",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A calculator is available for use (",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?1/38/1633?source=see_link\">",
"     calculator 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Clinical parameters from community cohorts",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the results from randomized trials constitute the basis for the use of anticoagulation in patients with AF, several questions have been raised concerning their applicability to routine medical practice:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Only a small proportion of subjects screened were randomized. In the SPAF-I trial, for example, 17,046 patients with AF were screened but only 1330 (8 percent) were enrolled into the trial [",
"      <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The trials had relatively short-term follow-up, averaging only one to two years, yet the therapeutic outcomes are typically extrapolated to decades or more. In addition, the number of patients withdrawn from",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      was high, ranging from 10 percent in BAATAF [",
"      <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/26\">",
"       26",
"      </a>",
"      ] to 38 percent in AFASAK [",
"      <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/29\">",
"       29",
"      </a>",
"      ]. In the case of BAATAF there was no loss to follow-up and the intention to treat (ITT) analysis was the same as the received treatment group.",
"     </li>",
"     <li>",
"      Limited information is available on patients who were withdrawn from therapy; these patients probably represent a sizable number in clinical practice.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A systematic review of patients with AF who were anticoagulated in actual clinical practice found stroke and bleeding rates that were similar to those in randomized trials, suggesting that clinical trials can reasonably be used to guide clinical practice [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/34\">",
"     34",
"    </a>",
"    ]. However, the clinical characteristics of trial participants may influence the risk models developed from the trials. Participants in clinical trials are younger, more likely to be men, and typically have fewer comorbidities than those in the community with AF [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A risk model based upon a community cohort was developed using data from the Framingham Heart Study. The analysis identified 705 participants with new onset AF who were not treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    at baseline [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/36\">",
"     36",
"    </a>",
"    ]. Risk scores for stroke and for stroke or death were developed with censoring when warfarin was initiated [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    During four years of follow-up, 83 patients had a stroke (2.9 percent per year) and 382 had a stroke or died (13.4 percent per year). Risk factors for stroke after multivariate analysis were similar to those from clinical trials and included [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/37\">",
"     37",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Increasing age",
"     </li>",
"     <li>",
"      Female sex",
"     </li>",
"     <li>",
"      Higher systolic blood pressure",
"     </li>",
"     <li>",
"      Diabetes mellitus",
"     </li>",
"     <li>",
"      Prior stroke or TIA",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H188195806\">",
"    <span class=\"h2\">",
"     Chronic kidney disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although not included in the many of the stroke risk prediction models (see",
"    <a class=\"local\" href=\"#H14\">",
"     'Risk models'",
"    </a>",
"    below), chronic kidney disease is a powerful predictor of stroke in AF patients. This issue is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/50/39721?source=see_link&amp;anchor=H1190658334#H1190658334\">",
"     \"Management of thromboembolic risk in patients with atrial fibrillation and chronic kidney disease\", section on 'Stroke'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Imaging parameters",
"    </span>",
"    &nbsp;&mdash;&nbsp;Imaging parameters have been studied in an attempt to identify patients with AF who are at high risk of thromboembolism. Transthoracic echocardiography (TTE) provides detailed information about cardiac anatomy and function, while TEE is a moderately invasive imaging technique that provides superior visualization of posterior structures, such as the left atrium and left atrial appendage [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/38-41\">",
"     38-41",
"    </a>",
"    ]. Computed tomography and magnetic resonance imaging of the left atrial appendage have also been evaluated [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/42\">",
"     42",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/50/2856?source=see_link\">",
"     \"Role of echocardiography in atrial fibrillation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Transthoracic echocardiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;TTE is particularly useful for determining LA size, mitral valve morphology and function, and left ventricular (LV) systolic function. A pooled analysis of 1010 patients from the three AF anticoagulation trials that incorporated echocardiography into their risk-stratification scheme (BAATAF, SPINAF, and SPAF I) found the following [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/41\">",
"     41",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      LV systolic dysfunction diagnosed by TTE was an independent risk factor for stroke in patients with AF. The relative risk of stroke was 2.5 for those with moderate to severe LV dysfunction compared to patients with mildly abnormal or normal LV function.",
"     </li>",
"     <li>",
"      LV systolic dysfunction interacted with clinical features in determining risk. Among 163 patients categorized as low risk based upon clinical features, 10 had moderate to severe LV dysfunction and a stroke rate of 9.3 percent per year. By comparison, the stroke rate was lower at 4.4 percent per year in 728 of the 847 patients at high risk for stroke based upon clinical criteria who had normal or mildly abnormal LV function on TTE.",
"     </li>",
"     <li>",
"      LA dimension was not a predictor of stroke in the pooled analysis, possibly because of the confounding impact of mitral regurgitation and mitral stenosis. In contrast, the SPAF investigators found that an LA dimension diameter &gt;2.5",
"      <span class=\"nowrap\">",
"       cm/m",
"       <sup>",
"        2",
"       </sup>",
"      </span>",
"      was an independent predictor of thromboembolism in addition to global LV dysfunction [",
"      <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/40\">",
"       40",
"      </a>",
"      ]. The association was weaker but still significant when LA dimension was not corrected for body surface area.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the SPAF I trial, TTE suggested a low-risk group (stroke incidence less than 1 percent per year) with no echocardiographic or clinical risk factors; this group accounted for 26 percent of all patients [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/40\">",
"     40",
"    </a>",
"    ]. However, as in the pooled analysis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/41\">",
"     41",
"    </a>",
"    ], TTE often changed the risk group based upon clinical criteria. Among patients placed in a low-risk group clinically (stroke incidence 2.5 percent per year), 38 percent were judged to be at high risk (stroke incidence greater than 5 percent per year) when TTE was performed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Transesophageal echocardiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;TEE is used in patients with AF primarily to evaluate left and right atrial appendages (LAA and RAA) anatomy, identifying those who are free of thrombi and are therefore candidates for early cardioversion. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/27/35257?source=see_link\">",
"     \"Anticoagulation prior to and after restoration of sinus rhythm in atrial fibrillation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The presence of thrombus in the left atrium or LAA also provides useful information for risk stratification. The ability of TTE to detect or exclude left atrial thrombi is limited compared with TEE. TEE also can identify other LA abnormalities that are associated with increased risk, including spontaneous echo contrast and complex aortic plaque [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/38,39\">",
"     38,39",
"    </a>",
"    ]. In addition, estimates of LAA ejection velocity can be made, providing a more quantifiable measure of stasis.",
"   </p>",
"   <p>",
"    The presence of clinical risk factors is associated with an increased likelihood of echocardiographic risk factors [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/38\">",
"     38",
"    </a>",
"    ]. However, these risk factors are dissociated in some patients, raising the possibility that TEE can be used for risk stratification. The potential utility of this approach was illustrated in the SPAF III TEE substudy of 382 clinically or TTE high-risk patients, defined as one or more of the following: women over 75 years of age, hypertension, previous thromboembolism, or recent heart failure, or fractional shortening of less than 25 percent on an M-mode echocardiogram [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/39\">",
"     39",
"    </a>",
"    ]. The patients were treated with either adjusted-dose",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    (goal INR 2.0 to 3.0) or low-intensity warfarin (goal INR, 1.2 to 1.5) plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    (325",
"    <span class=\"nowrap\">",
"     mg/day).",
"    </span>",
"   </p>",
"   <p>",
"    The risk of thromboembolism increased with one or both of the following findings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Any LA abnormality, including reduced LAA emptying flow, dense spontaneous echo contrast, or thrombus",
"     </li>",
"     <li>",
"      A complex aortic plaque (mobile, ulcerated, pedunculated, or &gt;4 mm thick) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/35/10809?source=see_link\">",
"       \"Embolism from aortic plaque: Thromboembolism\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Among the 178 patients treated with the relatively ineffective regimen of low-dose",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    , the following rates of thromboembolism were noted according to TEE findings:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Left atrial abnormality &mdash; 7.8 percent per year",
"     </li>",
"     <li>",
"      Complex aortic plaque &mdash; 12.0 percent per year",
"     </li>",
"     <li>",
"      Both &mdash; 20.5 percent per year",
"     </li>",
"     <li>",
"      Neither &mdash; 1.3 percent per year",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The last group, which comprised 37 percent of patients, demonstrated that some patients who are classified as high risk based upon clinical criteria may actually be at low risk when TEE features are considered. However, one cannot be confident that these patients are actually at low risk. Because of the relatively small number of patients, the 95 percent confidence interval in these groups was quite wide, including 0.2 to 9.5 percent per year in the low-risk group. Adjusted-dose",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    (INR 2 to 3) reduced the risk of stroke compared with low-dose warfarin plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    by about 75 percent in patients with high-risk TEE features.",
"   </p>",
"   <p>",
"    Routine TEE is",
"    <strong>",
"     not",
"    </strong>",
"    currently recommended in patients with AF purely for risk stratification. If TEE is obtained, the results can be used to identify patients who may derive particular benefit from",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    therapy. As such, TEE may be valuable for further clarifying thromboembolic risk in patients as increased risk for hemorrhagic complications. As previously mentioned, it may also be useful in some patients prior to elective cardioversion. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/27/35257?source=see_link\">",
"     \"Anticoagulation prior to and after restoration of sinus rhythm in atrial fibrillation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H90459388\">",
"    <span class=\"h3\">",
"     Computed tomography and magnetic resonance imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Though not adequate for exclusion of left atrial appendage thrombi, the left atrial appendage (LAA) is well visualized with both computed tomography and magnetic resonance angiography. As with TEE, it has been found to have variable shapes. In a study of 932 patients who were planning to undergo catheter ablation for drug-refractory AF, the LAA shape was characterized using one of these two imaging techniques [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/42\">",
"     42",
"    </a>",
"    ]. Four morphologies were described: Cactus (multiple small outpockets), Chicken Wing (smooth border), Windsock (distal accessory lobe), and Cauliflower (basal smooth border with distal multiple small outpockets); their relative frequencies were 30, 48, 19, and 3 percent, respectively. The prevalence of pre-procedure stroke or transient ischemic attack was 12, 4, 10, and 18 percent, respectively, and the corresponding CHADS2 scores of at least two were 19 percent, 9 percent, 16 percent, and 27 percent. After adjustment, the &ldquo;Chicken Wing&rdquo; morphology, compared to all other morphologies, had a lower risk of prior embolic event (odds ratio 0.21, 95% CI 0.05-0.91). The relationship between LAA morphology (using these imaging techniques) and the risk of embolization needs to be further evaluated in clinical studies before any change in anticoagulation management is recommended.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     RISK MODELS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Risk models derived from studies of patients with nonvalvular AF have been devised to predict thromboembolic risk and the likelihood of benefit from therapy with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/6\">",
"     6",
"    </a>",
"    ]. These multivariate models have used the clinical parameters presented above but have not included echocardiographic predictors, with the exception of left ventricular systolic function.",
"   </p>",
"   <p>",
"    The following are some of the major risk models:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The Stroke Prevention in Atrial Fibrillation (SPAF) investigators (",
"      <a class=\"graphic graphic_table graphicRef81802 \" href=\"UTD.htm?21/39/22140\">",
"       table 2",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/32\">",
"       32",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      A pooled analysis from the Atrial Fibrillation Investigators (AFI) [",
"      <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/43\">",
"       43",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      The CHADS2 score, which was based upon independent clinical predictors from SPAF and AFI and then tested and validated in other cohorts (",
"      <a class=\"graphic graphic_table graphicRef61615 \" href=\"UTD.htm?39/45/40668\">",
"       table 1",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/4,25,35,44\">",
"       4,25,35,44",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      The CHA2DS2-VASc score, which adds any vascular disease (prior myocardial infarction, peripheral artery disease, or aortic plaque), age 65 to 74 years, and female sex as risk factors as additional risk factors to the CHADS2 score [",
"      <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/45\">",
"       45",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      A community-based (moderately complicated) risk model from the Framingham Heart Study [",
"      <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/36,37\">",
"       36,37",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Clinical parameters from community cohorts'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The R2CHADS2 index, which was derived from the ROCKET-AF trial. This index assigns two points for a creatinine clearance &lt;60",
"      <span class=\"nowrap\">",
"       mL/min",
"      </span>",
"      to the score obtained using CHADS2 [",
"      <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/46\">",
"       46",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/32/42506?source=see_link&amp;anchor=H358919860#H358919860\">",
"       \"Antithrombotic therapy to prevent embolization in atrial fibrillation\", section on 'Rivaroxaban'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/50/39721?source=see_link&amp;anchor=H1190658334#H1190658334\">",
"       \"Management of thromboembolic risk in patients with atrial fibrillation and chronic kidney disease\", section on 'Stroke'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These models agreed on the following risk predictors:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Prior embolic event",
"     </li>",
"     <li>",
"      Hypertension",
"     </li>",
"     <li>",
"      Older age",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other features were regarded as high risk in some, but not all, of the models:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Left ventricular systolic dysfunction or heart failure &mdash; All models except that from the Framingham Heart Study",
"     </li>",
"     <li>",
"      Diabetes &mdash; All models except SPAF",
"     </li>",
"     <li>",
"      Vascular disease &mdash; CHA2DS2-VASc and R2CHADS2",
"     </li>",
"     <li>",
"      Female sex &mdash; The Framingham Study, CHA2DS2-VASc and, for women over the age of 75 years, SPAF",
"     </li>",
"     <li>",
"      Renal dysfunction &ndash; R2CHADS2",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Stroke risk rises continuously with age. The different models varied on the age at which they considered risk of stroke substantially elevated: women over 75 years in SPAF [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/32\">",
"     32",
"    </a>",
"    ], age 65 to 75 years as moderate risk in CHA2DS2-VASc [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/47\">",
"     47",
"    </a>",
"    ], and age at least 75 years in the CHADS2 score [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/35,48\">",
"     35,48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is not clear if patients with hypertension who are adequately treated have the same risk as those with sustained hypertension. Thus, patients with either a history of or current sustained hypertension are considered to be at equivalent risk.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H692407098\">",
"    <span class=\"h2\">",
"     CHADS2 score",
"    </span>",
"    &nbsp;&mdash;&nbsp;The predictive value of CHADS2 has been validated in a large (over 11,000 patients), community-based, clinical practice cohort (",
"    <a class=\"graphic graphic_table graphicRef61615 \" href=\"UTD.htm?39/45/40668\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/4,35\">",
"     4,35",
"    </a>",
"    ]. Patients in this community-based, clinical practice cohort (ATRIA) who were taking",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    had lower risks in all CHADS2 groups (range 0.25 to 4.60) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It should be noted that many experts believe that patients with a prior stroke, transient ischemic attack or systemic embolic event (CHADS2 = 2) are at higher risk of a recurrent event than other patients with a CHADS2 score of 2. As we recommend",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    for most patients with CHADS2 score of 2 or higher, this concern does not alter our recommendations. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/32/42506?source=see_link&amp;anchor=H31#H31\">",
"     \"Antithrombotic therapy to prevent embolization in atrial fibrillation\", section on 'Summary and recommendations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H692407161\">",
"    <span class=\"h2\">",
"     CHA2DS2-VASc score",
"    </span>",
"    &nbsp;&mdash;&nbsp;The CHA2DS2-VASc score (",
"    <a class=\"graphic graphic_table graphicRef83272 \" href=\"UTD.htm?30/23/31101\">",
"     table 3",
"    </a>",
"    ) is an attempt to improve risk stratification, particularly at the lower end of the risk stratum of CHADS2 [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/49\">",
"     49",
"    </a>",
"    ]. Inclusion of age 65 to 74 years, in addition to age &ge;75, recognizes that stroke risk increases across the age spectrum. Female sex has been observed to be a risk factor in some but not all studies. The presence of vascular disease is least well established as an independent risk factor for stroke in patients with AF.",
"   </p>",
"   <p>",
"    The predictive value of this score has been assessed in multiple cohorts [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/49,50\">",
"     49,50",
"    </a>",
"    ], but similar to the other models, is only moderately able to predict risk. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Comparison of models'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Comparison of models",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple studies have compared two or more of the risk models mentioned above for their ability to predict stroke in the individual patient. The following are representative:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The AFI and SPAF III risk models, as well as the CHADS2 score which was derived from these, were compared in a validation study of 1733 Medicare beneficiaries who were not prescribed",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      at hospital discharge [",
"      <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/35\">",
"       35",
"      </a>",
"      ]. During one year of follow-up, 94 patients were readmitted for a stroke or a TIA (4.4 percent per year). The CHADS2 score was found to be superior to the AFI and SPAF models.",
"     </li>",
"     <li>",
"      A second study evaluated data from nearly 2900 patients in six multicenter trials. The CHADS2 score was somewhat more effective at risk stratification than four other models, particularly in the highest-risk patients [",
"      <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/44\">",
"       44",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The larger ATRIA study found that the CHADS2 score was roughly as predictive as the five other risk-stratification models; the",
"      <span class=\"nowrap\">",
"       ACC/AHA/ESC",
"      </span>",
"      model was not evaluated [",
"      <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/25\">",
"       25",
"      </a>",
"      ]. ATRIA included almost 11,000 patients with nonvalvular AF who were not taking",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      at baseline and who had at least a 12-month period of time when they were off warfarin. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/32/42506?source=see_link&amp;anchor=H9#H9\">",
"       \"Antithrombotic therapy to prevent embolization in atrial fibrillation\", section on 'Net clinical benefit'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Each patient was assigned to a low-, intermediate-, or high-thromboembolic risk category constructed for each model. After a median follow-up of six years the following were noted:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The proportion of patients within each category varied widely among the five models (eg, low risk in 12 to 37 percent and high risk in 16 to 80 percent).",
"     </li>",
"     <li>",
"      The overall rate of thromboembolism was 2.1 per 100 person-years and the observed rates in all risk schemes increased from low- to high-risk categories.",
"     </li>",
"     <li>",
"      All risk schemes had only a fair ability to separate patients into categories that corresponded to different rates of thromboembolism (c-statistics ranging from 0.56 to 0.62). No risk scheme was clearly superior.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The predictive ability of the CHADS2 and CHA2DS2-VASc scores have been compared in multiple cohorts [",
"      <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/49,50\">",
"       49,50",
"      </a>",
"      ]. In the largest cohort of nearly 80,000 individuals the two scores had comparable, but modest, ability to predict stroke (c-statistic 0.69 versus 0.67 respectively) [",
"      <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/50\">",
"       50",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In all comparative studies, the Framingham model performs as well or better than other model [",
"      <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/36,49,50\">",
"       36,49,50",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H692407312\">",
"    <span class=\"h2\">",
"     Summary of risk models",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the risk models discussed above are generally similar in terms of their moderate predictive ability, we believe that the CHADS2 score (",
"    <a class=\"graphic graphic_table graphicRef61615 \" href=\"UTD.htm?39/45/40668\">",
"     table 1",
"    </a>",
"    ) is the easiest to implement and most clinically useful model for risk stratification of patients with nonvalvular AF (",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?1/38/1633?source=see_link\">",
"     calculator 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The 2006 American College of",
"    <span class=\"nowrap\">",
"     Cardiology/American",
"    </span>",
"    Heart",
"    <span class=\"nowrap\">",
"     Association/European",
"    </span>",
"    Society of Cardiology guidelines for the management of patients with AF, and its 2011 focused update, did not recommend use of a particular risk stratification scheme [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/11,51\">",
"     11,51",
"    </a>",
"    ]. The 2010 European Society of Cardiology guidelines for the management of AF recommended use of the CHADS2 score [",
"    <a class=\"abstract\" href=\"UTD.htm?26/23/27001/abstract/52\">",
"     52",
"    </a>",
"    ]. For those patients with CHADS2 scores of 0 or 1, the additional use of CHA2DS2-VASc (",
"    <a class=\"graphic graphic_table graphicRef83272 \" href=\"UTD.htm?30/23/31101\">",
"     table 3",
"    </a>",
"    ) was recommended.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     ATRIAL FLUTTER",
"    </span>",
"    &nbsp;&mdash;&nbsp;Few data are available on exclusively atrial flutter cohorts. Most trials addressing the issue of anticoagulation for patients with atrial fibrillation have included a small minority of patients with atrial flutter. As many patients with atrial flutter have periods of atrial fibrillation, we advocate risk assessment of atrial flutter patients using current atrial fibrillation approaches. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/40/37511?source=see_link\">",
"     \"Embolic risk and the role of anticoagulation in atrial flutter\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?0/16/261?source=see_link\">",
"       \"Patient information: Atrial fibrillation (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The absolute embolic risk varies among patients with atrial fibrillation, as does the risk of anticoagulant major bleeding. The decision to recommend no therapy,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    , or anticoagulant to patients requires an assessment and comparison of these two risks. The risk of bleeding with anticoagulation is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/32/42506?source=see_link&amp;anchor=H6#H6\">",
"     \"Antithrombotic therapy to prevent embolization in atrial fibrillation\", section on 'Warfarin'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For the purpose of deciding which patients with atrial fibrillation should receive antithrombotic therapy, we recommend assessment of embolic risk using validated models in all patients. We recommend the CHADS2 risk assessment score, as it is the best validated model and it is the model with which we make recommendations for the use of antithrombotic therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/32/42506?source=see_link&amp;anchor=H31#H31\">",
"     \"Antithrombotic therapy to prevent embolization in atrial fibrillation\", section on 'Summary and recommendations'",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H14\">",
"     'Risk models'",
"    </a>",
"    above.) For patients with CHADS2 score (",
"    <a class=\"graphic graphic_table graphicRef61615 \" href=\"UTD.htm?39/45/40668\">",
"     table 1",
"    </a>",
"    ) of 1, consideration of patient preference, CHA2DS2-VASc (",
"    <a class=\"graphic graphic_table graphicRef83272 \" href=\"UTD.htm?30/23/31101\">",
"     table 3",
"    </a>",
"    ), and R2CHADS2 should be considered.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/1\">",
"      Krahn AD, Manfreda J, Tate RB, et al. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med 1995; 98:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/2\">",
"      Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 1982; 306:1018.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/3\">",
"      Lloyd-Jones DM, Wang TJ, Leip EP, et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 2004; 110:1042.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/4\">",
"      Go AS, Hylek EM, Chang Y, et al. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? JAMA 2003; 290:2685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/5\">",
"      Singer DE, Chang Y, Fang MC, et al. The net clinical benefit of warfarin anticoagulation in atrial fibrillation. Ann Intern Med 2009; 151:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/6\">",
"      Rockson SG, Albers GW. Comparing the guidelines: anticoagulation therapy to optimize stroke prevention in patients with atrial fibrillation. J Am Coll Cardiol 2004; 43:929.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/7\">",
"      Ezekowitz MD, Falk RH. The increasing need for anticoagulant therapy to prevent stroke in patients with atrial fibrillation. Mayo Clin Proc 2004; 79:904.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/8\">",
"      Frost L, Engholm G, Johnsen S, et al. Incident stroke after discharge from the hospital with a diagnosis of atrial fibrillation. Am J Med 2000; 108:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/9\">",
"      van Walraven C, Hart RG, Connolly S, et al. Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators. Stroke 2009; 40:1410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/10\">",
"      Olesen JB, Fauchier L, Lane DA, et al. Risk factors for stroke and thromboembolism in relation to age among patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project. Chest 2012; 141:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/11\">",
"      Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol. 2006; 48:e149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/12\">",
"      Hart RG, Pearce LA, Rothbart RM, et al. Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators. J Am Coll Cardiol 2000; 35:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/13\">",
"      Hohnloser SH, Pajitnev D, Pogue J, et al. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy. J Am Coll Cardiol 2007; 50:2156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/14\">",
"      Stroke Risk in Atrial Fibrillation Working Group. Independent predictors of stroke in patients with atrial fibrillation: a systematic review. Neurology 2007; 69:546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/15\">",
"      Lip GY, Frison L, Grind M, SPORTIF Investigators. Stroke event rates in anticoagulated patients with paroxysmal atrial fibrillation. J Intern Med 2008; 264:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/16\">",
"      Stoddard MF, Dawkins PR, Prince CR, Ammash NM. Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiographic study. J Am Coll Cardiol 1995; 25:452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/17\">",
"      Israel CW, Gr&ouml;nefeld G, Ehrlich JR, et al. Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care. J Am Coll Cardiol 2004; 43:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/18\">",
"      Page RL, Wilkinson WE, Clair WK, et al. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation 1994; 89:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/19\">",
"      Glotzer TV, Daoud EG, Wyse DG, et al. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circ Arrhythm Electrophysiol 2009; 2:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/20\">",
"      Capucci A, Santini M, Padeletti L, et al. Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. J Am Coll Cardiol 2005; 46:1913.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/21\">",
"      Lip GY. Paroxysmal atrial fibrillation, stroke risk and thromboprophylaxis. Thromb Haemost 2008; 100:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/22\">",
"      Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347:1825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/23\">",
"      Van Gelder IC, Hagens VE, Bosker HA, et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002; 347:1834.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/24\">",
"      Seto TB, Buchholz WA, Douglas PS, Manning WJ. When the body and appendage of the left atrium disagree: \"Focal\" atrial fibrillation-implications for atrial thrombus formation and risk of thromboembolism. J Am Soc Echocardiogr 1999; 12:1097.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/25\">",
"      Fang MC, Go AS, Chang Y, et al. Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation. J Am Coll Cardiol 2008; 51:810.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/26\">",
"      The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. N Engl J Med 1990; 323:1505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/27\">",
"      Stroke Prevention in Atrial Fibrillation Study. Final results. Circulation 1991; 84:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/28\">",
"      Ezekowitz MD, Bridgers SL, James KE, et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. N Engl J Med 1992; 327:1406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/29\">",
"      Petersen P, Boysen G, Godtfredsen J, et al. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet 1989; 1:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/30\">",
"      Connolly SJ, Laupacis A, Gent M, et al. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol 1991; 18:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/31\">",
"      Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994; 154:1449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/32\">",
"      Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study. The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators. JAMA 1998; 279:1273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/33\">",
"      Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial. Lancet 1996; 348:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/34\">",
"      Evans A, Kalra L. Are the results of randomized controlled trials on anticoagulation in patients with atrial fibrillation generalizable to clinical practice? Arch Intern Med 2001; 161:1443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/35\">",
"      Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001; 285:2864.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/36\">",
"      Wang TJ, Massaro JM, Levy D, et al. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. JAMA 2003; 290:1049.",
"     </a>",
"    </li>",
"    <li>",
"     Risk functions for stroke and for stroke or death available at www.nhlbi.nih.gov/about/framingham/stroke.htm (Accessed 3/7/05).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/38\">",
"      Zabalgoitia M, Halperin JL, Pearce LA, et al. Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators. J Am Coll Cardiol 1998; 31:1622.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/39\">",
"      Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography. Ann Intern Med 1998; 128:639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/40\">",
"      Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators. Ann Intern Med 1992; 116:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/41\">",
"      Echocardiographic predictors of stroke in patients with atrial fibrillation: a prospective study of 1066 patients from 3 clinical trials. Arch Intern Med 1998; 158:1316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/42\">",
"      Di Biase L, Santangeli P, Anselmino M, et al. Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study. J Am Coll Cardiol 2012; 60:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/43\">",
"      Ezekowitz MD, Levine JA. Preventing stroke in patients with atrial fibrillation. JAMA 1999; 281:1830.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/44\">",
"      Gage BF, van Walraven C, Pearce L, et al. Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin. Circulation 2004; 110:2287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/45\">",
"      Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010; 137:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/46\">",
"      Piccini JP, Stevens SR, Chang Y, et al. Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts. Circulation 2013; 127:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/47\">",
"      Singer DE, Albers GW, Dalen JE, et al. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133:546S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/48\">",
"      Fuster V, Ryd&eacute;n LE, Cannom DS, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114:e257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/49\">",
"      Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010; 137:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/50\">",
"      Van Staa TP, Setakis E, Di Tanna GL, et al. A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice. J Thromb Haemost 2011; 9:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/51\">",
"      Wann LS, Curtis AB, January CT, et al. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011; 123:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/23/27001/abstract/52\">",
"      Dickstein K, Vardas PE, Auricchio A, et al. 2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Eur Heart J 2010; 31:2677.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1055 Version 15.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-183.1.191.153-B28792CD2A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_23_27001=[""].join("\n");
var outline_f26_23_27001=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATIENTS WITH VALVULAR HEART DISEASE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      INCIDENCE OF EMBOLISM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Patient age",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Type of AF",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Rhythm versus rate control",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      CHADS2 score",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      RISK STRATIFICATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Clinical parameters from randomized trials",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Clinical parameters from community cohorts",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H188195806\">",
"      Chronic kidney disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Imaging parameters",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Transthoracic echocardiography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Transesophageal echocardiography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H90459388\">",
"      - Computed tomography and magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      RISK MODELS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H692407098\">",
"      CHADS2 score",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H692407161\">",
"      CHA2DS2-VASc score",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Comparison of models",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H692407312\">",
"      Summary of risk models",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      ATRIAL FLUTTER",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/1055\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1055|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?2/1/2078\" title=\"figure 1\">",
"      Stroke rates AF risk category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1055|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?39/45/40668\" title=\"table 1\">",
"      CHADS2 score and thromboembolic risk with and without warfarin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?21/39/22140\" title=\"table 2\">",
"      Risk of thromboembolism in AF",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?30/23/31101\" title=\"table 3\">",
"      CHA2DS2-VASc score and stroke risk",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   CALCULATORS",
"  </h1>",
"  <div id=\"relatedCalculators\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?1/38/1633?source=related_link\" title=\"calculator 1\">",
"      Calculator: Atrial fibrillation CHADS(2) score for stroke risk",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/27/35257?source=related_link\">",
"      Anticoagulation prior to and after restoration of sinus rhythm in atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/11/18618?source=related_link\">",
"      Antithrombotic therapy in patients with prosthetic heart valves",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/32/42506?source=related_link\">",
"      Antithrombotic therapy to prevent embolization in atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/40/37511?source=related_link\">",
"      Embolic risk and the role of anticoagulation in atrial flutter",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/35/10809?source=related_link\">",
"      Embolism from aortic plaque: Thromboembolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/54/28522?source=related_link\">",
"      Epidemiology of and risk factors for atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/56/7048?source=related_link\">",
"      Indications for antithrombotic therapy in heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/50/39721?source=related_link\">",
"      Management of thromboembolic risk in patients with atrial fibrillation and chronic kidney disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/37/4697?source=related_link\">",
"      Medical management and indications for intervention in mitral stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/22/361?source=related_link\">",
"      Overview of atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/41/31384?source=related_link\">",
"      Paroxysmal atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?0/16/261?source=related_link\">",
"      Patient information: Atrial fibrillation (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/43/5817?source=related_link\">",
"      Rhythm control versus rate control in atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/50/2856?source=related_link\">",
"      Role of echocardiography in atrial fibrillation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_23_27002="Bullous pemphigoid multiple lesions";
var content_f26_23_27002=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F72866%7EDERM%2F58359%7EDERM%2F66179&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F72866%7EDERM%2F58359%7EDERM%2F66179&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Bullous pemphigoid",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple erythematous plaques, bullae, erosions, and crusts are present on the trunk and extremities.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.&nbsp;&nbsp;",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Bullous pemphigoid in childhood",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple tense bullae, inflammatory plaques, erosions, and crusts on the skin of this child with bullous pemphigoid.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Bullous pemphigoid",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple erosions are present on the oral mucosa in this patient with bullous pemphigoid.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_23_27002=[""].join("\n");
var outline_f26_23_27002=null;
var title_f26_23_27003="Management NK cell deficiency";
var content_f26_23_27003=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F68545&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F68545&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Management of NK cell deficiencies",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Intervention",
"      </td>",
"      <td class=\"subtitle1\">",
"       Reported or theoretical benefit",
"      </td>",
"      <td class=\"subtitle1\">",
"       Risks",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Antimicrobials",
"      </td>",
"      <td>",
"       Decrease incidence of disease",
"      </td>",
"      <td>",
"       <p>",
"        Adverse drug reactions",
"       </p>",
"       <p>",
"        Microbial resistance",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       IVIG",
"      </td>",
"      <td>",
"       Decrease incidence of disease",
"      </td>",
"      <td>",
"       <p>",
"        Adverse drug reactions",
"       </p>",
"       <p>",
"        Infections/neurodegeneration",
"       </p>",
"       <p>",
"        Inconvenience",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       IL-2",
"      </td>",
"      <td>",
"       Increase NK cell function",
"      </td>",
"      <td>",
"       <p>",
"        Adverse drug reactions",
"       </p>",
"       <p>",
"        Autoimmunity",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       IFN-alfa",
"      </td>",
"      <td>",
"       Increase NK cell function",
"      </td>",
"      <td>",
"       <p>",
"        Adverse drug reactions",
"       </p>",
"       <p>",
"        Autoimmunity",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Stem cell transplantation",
"      </td>",
"      <td>",
"       Correction of defect",
"      </td>",
"      <td>",
"       <p>",
"        Defect not corrected",
"       </p>",
"       <p>",
"        Transplant-related mortality or morbidity",
"       </p>",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_23_27003=[""].join("\n");
var outline_f26_23_27003=null;
var title_f26_23_27004="NF1 monitoring PI";
var content_f26_23_27004=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F87043&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F87043&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    How doctors monitor NF1",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"4\" width=\"25%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Type of exam or check",
"       </td>",
"       <td class=\"subtitle1\">",
"        What the doctor will do",
"       </td>",
"       <td class=\"subtitle1\">",
"        Why it's important",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Physical exam",
"        <em>",
"         (every year)",
"        </em>",
"       </td>",
"       <td>",
"        <p>",
"         Check for new or changing growths or tumors.",
"        </p>",
"        <p>",
"         Check for high blood pressure.",
"        </p>",
"        <p>",
"         Measure height, weight, and head size.",
"        </p>",
"        Check that the bones in the arms, legs, and back look normal.",
"       </td>",
"       <td>",
"        NF1 can cause problems with the way the body forms and grows. It can also cause high blood pressure, which can lead to heart disease or other problems.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Eye exam",
"        <em>",
"         (every year)",
"        </em>",
"       </td>",
"       <td>",
"        A full eye exam, including a vision check.",
"       </td>",
"       <td>",
"        NF1 can cause tumors to form on the nerves going to eye. This can affect vision.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Check for early puberty",
"        <em>",
"         (every year)",
"        </em>",
"       </td>",
"       <td>",
"        Check for signs of early puberty, such as:",
"        <ul>",
"         <li>",
"          Hair growth under the arms or between the legs",
"         </li>",
"         <li>",
"          Budding breasts (in girls)",
"         </li>",
"         <li>",
"          Growth of the penis or testicles (in boys)",
"         </li>",
"        </ul>",
"       </td>",
"       <td>",
"        Tumors caused by NF1 can press on or damage the part of the brain that controls the timing of puberty.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Check on learning and memory",
"        <em>",
"         (every year)",
"        </em>",
"       </td>",
"       <td>",
"        Check that the child has gone through the normal stages of learning for his or her age. Check for learning problems, including attention deficit disorder (also called ADHD).",
"       </td>",
"       <td>",
"        If the child has any learning problems, it's important to catch and treat them early.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Review school progress",
"        <em>",
"         (after child reaches school age)",
"        </em>",
"       </td>",
"       <td>",
"        If progress in school is not going as it should, the doctor can recommend certain tests to find out what the problem is.",
"       </td>",
"       <td>",
"        If the child has problems in school, there are often programs and special classes and tutors that can help.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Check on large or complex skin growths",
"        <em>",
"         (every year)",
"        </em>",
"       </td>",
"       <td>",
"        The doctor will ask the child whether any of the growths on his or her skin have grown or started to hurt more. This is especially important during the teenage years.",
"       </td>",
"       <td>",
"        Abnormal growths on the skin caused by NF1 can sometimes turn into cancer.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_23_27004=[""].join("\n");
var outline_f26_23_27004=null;
var title_f26_23_27005="ST segment resolution outcome";
var content_f26_23_27005=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F53047&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F53047&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 492px\">",
"   <div class=\"ttl\">",
"    Rapid ST segment resolution after thrombolysis is associated with a better outcome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 472px; height: 248px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    After a two-year follow-up, patients with rapid ST segment resolution after thrombolysis had a higher incidence of reinfarction (27 versus 9 percent), but a lower incidence of heart failure, mortality, and mortality and/or HF (3 versus 22 percent) compared to those without rapid ST segment resolution.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Matetzky S, Freimark D, Chouraqui P, et al. J Am Coll Cardiol 1998; 32:1326.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_23_27005=[""].join("\n");
var outline_f26_23_27005=null;
var title_f26_23_27006="Long axis HCM ASH SAM";
var content_f26_23_27006=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F55693&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F55693&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Asymmetric hypertrophy in hypertrophic cardiomyopathy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 209px; height: 236px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCADsANEDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5aopKK9IgWiij6UXQBRRRTAKKKKACiiigAooooACM0mKDUtrBLdXEVvbo0k0rBERerE9BU2TYEWO1JtFel6b4S8G2Ub2vi/xPcWOrI+2WK3tWmji9iwByR3xWd4s8JaLDave+CtdOu2lum673QNC8PocMBke4pOEdjP2yv1/Q4bAoYgUU2TtUT9yLaNRdw96QsDTKK5/bSeg7Dsj3oyKbRUczGOyPejI96bRRzgLkUZFJRRzMBc0UlFLmYE1FJQa9EgKWkHvSipjrqAUUUVYCUd6KWpsAlLSGlpgAopO+DS0kAh5ra8I3uoWerBdI8sXlwhgWRk3GMN1ZfQ471i11PgbyrO9+3zbsx527TyPes6snBOUdyoQU3yy2PY/DHh23/seB5bNZ7ZCVkmcbyXPJY9zyaxvFWhz6W39raPJBFJBAT5TLgTqT80bL3B9K2/Dvi69gl8u3gh8gjc0HRJOpB9hmpvEWtXF+wea1tVyCwBUbmyK+VhVxdPEXe3qfRyoYapQcV+R833EnmzySBFj3sW2IMBcnoPaoX7Vr+JbP7Hq0wXaEcl1C9s9qyH7V9ROSlTuj5y1nYZRRRXIMKKKKACiiigAooooAKKKKAJqQ9KKWvR3IG96cMU2nDJqYgFFFFaAFIPeigVD3QCg0UUVQBSClopdQCuu09Le0MREVwgdR+8xlSK5vTTaeeRfJK8ZHHlnnNb+nbhEFhuZGiYlFRoycD1rCtrob0l1Oottbjikke1QosabAz52kY5x7VFc38zR+X5m5VIZWjOSPasyOzke4VLC5BMf+sRhwfpn8K2Y9KlSEmd1iyOGRN2T7+9cEo04u51pzkrI5PxHZTyOWuCTMi5XA4YdTXLP2rt760uUUC1BkdDzLLxj/AArltT0+SyaISsGLru47H0rsh70OVHHVVnczqKk2CmkDPrUOlJbmdxtFLijFTysYlFLgUuBRysBtFOxSYo5WAlFLgUUcrC5JS0lBrvTIClFNyfTpS1MXcBaKKK0AKQdaWkFSAUtFJ3pgLWr4Z0S517U1tLOPewG5h7f41lV03hjUp9PsZ2sbd2mB3NKBnbWdVyUXy7l01FyXNsa114WtrG6KSytGhGGB6of5/nV2aysLaJJLXU5PtWAirIgx9BXLz32p61dSSNJhnUjcxwCB1FVdLXy3XdIrSK2PLfJH1FcrpzfxS1Ojnjf3VodxDDY29ruuLkIwPz7xg5q2NYtfsQIuWDA7cADcfYVw2qwsxL+bu3cHAxjvwKlTyLGEwGR5AyBjzxu9qylh1LVu5pGq46I3G12wso5C0XnXMh3fvTnH1HtXK+IbyW5lVX27M7xt5GT71DYNLJdSmO18+TB+8c7aguowIyTv8wHn+6PauqlSjCXmYTm5xKZpG70ppD61pU2MENFSz209vs8+GSLeu5d6ldw9RnqKfp86219bzvEsqxSLIY26OAc7T7GvVPjf8TtJ8fadoltpWimxezUmSV8ZyRjYuP4RWajHluyW5cySWh5HRRRWZYUUUUAFFFFAD6DQKDXXsiRBTu1NzS0otWAWiikq2wFNJ3oJwetIahyAd3pDmjvQad9AJIYZJ32RIXbGcKK1NAkmWZ1tPMjuMfeVuMehB61QsZXgmEscvlOvII6muhEunLJHPcLKs5OWkgkwxz1yuOlTN9LGsI9SpqEt3LHJIixSQk/vNikbSPbtWRa3k9qxaBtuTz710c1y6xS/ZJmeIZYO0eA49DnvWRPo986mRIRIvXEeDjv0FZKStZlTTTui8PFdw0YS4tLSXH8RQhvzzVGTVxJfid7ZBEOkKnC59ay3jeM4dGU+hGKZmp5Yx2RPtJPqdbZ6jp9w5aS4NioXnCE7j+FZmr3dsSF0+R2Uj5yV2j8B/WsXNOHSqppJg5toXOaQ4NH40hq6ktDNCDg0pJNJRWN3awwooopAFFFFABRRRQA+g9KKD0rq6MkQdaWm9xTqmmNgaD0ooq2IQmk78UporN3eowPb0p2DjPak7VLHE0jBUHXpnvVpAlcYuAwL5K+x5rUsc3d0CdkpHTzTtP0zWc0LAkBWLD7wx0rtPhf4F1Hxtrr2Gm3VpatFH5zzXTERgblVRkA8lmUAd80StYqGjM2F7yyunt54f9FPz7GTfgfUVrQXkUMLG2VbRpCSHLFQfx6H6V2Gi+Bta1GHVdR1CSLTI9IufsNwUt5bl/M5zmONSdoxyxwOay38AarrOmxXdpf2t3ZXWsHSUkt0lkG8AHzSNownI5Iz6iuOUed6nTzcpgea81m8kBjuYguGSRBknvtz1rkI7Bp5mG6OAZ6Sttx7V0/iTSH8P6xe6LflhJZXL20k8BPlyOpxkA9q5e8MjT7i+8564xWlOO6M52epJqWj3unKr3EREbfddeVP41nrW6Lq4W18p7oSrIOQDu2+wrOuLJos7HSQBdzFTwKqCd9dyJR6oqCmnrT/AMqa3U05rQzEooxRWTGFFFFABRRRQAlFLRU2Af3oNIOtKeldid0xCZpRTRTqmAB9aKKK0uIQ0d6U0g6Vm1qMXv6Vp2Er2sywTRxvHJjG4ZA9wRzWYKVWIIIPPUGq3GnY6G7tzEXkG12I58sk5HoR2rsfAXjJvC3hS9tdD0WKbUr+5hknursCSMRxEsqBCODvIbdnsOOBXB2mtToSLhIrjdgbpMgr+IroHtAbQyRF0diGCK5YD3BrGbcbKRurS1PTH+JunQ+I73xIND1bT9VuJI5pxp+rvFHKyqoKuoXayEjdgrnLHmoB8WdWis0MNs1hcya42s3AsruSFZ1bGYNqjkHHJJOe4rzaS2vViSaGWK6jc4cbcN9avabcS2TNbvHDIxGQxzuP/wBesJOy01KUFuyh478QXXiPxLqmqCxa1jvrl7hI2O4oWOducDP1xWFPbzweTLexP5UhwVPAre13UVEahMiQtnBHAqC/uZruwjjkBeYMCroBtWrjJpLSwpLzMvULP7HJG6Sxx55VQ24gepqzp9nbanJ5UZf7Qw3PI5ABHsKrz6fc3B3TErgcM5AB+gq9aeHLo2ok89Y3HICtz+NW5WWr1J67aGRqWmPZ3bQlkZs4VU5zn0q82kRWcCG/3Ncy9I1YEr+VXY9K1PaMWbyNnIkzjH0q1/Zd+k6rbwKzuMMCfm/FqJTVrXBQ12OcFnH9ld2mKgEkQqPmx71lEYr0rTPBdn53na/qGxCc+VG3X2zUPjnRrA6cbjTgoa2wvydCnv71z/WYSlyLX8i54eSjz7fmed0UUVqcwUUUUAFFFFADhSmkpT0rqWwhox+NOpp606oggCiiitRBR2o61LAqu22STYMcHGRmpGtSLtRTnQqT3AOMjpSU7AIKtWNwsU6mfzWh/iVGwaq0ClboF7HYRz21xAyaXfSRsw5jlGG/PvTDL9iSOO7iJd85lLZrlFzkbc59q6rT/EFnJpv2bUoAXXpIFya56lNx1Wv5m8J82+hdjiijaCKTb5UrDzHdS+AT1C98ZzivUPHHgKzk0YJ4Jgj1CykuoLaDUbTVUny0hChZoQgMbEnjB4OAa5HwZ4a1zxvq62vhl7driCI3Ilb5DGFxj5uxJwB7n0ya6bXNW8e+HbOK51nU1sdUhuhLBYxWNuJZnGVM0qqgXAGdrPkk4KjHzDJeY5N30NfxX8MtK0fxT4MtrRNRn03UtROk3k12MSJMj7SyErgK4yVPOQtM1X4S6fo3hvxdrNnqdxdXMTJdaRH5ikG3dlXdKNud2WdMccxk155ZeOtc02NIZtYu4beC7jvYlmiScrOn3X3OpIPPQHB7iucuPGF/ZW+r2ujajMsWrgC+JRf3oDFwASMr8xJ+XHWrjFvRENtHbObyDSBdX88cQAGQXAwPp61y2ua/ZyWiw2l4Ys9oxk/UtXESzzTACWWRwP7zE1u/Dzw1L4v8baNoMO4fbbhUkZeqRjl2H0UMfwohhFHWTNJ4lyVkhL+1tzZrNb37ySJlmkkkwM+ijuawpLu4eHymmcxZzt3cE17H41+D9vD4xtYtCuLqx8N3OkSaw1xqUbGW3iiX98rIACXHy/KP745715z468LP4V1CwjF5HfWeoWUWoWdyiFPMhkyAWU8q2VYEc9KbeljFy7HN0UUUiQooooAm+zn/AJ6w/wDfdFSfax/z7wf98/8A16KuyI98rg0ppM80E8VtdWZQdTSim56U6lBgxataZp9zqd0tvZxNJIeeOgHqfSqte3/AXSZoIrm5W3DyXsewMY9+1Pp7+tY43ErC0XVfQ3w1B16igjyS/sJrZ/LlhVDGMZx94+9VUKNMrCNlGcOF/pXqvjnw01ve3MUgCsOV2tgn6CvNprWeKXzIWMhTr6j6jrSoYmNeCkmXVoOlLlZuRWkKbWs0SWNwN8TDaRWNqmkPHKWgiZAefLbt9D3qOG8zcLLKJ/MQggocYH0rYl1WC/j3KJEmUfcJJU/j2q7yg9NRWjJHJMCpIIwR1zR1NalxHDdEujAN3XcAQfb1FSTaGwg82GeN1xnHp+Nbc6T1MXTfQy4JTBKHX8q3oYor2MPb2Ekz45IwAPoO9c86sjFWGCO1X9I1a+sJVFnMVJOACAf51FRN6x3CEraM+qvgpc+HvhH8PZtZ8STuur6wROtnChknEIH7tQvbOWbJIB3DnivHvjP8XJvHGtxXGmaYdIgiQx7mfdLOM8F+wxzgDPXqeMczb63fGcf2j9taI9o1zz+FVbnTrnVHdktLqV/4CSOh9RXOrXvUSKa6wOduby4ugouJWkx0yagrq4PBN7lWvJI7eP8AizyVq2/h3w7aSD7TrqSjHKxkZzWqxNJaR19Bexn109Tia1PD2v6p4curi60W6NrcT28lq8qorMI3GGCkg7SR/EMEdiK6CKw8NPcKEuxHHn77Ek/lV+/XRfKCwTSzRdo2AG7/AOtRLELblY1Re9zKsPiD4whh063tdXuJV095Wtw8SSsvmjEikspLKw6q2V9qx9f1bWPE+tCfWJ3uL0qsKgosaxoowqKigKigdgAK7z7XPcWIt9NtrLTIQuA+AZGrJs4tD012kvppNR1NznKcKDXOq6afu69t/wCvvNHQ1Vn+hlab4G1XUZlhs4jNMRkqgJCjuSayfEejtomoG0eeOZ1UFjGeFPofeut1v4haqmnnTNJlWys2HzrCMM3+83WuOYSX0ckkswGPmwQfmb6+tKl7aTcqiSXTuFWNJe7Tu2Z1FFFanOFFFFACjNKehpopx4+laxeghtPFNpy06e9gZe0nT5dQuhHCMhfmcnoBXtfhfWLvSzE0DhduFDJ8uMfTpXmPhdYoI+JHt7s5JZjgY7DHeu4sdQIdFdIklz8wX7rfn/KuDMI+1XI1dHoYR+yalezPcLvSrTxloKy/6Nc6hGuVmXEThvTjg14N428JXtpNJJc20tvOv8WzGR/XpXf+FdeuNKuhPZxqy4G6MHg/h2/Cuu1O40Txlp7LMLrTb+PJEiHfG31B/pXzGGq1stquO9P8vK3b5Hr1aMa8bpa+R80WmnQSWbNczJHL03GPbn8aoXAe1ieFxayY5DZ5/A13Gt6K9hcTwLOLhNxIkQcfqK5e9tTI2wxxgg4+Y4JPt2z7V9bRrKprfQ8ecHF8r3MO6kd1VwIvMAHKr19jWlb+KGWNIrmxgYpxuyUP6VC0C2koieNZ4zzjaQ49qtx+HIr5lW1lhjc9ix/rW0nC3v7GNpX90r6hrdtKpSXTrWVTyHSQ5H6da59mjLMQjL6DPStnVfDGoacheRUeP+8jZrFeCReq8eo5qoclvcdzKanf3kXLHU76BDFayHDDkYyTUkOqXMLM+8b/AEDEEVmYOeM/hUi2s75IifHrtNEorqhKUujJbrUbq5djJPKQexckVWFIQVbB60dQKINrYlu+rFp8czxkFWYY9DSGORUR2VhG4O1iOGx1x60jxyJGsjI4jfO1iOGx1waqUtBIvXGqO8arEvlkHlg2SfrVIzyZJLtk9TmmqC7AKuT6Cp4bGeUjaoA9ScCs1psXeUiOIgybpMsO/PWt+x0lbuBp7ndbxL9xFHJq3pNhbxxofKJYfeYnIJ+laN3e7G2LjcOWYjhR7Cs51ekTWEO5xeqWbWsxIjkWIn5S/eqVdxfzjVNPa2gtikZ5E0vBb3HtXEyIY5GR+qnBxSi3LcipFReg2ius+z+D/wDn81D/AL90Vryea/H/ACOf2nkzlBSnpTacelOL0ZoNqe3IEis4yoOSOtQ04dKdPcL2Os0pUugZLa5WFjyYpFBXP1rVtrlEcpJGIyPvJkkZ9RXG6bM8cp8s4GOQehrfivpGZFaEDHI2/d/GoqU22zqhK6ueiaMu1A1syZIywLfe9s1uw3ot5Ea4WWJc5EkeG2/Q1xuiS2d3EhJAkJA2MMc/4V6z8P8ATYbjfFqUMbxn7vmDr/usOlfN5hONFOc1f8z2cG5NadCzq2j2fivSVnsRFLdxp8xQYLccZryDVNPuba7aKaCdcEjgA4/qa+nrXwNpGmKmpQTSW0h6Bn3KfYFf61neIfD2meKVWBLlVvcjDYVnHsCMGvJw2ZfU5qnK7g9VfdfJX/TyLrKniFzR6b6Hy7d2wEWJWVs9GQYI+v8A9asi4tboAZlM0X3gQoJX+teteN/BGo6TctDLBNJHjPnCE9PTpXnZtZ9PZlCso9V4xX1WHxMaivF/1+h5dWk4O72Of1NpAgGImAwp3bgfxpYJ4jHsubWzeXvjOT+VaOoTRLEDPI8q9QNpB+lYLKJnzbQtB0zukziutaowtqbFvq1lBIVks4VcHHr71Sv/ABIy+bDBHEI5BgmMYqr5AeEBIY5WPG7nNZs1jMGXePKJHR/lqoU4PVkTlJaIpODvbOQc96Qepp8yFGGWVh2IOaaAcVvH4jnZ7JrGnW/ib4I/D62sde8PQXmkLqbXVreanDBMvmXG5AEY5JIUkD3HrXW/EW/8H6x8MtQ8I6T4i0+afwxFby6eWCxJOyLsn2SlsSl9zOAvcDFfN2PSlVdxx69zQ6fQQ3lcYPNaVla3UzJtJOeAvbHvUVnZtNny/nbPCoMnNdbp9gLZUFxHNKz4+Rf5fSs5yUDanC+5FaAWMaKRJd3HRY4hlVH1qaKC587z9RaJFzxGB0HvXXWVncFFjtbSKFccljz+PpWdrOmxOzJJNvdDuYQ84PpmuBYhSlyndKhJR5ilaXVtc3Lgx4ij4x3f2rnvHdsjTx3sMPlqw2uAMc9uK1YohDM8UMYhQ8lycsay9XuhJDLGr4iYYeSTknHYD1rWEbSujnqaxszkuPSipPLj/wCew/I0V1a/1Y47ojFONNFKehpx2GJTgabThn8KdPfQGSI21gwyGHIIrU0/UWiuonmj3FcAY71kirdicsFZQVz1xnH4VtJXRVOTTsj0zRL2OeeN44AEbglvfuK9i0bXp9D0TzrSKO7tuB5TDOCe+eMCvEfDZkyjQPGRjAXPBH07V6doN9DZqFvraVEfq0YymD2I5r5TNqCqLltddj6DL5KzUup0ul/FOBboR6xY+QHO1Tb8gfVevrXU2V9oOsyrLGbZZM7gJIWTcf8AfFeM65Z6fLqCz6XL5WGBAxgZ9fbFd74d8Ry2UEdtd28N1Coyu4KrHHcfrXh4rLqUIqrQi03ur2/r7zupx1aW/kdxret2dlYqjySkYwU87zQM+nt7Vx+o6B4e1exkmSApcYID42gn39KpXd5Z6jrcZjtUg2nHzHYrfjXf6QNItY1iuoITHJkMkeG5+tcNnhFFptSfyNJQjCFrXPANX8FIY5XifYinG3OQD9a5G68MPjYkYcsccHj8TX0Z420Xw/ICdKvNRtbgj7ggdoyM9+1ec/8ACJa/eyk6dbS3Jc8GJQM/Udq+nw2YysuaS/rz6nnVsPTkueMWkeXx+Gr+1ucxwIj/AN4Pn+dQalo2qXQw7RlCOCyheK9A1nwb4t0tGa+srqFSu47huGPqDXOPqU2nJsktjLNt5JJ5/CvUjiJyfutNo4JU4Wu72Oa/sG3ht1S5tJzJ/fUGsS+j8hWSKMpAD0kHNdm2oC+lPnTTREtgohP5c1KNLsJyBOpEYwTv7/U+tdMK7i7zMPZKWkThbXTprsZt7WUqTjr/AFrU03wlNJdBbxikeMkrz+FdVd6hpunW4itWiAGCoz/njpXOTeKNrfuYkznq/cfStFWq1E+RWE6VOLXMzp9H0eztptlnA/PUscE+9ac8UGnOJp44xMBlVRixArF0TVJruNgkaxju5PNbEcVsWJmMsr93UfLXm1XJS99nfTUXH3UZlzrN1ctsjhmSHOPkOAfqfyrOaBpHC/a5Vck/u4lyF/HvW7Pf2lqD9ntGmlx96dvlB9gKzI/EUNrKWeNpJ34CIAFHtWlPmS9yJjUs370rgPDs89okSiWBWHzO5yxrF1TQ7C3CxzTEbeTlgWJ9K6O+1nVL2yP2SKK2t2HLHj/9ZrkLaGFHDXjfa7mUkBM5UE+tbUfaPWbt5IyrezWkV95Q+z6L/wA/E36f4UV6f/wrHUv+ghoH/fa/40V3/V6n9NHn+2p91+P+R4nSmkoqE9ACnDpTaUU4OwD+lTWxdJA6ZGD17VXBqzYMRcIEYDnnccA1vzXQRWqO28JXjidWkj8xCecLjn/Oa9Mt7iIRBUMgIXIUttPToOxrgNCiOwMm2JjyVcDB+ldA8soGwSqsgx8j8Z47GvDxkVUme1hajgjSEkdzdGGaQo4Awdg5/H+tbSR29vbFZCJVA3AIcfy5rj7C6K3Q8x039Tu4bHse9bl7fJLCplLEgBiwAyOOlcVWk7qK2OyjVjZt7lrS7wSX4EUsTRqcKrSjP+PrXcvdWkkPmywoJFHGy5OR9BXlFlJFcXDFFDDGD/Cx/wD1cVtMyWwUK6gAcCRj/McVy4rCqcl0f9eZvh8Q1G71PQbLx5qthuitYY5UxgMrgt+ornte1/7XeJcx3d5YTKD9wbFOeeduPzrjryVzKXRkcequSfwNVruWURhlEjHnJOTj86mnl1OLTS/r8jOWIUW+Vasl8Q+ItUUu02pyypjBbzWbP4Zrzu71tpJHkNwytzjGc1s6rd3bBy9mWJ4yp5NczDZSXMwSd5ICScDYePxr38LQp046pL0PIr1JTe4aZcW0t4JJp5RLkZx/Efr+VdNc7jCoiaUpjPOBmqdn4KaR1xeLHFgneVJI9+K3JfBH2S0Vxqauh7MDV1K9HmXvChRqyV7HnOtMxlw0TJtOCSetZyKXkVcgZ7mt/VtAuo58RuZsngYNTWWgTWoWWTynkOMBjwvua7faxUdzjlTk5Gt4bu3t7ZFVlk247cCt1nvNRkEaPIq+pG1frVvw1NBEw3QRzOB1xwDU/iDVSWJkCoBxhSAAPSvIqVHKrZR17npwgo07uWnYrWfglrxGeW9QKBnIbj1rndd0iw0tyyXAaUHr978ahfxFbzOwkl8uMf8ALOLJ3GsfXNaEsQghgEY7lmyxGO/510UadfmvN6fcY1qtLltFDzqtoiFrq5uLuQdEzwKz59WV3BihUIGyqAcD6+prG96crlenHriuyMYpnA5tnf8A/CxZv+hf0n/v0aK4HzW9P1NFbc8TL2cRlHaijtWKKCiiigBafFIY5FZTyORUdLVqVmB1+k+J4VRI7uIoR/GnT8q1LzxFbmIvHLHPxgAnBFeeZoyfWsXRhJ3No15RVj0rQpoL1FxGFYcDLkfhVy8kWAErNJt/utg4rzWz1G5tARBKyg8leorQHiG6dh5yoy9CBxUyw7crp6GqxEbW2O70+6lbDRSQKxHBYHGPpV/z7rGXaE45HlnANcTa+ItOwoe2lhcDl1IPP9aupr+lY42jfwRsI/OsJ0JXvymsK6ta508uoXHykxRmEcHL4P4VIuuZAjzIBnhQcgc1yb6qlxJ5VvNAU25+YjFWbW7jWQxyXCBgPu54BrOWGjbVFrEO+jOpg1Ywj93AjMSPvL+dVru+nuSxMUJXsFTk/lVRZbdh+8giZl/i8wD6EVbtri2hb5lkkLZJEcowOaw5Ixd0tTVVHNavQ3tBu7G1VGvrKYv0wpAA/OofEmr298220szGO245IHviqVxc6ZGu4QguuCFecZB+lc/qmv6ajl2KjB4WN8/pWVLD89Tns7/15m08Sow5LqxM93ZQu3nzuZem1RnH+eKp6jJZzQs7LJIo/hz/AErPm8U6aqr5Vtu55O3BrPv/ABWssRSC0EeRjOcV6caMt7Hnzqx2uQT+J7uFfItFFvEvGAOaxrvUbq7z587uD6moJpWmkLvjJ9KjroUYrZHJKcn1AEg5BIPtRmiimiAooooAKKKKACg19p/8Mq+CP+gr4k/8CIP/AIzR/wAMq+CP+gr4k/8AAiD/AOM0rgfFlFfaf/DKvgj/AKCviT/wIg/+M0f8Mq+CP+gr4k/8CIP/AIzQmB8WUV9p/wDDKvgj/oK+JP8AwIg/+M0f8Mq+CP8AoK+JP/AiD/4zRcD4sor7T/4ZV8Ef9BXxJ/4EQf8Axmj/AIZV8Ef9BXxJ/wCBEH/xmi4HxYKXNfaX/DKvgj/oK+JP/AiD/wCM0f8ADKvgj/oK+JP/AAIg/wDjNPmA+LTRmvtL/hlXwR/0FfEn/gRB/wDGaP8AhlXwR/0FfEn/AIEQf/GaHID4tpM19p/8Mq+CP+gr4k/8CIP/AIzR/wAMq+CP+gr4k/8AAiD/AOM0uYD4szT0lkjOUdlPscV9of8ADKvgj/oK+JP/AAIg/wDjNH/DKvgj/oK+JP8AwIg/+M0cwHxazMzEsxJPUk0DNfaX/DKvgj/oK+JP/AiD/wCM0f8ADKvgj/oK+JP/AAIg/wDjNClYD4sor7T/AOGVfBH/AEFfEn/gRB/8Zo/4ZV8Ef9BXxJ/4EQf/ABmi4HxZRX2n/wAMq+CP+gr4k/8AAiD/AOM0f8Mq+CP+gr4k/wDAiD/4zRcD4sor7T/4ZV8Ef9BXxJ/4EQf/ABmj/hlXwR/0FfEn/gRB/wDGaLgfFlFfaf8Awyr4I/6CviT/AMCIP/jNL/wyr4I/6CniT/wIg/8AjNFwPiuivtP/AIZV8Ef9BXxJ/wCBEH/xmii4H//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The parasternal long axis view from a two dimensional echocardiogram in a patient with hypertrophic cardiomyopathy shows asymmetric septal hypertrophy (ASH), with typical thickened septum relative to the posterior wall, and systolic anterior motion (SAM) of the mitral valve. As a result of SAM, the left ventricular outflow tract is almost completely obliterated.",
"    <div class=\"footnotes\">",
"     LA: left atrium; Ao: aorta.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_23_27006=[""].join("\n");
var outline_f26_23_27006=null;
var title_f26_23_27007="Level of care matching";
var content_f26_23_27007=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F78806&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F78806&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 541px\">",
"   <div class=\"ttl\">",
"    Level of care treatment matching according to the American Society of Addiction Medicine patient placement criteria",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 521px; height: 526px; background-image: url(data:image/gif;base64,R0lGODlhCQIOAsQAAP///wAAAMDAwEBAQICAgIiIiLu7u0RERCIiIpmZmWZmZt3d3TMzMxEREe7u7szMzFVVVXd3d6qqqmBgYODg4KCgoNDQ0DAwMCAgIJCQkBAQEHBwcPDw8LCwsFBQUAAAACH5BAAAAAAALAAAAAAJAg4CAAX/ICCOZGmeaKqubOu+cCzPdG3feK7vfO//wKBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4iJiouMjY6PkJFJFQSVlpeYmZqbnJ2YFJKhopIDE56nqKmbGAKjrq+JA61ZsrC2t4C1tLO4vb51uljBv8TFa8NWyMbLzGDKVM/N0tNV0VLW1NnaSsMOBwEBDQU9B+Mw2Nvp6kDDEQwiCQdQ6Ov19jbtDAskCwzgEAXKBVhQAByCBwAggGPgwEAAfw0QlnMIEaEBBOAClKB3r6NHFt0UNHiYIKE8EQUQ/xgA8CAigAgAGQJgUMDhygMKAEwMcDNngwgAHG7k9bGoUZBESSQI4ABBSZQnl2ZEoCBjAAVCASjIuVPE1gUDg2okwfGo2Y7DAMJr4ADCSQABRbREiFKmiKxbddYcm1cc3LEjyp4drG5YSoMr+/2LizJjToXgEuDlutdrTqkYhxLefFQwkZSaOYtGm3RJwXAryZYezTqbZ26rW8tm9jpJ7dm4Rd0+sju3b0e9iwT/TRzR8CHHiysXVEqV8+edWC2f7ooS9OimrnMCRb27veTew5MWT/43+PLoXcdOz77z+vbwx8efb/Q8/fuiKFgN4AG//20YWJXBfwROM4FVFhSo4P8yFWSkwYIQEsNBRhNEaGEvF4BTwYUcwrIBONx1KKIkAgSAwYgoShLABim2CFwHLsaoSAYcyGhjGtZpp6MqId7oo3DZ7SgkJ9L9aCRy7zlh35FMqiZMkk1GGcOSO1AppZFW5pDllTdueYOXXMYIZg1jhpniMFIFgIA5PPmQFQplmjkimgig5BcTccrZIZ0jFPAOT2At5EBCGY3zUGQAKBYAUAmMFEBljYJjjgh56nkhn3dp1KYIYElQQAP7lAPAo3DVCQEELDVgwAFAZapTq6FZKiucRCVQZ12jGvDAN5HlpVeuANgKgFMiHCCZPwc8IJQByNJFKZSzmonppyXxpMD/Ow4EkEBKDjRl6ErCnsrSpglhBVi5TkarbmC1TvUUTwaMhFECDvij5rfB1qkoULweJFS/zgJQ6boEDtfUUzwMTLB/vWX0VsLQLtykwi5QLPF8FiN18awZr9Dxxul9nILIIJNH8gknl+xdc0O2nEmRKoeZY8sYBNlyjzHnjHLEOveMD88+Bz0l0EIXrbHRSH9JdNJMs9v00+csDbXQFgwwgAYXDMDi1FyXoIFVW3cttgdWSS12zBlYdfbZFmQ0wNpnBxjAgHB3fWAACdbNdYMP6s21fv35zfUFGwo+9QY4Gy4nBQI07vjjkEf+eAWSV25544qPSAAGVnfu+eeghy76/+ign5u5hZVIYfrpEKYexeqsK+g6FLDHTuDsT9Ruu3+4O6H77vf13sTvwM/XewSODVqDUIypQHzx8OEuAags6ZND8yk8Dz170qtaAmQMrQmAAw1IoGhOARW0VKABfLOSQ8qLoP326PXuZzjj+DkoTaCBBkFOC4hISt6nEcbkxVcjmB/9yCM8uZSvKslTFQNKgpGMbOskzMMgqMJCAgUuMDy4K4ACBtUSA+iPBApAAFvQ1ScMFvAdxWIAqkrgwQ92B3fMKpQIIKOtRJEqUfYaCGOE0pKrAEAC5EqgDfHTQCFgT4lLpE8TgRBACZyghlFUzhSTgMUsEmeLSOiiF30Dxv8jiHGMuCmjEc6IRtmosQhsbCNrCDCBy9nxjnh8XBzlKJoKkO6PnsMaIAfJxxalrJDlOSQixaPIRa7MbI50USMjOZ1JUlI5lrxkbihQiZoRoHCaZNKErFKhUDYpQxkBpSmNRACrJG6VNioROC4AyyZlJGy1/BHZAgCjXBopbXv05X/a9jZhGkkDBDCmkSaQN2X6YgODjKY0p0nN0XGumtjMpjZB10xnGmEAGcijOMdJznKa85zoTGfkLgBJb84gk4+AJyLl2Qh68tGei8BnG/UZi3a6c2jF4ecYwfOmJYiqBQUNQ0IF6kXDZMR6L8igQSe1goQOwaLZS00SXZWufxL/wTC3YgCsEBrMGhyUBRgNQkqvmBoULNSfHq0YUUDjraBUsCQQ7OFFMgIXeRzAXgAEarAcVYAH2GuG8HBMqTAiEx5SNH0DAV9DNJIm9KnwIQ4w6j/+oqaApWQkMuHVAZpiEEJhlSLheEBOwWIA9jHkpTH96EyVCoAGlGR6KHyHXyR6AHk4ZAH/S1REWNUnGKJgKQ5IyQLIty0EhOqpKoGLTGhSUMRyy1t+GsFcXoLUUnVrTZel7FhOKNqeAOu0PpQAXOMqBJBq5R3sAwdBHOXYsPB1HGBZQAUjk8NkAZYkSgkiQU7iFF+dtKdesYq5giVcxuDktxNMk5pI4Nyt5AQu/8vVinInc1qe7MqCq2UtO2YaUp8grFMvqZNfCoJcUeU2sCaAb6lIgACgIHG4InDKZcXXwrrETyj1PaIQ5RFAhKVksyaIS4H3u5dBnZCjeQmAFXN1rfFpK7zi9YFrE7WmnU63X3WSij/ai9uBKGogADtND/tkkAHnl14Q4S9URsBDyRSwxQTJCKpUXBIVX7cxW9UJOMZar+nWmLsQZGu81HRh0zE0i08GwhNdMGUkRHmJV/ZBlVmw5W/CNMO0CuiXwWyCLDNnzGTuqG/MvEA25wLNaX6WmOOcsKxt8854zrOe95xNDcA5zhZQp6AHfccLhJPQiE5042pE53j+udHEcf8zpG8h6UnDotKWdgWmM62bR3NaNpv+tCP0Y5XAiRo+cgMH3U7dnruBo5usRk+DwNG3WLNnlAEopa3Zg0pV7ro8HwrAK3/tnRKdiNjsWRGy2TOAXi67PDR6trT9NoD9WPva2M62trfN7W57+9vgDre4x83tZFo61JB4Y0zR/Qh1e5TdjnD3P+HdCHm7k96MsLc3RbZSZujbmQ4NcgkOulEUHPcE/XaTAiW6gi5f4d/KdK1uKVosirPg4CZIeA80nuCHqQHixtzw/3KagDQtZSVSRWtETN6nq76VqkpVFKpSzuQGQAYo51sqVit4q7tUsABQXZ9jPFySchxgTfIguRb/QC5M17YEYRUmuAknuxfTHpzBlWWKWwq7v6oPSx5LQVcAH6BYxlr0TqUiIHLretcG6MR62KtwFpjuy4Ab8VNllXpOr8Ldq58EJ0JJgHCJldyhj0VUALbKBV+c0Nz2VyzIjS2KzREXvE937uae9IZTm95XyW/q/+ULV0YaebsC2L5RfcuDIf8roch37U6BXwnQPsQXisCuJDhoQNAbgZ4/PPOQ3ryQ1RTiyLTpyKIPFqKAHABUMQ/HMjdrkysO+RPjd1gwvvxdiFr7VPGd579qr0F8bwW651JhDs+G+WuJfo+vY/2wxPci4L9K+SuC/qa0fyLwH0r9I4L/muR/hwCA/5ckgIZAgJRkgIWAgJGkgITAgI7kgIMAgYskgYJAgfPkaXMEfI1mgYGAgYXkgYAAgvekgaNBgnIkgn+AgvvULgbBJi2VAwWnDiyIRtOCduJRgwNVKz2XWfBSczcHROBgVUyVVUcFLGI1VRXxEhkhEe73CjrYUDw4AkLxgyuBAGCnEYE1dmVnV5mVQCaEAN1SWjqRExKWe0/oClEIZVOIKz9IfYlnQYzhFNBVLQbgKyLEXYcxQsWwhlF0g3aYFYinhT8GewZWJzyBdck3ArjXV77gh1jmgmryLgYgiOMgFNY3h9tiQUg4ZFNlGeQjKDqRhqMAiTakgn5gih+Ein2giv9tZoKi4Yr0w4p8IIvbA2/ksw8ugHGfJ4MxCAW2CD27wSsI00G/6FLPkxUcBw+kGBcHxYuoZQMz2ATBWDy9AY3TOAPLOHDFaHDmgI3HOAPZuATVCDzXmD8IUIRrlYSfsgAFholH5VZkpSbwCA5AkRJFKFjdEgABUz4BYXI/NYRCCA6VyBPa8lAOABPU9Q48hxDjqATluDvDAEGFmAKi0oV26Fn1Mg7uQBOQt3Ul0CnKqIWoUkIY+RKtQhO6lQAtQWLF4lep93kOQVGdglcKIA9qMQIB9pBJEJG2c46GCCx4eF0IAEMAhjDfxVtjcZTFsnjYV1d0ARMKIAFrsmM+9Y3/JbaSMjkWSakt2SIBrNIoD+AAOWWG4UiNHEhnQKmJo2JFDPYSR3eJWvgWFZYtNjYorleSiUhcCSABhtUSprJePtUq7hVVelmQXoEtPQQBdtUSbodYM2GWVOCTsTOMkcGWScaOYvgA0ydzSzYvRaYSGrEvhpiTtzcO94VcUhEPWfkATPWGQSEvPfQp+xNUBiGZU0CZrBNq2RI/95eWcUaLe6CbpyOcekCcmWOceYCciqOcPyBCv5dptyFd4BBRe7SN2lhS+XWW3mgC0FgDzGk4wfGdyIgD2CkD56kCF5ED5DkD4Sk445k/AvFbWCWPPOcQGGFz9jiQRLhzZTUCSudh/wUQfVL1Vf6pJvKocgihYspyU14hlw6xiV3lDeDgduVAoeFgcg35dgJJoKI4Au9JbURBkbuIjitBWpMikkvZJliofGInQI5ldrpTYWgHkpLVdYoYkhJmE2XImS2Fe3jVm2IxDpsFE7JXcUcafjrJLzAJWKpHdSQQonoTn2u3dwrQlTbGUYM4LIqniRZlebWli09ZeENYXVmBpZMhLJyyHwQxQ1khXXWCPH4hKnI6DqJClkpVmFpJpkYEosCZZlTKGKtXl02Gl4cnlyw0Y9iXpJzXe3U1KTa6egpmekzxWhaWpVpxpeSCeyPAABN2pi5RApy5ACc1qoQFmQxAGT7kpP9cdwJSWjeB+hZHJpvZJ5pwOJrNxZehmXvjF5uS4qGXqWPj4w8qQat62IQedhBux1FcxXd5uhcCuZr2QhW/klvAumIi8Kpwg4rpRwMRQHpVoK1rw62kKAfiejbOeQfnKjbpagfr2jWT1J7GKArvyjW7oWKRJa8lGo0owJP/96dkdq+3cgCdxZ4Wl1H0CrBgJrAi4JEXuRAOWUEQBENSJX34Ahlut6H+OoAKm2ETKZANNxV2WlT8qBXyQCop5I6JSHWK9SuJ6FgmsJPcOX8dK14MOy5gWQBqup5twhjWolzG9S0IhKcCubEHWLOsdbM+Wg6ciRBb17MnsbLx85Yvq4v/qIqbklCvU3OvVjGyXMUADnmiUYtyFlRkDSA+bcIroDKtWBsJWgs17VoHb/s0cUsHc9s0dTsHd8s0eWuuSBtXW2K0ViC4ZLC3ScO1CyGm82pGM5t7WMlSdvu362Y2oDET4MqvQ7Cx7Um4Y2C4SMOwNXUaB5ErCXooB4Ghbkd0JIBWo3saYLtWouuQ9lJyFiQqGtu4aeC5RvOxfaoCPpYqCKGQ5KKiTgsBSQqky5opxdu0JgssRYoqpAIaz0hRMhu50km5dVJhcJoraDpacYo/kiemWZESO4uI4GIV5psv4XehZYm5bqC7RXOzqYpgn0eomJqqmjUQnFoCWTG/Jfu0/1ZEv8AiLISlF1frvm0Av0JzsxP3u/BirA+1AA4hkMm6uhH8tQiRZA4MLsWnLeWgKNTKuWKgwEEzMOnJer1Awj5jwl10wjR7vf+hwj3Tt3EgwzrzZM2Th8QjwjCgr7kpue9mNtJVkQ13Et16As2jEgknuD48Ak0cBTacM7uhpjJwxL6LQXWyxLh7A08MjEA8b0Lse/gZDkG4L+yjAHGxZI0oVFVVpXJJrAtqELKLKFUFFhbBFA/7EA5pK1vBiV38BFEcM7xLxCYwxDzaomEnLiZpxPLgF43iDU06ApYlD0LqEMvrEsKLjkqBx49BGcx7k6NSsFF3sJgHwzNAxay3pf+EZyyCegCONyqkmpWClxH4VQBu6r3b2ybCMsuyFS+OVw7le1pgqqRdEMgqM8VifKgfeZhfGBfrxRZ6GmD3FReeylHzG6q9KCzSHBbp+Hck67Qnmxhn6Kh/7ATGXDJTvF3KXI+L4n1o7Fcj0YhZKboD1pKZkrjNKpnCQs/7cHLU57phWyy9Ws5oacpj8K1Q+MX3Bouccc4gQ8Nw4NAbA9FvINEXQ9Hvq9D7RrkXzAUuTAMEfQQWLTHye7mAENJGMNILA7riE7vNqizxnAB2LBaJJcejYivuQ9MkQHMV0Sh1kUEFQaqeOCqzqxMVdHThsA8ufSjawnJYoNIEM8hcplT/z+ujjDgOj4wT5fK8oWwZmbqQXcejOMFYbMc8kRVahqLJjujPa8LV0VsnKF0EUL0uDKu96EvFrzwQvjwQuZwae624VqqHB0CVkGdA1wWdugzXiGrA6DvAir0Fc60u8nul2GzVpwkXK9TNwLu4b1ewq8ddYCE+DEe1HNx6hyrAie15S6fRAIe9nAJaSsWgavwU/pzPqIVEx4h8Xq0VK8RwwzdWjm3a/6xUqb2apXxuDK0DVuy2rB1xyY0DVUQMkR0tGJ3AzR1yzz0Y080x2X0W2y0r1c0G320p4b0G460n4KRo6r3e7N3e7i0AppBp0MRn9F3foSNI9p3f9u1r08YG/+Xd31zw3wCuBQI+4E9i4N1R4AheDd294M2g4A7+BJy0OabA3xE+GrgGDrp24bKBShrC4WnkSiA+G7IUALQ04rNxSyg+G7vkbCs+GsD04rJBTDIuG8hU463BTDjOGi6+46Ew3/od5H8Eaz6OBun93ki+Tg1e5HLlBhC+sEsuHFHO5EEQak/usVOOJFSuBlae5VveA/S03ALj5V9eJZIoY1fsnaQ8A2J+5Tbbhp+y5kjQ5mRe5lrShpJlU4gioAGBur8C0Bzau/LDx+KTW2nsoMgDDgHj5kmL50KBvI/aQknKtCULyo74Vx00Q4XuYpB+hmVW53auNErRg/rAphyEXP91asC3sp56uribPlzhu4e+yeiAC+e4t7+RrqjjEsvMu3WtDobFgj6c3o23V4y0PrmbbBBPUcFL9igBMcFGlMdgW62nfloT7A/4layhiFVqFuph0OXeTgbgHu5iMO7k7gygrmHpfu5R4+Trzu4y5e7w/gXmPu9bMAB2JuT6/jl+Zu9dEGhJLgCGFvACwGj+fmYHnw7HTh8E3/AO//AQL/CHFvEUX/EWP2ywEAD7vvEcX20d//EgL00aH/IkX/JWgwHXrQjaiQcr7wgt/5vF8PJ1IPOLQPMc6wuMUyKNQ+SHkPMBsPPN4PONg/G20DgTUEfvjgYlDg64lAhLr2zMMGv/GbFqxJBqAVBrtrAfSa8FWt8MGS5syxBsGt4Lu1SdjlD2Nl8IHn5sxtABVmHhowBM/PEIcm9qzCD2Gy4hIo4LbaNqj9D3czMNbv/hzIBKbI8LX4M3kJD4PB/z4GDwxtBKUN8LB4L1jVD5rmHi0iBLPW4LDZL3jPD56jf5zPD4v6AfcJ8IqJ8NbdP5xeABJ/4LGED0iDD72mD5y5ABKZ8Iqa8IvV8Mv98LFtD4biAALnP8yF8J6zEzyd/8zv/8lYDxEw791F/9QjJszG/92r/9nRD8K0AAA8D94l8J4T8yNjP+6M/9MGMCAoDy6f/+2r/+ZHH+8F//yD8BxQSeu3/c/zsDAoA4kqV5oqm6sq37moOQCgN847m+uzLq84LCIXFUCxIIxSUxmQIyo9KpCGo6UrNanpXU3YLDKOzOKT4DzKcvug1mi8juuRYOp+OH8pw6L+2X3PkN6tztESLm2M0kNuIc3gA68kiOCE5iBjKeQGZ6Wm5qfo6WdL5UUhkE3BwU6KACXDK1wqiSio7Z8AQYFPHePoV6CQOD/cKYuvSpKogwA9CaRLvYokyPXI9Up8BaHQQsiHwvbJOUt2Rrr5acY7tOGuqOBCCIODTUqxy/7Jf0F4P6EapAgIIQTkRLh/BdinZo/gGAuCJZi2UFHQBQEKBZEYcqFFZUIpDEtwgAFv8UDFcEJAqPnuL5CyABQAJ6KyTq63UCJ7BFJArUW4CAoTtWRE+4xMMzFxKRzgK0usegGa0ADAomgOaKXkGNVk8WtOrgXIAECBRE/RaggdaMDFQCsAUUgVgS3UIdONDAQYRxchHQZTB2FdCCDK7KzBg267UCrcquStCgYAFbD4aS3Io46yCYJKAeAMDgQFDEJhcg/gXB8GBVZgsieOAVHEF6DyIaQCvO5AjJlAGsFqvgILQIqLsCcExwQXDBS3yOACoCgoLZCWpipVU7dsTN2MuOQMmars0REcI+MEA+Acrbqsauj2hWgXqs5nhBNvAA8UFeDhgQxwJFLFhkVgFoUbX/lSvSVeWKAggsgJJOYElAFnGtvOeObvclB+E9nIlwF0loSVYTOYR52EACf0UYgIOhjaAAA21Fh0AvthzAW1wBXDahOAp2SIhn8xTQgARD1QPBQQ80YAAEMPJSgHMMVOZiCQiY9AuTt0XQnwEotQhXcdFNWeUCD4BD3UkNPABUL1JiROVzxFQxUD1Mgigjja1sCUCXES1YD0goVbjOZzOJoCIAErB1QDNqKspoRMRFypY670Q54zwSyOnCgCtYJBSPjrb1i1mlvgmlfmqVRZZOtJzXgCt6NSDmjsnBiACIaTgVA14K1ASBKifiKoKucqlabJGw0SiCY0/FddUB6a2l/2NRpubjx5AilKVRAdLpKo5ZnPEy20bVODBbM6aGZdMvrUTAkTbSytZugvECQB5WzyoWlrxDQOesv8lNZlNCBXznbi+nZvMAqysaWuNGaLZLTq3giBeWhGBVrM48X67GQFZraeqpPK/0OuyzpFa1sKBbpcptbjM60GrEuP04ApoL5PigmMgau6uI2DTT5LBA5wtxsTg7RqifL/8EYznUqWKArCW0TFO2eWwrH5MOSKckAGg6uWSmGEFLUwBxrjtTnx/HhQCbKFAHJwmSNQncv/zaHUXAQYrgdASC8sbn3HAzbK1bANQMMdomqKgoCYDBKLnMie7q8eXO1lPWaC98qv9CqESjqnXp/PJiNVdKf/ZqlcjR8uBt0PIb7ghDiyPv0YTlqjTqMasFWLNL4wgbtWM38G/Wp3ZGZxwny1fjSaaNHZhqi1VzHD3NeLVAbRvhLBqMJBkP3GLGwqg9beMHB14Rf0uHDWz1YJeAdgNjq7b7cU1GVwL/lYdxBRNMfcpTE50UsHMIJM/WthGl8/nnMI9TQei40SuAEOiCw8DgKLpGiHv4qCfOkwUH6VBBFMCihHbRYEBUiAkPDiICJQPI31xIiBOeIIU2xJ0NEwHDHuKhhkDEAw5NoEMX8nCI2nIeAIqoxCkI8YltcOIKVYA0E/DLEUnMhHpeAJKluIAnP0z/AUt6eKAgRDF8UlzBATJ3AyrejoUey2IJ6JgDMKIsGJnZSQhRYEc+3soFCjjKHGH0xT7iQIxMNEU6DqmCPwaSBUmB2ySvhEgYpBGPUWOBRDSpxhT8opLh2QsP4BgiOdJufHVUZSK2CEgieHIE97AVFg1JyM3t4pKxWCT0WFDGHIgSBrHUxtYKMULnDROSYdTlHZnpx3/lwJS8IkHGCMi7OoYlNLVhwG1IUxBv1ipf5UudVdbyAAeoxVI44GFVNjMbnn0TbLVagIqe9b3LGM86q1Cdog6AGI7Yz08BSg4DhuUvfyJHfQZQDmS6UrPZJUoC1vkkLjgBvbKcJS0FaZSD/97SOlVc5XDO0iZgxMJAaMSzSBFSkS20B4Fqpmsx61DLAQYT0tkNUgh/U2hNRFCd5JQvcP7SnuLIedN3bpNaM5kKzoLDFgbWCyurIOqObmosZwqol5FgIaGuOLZfOAZNt9FNXtTWC8yMAEu4qRo06LM2SqDSG0CSDlgR4ID/uEKGcgorRNQaylVcTTLoDM2wRDMTSekGAlVaWlmH9SSZuelua6OSUBLAJBLoSZE0uOiFqvS4Vmzoo+/aG0kX8KFqAOWuctKrK2zx2BI47a8dUm2VekGqmk3QmCMZwWt50dOMKKBPf4oOjMTGJB+R07br6oVYMxIaRvV2oRAygV9vtP8K4xpttIuaoQ6k2QeHYe+avcmHY5jXRVpUIyrqWus6fhqrW4ZEj9dyGc5+mhyOIEBT5c1WTJHzVzBxi2euANNlGSeTHEnmePyiBZhsFyUYJSA1C+iSAo5UgIMsS2Hytag/XOentcyqAeHscDXsO9KlHau9HDljvjRlC9uN7WE4s4V9D1TiZlwYYMecHLkM8NvqJGxrteNMG0Xr0+WaLm4+fStuTNxf8MnWdm28MXDgiwytwqAPemqcV5v7JC+HBr0zRdhbmUrOI+sMHHyIK15gZrrEpNYBmOkLZviqk5qwLSIzscXVioTOAYMjAjqCgIqYxBa5aIrBaTLbQnNlEgn/gINJSZKV4BS44Stc1MMi2FnPpmtk4G5yyBmK85xJ09rrjm/L4EnMX+46FCozAFFo3DFvGT0s1ARXpD/RlHH7cWZQJwbMi0JAWXEDFJXgWTRtu1WvDXBj3ArBuynrn82WFiPDaNMw3Tz1j7R3FvYeWRXIWfOll1eP7tEUbHZFUwLsiR7EfNsrPeUnYwBNT4j6Wdm3YtJGFH0m6zVaYFwJx9UgHY7gWXq3HG7dj8QNvthx52NUJi6K/3cVQaV03dV2qer816/fpvvGBdYprTcNcJQ2gKnf+xe/FUDVT/+0e0lVxTm//a6Nept7Up1eQUxy4xxHG8unQGUPXZkITtGQ/5drzIGgiZDGpasg1noQujKIvkM2Qz2ISs+6G57OdSpIO+tG/3odtk52MXj97EwIO9THrnYpjPHtTEi73KfeFLFjHQflCCYOflkUE/Bdx5vNgTKHaY1bBl6YWM2Zwiuq+BMosxY3+zsTIs+OyRuB6vFte95vsPeIJZ6Mi2Uj4jH/gsDH/WN8YyXcgqCQz8PS2abfY+M3uIJnHUMilqeG6a/h9xaszMppW3gZrI7EzkueQ1L4/fA0F4bUb9LaHRbC62cfBE+yhO6t1z3r9d574e9g987HNBIGkITzoz/96l8/+9vv/vfDH/3mv/REEQq+AoK+nLFpKfW8CRW6hNN23P9G+yyWS31HgpiDvvBcAJiE/4FTi7AGjvwTTRQMUWyLpKRZ4/jLXIiFQlVNQ4FPp0xHvJxP9V3c8dAbNJDHA5pPB6aG7MUNZdSflf2NCAJHBDjGO5UTeHxPmDlGSdkGBm4aj4SFNVnDBNJCyHFFAwSHz8VHD7aFU8GUS0iTAMTfFV5hAGDhFrofE7GBnjQWOFzN5w2gsFzXkjRJWR1QvhSAcCnWdGEIqpkAnl3DGJ4h8hiAGv4CWlEIjhAWOOTIGpidgT2AWXiPl/BNiiRAdKkCUeDZn5CKSIFh6ZUhn7mCYOnhWX1LmTAiYBHSJF6a7YkAJBZNm4RG7gUK2RSLP4n/CZY8lCECXR/2ntk4zLfYFV6xFbGpDQBUiioG37HBlkxQoeY5gvWhgRVkGNSAiZrBXoe8GJHZD7dpRZDZVxwmTW9I2DQA2DOKi5j9CHhhBY7YmwHQiyiSHwlQicgMB8ysXtA4GAzShIQxSrvFGlskY/OljZuAg5pFhIAFEmjZyzsaFFzcY/aV3KLUUz0WS+65DPMEH+OsVzomwDqCY7UtBLdEY425Vc4YVLs4pA+aWEWyDvHdgjGeARRUWluASZ/lnwhMhWsxmjdqxdvMlpwt1mvly6MBIlGwJHDEpDSCFs1Um7/x1r90TZEUzdxkyoklTbNVg1oZHC/WSpG8VGIM/04UqlI1vKQnEsyf/eMmPo5TciWFPA1W+krtiZj3MOFCIgq2CBstJJvKJY9UyoZQKo0qFoXBtQKpjZ43Ws5b2qJKqNpd/oM0tYFJoh1ezI9KggN2XMV9GAaxUJVM3o9DhdSrTRV/bMdOSlY5LWADAmVlUJvS+FvwQNQuDR4JqOJV4kbLDRk+XQU8bmY4PFbjoBQ9QE3eqENk2kIKUqYrtI9lAVxvViDCtYVummNy1iYPhkb35I9XfA6DwVszrGY9dFy12RGrzMqsxFN6cVsC9Ut0cudaXKfvsJ5hPgQikFDdkVxqToIEdB8hwKcg1l4iFFQm3GcpEGMjIObzMRF7vv/PIAKo3xzkgC4Bep5Bf77BfxrorLlng85JfUJoECCoGCjoFqznhGKSgGqog9Jnh9pdMVxo2dGeFoifFBieInCoJxxDFy1Fij5eC53lLWRRG1neiYafKlVoGIxoFsiVFfUo5MVnCuAoLrWej67oFKDWkOaET7kZKC0eU/KDj2gfEURDivILPYENkxYpRd2eju5nIgQpFLUZkA5Bl0qfDsDoDUBfR4wp3MySlzIcFfRDlQ4B8/kRjJzRjTKpENDRjhqDeuLFBG6IrpwUNqwgAIZDUgHVN8UgeLQCaRxgxtBHfKiDa/DCfhgEbvzHQM2dgDIqRulOfDigot5mTTGQu1n/xW3sYFZMlKlAyWY0Kne0qjjZxnDsxrOkoKhC1SftFPUwFFw0x2AAYBPyz1pch0x9CbCWlGDAVO28idy4IHJwoGBMKo/sSM3YVko9xgFKH6BuwZsSKEnQYqGOJDaExhoORXOhhS+GRqVAg0f1xtrwC7xeCmTNkEzY4LgyRZqN1Sl6KrxmIhvGGZUsKbueYqBg1oz8gtQBCsG44cPGj7FEwLDszLME1l4EgKdWV3LKqE/iYWSRSZzUVr6kK1diIqaUTcgqYnjIxLMgXU0OhZrc27F9yLyi06MsV8Haoo/g2Z+GKSKI66fSXrf0Tjv8pnkZ6khlTEpEQ4RpzLM0LT9G/xIvMIdVjEzKkWi/ioDSftLU+qN3auSSem3+3GOmqtNfBRnOmMWT3QuOHQCA9eMvuK2vHqSUtRsrmctGtsVABtiVqgc0vubDPItiMaWj6EtZDBnUpoTVAFi5rNggQZiEAS1ADG2E5iVtWCdLMVlReCeYCZvl0AhU0oamiK7z7QNdRVifeihJCts/iO5v8uWoTQu2Pha2pCQvNN3lDA5Nsq2ulFkz4E3M9JnGLkzw2m3jNZsd9c1X3krxohNv8MLy9s5gOga0FQs9LSJpuaNOhgPlQNYtDkXteG/liqigks9viAoDqAgAbc1vNio3hSdhnVQ0zGbLgSfqLhQEGcB/OP8H3IGqtlEUeMJvurmvqspv/hgnL4hUWNhIo0KZy+Qc+pzYrvbCBNfpQVLVHwWnd95KCtaP1QLr0Y6mcgTI9xyE+nhP78ymWV1OuvENbKwPCYCrFlxugIIoDnPtLcTsCxXoKDjsJNRwFtyw0zFoDr9AmyLxCtjpEpMkKRSx4DkxFyTpFLdAE1tx5lku+maxij5oF/fAD4MxBQUtIURxe+YBmmIN+B1jkqoxE8RSMOHpGjOxGJ8pNJ3dENMpFzPeFrTjDswx4J3xD73xnKpplEZSH5eo6EkD+D1d6KUVIkvSGYNdGQ8CJVPxHPyxDgTy1j4xxSkFIssxGx9eHUuoEHT/kZuSgh5PASbvwI/W6uSMk3eQkpRQk2lQarVihAB+4K4Q4KliBFdshGFwjFj8RWDk1oZ+MRT6ZqKuxfeOk+zdFDpt1H2cIG78mAJQ81pYszm1BRTaHzSJqkZxc+zIq+OZo2+4CP+FhTSb0zZbSk5p6sYKFkGpQrH2XIdMhmDUb3cuobGqMymHKDC4sm5di8KegF8pbLjAGMgeVyKaVqHNTZc0Yh3BoS3S1sP6zMYIVaF0SES7URIPorvy4iXuxcDyYU6yl3JlyOWVITarWEvfh3LNJJyF2R+KycY2XOeC1pD+TSBCCwRoSnK1lUxDmy2nVVak2FmdrMyOHs/mYlMD/7UYsDKK8nHpMI89rJfZHsCRXIng6mnvBFk7VOOBRC7TqIpIIk1Ds+kgfqTccqZ31u2vuReIKR9d+ZiKfdjVaM5PtcJHMmZOe9h7QUNahuLHkiNUHI9A6jVhA93VigyueLUHI42jTJyNjdkHlyMYVHUUFLQXz1eSdS3y5o9UHMXy6lfv0GQ78CVforXMDOZah3QYP2joLshJh2ZcLtfEfRVcaOVuYwxTDaFv6zWf2K4PgoVg9zGnxYunzehzkwDV3CHZ8PbOBDHnCJCcUPY1ae+oiW9fSuN04PEUdDYcX7W53TJsIBnzRAAppTcDIs9GDBkE8y0JABA+jGdNvfZajf+mbL+ygEInYU1GP4UmBsNjdTjcvzicR91cyrnVuKWNXzsIbCC33G5OHMKOg0QcOn+saVoGXdDFgT/4xKjT93BGe2PEdkPwQbgvMKu4aYZBeS/BZ+NAhnqRQEOdEm8BJMOAmngyh6fAzqzA7pbyl3KQjPvCVQ8BpCWz3Om4FvC4L0UmhtoxZFoJDzA5CxRyHiA5LCn5GLPAk48xFndxlw8Bjbc1mCvzDqu5CpB5Fpu5EKD5mrd5mFfxGXTy+HFNldf582yxkBxxn3fNmvbdO+T58HEyjpvyh/Y5m4/CnIt0oy/6J4vBwexAlPMrdEs6DVuyH0B6D0wAF4r6qJN6qZv/evthgIAalTfPK7U2a7oYkrXQ23fYzwRqD9wuBzGFxWd2iGEgxkzMYHfYB2jHQKif+rEje7Ij+wR0eh58egtUgLJLO/thgLFP+7UnAQV8MVGTyhzSqyKCiYWXNAV6JTTgNM2yiciOgB06dJMcG0q8yMKWCkLXuPNEO7Zf+wCYH75PewX8eZ3beCbsAV3/C+PO8DXCy7/AtT8GduLmbTCGAzdCw8O/dkG6WVan+fFt+k00esBjwsCL+OSUb+/Eja6Nu58Btb/5uJSu+4JM94NdTtNYJdTkD7GX0BFJ+rM/kccLcabx9qwevO18DjsMeFbUj7+p8B85Zmbm8++s4mKi/7fNcxDON7rOKxHPOwK4gtCAYj0iUH2fW/0QdX0igKsMGejYD8LX13nYAxHa31CzZ7Hb54Hatznb95Dc+0Gcfx3e0wHdq7nd2xDfExHcW7Hgu4Hfgzngu5Dhz4Hecx3jowHij7HiqxDkTxHhT7Hli4HkgzHll5Dmn4EAYAC/k37pn3qqX93G60PHB/ooUIDpK3u1wz6ya7vGqz4KeD4Hgb4T7z6Icn4X5z4G9T4SD7+G/n4WB3/S3X7GLz+oGF/Os37zR7r0i87zV330U7+dZ78FbT+3YH/3n/L2H78VJ38xFD+Inj+Ejj8SU4AACEAAuL8FjDEHuP8FZIAAyD/4j/8A/QsACFyZYAHmiabqyrbuC8fy7ArCNNn0zvf+D7MEhkMC8IhMzoTEwEYJjUqBTOJzis1qT5rmZQsO97pEgfgMxjQ76LY7piay3/T6pHmt67We5v7Pc0fEAVgYJjhEaLgYVbHGCNmTQeQRaWniODRwyfmTGbDZKRpD4Td6elI6lIFaqBpg1Cqr8ho7OxsXetsZV7JbdzFk9nsbHDBMfLpRlHx5p9H8tgwd3TpdPdox5IttqD3RfaZdGS46Xn7JEUCN/qde0Q4WwBp/OV8POUCOD0zBjzXA3z9GAQcWIgDPoJs5CpUwbPjnIcQ3FgQOtDAgo8aNHDt6/AgypEiReYL/jDyJMqXKlSxbZuSWAqPLmTRr2mxZMsXNnTx7slQi4IKNoUSLGj2KNKnSpUoz6IIRlKnUqVSrWr2KVSiLqFi7ev0K9qvTFsfCmj2LFmsAoE+bCWhbA+7EKAOQpXg7VwxeFmvzSumLZG81wVDl+kVSd6vhw2zJMoYC+Ahht4tVTH58JPGKy5iTcDYRubOP0D8+7zJtubLoGZpTr45imvTrGbJ7oJ51G0Xu2S5a31XNW0bs4Dxq89iNCjkA5cRR+NYNfIsB4ykKHAAQwIA97SaG08keYzqAAwUYgT9BnQbhB00etDDAYAgD9yrEyzh//kX+7tH5p4BABAQADgEBCwcM/5GACtbxYF8SDb5AHmjcuRChTnZBh0IBRDSg4RANsEcEfStomCAAJL63VoUtLLifEuKpWNyE3pkA4hAaImDCdDiyMJ0COQbgI1kGLOjCi+Utsl96M0zmQAANuLBAA0EegIAD9SmJ3oT3ablcf12qEEEAR4Z5pIFlZnjdHg9SeCYMMJrw3AmTSRBAgQDQaWeTT7qgIQMmIBBAiSusueJ1LUbxJg35zWiCnn+CF2YEKAZgpQJAunDooCm2+UeSjaHgqAkHpHlCAX6e0IAECqSJQAKABoDAdPEh4N6rtFo6xALgDciAA7I6+QCuASwgp5eXkWkCsiaSFuEB8QGp6xAKdP9I668fOnCgk9Pp6t50DlAr4rIBzJdAXwooYGsBCDQwrgPlSvtuoNkt8KyP4yIYr6AAxOkfCnia8C8AoWLHqbqxSnBgAvRKC4ABr24KwIANRNsuiw6X50Cqpb7KwLMSiDuftQ9Ml2+HIWcXKK8OLDyEjIuFFqqGkgLq3qhXkpcxAz6Cy3J2C3YYwAO2jrzpqqJK+iOgDQwoqbAJ3hsoAENHTER5KvesJZYxMOnkCTajYPQJrYbdqn3TuScgCghIit+QvQLAQAHTaXeAvVwqd6yYyeq9rArNXrftgg98CEAEEMw9ngLe/ph4xAoM7p7hJ7Dn3qrlmnCufeo64AACZZb/i+2R2UHgY5TslafueJzy+6W/dQL8usBdg1aw5wpAUG4CpANgOocNb6ousSjoKoHFrgJw/MYL6FreqpQDsCridRsJwPPR622qlXFDkOaiL6cQqq4I0Jnm1yiQbHvdkBcuYPdDHsAel1JHYKSuyw97AuIIXHf5CQr4ib0d/SkCBZiY6rIHtwJwT0Io0FphwDc7FpgKBakiWwLM1pfNCctuEhIWkOxzLuzczVhwUZayzKQ63g1rQfGCFQh9FCYOiccAExtWCwWYPIf1L3MZLJ8CEvCsYVUoOw+Tl3aOlyjWzSl2ARuYBBGgqycFqojlIpaRQkijbAXKYhmDj76IBB7r/+QwVuZSHMTGCMImoKtE3nMMqCJ4IEDp60oLoFndbtgqCYlRgA7YIPXIE4EgMS6F4ingEHAEHlf1kQjnmlIBPLhGBqLnUycYmPlMoKspVSl1NLwgpX5nAp2BDm72+pgIETjIEAbAlMVaUgn5piwN+a08EbLfBNeXSkGyp38I2F/1CJeC53FvW/Qyo5UWFCVXSYpOCzgA0kYnSBEiD0fOVIES2xKwJkaQbxnCEQTKk7Jo+k6W5Ake5vzUpARYzEQM2FOp3Gci+AUtYgd44YskJcx6ZvBtJkhb/FrJFwi6813uvOSPFrAg9QEzYgWKn3X+ibxP6ox6DlsoKAk5rFUWDv+RR2yVRKdVpc4VAJUMrZ6nPPOUGs3ToA171nx4B6h2JsABs5qOfJb3LAT4CFe60s6AAvVC6OUKoFtry08FFKC+oSBbCajlsAYHJKCZEXNmlJZ9ysUdqWZIPjVzks5oCiugFYhaNkTQvILY02lGNGonuOZWPQS0D7WHYAoSIHYUhtZ3xSeF2WoADWG1RUNpp0ltAqN2fsZVe67lXepMLGB+mgCh3ctlbqTRXAHALkGydFte2xkjJRuf94kraDmdaoUYQKpBRuhFh+ToNFmmU7CGlWoIAu1JA+OlHxAKC3jLbTKItAW37oKGVroEo07RRTB0bo76oaQWdjuF3hoEuFr/EO4tGIA0435PFhE4VRaIkNoYOPAFzBGFdJuzA+ui9zjbXS8MxhuXbpzXvTFQL32F0977BhSl8iWhfmFg3//Gd78CVgF8W1DeTsy3wNa8EFFdJJtEwQC6muoBeCjcQPm5hsBIOBR1aaNhvoSYTZIkMYeBkGBOLJjBznFwv8Ig4UJkSkgPPPEUPryIGKPQxj4QgAZ8AmSVXMBYPw6ykY/MEw24uHVQeFG9SnZIosXnQw941uEy2i1KqSx/KarXeLzsNKetxWEIws6zEiAs4Smmsh0eUi/HVSPFveppZ8aWh0ToOYGlClwZNljF1tWueP2QCFhlmY+cBS9Cr+DALOBA/1oe3RWYvMDRkK60pS2tiA03OUWAE2J51mc46U3Luy/yEekQGDcuj6fTzWzoPM8pTfE0IEESkCLqXEve/B7BZ1DMmDrTNOs72dpEZCzuKXGkLlDbSY+9nvXmRHoC0A3RALsznc22pWNGs3jbL4ZwCu0XoRu+cAEAYoAnG1bDBUBS1U5tpujUyS5YxTqjTUjr8WaMIR6PRrRS+7UK651IHMUQnAboorlv2GdW+TtxQCSCuyVExXZnm9sU30GKiwQxcONzoUE1gbrs08vrkJTd5QF3eZip0Qgg8mOy1lfAscNKBOsaCD5T+AQx6/KOTi6j2kFXAxyAyxTU/E/+Tuba7v8kxGdSO5oSz66BKw71okqBevZjrFRfCLRzR5Q7kCW5CptZtfG0VqjyapitpHk8ng540ZDhd6ugKudDop2MDAMP8zzOyIQTXaziAtQCGHtWh7ebsWyPuuHXzA8da+G44cCxFrR9+PteXBaKzwLju+H470Z+8w82/OULDHnOo3fyo585g0MveuKQvjmfF7C2UZ96fKxe9aYHfQoIYAtMxT44s+d97V1/+9yzefei8TGSj4/8mgyZLMlvvvM/Ehrci5f4s6H0pa+P/bNIWjfZ7773mRL86VN//OQXjfTfW/70q38u52/u+t8P/3q0X/fxr7/9ozH/4d9///wXRf713X//ASiAf/B/hTeAB4iAdVCAT5eAA2FRKlBH3NSAELGAQjeBoyA5PsAeEOJ0F9gQFdhAHtgJqeYDN8cCTRIuImgQIDhJKmgJr4Z3AXAdGsMeHzMgzeN0diaDtLVsDjAgOGIrC9Ak8QEBLDNiLhgJLAga38eETeiET2gUwfRJAHMdTWIAEXJ0BIR0cBNzNtNTJigq/FRJq1RrJVJPhZNa1geFa8iGbYh9EyB8LDABz0eHdWiHd9gWJtg57WE4KmdSG4KCO2clKAgBTscextZwuZKBQBM7JiATeAiJkSiJR7ZkSCgKhbhz4fIu7rE5J1BrKPA8zoJZMQdRxGMiT4KJJWWJWasYe/HWNWFiIyZ1JDroM8uGOUNwAAtwiCmAKx/CMQWiMdWTU2rGisVojMeIjMmojMvIjM3ojM8IjdEojdNIjdVojdeIjdmojdvIjd3ojd8IjuEojuN4gCEAADs=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Gastfriend, D, and McLellan, A. Treatment matching: Theoretical basis and practical implications. Med Clin North Am 1997; 81:945. Illustration used with permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_23_27007=[""].join("\n");
var outline_f26_23_27007=null;
